Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AAGAB "FLJ11506, p34" ENSG00000103591 "Alpha and gamma adaptin binding protein" Q6PD74 15 67201033-67255195 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039371, HPA040174" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA039371: AB_10805476, HPA040174: AB_10805605" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (8.25e-2)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (2.84e-2)" "unprognostic (4.52e-2)" "unprognostic (9.10e-2)" "unprognostic (5.28e-2)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.36e-4)" "unprognostic (9.88e-2)" "unprognostic (3.05e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (1.53e-1)" 19.3 23.6 17.0 15.6 22.5 15.6 20.3 13.3 29.8 16.7 23.6 14.7 24.1 13.3 18.1 24.7 22.3 14.6 16.1 14.8 15.9 22.5 29.5 22.2 15.2 15.4 17.7 20.2 14.4 18.0 29.9 39.1 16.0 31.5 16.9 29.7 14.9 19.3 19.0 33.4 14.3 21.9 18.4 13.8 18.2 20.1 23.8 13.4 25.9 28.8 18.1 21.4 19.8 14.1 16.1 23.9 28.4 24.7 27.7 26.8 20.1 18.3 33.3 24.0 24.6 23.9 19.5 12.0 19.3 28.6 23.5 27.0 24.6 20.0 17.7 19.8 20.3 29.5 37.1 49.9 22.6 24.6 24.6 23.6 16.8 25.0 10.0 25.9 28.5 19.7 19.0 31.2 17.4 37.5 15.7 18.5 23.5 34.7 25.1 22.8 22.4 17.3 12.2 20.6 23.0 12.1 19.5 30.8 21.4 21.5 43.4 34.4 22.0 23.2 16.7 27.3 22.0 27.3 21.8 19.3 21.4 25.9 19.0 26.9 13.1 43.9 26.5 20.3 26.7 21.3 28.4 18.9 18.5 23.5 24.6 26.8 16.1 20.8 22.1 23.9 12.5 17.7 19.4 10.1 27.7 24.7 17.7 25.1 20.1 17.0 22.5 13.3 29.8 15.9 22.5 17.7 20.2 31.5 13.4 3.0 4.8 13.8 14.3 10.6 12.5 11.2 5.1 18.7 17.0 26.2 25.5 14.1 14.9 23.4 7.6 12.0 20.0 0.0 27.3 12.2 10.3 19.0 10.4 11.9 14.4 17.5 15.1 6.2 12.4 6.4 7.2 9.5 6.8 25.2 14.3 13.7 19.6 17.8 10.6 17.0 17.7 12.9 11.3 35.2 37.3 12.0 13.8 15.0 13.5 21.1 ABHD17A "C19orf27, FAM108A1, MGC5244" ENSG00000129968 "Abhydrolase domain containing 17A" Q96GS6 19 1876810-1885547 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043270, HPA047226, HPA069225" Uncertain Approved "Nuclear speckles,Vesicles" NA NA Vesicles "Nuclear speckles" "HPA043270: AB_2678401, HPA047226: AB_2679991, HPA069225: " "unprognostic (3.77e-2)" "unprognostic (1.85e-1)" "unprognostic (3.57e-2)" "prognostic favorable (1.73e-4)" "unprognostic (3.70e-2)" "prognostic favorable (6.46e-4)" "unprognostic (1.69e-2)" "unprognostic (1.92e-2)" "unprognostic (5.09e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.76e-5)" "unprognostic (1.29e-2)" "unprognostic (1.85e-3)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (3.17e-1)" "unprognostic (1.60e-2)" 28.1 11.9 26.6 8.9 23.9 10.0 6.8 16.4 29.4 9.0 14.1 15.3 10.3 16.5 8.8 7.0 9.9 7.1 11.7 12.9 30.9 14.4 11.9 8.2 13.0 9.1 19.0 16.7 9.4 16.6 3.8 7.7 13.4 13.2 13.9 2.1 8.4 21.0 11.2 47.4 20.7 15.8 5.2 25.5 25.7 23.3 12.1 7.9 10.9 11.4 9.6 7.1 6.3 7.3 4.5 1.5 5.9 1.5 4.7 8.5 1.0 16.7 5.8 1.7 6.6 3.1 3.8 13.2 11.3 3.5 3.1 3.1 2.7 2.9 8.2 4.6 2.4 0.7 10.5 1.1 4.4 0.1 19.0 25.0 6.1 2.2 7.4 4.5 6.0 20.8 4.1 3.5 1.7 1.2 2.0 6.5 8.3 10.4 9.3 2.2 9.4 10.9 12.0 12.8 3.2 13.1 12.8 5.8 12.3 2.2 3.4 7.8 18.0 5.9 6.4 10.7 0.4 6.6 11.1 12.4 3.7 8.7 15.2 11.0 37.4 22.4 6.9 8.5 8.1 6.1 2.5 1.5 5.9 8.5 0.9 6.2 4.5 3.9 5.5 1.5 2.4 4.1 4.4 1.7 4.7 1.0 1.5 3.5 1.0 26.6 23.9 16.4 29.4 30.9 14.4 19.0 16.7 13.2 7.9 3.0 7.2 31.2 18.9 28.6 40.6 3.0 28.1 1.4 7.9 14.0 37.3 59.5 8.3 27.9 4.8 47.9 44.2 23.3 32.7 33.7 26.8 25.1 10.3 18.7 55.3 52.4 29.3 55.9 28.5 4.0 27.9 25.8 25.3 26.2 27.8 45.9 34.1 27.9 34.3 15.9 29.8 12.9 16.4 12.3 22.9 40.1 54.9 96.5 25.1 26.6 AC023055.1 ENSG00000257390 12 55757275-55827546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "blood: 6.4;testis: 12.9" "Group enriched" "Detected in some" 16 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 4.6;Ciliated cells: 6.7;Club cells: 2.3;granulocytes: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 6.5" "HPA017653, HPA030902, HPA030903" Uncertain Approved "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA017653: AB_1847799, HPA030902: AB_10669872, HPA030903: AB_10964180" "unprognostic (8.84e-4)" "unprognostic (2.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.16e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.55e-3)" "unprognostic (1.86e-1)" "unprognostic (6.30e-2)" "unprognostic (3.79e-2)" "unprognostic (3.05e-2)" "unprognostic (2.16e-2)" "unprognostic (1.16e-5)" "unprognostic (6.36e-2)" "unprognostic (1.71e-1)" "unprognostic (1.22e-1)" "unprognostic (4.37e-3)" 0.3 0.1 0.1 0.0 0.1 0.6 0.0 0.3 0.4 0.0 0.1 0.3 0.0 0.6 0.2 0.1 0.7 0.2 0.2 0.1 0.1 0.3 0.1 0.5 0.2 0.0 0.1 0.4 0.1 0.0 0.3 0.7 0.0 0.0 0.4 0.2 0.7 0.0 0.1 0.1 0.2 12.9 0.0 0.3 0.4 0.0 6.4 4.1 5.3 5.9 5.7 5.8 4.7 0.3 0.0 2.8 4.1 3.1 0.0 3.2 1.7 1.4 0.3 1.2 1.1 0.8 3.1 0.6 2.0 1.2 1.5 2.5 3.1 1.3 0.0 2.7 2.2 0.6 0.3 1.2 2.7 2.9 0.7 0.0 1.4 0.6 0.0 0.4 1.7 1.3 0.0 0.6 0.0 1.6 2.4 4.5 3.0 0.0 2.9 3.2 1.8 1.7 0.8 4.3 1.3 0.9 4.5 6.5 1.7 1.1 1.1 0.0 0.0 0.3 0.6 0.9 0.0 2.3 1.8 0.8 0.3 0.6 2.8 2.6 5.3 5.6 3.2 3.5 6.4 4.9 4.5 4.1 3.5 3.9 5.8 1.5 5.7 5.9 2.7 5.2 4.7 6.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 6.7 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC105001.2 ENSG00000258724 8 10725399-10839847 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "Club cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 13 "NK-cells: 1.5" "Cell line enhanced" "Detected in some" "HaCaT: 6.1;HBEC3-KT: 2.5;SiHa: 2.2" "Not detected" "Not detected" HPA009065 Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA009065: AB_1857390" "unprognostic (2.57e-1)" "unprognostic (6.34e-2)" 6.7 2.7 1.9 3.7 3.1 1.7 2.7 2.9 3.9 9.8 3.1 2.6 0.9 3.3 3.6 1.7 4.0 2.1 3.1 3.2 2.0 1.9 2.2 4.8 4.7 2.2 2.8 2.1 3.8 4.1 1.7 2.3 3.3 4.2 2.7 1.8 3.6 3.4 2.0 8.7 4.6 3.0 2.1 2.5 3.3 3.2 6.3 1.7 4.6 2.6 4.3 3.8 2.2 15.2 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.3 0.0 0.1 0.2 0.4 0.0 0.1 0.0 0.3 6.1 0.4 2.5 0.0 0.1 0.2 0.0 0.0 0.2 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.2 1.2 0.0 0.0 0.3 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.3 0.2 0.0 0.1 1.0 0.1 0.1 0.3 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 3.1 2.9 3.9 2.0 1.9 2.8 2.1 4.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAM33 "C20orf153, dJ964F7.1, DKFZp434K0521" ENSG00000149451 "ADAM metallopeptidase domain 33" Q9BZ11 20 3667965-3682246 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 55.7;smooth muscle: 58.0" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 23.2;Leydig cells: 21.0;Peritubular cells: 9.6;Smooth muscle cells: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "ASC diff: 31.3;ASC TERT1: 40.6;BJ: 13.8;BJ hTERT+: 23.7;fHDF/TERT166: 14.1;U-2197: 18.9" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in all" "HPA067152, HPA071758" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA067152: AB_2685791, HPA071758: " "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (2.24e-2)" "unprognostic (3.35e-3)" "unprognostic (4.39e-3)" "unprognostic (7.43e-4)" "unprognostic (7.14e-3)" "unprognostic (1.67e-1)" "unprognostic (1.78e-3)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.56e-1)" "unprognostic (2.75e-11)" "unprognostic (1.05e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-5)" "unprognostic (3.10e-3)" 10.0 1.5 4.6 9.2 2.6 0.0 20.2 2.8 2.7 55.7 29.5 2.2 20.9 4.7 44.3 12.3 17.0 16.9 17.5 5.3 5.0 0.9 0.9 0.5 3.6 2.2 4.9 3.0 11.8 1.6 0.0 1.6 5.4 7.0 22.8 5.5 3.7 4.2 27.1 3.5 4.8 9.1 58.0 3.3 1.9 9.9 5.4 3.5 0.1 4.0 10.1 2.0 24.9 36.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.3 40.6 0.1 13.8 23.7 4.1 8.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 6.9 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.1 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.6 2.6 2.8 2.7 5.0 0.9 4.9 3.0 7.0 3.5 0.0 0.0 0.0 0.1 4.8 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.2 23.2 0.2 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 21.0 0.6 3.3 0.0 0.0 3.3 0.0 0.0 9.6 0.0 0.0 6.5 15.1 0.6 0.5 2.8 0.5 0.0 0.0 0.0 AKAP17A "721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y" ENSG00000197976 "A-kinase anchoring protein 17A" Q02040 X 1591593-1602514 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043247, HPA051020" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA043247: AB_10964776, HPA051020: AB_2681314" "unprognostic (4.55e-2)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.40e-4)" "unprognostic (5.38e-2)" "unprognostic (1.59e-2)" "unprognostic (9.73e-3)" "unprognostic (6.25e-2)" "unprognostic (2.09e-1)" "unprognostic (7.91e-3)" "prognostic favorable (2.42e-4)" "unprognostic (1.55e-3)" "prognostic unfavorable (3.52e-7)" "unprognostic (1.86e-2)" "unprognostic (2.71e-1)" "unprognostic (4.03e-2)" "prognostic favorable (1.11e-5)" 7.4 10.3 28.1 14.5 42.3 18.0 24.5 27.5 25.2 32.8 7.2 2.5 2.5 14.2 40.9 9.7 9.2 9.1 7.4 12.5 27.1 3.4 20.3 16.4 12.2 15.4 37.6 27.1 38.0 15.6 5.2 31.0 42.7 33.7 12.6 4.3 2.5 17.0 7.8 6.9 12.3 11.6 3.2 27.8 21.4 14.2 7.0 37.2 2.5 16.1 2.5 8.9 6.8 47.6 1.8 1.8 7.0 1.0 1.3 1.6 0.4 9.6 12.5 10.0 11.3 4.9 6.3 24.5 10.5 4.3 8.5 7.2 13.8 9.0 14.6 6.8 5.2 12.0 8.5 6.0 5.2 5.1 12.0 20.8 18.2 12.0 12.8 10.6 7.0 30.6 5.6 9.8 6.3 7.0 10.1 5.8 7.4 11.3 9.3 4.9 6.4 15.5 30.5 14.9 2.2 10.8 11.8 11.9 12.2 5.7 6.8 11.2 16.4 8.2 13.4 12.7 8.6 8.7 12.9 11.2 13.3 6.1 11.4 9.1 40.2 6.7 20.3 5.4 11.5 3.5 7.0 1.0 1.9 0.8 0.5 0.9 1.8 1.0 1.6 0.6 1.2 0.8 0.8 4.1 1.3 0.8 1.8 0.5 0.4 28.1 42.3 27.5 25.2 27.1 3.4 37.6 27.1 33.7 37.2 23.8 25.9 29.8 31.3 39.4 23.2 9.9 7.6 10.7 21.6 12.2 9.8 20.9 11.6 17.7 40.2 26.1 21.4 0.0 13.4 24.6 26.6 35.0 25.3 19.5 20.2 15.9 21.7 29.4 20.6 11.0 35.9 36.0 38.8 27.9 23.5 23.7 19.9 24.6 29.7 5.7 13.9 0.0 25.5 16.3 30.3 41.3 60.8 37.0 20.0 42.9 AL669918.1 ENSG00000250264 6 32813767-32838822 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 17.2;HDLM-2: 11.4;HEL: 12.4" HPA001312 Approved Approved "Nuclear speckles,Endoplasmic reticulum" NA NA "Nuclear speckles, Endoplasmic reticulum" "HPA001312: AB_1080206" "unprognostic (6.13e-2)" "unprognostic (8.76e-3)" "unprognostic (4.62e-1)" "unprognostic (9.88e-2)" "unprognostic (1.99e-1)" "unprognostic (3.39e-2)" "unprognostic (1.72e-1)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.49e-1)" "unprognostic (8.73e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" 6.5 3.6 2.8 25.5 3.1 3.8 3.6 3.1 3.3 4.8 7.7 3.5 1.0 5.7 4.6 2.5 4.8 3.6 5.7 3.5 2.1 2.6 5.3 10.0 8.5 12.6 3.2 2.8 4.7 2.1 1.7 5.0 2.4 3.6 3.8 3.1 3.6 7.0 1.4 2.5 3.3 15.1 2.7 2.8 18.1 12.3 2.5 3.1 14.0 7.5 3.2 10.6 3.8 3.9 8.6 5.5 8.1 4.8 2.3 4.6 5.1 2.1 3.2 0.0 0.7 1.6 1.7 0.5 0.6 0.3 0.0 0.6 0.0 3.3 17.2 2.0 0.2 0.2 7.8 1.6 1.7 0.6 11.4 0.2 12.4 2.1 0.3 0.5 0.0 0.5 0.0 0.9 0.5 0.2 0.0 0.0 1.9 3.1 2.9 0.2 0.6 1.4 0.9 0.2 0.0 2.9 6.0 0.6 5.5 0.0 0.0 0.3 0.3 0.5 5.3 1.4 0.0 5.1 1.3 0.0 1.3 1.9 0.4 0.7 1.4 2.8 7.6 0.7 3.6 0.4 1.6 3.1 6.1 3.5 3.2 3.4 8.0 2.8 3.9 5.5 8.6 2.1 4.6 8.1 2.3 4.8 5.2 4.2 5.1 2.8 3.1 3.1 3.3 2.1 2.6 3.2 2.8 3.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD44 PP6-ARS-B ENSG00000065413 "Ankyrin repeat domain 44" Q8N8A2 2 196967017-197311173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 34.7;lymphoid tissue: 38.2" "Cell type enhanced" "Detected in many" 6 "B-cells: 93.2;Macrophages: 60.1;T-cells: 81.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 26.6;HMC-1: 20.7;Karpas-707: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030122, HPA056549" Approved Approved "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "HPA030122: AB_10600980, HPA056549: AB_2683170" "unprognostic (3.64e-1)" "unprognostic (1.70e-2)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (2.63e-1)" "unprognostic (7.04e-5)" "unprognostic (1.97e-2)" "unprognostic (1.58e-3)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-2)" "unprognostic (6.94e-2)" "unprognostic (3.67e-2)" 6.0 6.0 4.9 29.4 8.8 12.5 4.3 3.7 5.1 8.6 6.7 10.8 3.9 3.2 6.5 3.9 4.3 4.9 7.6 6.4 6.4 4.7 5.6 4.5 15.4 36.7 9.4 4.7 5.1 3.5 6.0 6.1 6.4 6.4 5.0 4.8 7.4 8.0 4.7 2.9 3.0 12.6 9.6 8.0 17.8 5.6 7.1 8.9 38.2 5.1 3.0 27.0 9.0 9.8 15.7 9.4 34.7 11.4 12.0 13.4 6.3 1.0 0.6 1.6 1.7 3.9 1.6 0.3 2.5 1.1 1.3 1.2 0.4 0.6 9.0 1.1 2.1 2.3 0.1 0.6 0.5 1.0 26.6 2.3 0.3 3.2 0.1 0.2 6.5 20.7 0.8 0.3 1.3 0.1 1.9 1.7 2.2 1.5 15.0 1.9 1.5 3.1 5.3 0.2 0.3 1.7 5.7 1.9 12.3 3.1 0.8 1.7 7.4 0.8 0.6 7.0 1.3 0.9 6.4 9.3 4.6 2.5 1.3 1.8 3.7 4.4 11.4 3.1 8.2 2.6 21.8 9.5 21.0 13.1 9.8 12.4 11.6 9.8 11.1 9.4 15.7 11.3 13.4 34.7 12.0 11.4 6.2 9.3 6.3 4.9 8.8 3.7 5.1 6.4 4.7 9.4 4.7 6.4 8.9 14.9 19.2 93.2 4.0 3.1 5.0 7.8 25.5 12.0 13.6 10.4 3.9 3.9 1.7 3.0 10.6 6.7 1.1 0.0 4.0 0.7 5.8 3.2 52.0 7.4 16.4 3.2 2.4 44.2 57.8 12.9 14.4 60.1 35.4 19.8 1.1 10.8 3.8 3.5 16.6 1.1 11.1 19.4 6.1 3.0 3.6 3.1 1.1 81.3 0.8 4.3 ANXA9 ANX31 ENSG00000143412 "Annexin A9" O76027 1 150982017-150995634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 62.0;seminal vesicle: 78.1" "Cell type enhanced" "Detected in many" 15 "Cholangiocytes: 45.9;Hepatocytes: 14.9;Proximal tubular cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.5;Hep G2: 14.6;MCF7: 19.5;OE19: 17.0;T-47d: 48.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028404, HPA028698" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA028404: AB_10599190, HPA028698: AB_10600227" "unprognostic (4.06e-1)" "unprognostic (1.55e-2)" "unprognostic (3.15e-3)" "unprognostic (2.08e-3)" "unprognostic (2.93e-2)" "unprognostic (4.49e-2)" "unprognostic (1.84e-2)" "unprognostic (3.39e-2)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "unprognostic (2.97e-1)" "prognostic favorable (8.74e-6)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (8.99e-2)" "unprognostic (1.72e-2)" 2.4 1.1 1.2 0.9 1.2 0.3 2.6 1.3 2.5 2.3 0.9 0.6 62.0 1.4 6.0 11.6 10.7 2.3 12.5 1.9 1.4 1.0 12.1 15.8 1.2 0.5 1.8 0.8 1.8 32.0 9.9 1.2 0.7 1.3 4.1 0.0 1.2 2.5 78.1 0.9 18.9 1.2 0.9 3.2 1.0 1.3 3.6 0.6 1.3 10.4 9.1 21.1 4.5 4.4 0.5 3.8 2.5 3.1 0.1 0.8 0.8 4.0 0.9 1.4 1.4 0.0 0.0 4.1 0.3 0.2 0.0 0.0 12.1 14.5 0.1 0.8 0.0 0.4 2.4 0.0 0.2 0.0 1.2 1.4 2.0 1.4 14.6 0.0 0.7 0.9 0.0 0.1 0.0 0.0 3.2 0.0 0.6 0.9 4.4 0.0 19.5 0.1 1.0 0.3 17.0 0.2 0.9 0.2 4.8 0.0 5.7 2.2 1.2 0.9 10.0 0.5 0.8 48.4 1.2 1.5 0.3 0.4 0.2 0.2 1.3 4.1 6.3 2.1 1.3 1.1 0.0 3.1 1.8 0.1 1.8 0.8 0.5 0.3 0.5 3.8 0.1 0.8 0.2 2.5 0.1 0.4 0.0 0.0 0.8 1.2 1.2 1.3 0.9 1.4 1.0 1.8 0.8 1.3 0.6 0.0 0.6 0.0 0.3 0.1 0.0 0.3 45.9 1.4 0.0 12.2 0.0 1.7 3.3 10.1 0.7 0.0 0.0 0.0 6.8 0.2 0.6 0.1 1.1 14.9 1.8 0.0 0.0 0.0 0.8 0.0 1.4 0.0 1.7 0.0 0.0 0.0 3.1 0.0 1.1 33.2 0.0 0.0 0.1 6.1 0.1 0.0 1.3 0.0 0.4 4.9 AP001273.2 ENSG00000284057 11 93741664-93812378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 8.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 6.5" "HPA040511, HPA046619" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA040511: AB_10795369, HPA046619: " 2.4 3.0 1.8 4.2 3.4 0.6 2.7 2.8 2.4 3.6 6.1 3.5 3.6 8.2 2.6 3.0 2.9 2.5 3.3 4.0 2.0 16.9 17.6 3.6 1.7 3.9 1.9 4.8 5.4 5.3 5.9 2.8 3.2 4.5 2.7 4.2 3.8 2.8 4.2 3.7 11.1 2.9 4.5 1.9 3.7 2.6 3.6 4.2 5.7 2.0 1.8 3.0 1.0 2.7 2.9 4.4 2.9 3.0 3.8 2.0 0.2 0.0 4.5 0.8 3.3 0.0 0.6 0.0 1.4 0.9 1.9 1.5 1.1 0.3 4.0 2.4 0.0 1.7 5.0 0.7 0.0 1.3 0.0 0.0 1.5 0.0 0.8 0.0 0.9 0.0 0.7 0.0 0.5 3.4 0.0 2.6 0.9 0.5 5.2 0.0 2.1 3.5 1.9 6.5 0.0 1.0 2.6 1.7 4.8 0.0 0.3 0.4 0.0 1.3 3.5 3.8 2.0 0.9 2.2 0.0 0.8 0.7 1.8 0.9 0.9 3.7 0.3 1.1 1.6 2.9 2.9 4.4 3.2 2.1 3.0 2.7 2.6 2.6 2.9 1.0 2.9 3.6 4.4 3.0 2.3 1.5 3.8 2.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP5Z1 "KIAA0415, SPG48, zeta" ENSG00000242802 "Adaptor related protein complex 5 zeta 1 subunit" O43299 7 4775622-4794312 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035693 Supported Supported "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA035693: AB_10960687" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (3.01e-3)" "unprognostic (4.24e-2)" "unprognostic (2.43e-3)" "unprognostic (5.19e-1)" "prognostic unfavorable (1.35e-5)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-3)" "unprognostic (1.26e-2)" "unprognostic (5.32e-3)" "unprognostic (8.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.95e-2)" "unprognostic (2.22e-1)" 15.2 18.6 9.5 19.2 11.1 20.8 11.3 14.3 14.9 10.7 12.6 13.5 6.3 22.2 14.0 11.0 10.8 10.6 9.9 8.0 8.6 6.8 9.9 9.2 12.6 18.6 10.9 9.7 12.6 16.9 5.6 11.5 9.6 10.3 11.6 4.6 13.1 15.0 12.8 8.4 21.8 19.1 13.0 8.5 23.4 17.1 10.1 12.6 18.2 11.3 6.6 16.9 13.2 10.6 11.7 11.3 15.7 17.0 12.3 13.4 9.8 10.7 4.8 1.2 8.6 5.4 3.9 11.9 8.5 4.9 6.7 5.5 9.3 10.0 7.4 5.1 5.6 22.6 12.9 1.1 5.3 0.7 5.6 5.2 5.5 11.4 6.7 18.0 9.6 15.7 7.9 4.2 5.6 2.2 2.0 4.4 5.6 9.5 8.1 2.8 11.5 2.8 21.7 8.0 2.8 11.8 7.0 4.2 6.9 2.1 10.3 4.9 9.1 7.2 11.4 8.2 1.1 10.1 15.5 11.1 7.1 8.3 14.1 6.4 17.1 11.0 4.4 10.5 11.9 14.2 1.7 12.9 15.7 13.4 17.0 10.7 10.5 9.2 11.8 11.3 11.7 10.1 8.4 13.5 12.3 14.2 10.2 8.6 9.8 9.5 11.1 14.3 14.9 8.6 6.8 10.9 9.7 10.3 12.6 8.9 12.9 9.3 2.7 6.2 11.1 3.6 17.8 5.3 1.2 10.4 3.9 10.2 0.0 11.8 1.9 7.1 14.0 0.0 11.8 6.6 8.9 4.7 16.2 7.5 24.2 17.5 11.5 13.5 11.9 1.1 12.4 11.0 13.5 28.9 11.5 8.0 16.0 12.2 10.3 5.9 8.5 0.0 8.2 5.6 9.7 9.7 13.8 13.6 10.1 3.1 ARHGAP42 "AD031, FLJ32810, GRAF3, TMEM133" ENSG00000165895 "Rho GTPase activating protein 42" "A6NI28, Q9H2Q1" 11 100687653-100993941 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 38.0" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7;Early spermatids: 72.6;Rod photoreceptor cells: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.1;RH-30: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039924, HPA060528" Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA039924: AB_10674428, HPA060528: AB_2684308" "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.21e-3)" "unprognostic (2.74e-1)" "unprognostic (1.50e-2)" "unprognostic (4.17e-2)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.30e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (1.32e-1)" "unprognostic (1.75e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" 11.1 4.9 6.8 8.9 5.8 0.9 10.4 3.0 7.0 9.8 8.3 4.1 2.3 9.9 11.4 7.7 4.3 5.6 9.5 6.5 8.8 3.8 11.9 12.7 13.7 5.1 6.3 5.3 4.8 2.6 9.1 6.0 38.0 5.9 4.8 8.4 25.5 5.1 3.8 9.0 7.2 12.1 5.8 8.7 8.2 11.7 4.1 6.7 12.7 10.9 7.4 3.8 5.5 7.9 1.5 2.5 0.0 0.0 0.7 0.4 0.3 0.5 3.6 4.6 0.1 2.6 3.5 3.2 0.6 0.9 1.1 2.1 4.4 23.1 0.7 6.5 1.7 4.1 7.8 2.3 1.7 1.1 0.0 2.0 11.2 9.1 1.5 4.6 0.1 0.0 3.3 2.2 4.3 0.7 2.6 1.7 2.8 0.4 0.0 3.5 0.6 1.2 0.0 5.6 6.4 5.7 3.4 16.0 0.4 5.4 15.0 2.5 1.6 7.7 0.3 6.1 10.0 0.8 1.4 3.0 3.0 3.7 3.6 1.7 3.3 0.0 4.5 3.5 2.7 13.1 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.3 6.8 5.8 3.0 7.0 8.8 3.8 6.3 5.3 5.9 6.7 44.7 4.0 5.1 4.8 2.2 2.6 4.2 10.2 16.0 21.6 3.5 23.6 0.6 1.7 4.1 72.6 2.9 10.0 23.3 3.3 1.8 4.5 10.0 0.0 5.9 1.3 1.6 1.7 9.2 0.3 27.0 1.1 2.2 10.1 0.0 2.8 31.8 6.5 5.7 2.5 15.8 60.0 38.8 12.3 1.9 1.6 3.0 5.4 0.0 2.4 17.3 ATXN7L3 DKFZp761G2113 ENSG00000087152 "Ataxin 7 like 3" Q14CW9 17 44191805-44200113 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064316 Supported Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA064316: AB_2685243" "unprognostic (2.37e-2)" "unprognostic (8.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.74e-2)" "unprognostic (3.75e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (4.03e-4)" "unprognostic (2.86e-3)" "unprognostic (6.74e-3)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (1.21e-3)" "unprognostic (9.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.40e-1)" 14.0 12.9 36.7 18.9 25.1 23.8 11.9 23.0 53.1 13.2 16.1 11.3 16.7 19.1 14.3 16.9 22.3 14.2 14.9 12.4 30.7 24.8 12.4 12.6 14.3 20.8 22.7 32.1 13.2 13.7 16.3 17.1 18.8 23.6 13.0 15.3 7.9 16.9 18.5 11.3 19.0 16.5 16.1 15.1 17.6 15.5 17.0 14.1 13.9 14.3 11.3 21.3 16.7 22.4 5.1 4.4 6.7 3.2 1.3 4.8 2.6 16.9 28.7 31.8 20.6 22.2 22.1 17.3 20.9 23.3 26.7 25.3 21.9 19.3 29.8 16.8 23.4 24.7 18.7 24.7 19.6 22.5 34.7 24.6 20.2 23.7 24.3 21.9 31.5 41.1 24.9 30.0 22.4 23.7 28.4 25.8 23.1 27.0 18.7 17.5 12.8 37.7 24.0 23.8 15.3 22.6 26.1 30.7 22.3 21.5 24.4 20.2 25.7 12.3 10.9 21.3 46.2 26.7 28.1 22.1 27.0 28.3 14.0 19.4 22.7 29.4 36.1 17.8 13.7 15.7 1.4 3.2 3.7 4.8 2.2 2.9 3.6 3.8 3.0 2.7 5.1 2.9 3.6 6.7 1.3 2.3 4.4 2.0 2.6 36.7 25.1 23.0 53.1 30.7 24.8 22.7 32.1 23.6 14.1 3.0 3.0 4.8 4.4 6.4 16.5 5.3 5.1 4.0 4.5 17.4 15.7 5.1 3.3 6.5 12.7 8.0 14.8 0.0 11.2 6.0 6.2 6.9 2.3 7.3 7.3 27.0 13.8 12.3 10.8 25.8 8.3 7.6 5.0 10.8 11.9 7.6 11.5 11.5 5.3 3.6 13.1 6.5 6.2 6.4 8.9 9.3 11.4 5.4 9.3 7.5 BARD1 ENSG00000138376 "BRCA1 associated RING domain 1" Q99728 2 214725646-214809711 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 54.9;Basal keratinocytes: 60.9;Spermatogonia: 54.9;Suprabasal keratinocytes: 65.1;Urothelial cells: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB034106, HPA035354, HPA044864" Enhanced Supported "Nuclear speckles,Cytoplasmic bodies" No No "Nuclear speckles" "Cytoplasmic bodies" "CAB034106: AB_2061237, HPA035354: AB_2674585, HPA044864: AB_2679119" "unprognostic (4.85e-2)" "unprognostic (1.87e-2)" "unprognostic (1.74e-2)" "unprognostic (8.37e-3)" "unprognostic (2.57e-2)" "unprognostic (1.03e-2)" "unprognostic (6.25e-4)" "unprognostic (1.99e-1)" "unprognostic (2.16e-2)" "unprognostic (3.92e-3)" "unprognostic (2.80e-2)" "unprognostic (7.41e-2)" "unprognostic (1.94e-8)" "unprognostic (3.94e-2)" "unprognostic (2.28e-1)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" 4.4 1.9 3.2 11.8 4.8 16.1 4.9 1.2 5.8 7.3 5.4 5.4 3.6 3.7 6.8 5.0 10.0 4.1 3.9 3.6 3.4 2.8 2.2 2.1 5.3 8.2 5.1 1.9 5.8 3.7 3.6 6.3 3.8 4.5 5.7 6.1 1.9 4.7 6.5 12.4 16.3 4.5 7.5 5.3 4.7 3.8 9.5 3.9 25.8 4.0 8.0 9.9 8.3 7.8 9.7 6.6 6.0 3.4 6.1 16.0 2.0 7.8 4.3 11.9 6.1 1.6 2.0 8.2 9.6 5.6 9.4 10.9 5.5 7.8 8.5 4.6 3.9 5.8 8.6 8.5 5.6 13.5 6.7 4.4 8.4 8.0 5.8 0.6 9.4 8.5 2.7 0.8 8.3 4.6 3.2 3.2 9.4 4.7 23.9 9.1 6.5 16.8 9.8 9.4 4.9 2.2 14.5 12.0 7.7 2.8 6.6 3.7 6.0 8.8 10.1 3.5 7.1 10.3 9.4 2.7 12.2 8.6 7.1 8.6 7.2 8.0 17.2 4.9 7.2 8.1 2.9 1.7 6.0 4.8 3.4 3.1 8.9 5.3 5.2 3.0 9.7 2.5 3.6 0.5 6.1 2.9 6.6 16.0 2.0 3.2 4.8 1.2 5.8 3.4 2.8 5.1 1.9 4.5 3.9 6.0 2.1 9.5 54.9 60.9 3.3 12.5 15.3 12.0 9.1 8.7 0.0 9.4 3.3 6.8 8.1 7.5 3.4 23.3 6.0 13.6 7.7 21.0 15.0 3.6 10.6 1.6 1.2 12.3 8.8 3.6 5.8 8.8 3.3 17.2 11.3 3.3 5.6 5.8 9.6 0.6 6.8 19.4 15.5 19.7 54.9 65.1 4.2 8.6 11.0 57.3 BCAS2 "DAM1, Snt309, SPF27" ENSG00000116752 "BCAS2, pre-mRNA processing factor" O75934 1 114567557-114581639 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 118.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067881 Supported Supported "Nuclear speckles,Centrosome" NA NA "Nuclear speckles, Centrosome" "HPA067881: AB_2685915" "unprognostic (6.93e-2)" "unprognostic (1.88e-2)" "unprognostic (8.58e-3)" "unprognostic (4.74e-2)" "unprognostic (2.49e-1)" "unprognostic (2.99e-3)" "prognostic unfavorable (8.23e-7)" "unprognostic (1.16e-1)" "unprognostic (8.51e-3)" "prognostic favorable (7.96e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (4.27e-4)" "prognostic favorable (6.49e-4)" "unprognostic (2.25e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (5.24e-4)" "unprognostic (1.87e-1)" 23.2 28.0 36.7 17.6 34.1 43.0 25.0 30.4 40.6 21.3 19.7 16.5 17.3 16.7 22.9 33.2 26.0 16.6 20.7 24.5 31.6 41.8 28.7 32.9 17.5 22.4 37.0 28.8 26.8 18.2 22.9 32.5 17.4 39.0 24.1 21.0 13.9 19.5 26.7 38.4 19.0 19.0 20.1 26.9 20.8 18.3 21.2 24.6 20.0 27.8 24.5 22.1 31.1 19.5 30.4 24.8 30.9 22.6 35.4 40.1 32.9 19.3 7.1 14.7 13.9 7.8 9.1 22.0 14.6 11.3 19.4 20.0 9.9 8.0 17.2 20.2 9.4 13.1 9.4 17.0 14.4 27.0 15.6 15.3 9.0 14.1 14.3 14.2 22.7 9.8 8.3 15.9 20.0 24.8 9.1 12.6 18.8 17.2 12.9 15.9 118.8 20.2 16.9 25.5 11.9 16.2 14.5 26.0 12.0 13.6 17.0 19.2 12.8 18.2 14.1 22.4 12.7 12.4 18.0 11.1 11.9 15.9 23.8 27.4 14.1 14.5 27.9 23.2 19.0 44.8 21.6 18.5 30.9 29.3 21.9 40.1 30.4 36.7 35.7 19.4 26.7 38.2 37.2 17.6 35.4 22.6 24.8 35.8 32.9 36.7 34.1 30.4 40.6 31.6 41.8 37.0 28.8 39.0 24.6 26.8 38.4 63.6 94.6 69.1 63.3 63.3 28.1 42.8 36.4 47.1 35.3 67.4 81.2 56.2 17.0 43.9 22.2 23.3 58.4 73.6 49.8 51.7 99.1 27.7 58.7 36.5 47.9 27.0 31.0 13.7 36.8 54.3 64.1 50.5 30.7 70.3 45.0 31.1 41.1 72.5 55.6 38.8 78.0 57.0 37.7 55.5 84.7 66.0 31.3 106.5 BCL2L2-PABPN1 ENSG00000258643 "BCL2L2-PABPN1 readthrough" Q92843 14 23306835-23325369 "Cancer-related genes, Predicted intracellular proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 34 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.8;Ciliated cells: 8.1;Club cells: 2.3;granulocytes: 2.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 21.5;BJ hTERT+ SV40 Large T+ RasG12V: 23.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000637, HPA048740" Approved Uncertain "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553, HPA048740: " "unprognostic (1.32e-2)" "unprognostic (8.74e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-3)" "unprognostic (9.82e-3)" "unprognostic (2.85e-2)" "unprognostic (1.05e-6)" "unprognostic (4.39e-2)" "unprognostic (1.67e-1)" "unprognostic (1.84e-3)" "unprognostic (7.61e-2)" "unprognostic (3.47e-2)" "unprognostic (1.72e-7)" "unprognostic (3.13e-2)" "unprognostic (8.77e-2)" "unprognostic (3.46e-3)" "unprognostic (4.95e-2)" 11.4 5.3 14.2 5.8 17.7 12.0 17.7 16.4 24.2 17.9 21.0 14.4 11.4 4.5 13.7 6.9 14.4 16.1 16.0 11.2 17.8 9.5 7.1 6.9 10.3 6.4 13.1 21.2 8.0 21.4 29.1 11.4 18.0 17.5 16.3 5.6 7.5 22.1 37.7 7.0 14.5 7.7 18.6 20.2 9.7 13.0 15.0 14.8 0.0 14.4 5.7 5.4 16.6 12.1 1.9 1.1 2.1 4.4 3.5 0.3 1.1 5.1 6.6 4.2 3.4 0.3 9.6 3.3 1.4 13.8 21.5 23.4 5.4 16.8 1.7 1.2 7.2 5.2 7.3 4.8 6.6 5.6 3.5 5.3 0.4 0.9 8.7 2.9 1.8 10.4 8.7 12.2 7.9 1.5 1.7 5.1 0.1 1.6 5.1 6.5 7.9 0.2 1.1 5.3 1.0 4.2 3.2 0.1 1.1 3.7 2.1 7.0 2.8 2.1 7.1 1.9 0.7 3.8 2.8 1.9 5.6 4.4 5.5 3.6 2.8 2.6 0.5 2.3 3.8 8.6 2.1 4.4 0.3 0.2 1.6 0.2 1.4 0.0 0.0 0.6 1.9 0.3 0.1 0.8 3.5 2.6 1.1 0.0 1.1 14.2 17.7 16.4 24.2 17.8 9.5 13.1 21.2 17.5 14.8 3.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 8.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 BDNF ENSG00000176697 "Brain derived neurotrophic factor" P23560 11 27654893-27722058 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5;smooth muscle: 10.5" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 35.7;Cardiomyocytes: 9.6;Smooth muscle cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 22.7;BJ hTERT+ SV40 Large T+: 17.4;BJ hTERT+ SV40 Large T+ RasG12V: 13.2;HBF TERT88: 16.7;U-138 MG: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009564, HPA031440, HPA056104" Enhanced Supported "Nuclear speckles,Mitochondria" "Secreted to blood" NA NA 16000000 "Nuclear speckles, Mitochondria" "CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038" "unprognostic (1.25e-2)" "unprognostic (2.84e-1)" "unprognostic (4.35e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-2)" "unprognostic (6.82e-2)" "unprognostic (2.39e-2)" "unprognostic (2.21e-1)" "unprognostic (3.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.22e-2)" "unprognostic (3.88e-2)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (2.84e-3)" 0.9 1.3 5.0 0.6 4.5 0.5 0.6 9.4 14.5 1.6 0.8 0.6 0.7 0.8 0.7 8.2 1.4 0.5 2.1 5.8 8.5 5.7 0.9 0.5 4.1 0.4 2.5 4.7 1.2 1.0 0.2 2.3 3.7 12.7 4.9 0.4 3.0 0.9 4.2 1.3 2.1 0.5 10.5 1.0 0.6 0.9 1.3 0.0 0.0 2.3 0.0 0.4 3.2 1.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 1.6 6.7 0.2 0.0 2.4 1.9 0.0 22.7 4.4 17.4 13.2 0.0 2.6 0.0 2.1 8.2 0.3 1.0 0.1 0.2 16.7 0.1 0.1 0.0 2.2 0.0 10.1 0.1 0.1 5.9 2.2 3.8 2.2 10.6 0.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 2.1 0.0 1.8 0.0 1.3 0.0 2.5 0.0 0.1 0.6 4.3 0.0 0.0 1.0 0.1 0.0 7.5 24.4 4.1 9.4 5.0 0.3 0.0 0.0 9.4 0.6 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.1 0.7 0.4 0.0 0.1 0.0 0.4 1.0 0.1 5.0 4.5 9.4 9.4 8.5 5.7 2.5 4.7 12.7 0.0 35.7 0.3 0.0 0.2 0.6 4.7 9.6 0.0 0.0 0.0 1.8 3.9 0.2 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.3 4.1 0.4 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.3 0.0 1.7 0.0 0.0 0.1 0.2 0.0 0.0 0.3 1.5 0.0 6.6 0.4 0.7 0.0 0.6 0.0 0.0 0.0 BEND5 "C1orf165, FLJ11588" ENSG00000162373 "BEN domain containing 5" Q7L4P6 1 48727523-48776969 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 46.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 7.1;naive B-cell: 10.1" "Lineage enriched" "Detected in many" 5 "B-cells: 10.1" "Cell line enhanced" "Detected in some" "AF22: 4.2;HDLM-2: 13.6;JURKAT: 5.4;MOLT-4: 5.6;NTERA-2: 3.2;REH: 7.8;SH-SY5Y: 3.8" "Low region specificity" "Detected in many" "HPA054347, HPA058007" Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA054347: AB_2682456, HPA058007: AB_2683577" "prognostic favorable (2.50e-5)" "unprognostic (1.36e-2)" "unprognostic (7.19e-3)" "unprognostic (1.16e-1)" "unprognostic (1.11e-1)" "unprognostic (1.65e-2)" "unprognostic (4.42e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.41e-1)" "unprognostic (6.02e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.32e-2)" "unprognostic (4.28e-2)" "unprognostic (2.37e-3)" "unprognostic (3.35e-2)" "unprognostic (9.68e-2)" "prognostic favorable (8.30e-6)" 2.7 5.4 6.5 5.6 7.7 3.0 3.1 2.1 15.5 4.8 5.0 2.8 3.5 1.6 5.0 4.9 2.3 4.3 6.0 4.0 6.0 5.1 6.5 0.8 3.0 5.9 5.4 9.7 12.8 2.8 1.9 5.9 1.4 14.7 3.9 1.6 3.3 2.5 4.3 6.6 1.9 2.6 2.6 3.2 6.4 2.9 2.6 1.9 11.3 4.3 0.5 4.1 4.4 2.9 10.1 1.9 0.2 0.0 1.1 2.0 0.6 0.0 0.0 4.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 0.0 5.6 0.2 3.2 0.0 0.0 7.8 1.4 0.0 0.1 1.5 1.4 3.8 0.0 0.0 0.3 1.6 0.0 0.4 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.1 0.2 1.9 10.1 2.0 1.2 0.2 1.1 0.0 1.9 0.0 0.6 6.5 7.7 2.1 15.5 6.0 5.1 5.4 9.7 14.7 1.9 6.0 1.9 5.9 4.6 1.6 12.3 5.3 12.7 9.4 7.9 5.2 15.7 0.3 46.4 4.6 7.5 6.3 0.0 0.0 1.6 0.4 5.4 0.9 1.1 0.0 0.2 7.9 11.6 1.8 0.0 3.6 12.0 0.5 3.3 0.0 0.6 18.0 2.4 5.5 20.1 19.2 14.9 6.5 3.4 3.2 8.1 1.9 0.1 0.0 1.5 1.4 BNIP3L "BNIP3a, Nix" ENSG00000104765 "BCL2 interacting protein 3 like" O60238 8 26382898-26505636 "Cancer-related genes, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Erythroid cells: 467.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015652, CAB025371" Enhanced Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "CAB025371: , HPA015652: AB_1845406" "unprognostic (1.02e-1)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (8.36e-2)" "unprognostic (6.24e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (2.02e-1)" "unprognostic (2.06e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (5.92e-5)" "unprognostic (8.72e-3)" "unprognostic (5.16e-2)" "prognostic unfavorable (3.95e-4)" "unprognostic (7.59e-3)" 61.7 27.8 32.7 18.2 39.1 79.4 40.1 26.1 39.0 35.0 19.9 32.3 30.7 11.5 27.3 34.0 26.7 26.4 28.0 36.0 36.0 27.4 39.9 22.9 31.3 20.7 43.1 31.9 63.4 10.4 26.8 16.0 51.2 41.0 23.7 14.9 20.9 22.1 39.2 21.0 38.1 14.5 26.5 47.9 19.5 16.7 33.0 43.9 17.8 21.5 12.4 25.2 48.3 30.8 14.2 30.4 68.7 53.9 7.8 17.6 36.3 17.9 6.9 16.4 11.1 45.7 28.8 13.9 18.2 53.5 17.1 37.9 3.1 8.7 5.5 17.2 34.2 23.9 9.2 8.1 23.4 57.0 3.6 4.5 22.9 7.1 5.4 25.5 2.0 39.8 34.6 18.4 19.3 11.6 56.7 21.8 13.7 10.3 13.4 35.8 7.8 14.2 7.6 5.3 11.3 7.5 7.6 20.8 10.9 17.7 11.7 17.5 15.6 8.8 1.7 13.8 18.8 9.0 4.3 28.6 32.1 13.9 20.0 4.1 19.7 8.9 7.4 48.9 4.1 7.2 49.9 53.9 32.1 7.6 27.8 6.7 12.4 11.4 8.3 30.4 14.2 17.6 12.8 68.7 7.8 17.4 6.9 15.0 36.3 32.7 39.1 26.1 39.0 36.0 27.4 43.1 31.9 41.0 43.9 80.4 113.7 54.1 47.2 87.7 108.8 31.1 30.6 89.7 69.4 97.7 31.4 24.2 41.4 101.3 153.2 88.4 28.4 467.2 33.9 141.0 136.5 90.8 116.8 23.2 118.2 77.9 115.7 155.9 197.5 155.5 296.6 132.1 101.3 70.3 45.5 412.0 125.0 28.8 326.7 215.8 62.1 142.3 150.4 113.3 98.5 110.7 135.9 55.4 28.1 62.0 BORCS7 "C10orf32, FLJ40752" ENSG00000166275 "BLOC-1 related complex subunit 7" Q96B45 10 102854223-102864961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA037648 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA037648: AB_10673634" "unprognostic (2.16e-1)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (2.05e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-3)" "unprognostic (3.55e-2)" "unprognostic (1.35e-2)" "unprognostic (7.46e-3)" "unprognostic (3.16e-2)" "unprognostic (1.77e-1)" "prognostic favorable (9.08e-8)" "unprognostic (9.85e-2)" "unprognostic (1.77e-1)" "unprognostic (1.06e-1)" "unprognostic (1.67e-3)" 16.0 40.4 22.7 8.1 26.5 13.2 20.2 14.3 22.1 15.6 11.9 16.4 15.2 15.2 15.2 19.4 9.7 20.2 17.7 15.1 19.7 20.9 26.0 42.7 15.7 10.4 18.0 22.5 15.4 15.2 32.8 23.2 21.2 20.1 18.7 10.3 15.0 11.2 12.6 17.2 9.1 17.7 11.8 17.8 18.1 13.7 18.0 17.3 8.9 36.9 14.2 7.9 11.3 10.9 16.2 29.7 16.8 21.6 16.4 13.5 8.6 7.7 10.5 12.9 11.1 14.3 19.6 10.6 11.5 23.7 8.9 8.5 7.0 8.8 4.9 6.1 18.3 9.3 6.5 4.2 5.9 6.6 6.2 9.0 11.3 7.2 14.4 16.4 20.4 19.5 24.5 16.2 6.0 9.6 18.7 15.4 7.1 6.6 5.2 14.1 5.7 5.6 8.4 4.3 10.6 10.0 10.3 17.1 7.1 7.3 8.6 3.7 14.0 4.2 7.7 17.6 6.0 14.5 11.7 11.5 7.5 8.0 7.6 8.0 13.7 20.7 5.9 15.9 11.9 2.6 16.8 19.5 13.6 11.8 21.6 12.9 16.2 12.1 11.9 13.8 14.4 13.5 12.4 6.0 16.4 19.3 29.7 11.8 8.6 22.7 26.5 14.3 22.1 19.7 20.9 18.0 22.5 20.1 17.3 50.6 70.6 27.0 51.2 0.0 46.2 0.0 40.8 80.3 59.1 40.1 37.3 78.2 170.8 26.2 15.7 60.9 31.5 0.0 29.2 33.5 48.6 70.1 31.4 65.1 44.2 60.4 32.8 48.5 50.0 18.3 39.1 38.2 0.0 28.9 46.3 74.6 26.7 50.1 58.4 157.9 44.6 38.8 0.0 68.3 47.1 0.0 101.6 35.9 48.9 49.9 BRK1 "C3orf10, HSPC300, MDS027" ENSG00000254999 "BRICK1, SCAR/WAVE actin nucleating complex subunit" Q8WUW1 3 10115592-10127190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 1965.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060391 Approved "Nuclear speckles,Cell Junctions" NA NA 130000 "Nuclear speckles" "Cell Junctions" "HPA060391: AB_2684272" "unprognostic (4.99e-2)" "unprognostic (3.48e-2)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (2.91e-1)" "unprognostic (9.60e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.49e-2)" "unprognostic (2.89e-1)" "unprognostic (1.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.37e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-1)" "unprognostic (9.40e-2)" "unprognostic (4.35e-2)" "unprognostic (7.75e-3)" 67.1 47.6 53.4 40.4 57.1 52.4 62.9 33.4 69.5 52.8 58.6 36.1 47.3 37.9 63.2 68.3 73.0 59.4 70.8 54.4 42.6 45.3 66.8 57.3 49.3 53.2 43.3 53.6 62.7 57.8 38.8 39.2 44.4 40.7 60.8 51.8 41.5 84.2 53.1 62.7 57.0 46.5 74.3 37.2 47.0 57.2 65.2 34.2 50.2 83.3 62.4 64.8 63.0 61.0 67.4 89.7 76.1 75.4 47.2 61.0 89.1 30.6 36.8 39.2 20.4 65.7 71.8 93.0 45.7 45.6 42.9 42.7 25.2 36.1 35.4 21.8 52.5 37.7 16.1 28.2 46.3 47.1 39.0 39.0 48.8 42.5 37.6 37.4 46.4 37.0 47.1 44.8 48.0 35.0 56.6 59.9 29.9 31.6 41.5 64.7 67.4 30.0 37.2 45.2 43.7 46.7 29.1 40.4 38.4 56.4 50.9 15.2 26.5 36.7 32.1 36.9 40.8 52.1 40.7 54.0 43.3 33.1 50.5 40.6 23.9 64.1 79.8 62.6 63.8 35.5 54.1 75.4 75.9 56.5 72.4 50.3 67.4 55.0 53.1 84.3 67.4 50.1 54.4 76.1 47.2 70.9 89.7 61.0 89.1 53.4 57.1 33.4 69.5 42.6 45.3 43.3 53.6 40.7 34.2 59.6 65.2 192.9 249.1 234.3 35.8 112.3 242.0 80.3 80.8 193.7 19.6 217.7 417.8 328.3 849.5 294.2 166.8 93.5 317.6 231.0 237.3 296.5 172.8 204.5 385.0 44.5 286.9 207.5 335.1 1965.9 229.0 331.9 335.8 527.6 186.8 106.0 371.4 168.4 238.6 736.5 29.7 232.8 294.2 162.6 168.0 275.8 178.3 223.7 210.0 344.6 C19orf24 FLJ20640 ENSG00000228300 "Chromosome 19 open reading frame 24" Q9BVV8 19 1275438-1279249 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA043279, HPA047026" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA043279: AB_10794656, HPA047026: AB_2679906" "unprognostic (1.10e-1)" "unprognostic (3.39e-1)" "unprognostic (1.12e-1)" "unprognostic (1.65e-3)" "unprognostic (7.05e-2)" "unprognostic (4.90e-1)" "unprognostic (4.23e-3)" "unprognostic (3.12e-2)" "unprognostic (1.18e-1)" "unprognostic (3.59e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (2.54e-3)" "unprognostic (2.16e-1)" "unprognostic (1.10e-1)" "unprognostic (2.25e-2)" 20.2 25.3 13.4 20.9 14.9 17.1 65.7 11.3 15.8 11.7 15.6 9.1 17.5 21.8 13.8 22.0 18.7 13.0 26.5 14.3 13.3 10.9 22.6 48.6 17.0 55.0 13.4 7.0 16.6 41.6 5.9 16.9 18.4 9.7 17.6 6.0 11.1 29.6 22.5 6.9 16.6 19.6 10.5 10.9 22.8 16.6 16.8 10.0 23.1 25.7 19.0 15.8 15.5 21.9 40.9 44.8 9.5 27.5 19.0 33.8 21.3 25.7 24.6 2.3 20.3 4.0 9.3 9.5 12.6 6.7 13.4 11.8 28.1 14.4 7.4 17.6 4.4 9.0 13.8 4.1 13.3 1.5 27.1 21.2 8.0 22.0 16.3 16.6 17.0 17.9 11.1 17.2 10.1 4.4 3.9 9.8 23.5 15.3 43.1 5.3 25.8 20.4 25.2 11.9 12.0 24.9 15.2 4.7 46.3 7.4 13.7 16.7 10.8 8.0 19.4 29.0 1.7 14.1 28.7 6.2 24.6 7.8 29.9 29.7 28.3 36.8 9.3 26.6 21.3 22.0 9.5 26.8 9.2 31.2 27.5 30.9 40.9 33.8 32.9 26.7 36.0 31.9 32.3 4.7 19.0 23.1 44.8 31.9 21.3 13.4 14.9 11.3 15.8 13.3 10.9 13.4 7.0 9.7 10.0 11.9 22.9 82.7 40.2 67.5 16.8 7.4 45.9 10.7 5.7 38.4 11.8 75.5 51.4 88.8 46.4 40.0 109.8 0.0 100.0 114.9 38.2 84.3 42.5 125.4 107.8 4.8 59.3 39.9 79.4 237.5 39.4 64.3 65.8 66.7 84.4 22.5 100.5 97.9 28.3 142.5 12.1 19.4 34.8 26.3 98.6 73.5 80.4 49.8 87.4 59.9 C1orf127 FLJ37118 ENSG00000175262 "Chromosome 1 open reading frame 127" 1 10946471-10982037 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 5.1;skeletal muscle: 17.3" "Cell type enriched" "Detected in some" 11 "Intestinal endocrine cells: 19.5" "Cancer enriched" "Detected in single" 9 "pancreatic cancer: 2.8" "Group enriched" "Detected in some" 4 "classical monocyte: 1.7;myeloid DC: 4.2" "Group enriched" "Detected in many" 30 "dendritic cells: 4.2;monocytes: 1.7" "Cell line enriched" "Detected in some" 4 "THP-1: 7.6" HPA027654 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA027654: AB_10611814" "unprognostic (1.82e-2)" "unprognostic (8.57e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-2)" "unprognostic (3.81e-2)" "unprognostic (1.32e-2)" "unprognostic (9.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.82e-2)" "unprognostic (8.47e-2)" "unprognostic (1.59e-2)" "unprognostic (3.31e-1)" "unprognostic (1.34e-1)" "unprognostic (1.04e-1)" "unprognostic (4.03e-1)" 0.1 0.6 0.0 0.0 0.4 0.0 0.0 3.3 0.0 0.0 0.2 0.6 0.0 0.0 0.5 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.3 0.5 0.8 0.0 5.1 0.0 0.2 0.1 0.0 0.5 0.2 0.0 17.3 0.0 0.2 0.0 0.1 0.5 2.5 0.6 0.1 0.0 0.0 0.0 0.0 4.2 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 1.4 0.5 0.0 0.0 7.6 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.7 0.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 19.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 C1orf194 ENSG00000179902 "Chromosome 1 open reading frame 194" Q5T5A4 1 109105951-109113857 "Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 36.5;fallopian tube: 60.2;testis: 77.6" "Group enriched" "Detected in some" 10 "Ciliated cells: 776.3;Early spermatids: 1757.0;Late spermatids: 2679.4" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8" "Region enriched" "Detected in many" 5 "pons and medulla: 36.5" "Cell type enriched" "Detected in some" 5 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 5.3" "Cell line enhanced" "Detected in some" "AF22: 4.5;RPTEC TERT1: 1.1;SCLC-21H: 6.3;U-87 MG: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031144, HPA049684" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA031144: AB_10602109, HPA049684: AB_2680849" "unprognostic (9.91e-3)" "unprognostic (7.60e-3)" "unprognostic (2.28e-2)" "prognostic favorable (1.36e-4)" "unprognostic (3.03e-1)" "unprognostic (1.14e-2)" "unprognostic (4.53e-1)" "unprognostic (3.91e-3)" "unprognostic (5.27e-2)" "unprognostic (9.21e-3)" "unprognostic (3.98e-3)" "unprognostic (1.52e-1)" "unprognostic (6.08e-6)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.27e-3)" 0.3 0.4 1.5 0.3 6.8 0.3 0.4 0.3 2.6 1.8 0.3 12.3 0.0 0.4 1.0 11.1 0.4 60.2 0.3 0.3 3.0 1.6 0.3 0.3 7.5 0.4 0.5 1.8 10.3 0.7 0.4 2.7 0.3 36.5 0.4 0.4 0.0 0.3 0.3 0.3 0.3 0.4 0.4 0.7 0.3 0.5 77.6 2.3 0.0 0.5 0.0 0.3 0.5 0.2 0.2 0.0 5.3 0.0 0.0 0.3 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 6.3 0.3 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 6.8 0.3 2.6 3.0 1.6 0.5 1.8 36.5 2.3 0.0 2.6 0.0 0.2 0.0 0.6 2.0 0.0 776.3 56.9 0.0 0.0 0.0 0.0 0.0 1757.0 0.0 0.0 0.0 0.2 0.0 0.2 1.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 2679.4 19.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 17.7 0.0 0.0 6.5 0.0 176.3 13.0 0.1 0.0 0.0 0.0 0.0 C5orf46 "MGC23985, SSSP1" ENSG00000178776 "Chromosome 5 open reading frame 46" Q6UWT4 5 147880726-147906538 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "salivary gland: 107.9;skin 1: 42.7" "Group enriched" "Detected in some" 7 "Early spermatids: 262.3;Late spermatids: 107.1" "Cancer enhanced" "Detected in many" "renal cancer: 8.3" "Region enriched" "Detected in single" 5 "cerebellum: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 23.8;PC-3: 39.1;SiHa: 8.7;U-2 OS: 25.5;U-251 MG: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058999, HPA079692" Supported Approved "Nuclear speckles,Mitochondria" "Secreted in other tissues" NA NA "Nuclear speckles" Mitochondria "HPA058999: , HPA079692: " "unprognostic (1.72e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.26e-4)" "unprognostic (9.75e-3)" "unprognostic (2.95e-3)" "unprognostic (1.69e-3)" "unprognostic (1.99e-2)" "unprognostic (3.08e-2)" "unprognostic (2.22e-1)" "unprognostic (4.96e-2)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.75e-9)" "unprognostic (6.48e-3)" "unprognostic (3.47e-2)" "unprognostic (6.01e-2)" "unprognostic (2.79e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 5.2 2.0 0.1 0.6 0.1 0.1 0.1 0.0 0.3 0.6 0.2 0.0 0.2 3.0 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 0.6 0.0 0.1 4.3 0.4 0.4 0.0 0.2 107.9 0.4 0.6 42.7 0.1 1.0 0.1 0.1 0.0 6.5 0.2 0.2 0.1 1.1 0.6 0.2 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 4.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.7 0.1 0.1 5.1 0.0 0.0 0.0 4.6 25.5 0.3 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.1 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 8.7 25.5 0.0 0.0 1.8 0.0 0.1 0.0 12.4 262.3 0.0 0.0 0.0 2.9 0.1 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 107.1 1.7 0.0 3.3 1.0 0.0 6.7 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.8 18.1 1.1 0.0 0.0 0.1 C6orf52 ENSG00000137434 "Chromosome 6 open reading frame 52" Q5T4I8 6 10671418-10694797 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 17.7" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 33.5;Early spermatids: 33.2;Late spermatids: 22.3;Spermatocytes: 32.4;Spermatogonia: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 8.7;NB-4: 7.7" "Low region specificity" "Detected in all" HPA051142 Uncertain Approved "Nuclear speckles,Intermediate filaments" No No "Nuclear speckles" "Intermediate filaments" "HPA051142: AB_2681359" "unprognostic (1.14e-2)" "unprognostic (2.21e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.50e-5)" "unprognostic (9.12e-2)" "unprognostic (2.96e-1)" "unprognostic (1.11e-3)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-2)" "unprognostic (3.92e-2)" "unprognostic (9.31e-3)" "unprognostic (7.65e-2)" 1.6 2.4 5.6 1.4 4.8 0.9 3.0 2.7 4.3 1.2 1.5 4.4 5.5 7.7 1.4 9.0 0.9 8.0 1.2 0.7 4.9 5.3 3.8 1.4 1.7 1.1 4.5 3.2 1.9 7.7 1.5 2.9 1.5 4.4 3.1 1.0 0.7 1.8 1.7 1.2 2.5 2.1 0.9 4.0 1.0 1.6 17.7 2.6 1.6 2.1 1.0 1.6 1.0 2.0 0.7 1.0 4.7 1.0 1.4 6.2 0.6 1.1 2.7 2.5 2.2 0.9 0.0 4.4 0.2 0.1 0.3 0.6 3.0 2.4 0.1 4.0 0.0 2.9 0.2 2.4 0.0 1.0 1.4 4.2 0.6 0.5 0.4 0.0 0.8 0.4 0.5 3.9 1.1 1.5 0.3 0.0 2.5 4.7 0.3 1.1 8.7 1.8 7.7 2.3 1.6 3.0 1.5 0.2 1.0 1.2 0.6 5.0 3.1 0.9 0.6 4.9 2.6 0.2 1.5 0.4 2.0 0.7 1.5 1.8 3.6 7.5 1.5 3.5 1.1 1.9 0.0 0.5 4.7 1.2 1.0 0.4 0.5 1.5 1.3 1.0 0.7 0.7 0.6 0.6 1.4 0.7 0.8 6.2 0.6 5.6 4.8 2.7 4.3 4.9 5.3 4.5 3.2 4.4 2.6 0.0 2.4 0.0 1.7 1.3 1.8 0.5 2.5 33.5 1.2 3.5 2.0 2.4 5.0 3.1 33.2 1.0 1.1 0.0 5.3 2.1 1.5 1.5 0.0 1.6 1.0 1.6 2.9 2.5 0.3 22.3 2.0 0.7 3.3 2.8 0.5 3.8 2.8 2.9 0.0 8.1 0.6 0.0 2.1 32.4 23.4 1.3 1.1 0.0 1.8 0.7 CCDC32 "C15orf57, MGC20481" ENSG00000128891 "Coiled-coil domain containing 32" Q9BV29 15 40528683-40565057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 75.8;Hofbauer cells: 59.5;Syncytiotrophoblasts: 68.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041688 Uncertain Approved "Nuclear speckles,Vesicles" NA NA "Nuclear speckles" Vesicles "HPA041688: AB_10796779" "unprognostic (7.10e-2)" "unprognostic (1.04e-1)" "unprognostic (9.86e-3)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (4.25e-5)" "unprognostic (4.03e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-1)" "unprognostic (4.70e-2)" "unprognostic (2.34e-1)" "unprognostic (1.23e-2)" "unprognostic (5.77e-2)" "unprognostic (3.72e-1)" "unprognostic (1.18e-1)" "unprognostic (2.20e-1)" "unprognostic (6.47e-2)" 22.7 23.5 17.9 17.2 24.3 19.0 17.9 17.6 24.0 17.1 18.4 17.6 17.4 18.4 24.5 20.0 12.6 20.3 19.4 21.4 20.7 21.9 25.9 15.3 16.6 27.8 17.6 21.0 28.2 32.6 15.8 26.5 22.6 20.8 16.5 22.0 20.5 20.7 17.4 22.4 11.5 18.5 18.5 16.7 25.2 18.9 9.2 16.1 16.2 24.4 9.4 26.8 26.9 22.2 50.6 16.3 12.7 9.6 7.7 13.8 11.6 7.9 5.7 7.6 12.3 15.5 16.3 4.5 6.4 9.6 11.4 12.0 8.6 11.2 3.0 18.0 9.5 16.4 15.0 7.5 7.2 8.2 18.0 8.7 32.6 9.8 10.7 10.6 12.2 17.2 14.1 7.7 8.9 6.0 10.7 14.2 11.7 17.8 19.9 8.6 6.9 5.5 10.7 3.0 18.2 7.4 9.8 9.6 9.9 21.0 19.3 8.4 8.6 9.5 10.0 4.7 9.4 10.5 22.7 15.7 10.6 9.3 18.6 9.2 10.8 10.6 9.6 11.2 19.4 14.9 12.7 9.4 9.3 9.8 9.6 7.9 40.9 11.0 10.6 12.2 50.6 11.2 9.5 9.9 7.7 9.4 16.3 13.8 11.6 17.9 24.3 17.6 24.0 20.7 21.9 17.6 21.0 20.8 16.1 11.9 12.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 18.2 19.2 0.0 75.8 24.9 23.7 0.0 0.0 0.0 0.0 25.7 28.6 0.0 0.0 5.8 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 18.0 0.0 0.0 28.2 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 68.1 0.0 0.0 0.0 CD2BP2 "LIN1, PPP1R59, Snu40, U5-52K" ENSG00000169217 "CD2 cytoplasmic tail binding protein 2" O95400 16 30350766-30355361 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041508, HPA061309" Enhanced Enhanced "Nuclear speckles,Cytosol" Yes No "Nuclear speckles" Cytosol "HPA041508: AB_2677523, HPA061309: AB_2684476" "unprognostic (5.66e-2)" "unprognostic (7.50e-3)" "unprognostic (1.47e-1)" "unprognostic (2.82e-2)" "unprognostic (1.65e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.71e-2)" "unprognostic (1.16e-1)" "unprognostic (9.76e-2)" "unprognostic (2.30e-2)" "unprognostic (7.47e-2)" "unprognostic (2.09e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-2)" "unprognostic (1.75e-1)" "unprognostic (1.66e-1)" 24.6 33.0 23.6 27.8 24.4 17.8 22.5 27.6 43.4 24.2 25.4 27.4 31.8 25.8 32.3 29.0 23.1 30.0 35.6 27.4 23.1 23.7 24.8 18.2 22.3 30.2 23.2 27.3 29.7 30.9 46.3 30.3 22.3 20.3 25.8 21.3 20.8 27.4 40.7 31.7 22.0 22.6 28.1 20.6 32.0 24.5 23.4 19.8 26.8 29.8 25.9 36.5 22.9 19.9 38.2 28.1 51.3 39.0 29.2 37.6 29.9 21.7 26.5 22.4 20.2 18.7 17.8 19.0 24.2 29.2 27.6 29.7 20.2 26.3 33.6 30.0 26.3 25.4 24.0 22.8 28.4 22.2 19.9 26.8 14.2 25.1 23.7 26.9 20.1 26.3 19.1 24.1 30.6 19.7 19.0 28.6 25.2 16.0 25.9 27.6 52.3 27.7 17.1 30.1 17.0 15.7 41.1 18.6 25.3 22.4 21.9 18.4 35.2 16.2 28.7 16.3 19.3 27.2 16.3 20.4 31.9 22.2 16.0 21.1 43.5 31.6 30.9 21.8 18.7 26.0 36.3 26.3 46.2 31.7 30.8 25.1 36.2 25.8 29.4 23.3 38.2 21.8 26.9 51.3 29.2 39.0 28.1 37.6 29.9 23.6 24.4 27.6 43.4 23.1 23.7 23.2 27.3 20.3 19.8 29.8 25.3 41.6 42.3 25.5 27.7 23.3 38.2 32.1 18.2 34.9 19.6 52.1 51.4 70.2 14.8 35.4 46.6 23.3 84.6 47.7 31.5 34.5 47.3 12.4 61.0 11.1 31.7 24.5 37.6 11.3 32.8 32.5 37.1 107.4 29.5 41.6 75.5 63.1 33.6 64.1 25.0 38.8 44.3 34.6 43.2 26.6 74.1 50.1 29.2 46.0 CDK11A "CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE" ENSG00000008128 "Cyclin dependent kinase 11A" Q9UQ88 1 1702730-1724324 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 104.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB010467, HPA025061, HPA073626" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: AB_2686619" "unprognostic (6.25e-2)" "unprognostic (8.32e-2)" "unprognostic (1.47e-2)" "unprognostic (2.74e-1)" "unprognostic (9.32e-3)" "unprognostic (3.54e-2)" "unprognostic (2.25e-3)" "unprognostic (7.97e-2)" "prognostic unfavorable (5.06e-4)" "unprognostic (1.28e-1)" "unprognostic (5.58e-3)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.15e-6)" "unprognostic (1.97e-1)" "unprognostic (5.98e-2)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" 14.3 14.9 17.2 23.7 26.9 39.7 13.0 35.2 32.7 12.5 16.4 14.3 6.1 29.2 16.5 8.5 12.1 12.6 10.2 10.2 19.4 8.4 11.7 12.5 19.0 20.3 22.6 9.0 16.2 12.9 12.2 27.5 12.9 17.1 14.4 14.6 11.6 12.7 10.3 21.5 15.1 34.9 13.1 26.0 24.2 15.7 16.4 25.1 14.9 14.6 7.6 22.4 13.5 15.2 7.4 11.8 33.5 6.3 4.4 5.5 1.4 16.3 9.9 7.1 6.5 9.4 7.5 7.0 16.1 7.2 8.0 9.4 12.3 15.0 17.4 9.9 4.7 10.4 12.2 6.5 8.4 6.4 13.3 10.6 15.5 18.5 11.0 6.2 17.3 22.4 8.7 5.7 7.0 4.6 9.7 13.8 9.4 18.1 14.6 6.7 9.2 8.0 13.6 9.9 10.0 8.4 14.7 10.8 8.4 6.5 7.4 7.9 11.4 14.1 16.6 19.3 3.6 11.1 7.2 14.0 12.6 12.3 5.6 8.9 20.4 14.8 21.9 4.3 14.0 4.0 16.7 6.3 7.7 5.5 3.4 4.2 6.2 4.7 4.2 2.0 7.4 4.7 4.0 33.5 4.4 3.7 11.8 4.5 1.4 17.2 26.9 35.2 32.7 19.4 8.4 22.6 9.0 17.1 25.1 47.6 54.9 22.4 11.6 12.5 31.1 1.2 12.7 53.5 58.0 14.0 25.5 13.8 8.3 17.1 29.6 20.3 32.5 23.3 13.2 19.0 13.9 10.7 79.0 12.3 10.9 38.1 8.7 11.6 8.2 11.1 32.8 22.6 10.1 23.4 23.2 20.4 21.0 46.0 20.1 9.6 39.2 12.9 9.1 104.7 84.3 12.8 25.5 25.5 18.6 12.9 CDK12 "CRK7, CRKR, CRKRS, KIAA0904" ENSG00000167258 "Cyclin dependent kinase 12" Q9NYV4 17 39461511-39564907 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 87.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008038, HPA073305" Supported Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA008038: AB_1078570, HPA073305: " "unprognostic (2.02e-1)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (7.56e-2)" "unprognostic (1.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.56e-3)" "unprognostic (2.37e-2)" "unprognostic (3.86e-2)" "unprognostic (3.00e-3)" "unprognostic (6.87e-3)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "unprognostic (9.10e-2)" "unprognostic (1.24e-1)" "unprognostic (2.22e-2)" "unprognostic (5.32e-1)" 16.0 13.1 12.4 17.4 9.2 32.4 14.0 23.4 17.8 18.2 17.6 9.6 15.7 11.1 15.7 12.0 16.9 12.2 12.5 11.0 10.1 6.7 10.2 18.5 13.5 15.2 10.9 14.3 17.4 11.3 19.0 12.2 18.4 9.5 12.7 11.7 10.4 15.6 11.1 11.1 17.0 16.5 11.0 10.6 16.3 11.8 18.9 8.3 29.0 15.0 5.4 17.3 16.3 20.5 5.1 4.0 10.4 2.9 6.6 4.0 0.9 8.9 11.1 6.7 6.2 4.9 5.5 6.2 8.1 6.9 11.1 8.3 13.6 5.5 12.7 7.1 8.5 11.3 14.6 13.3 10.2 10.8 8.3 11.4 13.7 7.5 10.5 4.8 18.7 9.6 5.9 7.1 13.5 10.7 4.6 6.7 7.7 23.2 8.4 6.3 4.2 15.3 4.8 7.0 4.4 5.0 10.1 14.4 7.2 4.2 10.7 7.2 4.6 10.3 87.5 7.0 10.1 11.2 8.1 7.2 10.1 8.1 7.0 10.4 6.9 4.9 17.9 7.2 7.9 6.6 10.4 2.9 4.1 4.0 2.2 3.0 2.9 2.5 2.7 1.8 5.1 2.9 2.7 9.7 6.6 1.8 4.0 2.0 0.9 12.4 9.2 23.4 17.8 10.1 6.7 10.9 14.3 9.5 8.3 23.8 26.1 37.7 45.0 57.5 45.4 12.1 35.7 29.4 40.9 36.6 60.9 27.7 11.6 24.4 15.9 29.6 32.0 23.3 23.8 24.7 35.7 62.9 27.8 38.9 23.9 33.4 29.9 27.6 37.0 14.0 34.5 34.5 25.3 27.9 26.9 31.5 36.1 31.6 31.8 12.9 67.7 32.3 33.0 113.1 90.5 60.3 48.7 42.9 28.8 77.9 CDK5RAP1 "C20orf34, C42, CGI-05, HSPC167" ENSG00000101391 "CDK5 regulatory subunit associated protein 1" Q96SZ6 20 33358839-33401561 "Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066301 Approved "Nuclear speckles,Mitochondria" NA NA "Nuclear speckles" Mitochondria "HPA066301: AB_2685653" "unprognostic (2.86e-1)" "unprognostic (7.19e-2)" "unprognostic (1.31e-1)" "unprognostic (1.66e-3)" "unprognostic (2.25e-1)" "unprognostic (6.49e-2)" "unprognostic (7.68e-3)" "unprognostic (2.18e-2)" "unprognostic (5.10e-1)" "unprognostic (2.36e-1)" "unprognostic (5.90e-3)" "prognostic unfavorable (8.07e-4)" "unprognostic (3.51e-2)" "unprognostic (8.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-1)" 13.9 12.8 15.1 13.0 23.0 20.8 14.8 29.2 22.4 11.1 12.2 18.3 12.3 11.3 15.4 15.4 13.2 12.8 8.3 15.0 11.2 9.5 11.8 14.6 12.5 14.7 12.2 16.2 14.0 12.4 16.6 17.9 13.1 15.5 11.5 16.2 15.5 19.7 12.0 29.2 19.0 14.5 14.1 10.1 15.8 13.0 14.8 15.9 14.4 15.8 11.2 18.7 13.4 12.5 16.0 14.2 8.5 16.3 15.6 17.4 10.8 11.0 11.5 8.0 7.2 7.6 5.9 17.7 6.7 9.6 19.5 20.5 48.5 10.0 19.6 9.0 7.2 12.6 16.4 13.6 19.0 15.1 3.6 7.2 23.6 11.9 18.4 9.0 14.9 7.5 7.7 8.2 12.9 15.7 4.9 10.7 5.6 14.9 8.2 8.4 11.1 15.2 11.2 5.9 12.4 17.0 11.3 18.2 15.0 10.6 9.8 11.0 6.1 21.3 10.2 14.1 9.6 14.8 7.2 7.9 14.4 11.8 9.8 11.2 7.1 8.0 14.5 8.6 16.1 6.8 3.3 12.7 8.5 14.7 16.3 17.4 16.0 14.5 14.0 14.2 9.8 13.1 11.3 0.7 15.6 13.0 9.9 12.4 10.8 15.1 23.0 29.2 22.4 11.2 9.5 12.2 16.2 15.5 15.9 14.9 18.3 13.4 9.5 10.8 25.5 14.2 12.7 9.4 3.4 7.0 25.5 27.3 11.6 14.6 1.5 10.7 10.1 23.3 15.9 14.6 8.0 6.7 28.9 13.4 15.2 11.1 12.1 4.3 10.5 2.5 12.0 15.9 10.1 15.4 9.4 15.1 10.4 10.5 9.9 12.4 37.2 19.4 10.8 25.0 21.5 9.2 13.4 19.2 11.9 7.8 CLIC5 DFNB102 ENSG00000112782 "Chloride intracellular channel 5" Q9NZA1 6 45880827-46080348 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Hearing, Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel, Voltage-gated channel" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9" "Cell type enhanced" "Detected in many" 20 "Alveolar cells type 1: 473.4;Cardiomyocytes: 276.0;Enterocytes: 100.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 8.8" "Lineage enriched" "Detected in single" 23 "T-cells: 8.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.6;EFO-21: 9.6;HDLM-2: 5.0;REH: 11.7;U-266/70: 12.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA074371 Supported "Nuclear speckles,Plasma membrane" NA NA 1000000 "Plasma membrane" "Nuclear speckles" "HPA074371: " "unprognostic (4.95e-2)" "unprognostic (1.59e-2)" "unprognostic (8.84e-2)" "unprognostic (5.05e-2)" "unprognostic (2.44e-1)" "unprognostic (6.73e-2)" "unprognostic (3.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (6.46e-2)" "unprognostic (5.50e-2)" "unprognostic (3.65e-1)" "unprognostic (6.77e-3)" "unprognostic (1.22e-1)" "unprognostic (1.99e-1)" "unprognostic (8.26e-2)" "unprognostic (1.01e-1)" 7.4 0.6 0.8 3.2 1.5 0.0 2.3 0.6 1.1 6.0 10.2 0.3 0.4 5.6 0.8 2.5 2.2 1.2 2.1 65.6 0.9 1.2 17.5 0.5 32.8 0.4 1.1 1.4 0.7 0.7 0.4 1.3 22.0 0.8 0.9 7.5 7.8 2.0 0.4 99.9 0.7 46.2 1.4 0.9 16.1 0.9 1.0 0.0 0.2 4.8 18.8 1.5 1.0 4.3 0.3 0.0 0.0 0.0 0.3 8.8 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 13.6 0.0 9.6 0.0 0.0 0.3 0.0 0.1 0.0 5.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.3 1.5 0.0 11.7 0.3 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 12.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 8.8 0.3 3.6 2.2 0.0 0.0 0.6 0.5 0.0 0.3 0.0 0.0 1.6 0.8 0.8 1.5 0.6 1.1 0.9 1.2 1.1 1.4 0.8 0.0 473.4 23.0 0.5 0.0 0.1 0.1 276.0 0.0 20.1 48.9 14.0 0.0 0.1 0.0 1.4 38.1 3.8 100.0 0.0 0.2 0.0 0.2 1.5 1.1 0.0 0.0 0.0 12.5 0.6 0.0 75.0 0.9 0.0 0.0 1.0 16.3 47.6 1.9 24.6 0.7 2.1 1.1 0.0 2.1 0.6 0.1 0.1 1.8 2.9 9.8 0.8 CMTR2 "AFT, FLJ11171, FTSJD1, MTr2" ENSG00000180917 "Cap methyltransferase 2" Q8IYT2 16 71281389-71289715 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041700, HPA048265" Uncertain Approved "Nuclear speckles,Cell Junctions" NA NA "Cell Junctions" "Nuclear speckles" "HPA041700: AB_2677623, HPA048265: AB_2680334" "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (2.94e-3)" "unprognostic (1.43e-1)" "unprognostic (6.30e-2)" "unprognostic (3.82e-2)" "unprognostic (1.93e-3)" "unprognostic (2.86e-2)" "unprognostic (7.93e-2)" "unprognostic (3.41e-1)" "unprognostic (1.85e-2)" "unprognostic (7.39e-2)" "prognostic favorable (4.97e-5)" "unprognostic (9.55e-2)" "unprognostic (5.99e-2)" "unprognostic (1.54e-1)" "unprognostic (5.34e-2)" 10.4 14.9 7.1 11.7 9.0 5.4 15.9 5.3 9.1 10.6 13.4 11.5 15.6 14.1 12.5 16.4 20.4 8.8 11.0 9.0 8.5 6.9 13.5 18.2 10.7 14.7 12.4 3.4 16.2 12.2 12.7 24.3 17.4 9.0 11.9 10.5 10.6 13.6 14.1 8.4 9.9 16.1 9.4 9.5 17.5 8.9 16.0 9.3 20.9 14.3 7.6 15.4 9.6 14.2 11.2 10.3 11.0 8.0 13.1 11.2 8.6 11.5 8.1 11.6 11.5 13.1 11.4 6.5 9.4 9.2 10.7 10.3 4.8 16.0 6.2 11.4 7.4 12.0 11.4 7.1 8.5 13.1 6.5 4.8 17.2 4.7 6.0 16.3 10.2 23.7 8.2 16.2 7.8 10.6 7.8 12.1 12.3 7.5 4.7 17.7 10.3 12.3 17.2 7.2 9.6 4.8 16.6 7.4 13.5 13.2 7.8 7.7 8.6 10.6 9.3 10.4 6.7 13.9 7.4 11.6 12.1 11.2 12.3 7.3 8.7 9.0 11.1 9.1 10.4 10.4 11.0 7.2 7.1 9.8 8.0 11.2 11.2 9.2 10.3 10.3 10.2 10.5 10.3 0.4 13.1 5.2 3.6 8.0 8.6 7.1 9.0 5.3 9.1 8.5 6.9 12.4 3.4 9.0 9.3 3.0 10.2 29.3 13.2 12.6 20.9 6.7 10.2 0.0 6.8 15.7 29.5 18.6 6.6 10.2 75.3 15.7 25.5 0.0 8.3 10.6 10.4 12.0 8.1 23.6 13.9 14.3 17.9 18.4 15.4 21.7 15.5 13.0 1.7 8.2 17.2 17.1 10.3 15.2 11.7 12.9 27.8 6.5 7.4 23.0 11.7 21.2 22.1 25.4 15.5 15.2 COG6 "COD2, KIAA1134" ENSG00000133103 "Component of oligomeric golgi complex 6" Q9Y2V7 13 39655627-39791665 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040410, HPA040441" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles, Golgi apparatus" "HPA040410: AB_10793964, HPA040441: AB_10794030" "unprognostic (2.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.85e-2)" "unprognostic (1.05e-2)" "unprognostic (4.81e-2)" "unprognostic (4.99e-2)" "unprognostic (6.81e-2)" "unprognostic (9.59e-2)" "unprognostic (3.66e-2)" "unprognostic (1.14e-1)" "unprognostic (9.07e-2)" "unprognostic (1.62e-1)" "unprognostic (6.60e-3)" "prognostic favorable (2.81e-4)" "unprognostic (4.87e-2)" "unprognostic (2.14e-1)" "unprognostic (2.24e-1)" 11.7 16.1 16.3 9.5 18.8 2.6 13.6 23.8 18.7 17.1 12.0 11.4 9.6 13.1 12.6 8.5 13.8 13.2 13.8 19.6 13.3 12.9 13.7 11.8 8.9 9.9 13.3 17.9 19.1 23.4 18.6 37.7 19.4 17.9 17.6 11.4 8.8 16.4 15.7 10.2 13.0 13.3 14.6 15.4 9.9 15.4 24.0 14.1 10.3 18.5 7.9 10.1 14.2 11.5 7.6 6.4 5.6 7.2 10.0 10.3 5.6 7.0 4.6 8.0 5.4 15.3 19.2 14.2 11.2 16.4 10.0 12.3 5.7 11.6 12.1 6.6 17.3 12.2 9.5 8.4 8.8 11.2 13.8 10.7 11.6 5.0 8.6 9.0 11.6 12.6 8.1 10.9 6.3 7.4 13.3 9.8 11.2 4.9 4.6 16.5 7.1 8.3 11.2 7.3 21.6 6.1 8.4 20.2 5.9 7.5 9.1 4.3 5.7 10.4 8.9 8.9 11.6 10.2 7.4 13.9 5.5 6.5 11.9 5.7 3.8 3.6 9.0 16.4 6.5 16.2 4.4 4.7 5.6 6.1 7.2 10.3 7.6 7.8 8.2 6.4 6.6 6.6 8.5 1.1 10.0 4.2 3.6 8.9 5.6 16.3 18.8 23.8 18.7 13.3 12.9 13.3 17.9 17.9 14.1 17.9 5.6 10.2 5.5 8.7 13.9 19.9 0.0 6.7 5.7 12.2 9.8 13.7 5.0 6.2 18.1 6.4 7.0 0.0 8.7 26.5 9.8 5.4 9.3 8.2 7.6 4.8 8.7 11.6 5.3 8.6 12.4 5.6 1.7 1.0 19.1 14.1 7.7 8.6 12.0 9.8 11.3 6.5 10.9 32.6 27.9 11.7 13.4 8.7 9.9 4.4 CPSF6 "CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7" ENSG00000111605 "Cleavage and polyadenylation specific factor 6" Q16630 12 69239537-69274358 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039973 Supported Enhanced "Nucleoplasm,Nuclear speckles" No No 500000 "Nucleoplasm, Nuclear speckles" "HPA039973: AB_10795242" "unprognostic (1.50e-1)" "unprognostic (3.33e-2)" "unprognostic (4.37e-3)" "unprognostic (5.47e-2)" "unprognostic (4.24e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.91e-6)" "unprognostic (6.82e-2)" "unprognostic (2.91e-3)" "unprognostic (8.57e-2)" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.20e-1)" "unprognostic (7.63e-2)" "unprognostic (2.05e-1)" "unprognostic (7.41e-2)" 22.3 26.4 29.4 28.1 32.6 52.0 23.1 49.1 32.2 24.8 20.7 24.3 21.3 21.8 27.4 34.5 27.1 23.2 17.0 21.8 24.3 16.4 20.0 19.7 21.6 36.1 23.6 26.8 42.2 23.5 28.6 36.4 21.0 24.9 21.5 21.5 22.2 25.6 21.4 25.4 23.3 23.1 22.3 20.7 24.7 21.9 22.1 25.8 42.8 25.5 10.5 32.9 21.3 24.2 22.0 25.5 21.0 21.5 19.3 30.2 12.4 28.7 24.2 35.8 25.1 13.9 15.9 27.0 19.0 22.7 27.1 25.7 25.2 19.8 45.9 19.6 19.2 15.1 27.2 35.1 22.4 29.0 29.9 23.9 37.0 25.0 28.8 20.8 49.9 27.1 19.0 17.8 21.8 9.0 18.2 20.8 27.7 38.0 49.3 22.4 33.5 46.7 32.7 34.6 24.0 20.7 47.5 28.4 32.1 21.3 34.3 30.2 26.6 25.5 23.9 25.9 22.4 28.7 35.4 23.9 20.5 25.1 19.3 31.0 31.7 25.6 57.4 16.6 29.3 26.3 21.0 17.1 18.7 19.7 21.5 20.9 22.0 22.0 20.2 25.5 19.0 17.0 20.1 5.2 19.3 17.8 18.3 30.2 12.4 29.4 32.6 49.1 32.2 24.3 16.4 23.6 26.8 24.9 25.8 11.9 19.8 32.8 39.9 67.5 52.9 29.0 22.9 21.4 25.0 17.4 35.3 55.0 31.5 46.3 14.2 31.0 20.8 0.0 49.2 71.9 38.1 25.5 34.6 18.7 34.7 84.2 50.4 17.2 27.8 13.5 52.6 28.0 23.6 55.9 26.2 35.0 48.6 21.0 49.8 20.2 42.9 38.8 30.4 71.1 72.7 51.7 42.8 35.2 31.1 46.0 CRY2 ENSG00000121671 "Cryptochrome circadian regulator 2" Q49AN0 11 45847118-45883248 "Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 128.4;Horizontal cells: 95.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037577 Supported Supported "Nuclear speckles,Cytosol" "Intracellular and membrane" NA NA "Nuclear speckles" Cytosol "HPA037577: AB_10672497" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "prognostic unfavorable (1.67e-4)" "unprognostic (1.31e-2)" "unprognostic (9.16e-2)" "unprognostic (3.09e-2)" "prognostic favorable (6.82e-5)" "unprognostic (1.48e-3)" "unprognostic (1.67e-1)" "unprognostic (5.07e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.01e-1)" "prognostic favorable (6.44e-15)" "unprognostic (8.13e-3)" "unprognostic (1.89e-1)" "unprognostic (4.24e-2)" "unprognostic (2.24e-1)" 17.4 13.3 18.2 8.8 27.4 17.2 16.7 29.8 36.5 17.7 12.1 15.4 10.5 7.6 16.2 12.4 11.2 20.8 18.7 39.5 15.6 13.1 15.7 27.8 15.7 6.7 12.7 15.0 26.3 23.4 20.6 16.4 9.3 11.5 15.0 7.3 35.5 14.4 17.1 58.2 24.3 8.5 18.7 10.4 9.2 12.2 17.4 9.6 5.9 23.6 22.4 10.3 17.4 10.6 7.8 5.2 7.6 10.6 10.4 10.4 7.1 1.2 3.6 5.6 6.6 15.2 7.7 12.2 4.3 7.8 5.5 4.1 5.8 2.9 8.3 3.4 9.0 5.3 7.4 5.3 4.5 3.8 8.8 4.8 5.5 6.3 8.0 5.8 6.7 7.5 9.0 6.7 4.2 6.8 6.3 3.8 6.5 10.6 14.3 4.9 4.5 5.7 8.0 15.1 15.2 4.3 9.7 8.0 3.9 4.0 6.8 9.0 3.4 7.2 6.6 3.7 7.4 8.8 4.7 4.8 7.8 4.8 11.9 3.0 13.3 9.1 6.9 4.8 2.9 4.7 5.7 5.0 7.6 8.7 7.1 7.2 7.8 8.4 9.3 5.2 7.7 10.3 10.4 2.6 10.4 10.6 3.8 6.9 7.1 18.2 27.4 29.8 36.5 15.6 13.1 12.7 15.0 11.5 9.6 11.9 15.6 3.2 9.8 15.0 128.4 29.0 12.7 14.7 13.6 7.0 25.5 6.2 24.9 3.9 19.1 8.3 11.3 0.0 4.0 4.6 16.6 11.6 14.9 37.0 3.3 95.3 6.8 9.2 9.4 7.2 29.1 7.2 15.1 2.8 5.4 32.7 4.7 6.5 37.4 10.5 25.6 19.4 17.6 21.0 12.7 15.3 7.8 4.5 4.5 9.5 CWC15 "AD002, C11orf5, Cwf15, HSPC148" ENSG00000150316 "CWC15 spliceosome associated protein homolog" Q9P013 11 94962622-94973612 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 683.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039878 Supported Approved "Nuclear speckles,Mitochondria" NA NA "Nuclear speckles, Mitochondria" "HPA039878: AB_2676722" "unprognostic (1.97e-1)" "unprognostic (5.51e-2)" "unprognostic (1.66e-2)" "unprognostic (8.64e-2)" "unprognostic (3.81e-1)" "unprognostic (6.85e-2)" "unprognostic (1.29e-1)" "unprognostic (1.52e-1)" "unprognostic (4.84e-3)" "prognostic favorable (9.75e-4)" "unprognostic (4.69e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (1.44e-1)" "unprognostic (1.34e-1)" "prognostic favorable (7.17e-4)" "unprognostic (5.23e-2)" 9.5 9.6 9.9 7.9 12.0 10.6 13.5 12.4 11.9 10.1 9.2 7.2 7.7 5.8 8.6 14.9 10.0 9.2 5.5 14.1 9.8 9.6 14.0 15.6 8.8 8.7 10.3 10.1 11.8 8.6 7.5 12.1 11.1 12.6 9.5 8.1 6.4 10.2 9.1 24.4 9.0 10.1 7.3 11.7 10.7 9.5 17.2 12.4 11.2 11.2 14.7 9.6 9.8 10.6 31.8 31.3 36.8 33.0 26.1 35.8 25.7 10.8 8.8 26.3 12.5 25.0 22.8 13.7 16.3 23.0 27.4 22.7 39.3 24.8 16.8 33.1 23.1 20.3 11.4 15.9 20.6 29.4 21.3 14.0 21.1 10.5 17.7 21.5 26.3 13.1 22.6 23.7 18.3 24.5 22.8 26.6 20.5 24.8 14.6 24.6 14.3 25.3 35.6 12.6 30.5 22.2 17.2 16.0 17.7 27.2 13.1 14.9 11.6 18.0 17.8 14.1 25.5 28.6 21.3 14.6 18.0 14.4 25.0 16.2 6.9 17.6 23.2 10.1 30.4 17.5 36.8 25.1 34.5 26.8 27.3 35.8 31.8 34.6 32.8 31.3 27.6 34.4 34.7 29.5 26.1 33.0 29.7 35.4 25.7 9.9 12.0 12.4 11.9 9.8 9.6 10.3 10.1 12.6 12.4 68.5 52.8 80.4 76.4 52.7 51.9 156.1 96.8 103.1 97.8 48.8 13.7 121.9 187.3 96.3 683.1 78.7 55.1 140.2 125.1 102.3 82.2 67.4 99.6 99.5 111.8 38.1 27.3 83.4 57.4 99.0 104.4 88.5 67.4 94.6 54.4 99.4 104.3 80.6 87.4 170.4 46.4 135.8 50.5 192.5 186.1 55.8 99.8 69.1 59.8 59.2 CWC22 "EIF4GL, fSAPb, KIAA1604, NCM" ENSG00000163510 "CWC22 spliceosome associated protein homolog" Q9HCG8 2 179944876-180007113 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036748 Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA036748: AB_10669913" "unprognostic (1.90e-1)" "unprognostic (7.10e-2)" "unprognostic (7.30e-2)" "unprognostic (6.14e-2)" "unprognostic (4.96e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (7.42e-4)" "unprognostic (3.15e-1)" "unprognostic (1.31e-2)" "unprognostic (3.30e-2)" "unprognostic (3.84e-2)" "unprognostic (4.80e-2)" "prognostic unfavorable (7.76e-5)" "unprognostic (1.74e-1)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-3)" 20.4 14.2 15.8 17.3 16.8 18.1 19.2 33.5 24.6 21.1 17.0 10.5 13.5 12.4 21.5 14.3 18.4 17.6 15.5 14.8 17.5 11.9 17.2 20.7 14.7 21.3 14.4 19.6 25.4 14.7 21.8 25.0 17.8 17.0 20.4 15.2 9.1 15.4 14.7 20.2 15.9 17.4 23.6 19.0 20.5 15.4 10.9 16.3 26.5 20.7 17.6 21.7 21.8 23.8 12.4 9.9 26.4 11.9 10.9 16.4 8.2 9.6 6.0 16.8 11.2 12.2 14.5 12.8 12.8 15.1 15.8 15.4 13.5 12.2 19.0 11.5 9.2 13.8 10.6 15.9 11.9 23.9 16.7 14.0 25.4 7.8 18.4 12.0 35.3 14.2 9.5 14.5 19.8 26.9 10.3 11.7 13.2 27.6 11.7 10.3 9.7 18.4 18.4 25.8 11.6 9.7 17.0 20.8 14.2 10.9 12.2 11.5 15.6 10.5 8.4 14.6 18.8 6.3 22.4 10.0 13.5 11.5 8.8 13.2 10.3 10.8 23.2 12.1 14.3 13.5 26.4 9.5 21.5 12.3 11.9 12.4 12.4 13.3 14.5 9.9 11.3 16.4 12.8 15.9 10.9 8.9 6.3 11.3 8.2 15.8 16.8 33.5 24.6 17.5 11.9 14.4 19.6 17.0 16.3 17.9 26.0 19.8 23.6 16.9 14.6 25.2 22.9 52.2 35.2 10.4 23.6 15.7 8.3 21.1 1.2 21.7 10.5 0.0 16.6 14.4 15.9 13.2 26.5 12.4 12.1 12.7 15.0 15.4 19.7 1.5 21.6 21.4 3.3 21.6 15.8 16.3 16.2 16.7 17.3 14.4 16.9 45.3 13.2 25.1 21.5 16.3 20.7 17.5 13.5 15.4 CWF19L2 FLJ32343 ENSG00000152404 "CWF19 like 2, cell cycle control (S. pombe)" Q2TBE0 11 107326345-107457844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038166 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA038166: AB_10669518" "unprognostic (1.38e-1)" "unprognostic (9.41e-2)" "unprognostic (1.37e-1)" "unprognostic (7.35e-2)" "unprognostic (7.17e-2)" "unprognostic (6.42e-2)" "unprognostic (8.78e-2)" "unprognostic (1.63e-1)" "unprognostic (4.19e-2)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-2)" "unprognostic (4.48e-2)" "unprognostic (1.26e-1)" "unprognostic (4.74e-2)" "unprognostic (1.76e-2)" 16.5 9.9 19.0 18.2 24.4 11.5 18.4 43.7 25.1 23.0 13.6 5.6 14.9 8.0 17.7 13.9 11.5 13.2 9.8 11.3 16.2 10.7 18.2 13.3 11.4 14.8 16.3 16.9 23.8 9.6 17.7 27.9 13.2 17.9 16.6 10.3 5.1 11.4 14.6 29.1 13.0 11.3 14.9 23.5 18.0 11.1 9.0 21.7 15.8 15.8 9.2 16.8 21.0 47.4 19.4 12.5 22.2 6.8 11.2 13.9 2.8 6.2 5.1 11.1 5.3 9.2 10.4 8.3 8.2 7.7 6.5 8.7 11.9 14.8 10.9 15.8 5.8 8.3 15.3 12.2 6.3 11.4 12.1 6.8 12.1 5.9 7.7 6.0 14.2 10.2 5.3 11.1 7.5 11.3 7.5 8.7 6.6 18.2 6.3 9.4 4.6 10.9 12.9 10.4 10.4 7.3 9.6 10.6 14.6 7.6 7.8 6.4 5.3 12.0 9.0 4.5 9.7 12.1 6.8 7.9 10.8 8.7 5.6 7.3 3.4 6.2 10.8 3.2 14.0 9.9 22.2 6.8 11.8 9.8 6.0 10.8 17.6 11.4 9.7 2.9 19.4 13.9 10.6 13.0 11.2 6.3 12.5 9.7 2.8 19.0 24.4 43.7 25.1 16.2 10.7 16.3 16.9 17.9 21.7 35.7 53.5 49.4 17.3 15.9 90.9 22.6 50.9 24.1 46.6 78.5 90.3 21.2 28.2 18.3 2.6 43.6 16.9 0.0 16.0 18.5 22.2 6.0 44.0 50.5 13.8 65.2 12.6 47.9 27.5 6.2 50.3 29.7 13.5 26.2 20.7 53.3 13.8 22.9 60.1 37.1 129.6 38.8 23.1 49.8 46.9 11.7 14.2 43.6 20.3 6.7 CYGB "HGB, STAP" ENSG00000161544 Cytoglobin Q8WWM9 17 76527356-76551175 "Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 88.6;Melanocytes: 74.2;Sertoli cells: 90.5;Smooth muscle cells: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 25.0;Hep G2: 19.1;HHSteC: 38.0;HSkMC: 31.0;SH-SY5Y: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017757, HPA061642" Approved Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA017757: AB_1847410, HPA061642: AB_2684573" "unprognostic (6.96e-2)" "unprognostic (1.39e-1)" "unprognostic (3.97e-2)" "prognostic favorable (2.55e-5)" "prognostic unfavorable (1.85e-4)" "unprognostic (3.36e-2)" "unprognostic (3.31e-3)" "unprognostic (2.01e-1)" "unprognostic (7.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.08e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (3.34e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-2)" "unprognostic (7.76e-2)" 48.1 16.1 6.2 9.5 8.3 1.1 34.4 10.9 11.6 13.3 19.0 1.5 8.4 15.2 8.8 8.4 12.5 8.8 24.1 43.4 4.2 11.2 6.9 13.6 17.8 9.5 6.3 5.5 11.2 7.6 8.5 5.0 10.0 17.7 22.8 7.0 23.7 10.4 9.4 17.1 8.2 17.8 17.6 3.5 8.0 13.1 9.3 2.2 1.1 22.0 11.4 3.4 35.1 41.5 4.4 0.4 2.4 0.3 2.5 1.3 0.5 0.0 0.3 0.6 0.1 25.0 7.4 8.4 0.2 0.6 0.1 0.3 0.0 0.1 0.0 8.1 0.7 0.1 0.2 0.0 10.7 0.0 0.0 0.0 0.1 0.1 19.1 38.0 0.0 0.0 31.0 2.3 0.8 0.8 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.2 41.5 0.0 0.0 0.8 1.9 0.0 0.2 0.0 1.0 0.5 0.1 0.0 0.4 0.0 0.1 0.0 0.1 3.2 0.0 0.3 0.4 0.5 0.2 0.3 3.4 0.4 0.2 0.4 4.4 0.7 1.3 2.4 2.5 0.2 0.0 0.5 0.5 6.2 8.3 10.9 11.6 4.2 11.2 6.3 5.5 17.7 2.2 3.0 1.3 0.0 1.2 9.6 24.0 3.4 0.0 25.4 10.3 0.0 0.0 0.9 0.0 0.8 0.7 16.2 0.0 0.0 0.2 0.5 13.7 0.7 0.0 0.9 0.4 7.9 0.0 3.7 0.0 1.1 88.6 3.5 74.2 0.0 0.0 17.5 0.2 0.0 21.9 0.0 10.0 90.5 44.5 1.0 1.2 5.8 2.4 0.5 0.0 0.6 DBNDD1 "FLJ12582, MGC3101" ENSG00000003249 "Dysbindin domain containing 1" Q9H9R9 16 90004865-90020128 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.6;skeletal muscle: 39.7" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 13.8;Exocrine glandular cells: 16.0;Horizontal cells: 28.6;Pancreatic endocrine cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "naive B-cell: 14.4" "Lineage enriched" "Detected in many" 6 "B-cells: 14.4" "Cell line enhanced" "Detected in many" "MCF7: 47.7" HPA043018 Uncertain Approved "Nuclear speckles,Cytosol" No No "Nuclear speckles" Cytosol "HPA043018: AB_10794921" "unprognostic (1.07e-1)" "unprognostic (8.40e-2)" "unprognostic (8.70e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-2)" "unprognostic (4.18e-2)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.07e-2)" "unprognostic (9.52e-2)" "unprognostic (1.54e-1)" "unprognostic (2.86e-2)" "prognostic favorable (2.75e-7)" "unprognostic (1.03e-1)" "unprognostic (5.67e-1)" "unprognostic (2.44e-2)" "unprognostic (2.00e-2)" 2.1 6.9 21.5 2.3 13.7 0.8 4.7 16.1 31.6 2.6 2.0 6.5 1.9 1.9 1.4 9.6 13.9 3.9 3.9 3.4 15.7 14.6 6.9 6.2 3.0 3.9 17.6 9.4 3.1 14.1 6.3 3.0 0.6 19.2 3.7 1.8 3.9 11.9 3.8 39.7 3.9 1.2 1.6 6.8 1.6 4.3 1.1 4.5 0.0 3.6 2.3 4.7 2.0 2.3 14.4 0.1 0.6 0.0 0.0 2.5 0.8 7.8 12.0 1.1 14.5 0.3 0.1 8.6 1.7 2.2 3.5 1.7 11.7 6.4 0.0 1.0 0.3 3.3 8.2 12.7 0.3 3.4 0.0 23.1 0.0 1.7 19.1 0.5 0.1 1.3 0.3 1.0 6.1 0.0 8.1 15.2 0.2 2.2 0.1 1.2 47.7 0.0 9.9 20.3 5.7 5.1 4.8 11.0 0.2 19.8 1.5 17.5 18.7 1.9 1.7 14.9 3.3 11.3 1.3 12.2 2.8 5.5 0.1 7.8 0.0 0.1 0.0 1.2 0.9 6.9 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.6 0.4 0.0 14.4 2.5 0.4 0.0 0.0 0.0 0.1 0.0 0.8 21.5 13.7 16.1 31.6 15.7 14.6 17.6 9.4 19.2 4.5 3.0 1.3 0.8 0.5 0.3 1.3 2.2 7.6 1.4 2.3 8.7 0.0 0.1 8.3 13.8 0.0 0.6 0.3 0.0 16.0 0.2 0.2 4.5 0.0 2.0 0.3 28.6 5.8 1.8 0.0 0.0 1.1 0.0 3.3 0.0 2.1 5.1 15.0 2.9 0.4 7.3 1.2 0.0 0.7 0.0 1.9 0.9 0.0 0.0 0.6 1.0 DDX46 "FLJ25329, KIAA0801, Prp5, PRPF5" ENSG00000145833 "DEAD-box helicase 46" Q7L014 5 134758771-134855133 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036554, HPA057501" Supported Supported "Nucleoli fibrillar center,Nuclear speckles" NA NA "Nuclear speckles" "Nucleoli fibrillar center" "HPA036554: AB_10673621, HPA057501: AB_2683449" "unprognostic (1.88e-1)" "unprognostic (1.21e-1)" "prognostic favorable (9.01e-6)" "unprognostic (7.00e-2)" "unprognostic (3.37e-2)" "unprognostic (1.71e-2)" "unprognostic (2.04e-3)" "unprognostic (1.07e-1)" "unprognostic (1.60e-2)" "unprognostic (5.05e-2)" "unprognostic (9.21e-2)" "unprognostic (6.02e-2)" "unprognostic (9.70e-3)" "unprognostic (4.36e-2)" "unprognostic (4.35e-2)" "unprognostic (1.64e-2)" "unprognostic (4.50e-2)" 22.2 21.8 18.8 29.4 23.8 22.7 22.7 39.0 24.8 25.1 21.4 17.5 18.6 19.0 26.8 19.8 23.7 21.0 15.8 18.3 17.7 13.0 22.9 22.7 21.6 26.6 22.9 15.1 25.8 24.2 27.2 37.5 22.1 21.7 19.0 24.2 12.8 23.9 23.3 46.6 26.3 23.0 24.6 27.8 30.0 22.2 17.8 25.9 40.4 22.1 21.0 29.1 23.1 28.9 27.0 23.5 34.6 19.9 19.4 20.4 9.7 26.0 23.9 17.1 22.2 6.7 7.5 23.6 17.5 13.6 18.5 20.9 36.2 19.1 32.9 15.1 11.7 19.7 16.2 25.1 16.7 21.9 22.1 22.8 39.6 26.2 14.6 5.8 35.9 21.4 6.7 9.1 19.5 11.0 7.9 14.6 26.6 33.6 14.2 13.7 12.4 30.9 14.0 23.5 15.2 10.8 27.0 44.7 16.6 10.1 22.6 20.3 19.4 24.5 11.6 12.6 20.8 18.2 20.6 18.1 19.7 13.7 15.0 34.6 11.2 30.3 43.7 13.6 34.2 12.4 25.7 19.9 27.6 20.0 17.5 18.0 22.0 19.6 19.8 15.2 27.0 20.4 20.3 34.6 19.4 15.7 23.5 17.1 9.7 18.8 23.8 39.0 24.8 17.7 13.0 22.9 15.1 21.7 25.9 71.5 105.7 105.4 97.5 101.1 127.7 65.7 58.6 77.6 91.0 97.7 78.5 115.9 48.0 74.4 33.8 94.6 63.5 46.7 93.1 132.3 81.3 98.0 97.2 105.0 85.5 114.4 88.5 70.0 102.8 19.1 103.6 110.8 54.0 131.7 71.2 91.8 98.0 56.1 106.4 70.1 171.0 97.0 97.9 194.9 273.4 119.7 131.5 115.4 84.3 132.0 DENND1B "C1orf218, FAM31B, FLJ20054, MGC27044" ENSG00000213047 "DENN domain containing 1B" Q6P3S1 1 197504748-197775696 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042586 Uncertain Supported "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA042586: AB_2678064" "unprognostic (8.79e-2)" "unprognostic (1.58e-1)" "unprognostic (4.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.39e-1)" "unprognostic (7.13e-3)" "unprognostic (2.69e-1)" "unprognostic (9.54e-2)" "unprognostic (7.79e-3)" "unprognostic (3.99e-2)" "unprognostic (3.13e-2)" "unprognostic (5.36e-2)" "unprognostic (6.11e-2)" "unprognostic (5.61e-3)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-2)" 5.9 3.9 6.2 12.7 8.3 6.4 8.7 3.9 5.6 5.7 13.0 1.4 8.8 7.5 3.6 6.4 9.0 3.1 5.4 7.3 4.9 4.9 7.9 6.6 7.3 7.8 4.0 2.7 5.6 8.7 9.9 15.9 3.6 3.7 7.5 7.8 6.4 9.9 15.8 6.5 3.8 21.6 4.1 3.5 7.7 6.1 4.4 2.6 17.9 8.2 6.5 11.7 6.9 6.8 2.3 2.0 5.0 0.6 5.8 3.6 0.7 6.0 1.5 1.7 2.9 0.8 4.5 2.7 4.6 3.2 2.9 1.7 1.6 3.9 11.0 2.4 7.1 1.7 3.1 2.7 3.4 2.5 8.3 3.0 4.0 3.0 0.8 2.4 12.9 4.9 1.5 4.6 1.1 3.2 8.8 1.2 6.4 3.0 17.1 2.8 1.1 6.9 6.6 0.6 1.5 1.5 4.3 1.5 8.6 7.1 5.7 3.0 4.7 7.1 4.8 1.2 2.9 2.0 11.3 3.4 0.3 2.8 0.1 2.7 8.7 0.0 5.6 3.0 5.3 5.3 5.0 0.3 2.3 2.1 0.6 1.1 2.3 1.4 3.3 1.5 0.7 0.8 1.5 1.0 5.8 0.6 2.0 3.6 0.7 6.2 8.3 3.9 5.6 4.9 4.9 4.0 2.7 3.7 2.6 38.7 11.5 19.6 20.9 7.4 19.3 24.6 12.7 4.0 12.5 14.0 23.6 8.1 14.9 8.1 25.6 4.8 51.6 0.0 19.9 7.7 8.9 21.4 63.5 14.3 17.9 4.8 13.8 8.0 21.7 19.7 22.2 29.4 15.1 13.6 24.1 7.1 17.6 42.1 12.4 13.2 13.8 0.0 2.9 8.0 13.3 10.7 6.2 33.8 22.4 47.8 DEXI MYLE ENSG00000182108 "Dexi homolog" O95424 16 10928891-10942460 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041511 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA041511: AB_10796675" "unprognostic (4.14e-1)" "unprognostic (8.52e-2)" "unprognostic (1.29e-1)" "unprognostic (9.70e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (1.19e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "unprognostic (1.47e-2)" "prognostic favorable (4.23e-4)" "unprognostic (5.21e-2)" "unprognostic (1.33e-3)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.75e-2)" "unprognostic (1.83e-2)" 15.0 25.2 15.7 8.0 20.8 4.1 10.7 14.0 27.5 12.2 13.9 9.8 12.7 11.1 11.7 18.5 12.9 14.5 11.6 32.2 13.1 13.6 13.3 26.3 9.5 9.9 18.8 12.3 15.9 18.0 22.1 12.9 13.3 21.3 13.6 6.6 13.7 15.4 16.6 81.6 10.3 11.1 12.1 9.4 12.7 10.6 8.9 11.9 13.7 18.4 10.6 8.1 10.9 10.5 4.0 2.4 8.2 0.7 3.9 7.0 1.2 9.5 13.9 7.5 13.2 30.6 16.9 6.9 14.7 15.4 9.7 9.2 6.5 10.0 11.3 22.2 16.6 10.5 12.4 8.8 15.8 8.3 26.6 19.8 5.6 9.1 27.5 17.6 9.6 10.7 17.1 18.3 9.4 11.0 15.7 13.9 16.2 12.8 11.4 10.7 16.8 11.9 10.5 10.5 11.8 14.5 11.1 9.9 17.3 11.9 7.1 15.5 13.6 14.0 15.5 11.7 6.6 12.3 16.8 15.2 9.8 10.5 23.0 9.6 15.1 11.6 3.3 8.6 20.7 11.0 1.7 0.6 8.2 6.0 0.7 5.6 0.6 5.2 7.0 0.4 4.0 6.4 6.0 0.7 3.9 0.3 2.4 3.9 1.2 15.7 20.8 14.0 27.5 13.1 13.6 18.8 12.3 21.3 11.9 6.0 8.9 13.4 27.4 29.7 18.1 0.0 48.4 8.1 2.3 26.2 11.8 20.0 64.6 22.3 6.3 18.5 9.7 0.0 31.5 17.9 28.6 35.2 1.1 87.3 33.0 22.3 14.3 38.1 12.3 11.5 69.6 8.7 15.1 16.2 13.5 38.1 25.7 13.9 80.6 56.2 12.9 19.4 35.5 2.4 2.7 28.4 9.7 18.1 16.8 37.0 DRP2 ENSG00000102385 "Dystrophin related protein 2" Q13474 X 101219769-101264497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.3" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 2.3;Intestinal endocrine cells: 1.7;Peritubular cells: 2.1" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 11.3;TIME: 19.0;U-87 MG: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002949 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles, Plasma membrane" "HPA002949: AB_1078706" "unprognostic (8.47e-4)" "unprognostic (3.56e-3)" "unprognostic (1.01e-2)" "unprognostic (5.58e-4)" "unprognostic (1.74e-2)" "unprognostic (2.47e-2)" "unprognostic (7.93e-3)" "unprognostic (2.94e-3)" "unprognostic (1.27e-2)" "unprognostic (5.46e-3)" "unprognostic (1.42e-1)" "unprognostic (4.61e-2)" "unprognostic (4.44e-16)" "unprognostic (3.71e-4)" "unprognostic (4.22e-1)" "unprognostic (9.03e-2)" "unprognostic (1.25e-1)" 1.1 1.5 9.3 1.2 17.2 1.1 0.8 0.4 20.3 1.7 2.8 1.2 0.0 1.1 2.5 2.7 1.3 1.0 1.3 0.9 5.8 4.2 0.7 0.6 0.8 0.8 4.6 10.1 4.4 0.6 0.6 2.4 0.7 2.6 4.1 1.8 0.5 0.7 3.1 0.7 0.8 1.2 2.2 3.1 0.7 0.7 1.6 2.2 0.9 0.6 0.0 0.8 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.7 2.4 0.1 0.1 0.2 0.1 0.5 0.1 0.4 1.0 0.0 0.4 0.3 0.3 0.1 0.7 0.0 0.3 0.0 0.8 0.1 0.2 0.2 0.5 0.0 0.2 0.1 0.5 1.5 0.0 0.8 0.0 0.1 1.4 0.5 0.0 1.0 1.6 0.0 1.3 0.5 0.1 0.1 0.1 0.3 11.3 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.5 0.0 0.1 19.0 0.2 0.7 0.2 0.4 0.0 0.1 0.0 4.6 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 9.3 17.2 0.4 20.3 5.8 4.2 4.6 10.1 2.6 2.2 0.0 0.0 0.0 0.0 0.1 2.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUSP28 "DUSP26, VHP" ENSG00000188542 "Dual specificity phosphatase 28" Q4G0W2 2 240560054-240564014 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047456, CAB069448" Uncertain Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB069448: , HPA047456: AB_10961145" "unprognostic (1.88e-2)" "unprognostic (9.29e-2)" "unprognostic (4.86e-2)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (7.56e-3)" "unprognostic (4.13e-3)" "unprognostic (3.71e-2)" "prognostic favorable (1.84e-4)" "unprognostic (9.85e-2)" "unprognostic (1.80e-3)" "unprognostic (6.99e-2)" "unprognostic (2.52e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-3)" 1.8 2.8 2.7 3.0 3.4 7.9 3.5 6.3 3.7 3.1 2.6 3.3 6.5 2.9 2.6 5.0 3.5 3.1 4.4 16.3 2.8 2.7 3.2 3.4 2.5 6.1 3.5 2.4 2.6 10.2 2.6 5.0 3.2 2.8 4.3 2.8 2.7 3.7 2.4 21.2 4.9 4.2 4.3 2.2 5.9 4.2 8.2 2.3 2.6 4.4 13.4 4.2 2.8 4.5 3.8 3.3 10.7 2.1 2.7 3.3 2.0 1.7 1.6 2.2 2.6 1.4 0.8 2.4 1.9 1.2 1.5 1.1 1.0 4.5 2.7 1.0 1.2 2.3 5.1 1.7 0.7 1.6 3.4 6.4 3.9 3.4 2.5 1.0 2.5 6.7 1.7 1.8 1.0 1.3 2.9 0.7 3.9 2.7 3.3 1.3 1.9 3.1 4.0 1.4 2.6 1.4 3.8 4.8 3.6 1.1 2.9 4.9 2.7 1.8 1.9 2.2 1.4 2.4 4.4 1.7 3.5 2.9 2.2 1.7 13.2 3.8 4.4 2.2 1.9 2.8 10.7 2.1 0.7 2.7 1.4 3.0 2.1 2.8 2.8 1.2 3.8 3.3 3.0 3.6 2.7 1.5 3.3 2.2 2.0 2.7 3.4 6.3 3.6 2.8 2.7 3.5 2.4 2.8 2.3 0.0 5.0 5.1 6.9 3.3 6.3 12.9 12.7 6.7 1.2 12.2 3.9 6.4 13.3 4.1 27.6 3.1 11.8 0.0 5.1 4.0 4.1 8.4 6.9 6.6 10.0 7.9 8.1 2.5 10.3 29.8 2.8 7.0 6.8 8.2 8.1 7.4 3.9 11.8 1.4 11.2 6.6 6.5 5.6 41.1 17.6 4.6 5.8 12.5 10.1 6.8 EEPD1 KIAA1706 ENSG00000122547 "Endonuclease/exonuclease/phosphatase family domain containing 1" Q7L9B9 7 36153149-36301543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 28.1;Hofbauer cells: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.2;neutrophil: 21.9" "Group enriched" "Detected in many" 6 "granulocytes: 23.2;T-cells: 11.5" "Cell line enhanced" "Detected in many" "GAMG: 13.4;HDLM-2: 13.9;PC-3: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053668 Approved "Nuclear speckles,Vesicles" NA NA "Nuclear speckles" Vesicles "HPA053668: AB_2682223" "unprognostic (1.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.54e-3)" "unprognostic (5.21e-3)" "unprognostic (1.14e-1)" "unprognostic (4.76e-1)" "unprognostic (1.19e-2)" "unprognostic (3.75e-2)" "unprognostic (7.89e-2)" "unprognostic (8.77e-2)" "unprognostic (7.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (6.52e-2)" "unprognostic (2.23e-2)" "unprognostic (4.59e-2)" 20.3 5.1 4.9 6.4 8.6 8.1 22.5 3.3 19.3 9.6 15.2 11.8 6.5 11.0 12.5 5.6 6.5 5.4 18.4 6.2 6.4 5.4 3.7 15.2 8.7 4.6 13.3 3.5 6.9 8.1 2.4 3.3 4.6 5.6 8.2 4.5 5.7 3.8 4.3 39.7 10.2 23.6 9.1 10.2 7.5 10.5 3.4 7.7 11.5 2.2 4.4 3.6 6.1 10.9 0.1 1.5 23.2 2.8 1.7 11.5 2.0 1.6 4.6 1.4 4.4 13.1 2.8 0.1 1.1 5.6 0.9 1.6 0.9 3.5 4.5 1.4 1.7 13.4 1.9 1.9 2.2 0.8 13.9 3.1 0.6 0.4 8.4 1.2 0.7 4.4 5.9 1.4 0.5 0.3 3.6 0.1 3.4 5.4 0.5 1.0 1.8 4.5 11.1 6.4 5.7 17.6 1.2 1.6 0.9 2.8 3.6 3.5 2.4 0.4 0.6 1.7 2.7 1.4 5.4 0.4 1.7 5.2 1.2 1.3 3.5 3.7 0.0 4.3 2.9 1.1 10.0 2.8 23.2 1.5 1.7 2.6 0.1 11.5 3.3 1.5 0.0 2.6 0.7 21.9 1.7 0.7 1.3 5.1 2.0 4.9 8.6 3.3 7.5 6.4 5.4 13.3 3.5 5.6 7.7 0.0 0.3 0.5 11.6 2.4 2.1 3.4 28.1 2.7 0.0 0.0 19.6 0.1 5.0 17.7 15.1 12.6 10.1 0.0 6.5 0.2 2.3 7.2 9.2 16.0 25.1 6.4 9.2 0.6 5.2 3.6 4.6 6.2 3.3 1.8 5.8 1.9 11.6 6.8 15.6 1.9 0.8 6.5 5.9 0.5 4.1 3.4 0.5 1.5 5.9 8.1 EGFL8 "C6orf8, NG3" ENSG00000241404 "EGF like domain multiple 8" Q99944 6 32164583-32168281 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061173 Uncertain Approved "Nuclear speckles,Vesicles" "Secreted - unknown location" NA NA Vesicles "Nuclear speckles" "HPA061173: AB_2684443" "unprognostic (7.13e-2)" "unprognostic (1.86e-1)" "unprognostic (6.79e-3)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (7.60e-4)" "unprognostic (3.42e-2)" "unprognostic (2.49e-1)" "unprognostic (6.42e-3)" "unprognostic (1.97e-1)" "unprognostic (7.60e-3)" "unprognostic (8.11e-3)" "unprognostic (1.07e-4)" "unprognostic (1.11e-1)" "unprognostic (6.79e-2)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" 4.5 6.3 7.3 2.6 7.6 4.5 5.0 6.3 9.4 7.1 6.7 8.4 8.7 4.7 6.4 5.5 4.3 4.8 8.4 4.8 8.2 4.4 4.3 1.8 4.3 2.0 25.7 3.9 14.4 2.9 1.3 2.9 9.2 14.1 6.0 2.7 14.7 3.9 5.3 3.8 12.9 5.8 3.0 11.9 3.5 3.9 2.3 7.0 0.2 3.1 8.3 2.0 5.2 6.8 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.3 1.3 3.2 0.4 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.2 0.0 0.0 2.0 1.3 0.4 0.0 0.0 1.9 0.0 1.0 3.6 1.1 0.0 0.7 0.0 0.3 0.3 0.0 0.1 0.7 2.2 0.3 0.0 0.0 1.7 1.0 3.0 0.0 0.3 0.0 1.1 0.1 0.0 0.2 0.6 0.5 1.2 0.0 0.1 3.7 0.0 1.4 2.2 0.0 0.8 1.7 0.0 0.1 0.0 0.1 0.1 0.1 1.1 1.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.3 7.6 6.3 9.4 8.2 4.4 25.7 3.9 14.1 7.0 6.0 5.5 0.0 0.6 1.3 1.4 0.1 0.0 2.7 2.3 1.8 2.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.2 0.3 0.8 0.6 0.0 0.0 0.2 0.0 0.0 2.5 0.3 0.0 3.4 0.0 0.0 0.0 1.0 1.1 0.2 0.0 1.1 0.0 1.1 0.0 1.2 0.4 0.4 1.9 0.7 0.0 1.2 0.4 EHMT2 "BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a" ENSG00000204371 "Euchromatic histone lysine methyltransferase 2" Q96KQ7 6 31879759-31897687 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HL-60: 10.3;NTERA-2: 15.8;U-266/84: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050550, HPA060259" Supported Supported "Nucleoplasm,Nuclear speckles" "Intracellular and membrane" NA NA "Nuclear speckles" Nucleoplasm "HPA050550: AB_2681170, HPA060259: AB_2684234" "unprognostic (3.11e-2)" "unprognostic (2.72e-1)" "unprognostic (4.39e-2)" "unprognostic (1.92e-2)" "unprognostic (5.44e-2)" "unprognostic (3.51e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (3.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.89e-2)" "unprognostic (1.88e-1)" "unprognostic (9.78e-3)" "unprognostic (8.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.25e-1)" "unprognostic (9.03e-2)" 9.4 12.2 13.1 9.6 21.4 7.6 6.3 17.1 17.5 8.0 7.7 12.3 8.4 14.6 15.0 11.7 18.0 7.6 8.1 7.6 12.3 12.4 5.3 4.4 8.5 6.9 12.6 10.6 10.6 13.2 2.2 8.1 6.0 10.3 10.4 4.3 7.2 5.6 9.6 5.2 5.5 10.1 9.6 8.4 9.1 9.8 7.6 14.9 14.6 9.5 4.8 7.2 8.7 7.6 0.3 0.6 0.0 0.7 0.1 1.1 1.3 0.0 3.6 6.4 0.0 2.8 1.5 4.1 2.8 2.3 3.2 2.6 0.0 0.0 0.0 6.3 4.5 3.3 0.0 0.0 6.9 1.5 4.2 9.6 0.0 0.0 0.0 0.0 10.3 0.0 3.9 1.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 7.3 0.0 15.8 0.0 0.0 6.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.8 5.3 2.7 0.0 0.0 3.0 3.4 2.6 5.7 0.0 9.1 12.4 3.0 3.9 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.2 0.1 0.8 0.6 0.3 0.3 1.1 1.1 0.0 0.1 0.7 0.6 0.2 1.3 13.1 21.4 17.1 16.5 12.3 12.4 12.6 10.6 10.3 14.9 14.9 11.8 22.3 5.6 7.4 59.2 4.5 22.9 9.4 19.4 24.4 39.3 19.7 6.6 12.9 33.8 11.9 8.9 0.0 10.6 12.5 13.2 5.8 13.9 6.4 14.1 36.5 21.7 20.3 9.1 44.9 25.3 9.9 18.6 16.2 15.5 28.2 11.0 5.8 21.5 7.8 48.2 25.8 8.5 6.1 30.6 9.7 4.7 14.9 15.0 2.6 ELOA "SIII, TCEB3, TCEB3A" ENSG00000011007 "Elongin A" Q14241 1 23743155-23762059 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 68.1;monocytes: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005910 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA005910: AB_1080227" "unprognostic (6.90e-2)" "unprognostic (5.99e-3)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.99e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.72e-1)" "unprognostic (8.84e-3)" "unprognostic (6.00e-2)" "unprognostic (4.94e-2)" "unprognostic (2.14e-2)" "unprognostic (2.95e-3)" "unprognostic (2.90e-1)" "unprognostic (4.27e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 25.6 13.7 10.0 14.2 16.1 22.9 16.3 16.0 17.2 13.7 12.2 15.2 15.1 9.8 15.0 9.0 23.6 13.3 15.7 12.9 9.9 9.8 18.1 41.7 20.3 24.1 10.3 12.5 16.0 41.5 19.1 17.1 19.6 12.7 13.6 13.5 13.0 18.6 13.4 26.0 18.3 14.1 14.0 10.9 20.5 24.6 14.4 10.0 19.3 18.4 22.4 21.8 15.6 14.5 20.7 18.8 18.3 20.9 11.0 14.8 13.2 20.3 11.4 16.5 14.1 19.5 12.2 10.4 21.1 19.1 31.5 27.6 13.9 17.9 10.7 26.0 21.4 17.7 19.6 33.8 22.2 35.3 30.6 16.7 24.1 17.8 16.2 17.3 25.2 14.6 12.9 18.0 34.3 26.3 11.7 18.8 17.7 35.6 18.6 25.1 15.4 13.0 10.3 19.1 22.9 17.3 19.6 21.0 20.3 14.8 13.9 31.5 17.7 19.2 19.4 23.4 19.2 14.0 9.3 19.9 24.8 21.9 43.9 24.8 19.3 21.5 23.6 21.7 25.2 24.7 18.3 19.8 15.4 14.8 20.9 14.6 20.7 12.4 13.3 18.8 16.6 10.2 13.4 5.5 11.0 18.4 15.5 14.0 13.2 10.0 16.1 16.0 17.2 9.9 9.8 10.3 12.5 12.7 10.0 26.8 68.1 0.0 0.0 0.0 0.0 0.0 0.0 30.8 33.0 17.4 0.0 23.2 5.0 34.1 0.0 0.0 0.0 0.0 28.4 28.4 0.0 0.0 12.8 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 61.3 0.0 0.0 32.3 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 EPOR ENSG00000187266 "Erythropoietin receptor" P19235 19 11377205-11384342 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted membrane proteins" Receptor "Cancer-related genes, Congenital erythrocytosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Ito cells: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA077654 Supported "Nuclear speckles,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA077654: " "unprognostic (9.13e-2)" "unprognostic (7.14e-2)" "unprognostic (1.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (1.11e-1)" "unprognostic (3.70e-1)" "unprognostic (1.50e-2)" "unprognostic (5.60e-2)" "unprognostic (9.00e-2)" "prognostic favorable (3.17e-5)" "unprognostic (6.37e-3)" "unprognostic (1.59e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-1)" "unprognostic (7.48e-2)" "unprognostic (1.01e-3)" 5.5 8.6 2.1 1.1 2.9 14.7 2.6 1.3 1.7 3.9 3.3 2.8 13.3 1.0 3.6 11.6 2.4 3.2 1.8 11.2 1.9 1.4 12.1 8.4 8.5 6.9 1.9 1.6 1.9 9.2 28.1 5.2 12.7 2.3 3.1 1.4 3.3 8.7 18.3 2.0 1.1 1.7 1.5 4.0 8.0 3.7 2.2 1.0 1.6 21.5 1.0 1.5 1.9 2.1 2.6 2.5 12.2 7.7 0.9 4.8 2.9 3.5 1.2 3.5 4.1 5.4 3.4 2.1 2.2 6.8 3.6 4.6 1.2 1.3 2.4 3.9 4.0 5.0 0.9 2.7 1.4 4.2 2.0 1.6 13.1 1.1 2.0 3.8 2.7 5.5 2.5 0.5 4.8 3.3 8.4 8.3 5.1 11.6 11.7 4.0 3.1 2.5 3.3 1.9 1.9 9.4 6.7 6.0 5.3 3.3 1.8 1.4 11.0 1.4 2.0 6.1 3.9 3.6 4.7 3.4 1.9 2.7 6.5 2.0 6.0 4.3 2.6 10.5 2.7 2.0 8.1 4.2 3.3 2.1 5.1 4.5 2.6 4.2 3.1 2.5 1.6 4.8 2.8 12.2 0.9 7.7 0.1 3.7 2.9 2.1 2.9 1.3 1.7 1.9 1.4 1.9 1.6 2.3 1.0 17.9 16.8 5.3 3.5 2.1 2.5 5.1 7.6 2.7 4.5 19.2 0.0 1.8 3.3 2.0 0.7 6.5 0.3 70.0 2.9 11.5 7.6 2.4 26.5 1.9 32.5 1.6 8.1 78.5 15.6 0.0 2.6 3.1 8.5 1.0 2.3 11.1 3.8 0.0 3.9 0.8 2.2 19.4 20.8 3.3 6.4 0.9 2.5 8.7 1.4 1.1 ERBIN "ERBB2IP, LAP2" ENSG00000112851 "Erbb2 interacting protein" Q96RT1 5 65926475-66082549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 65.5;Alveolar cells type 2: 48.1;Ciliated cells: 44.2;Club cells: 58.0;Collecting duct cells: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048606, HPA059863" Approved Supported "Nuclear speckles,Plasma membrane" NA NA 250000 "Nuclear speckles, Plasma membrane" "HPA048606: AB_2680461, HPA059863: AB_2684146" "unprognostic (4.34e-1)" "unprognostic (5.56e-2)" "unprognostic (9.88e-2)" "unprognostic (2.15e-2)" "unprognostic (2.04e-1)" "unprognostic (4.23e-3)" "unprognostic (1.74e-1)" "unprognostic (1.01e-1)" "unprognostic (1.46e-2)" "unprognostic (6.52e-2)" "unprognostic (5.45e-3)" "unprognostic (7.98e-2)" "unprognostic (5.62e-3)" "unprognostic (7.21e-3)" "unprognostic (3.08e-1)" "unprognostic (6.86e-2)" "unprognostic (7.81e-2)" 20.1 8.7 33.2 28.5 32.7 13.3 13.0 5.4 15.9 16.1 21.1 10.6 16.3 12.1 14.5 22.1 17.2 10.5 17.2 12.6 29.5 22.5 15.8 24.1 20.1 21.1 32.5 7.4 11.1 13.7 15.4 6.9 10.4 16.0 18.2 13.8 11.1 17.3 26.0 16.4 16.9 37.4 15.3 31.0 27.6 20.3 13.3 17.6 40.2 19.6 16.3 19.6 20.7 14.9 6.2 4.5 13.5 7.6 5.0 7.1 3.6 30.6 10.3 13.5 16.1 10.1 12.3 10.3 19.7 20.3 28.2 31.5 9.8 36.6 25.9 19.3 30.5 22.2 10.3 8.6 14.4 49.9 11.3 3.9 9.0 13.1 7.7 13.3 6.8 8.7 13.3 9.6 15.4 22.5 16.6 10.4 11.9 9.0 17.8 19.0 10.4 18.1 7.9 3.3 3.0 3.0 16.7 10.9 14.2 16.5 20.9 6.6 6.1 21.0 7.0 14.9 10.6 12.2 16.9 9.5 16.0 28.5 9.6 25.3 15.4 9.6 22.2 10.5 11.4 9.1 13.5 5.2 6.7 7.1 7.6 6.5 6.2 5.5 6.3 4.5 4.9 6.5 6.7 11.9 5.0 6.0 2.9 4.8 3.6 33.2 32.7 5.4 15.3 29.5 22.5 32.5 7.4 16.0 17.6 65.5 48.1 0.0 0.0 0.0 0.0 0.0 0.0 44.2 58.0 50.6 0.0 5.1 10.0 23.8 0.0 0.0 0.0 0.0 21.5 8.9 0.0 0.0 25.6 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 10.0 0.0 0.0 35.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 FAM160B1 "bA106M7.3, KIAA1600" ENSG00000151553 "Family with sequence similarity 160 member B1" Q5W0V3 10 114821744-114899832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043624 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA043624: AB_10797145" "unprognostic (2.61e-1)" "unprognostic (2.47e-2)" "unprognostic (2.62e-1)" "unprognostic (8.45e-3)" "unprognostic (6.43e-2)" "unprognostic (9.87e-3)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (2.29e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (4.02e-6)" "unprognostic (3.41e-3)" "unprognostic (3.35e-1)" "unprognostic (2.10e-1)" "unprognostic (1.25e-2)" 15.9 13.3 9.9 12.1 13.1 40.9 31.0 10.2 15.7 11.7 10.8 6.1 11.8 11.2 18.4 10.6 9.8 13.4 11.0 18.1 7.7 5.9 7.4 16.8 13.4 18.7 5.9 8.5 15.1 10.8 13.6 11.4 14.4 7.0 10.0 7.6 8.5 9.6 11.0 42.6 9.4 13.4 18.7 6.7 12.1 10.9 16.0 5.2 17.7 12.9 7.2 8.8 13.6 19.7 3.4 3.2 15.0 2.7 3.9 8.7 2.0 9.0 5.1 5.6 8.3 13.7 15.7 6.4 16.5 16.6 9.9 8.0 1.8 3.6 5.5 4.9 15.5 2.5 6.2 2.7 6.8 11.7 18.5 5.2 2.2 8.9 4.0 10.0 5.8 7.5 12.2 6.6 7.4 12.0 21.3 13.2 11.5 2.9 14.2 18.4 4.3 10.0 5.8 3.6 2.7 3.5 8.7 9.2 3.7 6.7 5.6 1.2 5.0 7.3 7.9 8.5 6.9 3.1 3.4 13.2 6.1 3.9 17.8 5.8 5.4 1.5 6.4 7.9 14.8 5.7 15.0 2.7 3.9 5.0 2.1 3.7 3.4 6.8 8.5 3.1 3.2 3.8 5.0 13.6 3.9 2.3 3.2 8.7 2.0 9.9 13.1 10.2 15.7 7.7 5.9 5.9 8.5 7.0 5.2 14.9 7.2 2.9 5.4 6.3 13.1 13.7 5.1 5.3 5.7 3.5 11.8 9.9 1.7 8.9 20.4 15.8 12.8 0.0 8.4 8.6 13.4 13.2 2.3 25.6 5.4 9.5 7.5 22.7 17.0 26.1 26.4 6.1 3.3 4.6 8.1 10.1 11.9 4.2 20.8 5.7 16.3 6.5 8.5 10.4 4.8 4.3 10.5 10.7 5.2 8.8 FAM178B LOC51252 ENSG00000168754 "Family with sequence similarity 178 member B" Q8IXR5 2 96875882-96986592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.2;lymphoid tissue: 13.3;testis: 29.5" "Cell type enhanced" "Detected in some" 17 "Extravillous trophoblasts: 6.9;Late spermatids: 5.1;Spermatogonia: 19.4" "Cancer enriched" "Detected in many" 5 "melanoma: 8.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD4 T-cell: 2.6" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Cell line enhanced" "Detected in some" "K-562: 17.5;OE19: 4.8;RH-30: 4.8;RPMI-8226: 19.1;WM-115: 19.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042516, HPA062110" Uncertain Uncertain "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA042516: AB_10806241, HPA062110: " "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (1.08e-2)" "unprognostic (8.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.28e-2)" "unprognostic (9.02e-4)" "unprognostic (4.70e-2)" "unprognostic (8.55e-2)" "unprognostic (6.49e-3)" "unprognostic (1.49e-1)" "unprognostic (5.13e-2)" "unprognostic (9.82e-11)" "unprognostic (6.93e-2)" "unprognostic (1.57e-1)" "unprognostic (9.63e-3)" "unprognostic (1.08e-1)" 0.8 0.0 2.4 0.6 3.8 18.2 0.6 1.0 1.5 0.6 1.0 0.6 0.6 0.1 0.7 6.8 0.6 1.5 0.6 0.6 3.4 1.9 0.6 0.6 0.6 0.6 5.3 0.6 0.6 0.6 0.0 0.6 1.1 0.6 0.6 0.2 1.0 0.6 1.0 0.6 1.2 0.6 0.6 8.5 13.3 0.0 29.5 0.6 0.6 0.6 0.6 0.6 1.0 0.6 0.0 0.8 0.0 0.0 0.1 2.6 0.6 4.2 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.4 1.7 0.0 0.0 0.1 4.8 0.0 0.0 4.8 19.1 0.0 0.0 0.6 0.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 19.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 1.7 0.0 0.1 0.0 0.8 0.0 0.6 2.4 3.8 1.0 1.5 3.4 1.9 5.3 0.6 0.6 0.6 0.0 0.0 0.8 0.6 0.7 0.1 0.3 0.0 0.0 0.0 0.0 2.0 2.7 0.0 0.0 2.4 0.0 0.0 0.0 0.0 6.9 1.4 0.2 0.0 0.0 1.1 1.6 0.0 0.6 0.0 5.1 0.9 0.3 3.3 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 1.7 19.4 1.5 2.1 0.0 0.0 0.1 FASTK FAST ENSG00000164896 "Fas activated serine/threonine kinase" Q14296 7 151076593-151080866 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031621, CAB032539" Approved Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "CAB032539: AB_2101115, HPA031621: AB_10611966" "unprognostic (7.67e-2)" "unprognostic (6.41e-3)" "prognostic unfavorable (4.73e-4)" "unprognostic (2.60e-1)" "unprognostic (1.75e-3)" "unprognostic (2.03e-3)" "unprognostic (1.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-2)" "prognostic favorable (3.99e-4)" "unprognostic (3.49e-2)" "unprognostic (2.79e-2)" "unprognostic (4.12e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.17e-2)" 13.8 16.8 18.8 15.7 19.0 6.4 10.2 19.0 26.4 18.0 20.6 13.4 20.3 21.2 12.4 14.6 20.3 16.7 16.8 35.7 17.6 12.9 17.7 25.6 9.5 10.4 12.0 15.0 14.4 20.7 20.2 21.8 18.5 12.0 16.8 10.6 14.0 21.7 17.9 89.5 14.4 25.8 11.3 9.2 14.9 14.8 10.6 10.9 11.2 16.8 28.1 16.9 17.4 11.8 15.4 26.0 19.7 22.3 13.1 19.0 14.5 15.9 18.6 5.9 14.2 22.1 10.0 9.9 12.8 17.4 10.9 13.1 12.8 13.7 3.8 17.5 17.3 20.1 10.3 5.7 15.3 2.9 10.9 10.2 4.6 4.6 10.8 28.1 3.2 10.5 13.0 22.5 12.6 9.3 8.9 12.8 9.5 6.8 8.0 12.6 31.9 7.8 9.2 9.9 19.8 21.8 5.2 7.1 11.8 14.8 10.9 7.1 7.4 16.9 26.2 17.0 5.3 14.1 12.7 10.4 13.9 3.0 13.0 11.3 21.4 13.0 2.4 27.7 7.2 15.9 10.5 22.3 19.7 16.4 21.7 17.1 13.7 17.3 16.9 19.4 15.4 19.0 16.3 4.8 13.1 20.8 26.0 18.7 14.5 18.8 19.0 19.0 26.4 17.6 12.9 12.0 15.0 12.0 10.9 0.0 6.5 32.8 35.2 21.9 39.2 16.5 28.1 2.7 12.5 24.4 23.6 42.5 72.9 43.5 7.1 22.2 63.6 0.0 41.8 23.0 34.8 27.1 39.1 31.6 38.4 35.0 43.1 22.7 26.6 11.6 33.6 25.5 89.4 34.3 42.5 51.0 35.5 39.6 32.2 50.2 48.9 12.9 27.8 47.1 68.2 22.1 50.6 38.4 50.8 26.7 FOXO4 "AFX1, MLLT7" ENSG00000184481 "Forkhead box O4" P98177 X 71096197-71103535 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 98.6" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 207.8;Syncytiotrophoblasts: 257.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "BEWO: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039560, HPA040232" Enhanced Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA039560: AB_2676572, HPA040232: AB_2676894" "unprognostic (4.64e-2)" "unprognostic (2.94e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (4.79e-2)" "prognostic favorable (4.61e-4)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" "unprognostic (1.58e-1)" "unprognostic (7.18e-2)" "unprognostic (2.13e-2)" "unprognostic (8.16e-2)" "prognostic favorable (3.46e-4)" "unprognostic (2.45e-2)" "unprognostic (2.07e-1)" "unprognostic (1.20e-1)" "unprognostic (1.75e-3)" 8.5 13.2 21.7 3.8 21.5 9.9 5.1 9.1 15.6 4.8 8.4 9.1 11.9 6.3 6.8 10.2 7.3 7.7 5.8 9.7 21.4 14.5 5.2 3.6 5.5 3.6 22.8 8.4 13.4 6.8 8.7 3.0 98.6 9.2 7.0 4.7 4.9 8.5 11.3 33.8 5.5 6.6 9.4 17.3 6.0 5.2 13.9 13.1 4.4 5.9 7.5 4.2 7.5 11.0 0.9 0.2 3.4 0.6 1.0 1.8 0.9 1.8 0.5 1.4 1.8 3.4 2.4 61.2 1.4 1.6 0.7 1.7 1.2 2.4 2.4 1.8 1.8 0.8 0.8 3.7 1.6 0.9 2.4 5.6 3.4 11.4 2.0 1.9 2.0 2.7 2.0 3.9 0.7 0.4 3.3 1.9 3.5 7.0 4.7 0.3 0.4 3.1 3.2 6.6 4.6 2.2 2.1 3.6 3.6 1.2 1.0 1.0 3.0 2.9 0.4 3.2 10.9 0.7 1.2 1.7 0.4 0.9 3.2 0.3 3.1 1.6 0.4 1.6 5.3 0.5 0.2 0.6 3.2 0.9 0.6 0.3 0.8 0.5 0.9 0.2 0.9 0.4 1.8 3.4 1.0 0.3 0.0 1.3 0.9 21.7 21.5 9.1 15.6 21.4 14.5 22.8 8.4 9.2 13.1 0.0 2.4 1.4 4.1 4.7 1.2 6.5 5.1 0.0 1.2 8.7 3.9 207.8 1.7 2.0 0.2 3.8 12.7 23.3 2.6 8.6 4.4 3.4 2.3 2.4 19.4 1.6 5.8 4.3 3.1 0.4 6.4 3.2 3.3 1.0 11.4 2.8 2.6 8.6 14.5 3.3 0.8 6.5 2.5 0.3 0.4 3.0 257.4 5.0 6.0 3.1 GPATCH8 "GPATC8, KIAA0553" ENSG00000186566 "G-patch domain containing 8" Q9UKJ3 17 44395284-44503430 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044380 Approved Approved "Nuclear speckles,Mitochondria" NA NA "Nuclear speckles" Mitochondria "HPA044380: AB_10965696" "unprognostic (3.37e-1)" "unprognostic (5.90e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (6.07e-3)" "unprognostic (2.13e-2)" "unprognostic (5.86e-3)" "unprognostic (2.25e-1)" "unprognostic (1.38e-1)" "unprognostic (6.84e-3)" "unprognostic (8.47e-2)" "unprognostic (6.99e-2)" "unprognostic (2.04e-2)" "unprognostic (1.50e-1)" "unprognostic (9.91e-2)" "unprognostic (7.58e-2)" "unprognostic (2.49e-1)" 8.6 8.5 7.1 12.0 9.3 11.9 7.7 22.2 11.7 8.3 6.5 9.9 6.4 6.9 10.2 4.7 8.5 7.4 6.7 8.1 7.8 5.6 6.4 4.8 7.5 10.0 8.7 6.8 11.2 7.7 14.7 18.1 11.0 9.0 7.1 7.5 9.2 9.1 5.8 21.0 8.3 8.6 8.0 8.3 9.3 6.5 7.6 10.1 9.6 7.7 3.8 9.5 11.6 12.8 10.1 9.6 10.3 16.0 12.4 13.2 6.1 10.4 7.5 8.9 8.6 5.8 7.9 8.8 8.6 10.2 10.7 11.3 10.3 7.0 13.1 5.0 10.6 8.6 6.9 11.9 8.1 13.1 15.5 7.7 15.4 7.0 5.7 4.2 12.7 10.4 8.1 4.4 11.3 10.6 6.9 8.7 8.9 10.5 11.1 6.4 3.3 16.2 1.1 6.0 3.7 7.4 14.5 11.6 9.2 1.5 7.6 8.4 6.5 10.1 4.4 5.9 8.1 6.2 7.0 7.0 6.7 6.1 10.0 10.1 11.5 10.1 14.2 7.5 5.0 6.7 10.3 8.2 6.7 13.2 7.9 12.4 10.1 10.4 9.4 7.9 9.7 9.7 9.7 6.4 12.4 16.0 9.6 5.2 6.1 7.1 9.3 22.2 11.7 7.8 5.6 8.7 6.8 9.0 10.1 20.8 23.8 50.6 42.6 43.3 67.0 29.0 25.5 30.8 42.1 24.4 115.8 36.1 8.3 27.4 11.0 37.3 24.2 0.0 21.4 32.6 47.0 35.6 40.5 17.1 20.3 138.2 37.2 35.0 27.8 3.4 58.4 36.3 21.9 33.3 16.6 56.6 26.2 21.0 40.7 10.2 119.5 51.8 45.7 62.6 70.0 40.9 44.6 77.1 24.9 50.3 GPN3 "ATPBD1C, MGC14560" ENSG00000111231 "GPN-loop GTPase 3" Q9UHW5 12 110452484-110469268 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 166.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039764, HPA047793" Uncertain Approved "Nuclear speckles,Cytosol" Yes No "Nuclear speckles" Cytosol "HPA039764: AB_2676669, HPA047793: AB_2680157" "unprognostic (1.68e-3)" "unprognostic (1.11e-2)" "unprognostic (9.82e-2)" "unprognostic (4.96e-2)" "unprognostic (2.09e-1)" "unprognostic (3.27e-3)" "prognostic unfavorable (3.98e-5)" "unprognostic (5.50e-2)" "unprognostic (4.45e-2)" "unprognostic (2.70e-1)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" "prognostic favorable (2.65e-6)" "unprognostic (5.81e-2)" "unprognostic (2.85e-1)" "unprognostic (1.62e-1)" "unprognostic (2.27e-1)" 17.8 15.1 14.1 11.2 17.3 9.6 26.7 18.4 14.2 13.0 12.5 11.9 10.1 5.9 14.9 11.8 15.6 15.1 10.2 24.8 11.4 10.9 23.3 23.2 13.6 14.8 26.6 11.4 19.4 14.5 19.6 12.2 15.4 18.6 17.0 10.0 11.0 16.6 14.3 35.1 9.6 8.7 17.5 20.0 16.0 13.6 28.3 19.4 11.8 20.1 22.0 12.6 16.5 13.1 20.2 28.0 34.4 31.4 11.8 18.9 16.8 15.4 24.0 16.7 16.3 18.8 11.9 22.1 21.3 13.0 24.1 19.6 22.3 9.3 29.8 14.9 11.6 17.9 14.3 20.6 19.1 32.8 17.0 19.2 17.6 12.9 18.4 13.1 27.4 16.3 12.7 12.1 23.6 15.3 13.5 17.3 25.4 29.6 6.8 16.8 10.5 25.1 52.4 20.4 21.8 24.6 8.6 23.1 22.9 15.1 13.9 12.8 13.3 21.7 14.9 18.0 22.3 25.4 32.5 9.5 20.1 14.7 19.5 24.6 9.4 24.3 31.0 14.7 25.4 22.8 15.3 24.5 34.4 14.0 31.4 15.5 20.2 15.0 15.8 22.6 19.9 18.9 12.6 12.6 11.8 31.1 28.0 12.3 16.8 14.1 17.3 18.4 14.2 11.4 10.9 26.6 11.4 18.6 19.4 23.8 28.0 25.6 41.8 26.6 16.7 38.6 20.4 36.1 26.1 31.4 13.7 52.1 91.2 21.8 68.6 20.5 3.3 0.0 18.6 61.2 26.5 33.4 30.1 31.6 80.2 20.6 7.9 13.5 18.3 13.4 18.4 30.1 15.1 46.9 8.4 17.2 19.9 10.4 22.3 56.6 24.3 25.8 27.8 166.3 65.2 22.2 39.0 16.7 11.8 35.7 H2AFX H2AX ENSG00000188486 "H2A histone family member X" P16104 11 119093854-119095467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 135.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012264, HPA041189, HPA051647" Supported Supported "Nucleoplasm,Nuclear speckles" Yes No Nucleoplasm "Nuclear speckles" "CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563" "unprognostic (1.44e-1)" "unprognostic (1.96e-1)" "unprognostic (6.46e-2)" "unprognostic (6.41e-2)" "unprognostic (3.07e-1)" "unprognostic (3.25e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (2.32e-3)" "unprognostic (1.93e-1)" "unprognostic (3.07e-3)" "unprognostic (6.78e-2)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.47e-9)" "unprognostic (1.21e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" 5.9 10.1 10.7 17.9 9.4 24.0 4.2 9.4 13.9 5.0 12.0 15.2 2.5 15.4 5.7 2.8 9.8 5.5 4.0 4.7 10.6 10.1 6.4 5.0 7.1 17.0 13.3 5.3 8.0 9.2 3.8 8.1 12.8 9.3 6.4 5.4 6.3 5.8 6.3 7.2 10.8 13.7 4.2 13.6 11.1 12.6 28.3 9.5 135.1 5.9 11.3 23.2 4.8 6.6 2.0 3.4 7.4 2.4 3.8 3.4 1.8 26.4 16.0 25.3 15.1 2.3 1.7 26.7 30.1 9.2 17.0 15.0 25.3 11.4 18.2 18.2 6.9 12.8 27.5 11.9 8.6 4.6 26.8 33.5 36.9 4.4 26.0 2.4 18.1 23.0 1.4 1.9 7.2 4.4 2.7 8.5 24.0 29.8 30.0 8.1 67.5 41.4 54.2 18.4 12.1 33.9 40.5 29.8 8.5 7.7 11.5 27.0 32.1 23.9 13.9 4.2 4.5 20.8 13.8 10.4 16.5 43.6 13.4 22.3 8.2 8.0 18.4 3.8 29.5 32.1 7.0 2.4 7.4 3.4 1.1 1.8 2.0 3.4 3.4 3.4 1.8 2.3 2.0 1.2 3.8 1.5 1.5 2.8 1.8 10.7 9.4 9.4 13.9 10.6 10.1 13.3 5.3 9.3 9.5 6.0 12.6 41.6 30.9 27.4 17.4 16.3 15.3 2.7 9.1 7.0 19.6 39.1 10.0 14.6 7.0 21.1 36.5 46.7 9.9 93.2 26.6 29.8 32.3 3.6 37.9 9.5 33.3 25.8 20.0 2.5 13.3 24.5 18.6 37.9 33.9 37.9 14.1 24.5 10.3 7.5 43.2 12.9 36.5 72.1 17.9 24.7 53.7 30.5 50.3 20.8 HEATR5B "DKFZp686P15184, KIAA1414" ENSG00000008869 "HEAT repeat containing 5B" Q9P2D3 2 36968383-37084342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042025, HPA055639" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA042025: AB_10959880, HPA055639: AB_2682870" "unprognostic (3.11e-2)" "unprognostic (1.65e-2)" "unprognostic (4.07e-1)" "unprognostic (6.05e-2)" "unprognostic (3.70e-2)" "unprognostic (7.75e-2)" "unprognostic (5.95e-2)" "unprognostic (3.33e-3)" "unprognostic (8.26e-2)" "unprognostic (3.08e-2)" "unprognostic (1.66e-1)" "unprognostic (8.07e-2)" "unprognostic (5.80e-3)" "unprognostic (8.69e-2)" "unprognostic (4.18e-1)" "unprognostic (2.72e-1)" "unprognostic (3.95e-1)" 14.7 13.6 13.5 14.1 23.8 21.8 15.0 23.3 22.8 11.1 10.2 15.4 10.1 10.9 16.5 18.0 14.9 9.7 10.9 10.7 11.4 12.1 9.9 12.9 12.5 29.6 13.0 16.6 12.3 23.8 17.9 16.6 10.3 21.6 12.2 14.0 12.4 18.0 9.6 7.1 18.0 14.9 9.4 16.1 18.0 12.8 9.6 14.5 16.0 13.6 8.4 30.0 11.3 12.9 15.2 10.7 15.8 4.9 7.0 9.1 5.0 10.4 5.3 7.9 11.9 8.2 8.2 10.0 6.6 4.9 6.1 6.2 6.0 7.2 22.4 4.8 5.6 8.1 8.9 7.7 5.4 8.0 10.9 8.4 14.6 7.0 8.5 5.1 15.6 19.3 7.4 7.6 8.7 8.4 6.7 10.1 12.1 13.8 19.9 7.3 6.2 13.6 11.2 5.1 10.9 3.7 13.2 8.0 16.8 7.1 9.0 9.7 8.6 6.9 11.2 5.2 8.3 8.0 5.1 11.3 9.3 5.3 6.6 5.1 12.5 10.2 24.7 7.5 9.4 6.1 15.8 4.9 11.3 7.9 2.6 7.2 9.9 8.8 8.8 8.6 15.2 9.1 7.9 5.1 7.0 3.8 10.7 8.9 5.0 13.5 23.8 23.3 22.8 11.4 12.1 13.0 16.6 21.6 14.5 20.8 9.3 11.1 4.0 8.8 13.3 19.3 7.6 8.1 5.7 5.2 9.8 6.2 1.7 3.8 5.6 9.8 9.9 0.0 5.3 5.4 6.6 6.3 6.9 7.3 5.5 15.9 5.2 14.1 16.5 1.9 8.3 10.3 6.8 3.6 9.6 6.3 6.8 5.8 6.0 4.5 15.0 19.4 7.6 2.7 8.5 10.2 4.7 10.0 6.9 4.6 HELQ Hel308 ENSG00000163312 "Helicase, POLQ like" Q8TDG4 4 83407343-83455856 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036852, HPA036853" Approved Approved "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA036852: AB_2675349, HPA036853: AB_10672102" "unprognostic (4.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.12e-2)" "unprognostic (1.12e-1)" "unprognostic (4.80e-2)" "unprognostic (5.56e-2)" "unprognostic (1.14e-1)" "unprognostic (5.13e-3)" "unprognostic (7.14e-2)" "unprognostic (8.62e-2)" "prognostic favorable (9.07e-4)" "unprognostic (2.03e-1)" "prognostic favorable (2.76e-4)" "unprognostic (3.54e-2)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.37e-1)" 10.5 20.8 6.3 12.2 7.8 7.2 10.4 12.6 9.2 10.7 9.8 9.3 8.2 5.6 9.9 8.7 8.2 9.1 9.0 10.5 6.2 5.7 11.9 10.0 8.0 15.3 6.8 5.7 17.4 8.1 13.3 20.7 11.7 9.0 11.4 7.2 11.0 10.0 10.4 14.6 8.7 9.8 8.0 8.4 14.4 8.4 10.7 7.4 18.5 14.3 8.3 13.4 10.2 9.2 10.1 4.6 6.8 4.7 5.5 9.7 2.9 4.3 3.3 7.1 4.6 8.7 9.2 3.7 6.5 9.8 8.5 8.4 3.1 4.5 12.2 5.2 5.6 5.8 4.4 8.6 4.8 8.9 7.0 3.8 7.3 5.4 4.2 5.6 8.8 18.0 7.1 6.5 6.7 7.0 7.5 6.7 8.2 9.6 10.7 8.6 5.1 8.0 6.3 3.6 6.9 2.4 6.2 8.2 4.3 7.0 2.7 5.8 4.8 6.3 6.9 7.1 7.1 4.3 9.5 5.1 6.4 5.6 8.2 5.1 9.9 4.2 10.3 5.4 6.7 7.1 5.4 3.7 6.8 5.7 4.0 5.4 5.8 6.3 6.4 4.6 10.1 9.7 8.7 2.3 5.5 4.7 4.5 7.8 2.9 6.3 7.8 12.6 9.2 6.2 5.7 6.8 5.7 9.0 7.4 3.0 9.4 10.0 8.0 3.8 9.2 9.2 7.6 22.7 7.9 5.2 7.9 9.6 10.0 5.1 20.9 7.1 3.5 0.0 4.8 8.1 6.4 4.9 7.0 4.0 9.1 6.4 0.0 10.4 5.6 5.8 12.0 8.4 6.8 7.2 4.5 9.1 4.7 6.0 7.4 8.8 13.2 0.0 8.2 20.0 12.8 3.3 9.6 13.1 5.2 4.7 HEXIM2 FLJ32384 ENSG00000168517 "Hexamethylene bisacetamide inducible 2" Q96MH2 17 45160700-45170040 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 36.4" "Group enriched" "Detected in many" 6 "Early spermatids: 121.3;Late spermatids: 208.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023323, HPA028455" Enhanced Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA023323: AB_1850651, HPA028455: AB_10602603" "unprognostic (9.03e-3)" "unprognostic (2.18e-2)" "unprognostic (4.01e-2)" "prognostic favorable (2.53e-4)" "unprognostic (2.36e-1)" "unprognostic (6.35e-3)" "unprognostic (9.70e-2)" "unprognostic (1.34e-2)" "unprognostic (1.03e-1)" "prognostic favorable (9.85e-4)" "unprognostic (2.34e-3)" "unprognostic (1.93e-1)" "unprognostic (1.29e-2)" "unprognostic (2.32e-3)" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (1.90e-2)" 4.0 7.7 8.3 4.2 8.0 3.6 3.4 9.0 11.8 4.3 4.8 5.0 6.5 8.8 4.3 5.6 4.2 5.1 7.9 6.3 6.7 6.2 9.3 9.6 4.1 5.6 7.8 6.7 5.7 9.3 7.5 6.1 3.0 6.6 5.1 2.5 6.9 9.9 5.5 36.4 5.6 6.4 4.3 5.4 5.2 6.9 27.7 6.4 6.4 9.1 6.6 3.0 4.7 4.7 9.7 13.2 10.0 12.2 7.3 8.6 13.3 5.0 18.2 4.0 8.9 4.5 7.4 7.7 2.8 3.4 4.6 5.1 6.9 13.5 3.1 14.8 2.0 2.3 8.4 3.9 3.4 1.4 7.2 6.3 2.3 17.0 30.9 3.2 2.0 5.2 6.4 3.3 4.0 1.4 8.9 2.2 6.5 2.5 7.8 2.1 8.7 3.2 4.3 4.4 7.1 8.0 4.3 6.1 9.5 5.8 5.0 4.8 4.2 2.5 5.1 11.7 3.0 13.6 3.4 2.2 8.3 4.4 5.5 6.6 12.2 12.9 2.9 6.5 3.7 6.2 8.4 12.2 10.0 5.4 9.7 8.6 9.7 3.8 6.1 10.3 6.5 3.0 5.3 8.3 7.3 3.0 13.2 4.6 13.3 8.3 8.0 9.0 11.8 6.7 6.2 7.8 6.7 6.6 6.4 0.0 1.0 4.7 3.5 1.8 12.7 0.2 5.1 0.0 1.2 1.8 3.9 10.7 16.6 3.9 121.3 4.0 4.0 0.0 1.4 4.5 3.4 1.8 6.9 6.2 6.3 3.2 4.6 2.5 7.0 208.9 5.5 2.8 3.3 4.6 4.3 8.0 2.1 3.5 6.7 26.1 10.6 0.0 3.4 18.2 12.0 2.6 5.1 1.3 4.1 1.6 HOXA6 "HOX1, HOX1B" ENSG00000106006 "Homeobox A6" P31267 7 27145396-27150603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 10.4" "Cell type enhanced" "Detected in some" 12 "Distal tubular cells: 5.0;Enterocytes: 3.5;Intestinal endocrine cells: 8.6;Paneth cells: 4.8;Undifferentiated cells: 4.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 5.9;NK-cell: 2.0" "Group enriched" "Detected in many" 8 "granulocytes: 5.9;NK-cells: 2.0" "Group enriched" "Detected in some" 9 "AN3-CA: 29.3;HEK 293: 39.9" "Region enriched" "Detected in single" 34 "pons and medulla: 3.5" "HPA004203, HPA077900" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA004203: AB_1079079, HPA077900: " "unprognostic (1.70e-1)" "unprognostic (6.76e-3)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.06e-1)" "unprognostic (6.06e-2)" "unprognostic (9.73e-2)" "unprognostic (6.32e-2)" "unprognostic (2.94e-2)" "unprognostic (7.82e-2)" "unprognostic (2.17e-1)" "prognostic favorable (2.03e-4)" "unprognostic (1.45e-1)" "unprognostic (2.81e-2)" "unprognostic (3.93e-1)" 3.2 2.9 0.0 1.2 0.0 0.0 2.3 0.0 0.0 1.6 5.4 0.0 6.7 4.6 0.1 10.4 0.0 0.0 0.0 0.0 5.9 0.0 2.3 0.8 0.0 0.0 0.0 0.5 0.0 0.0 2.5 1.5 0.0 2.2 1.0 3.2 4.2 1.4 1.0 0.0 1.2 0.0 0.0 0.0 4.3 1.3 0.1 0.5 5.9 0.1 2.0 0.2 0.0 0.5 0.9 0.0 29.3 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.7 3.4 0.7 1.1 0.2 0.1 1.3 0.7 0.0 0.0 0.8 39.9 0.4 0.5 0.4 0.0 0.6 1.0 2.4 0.0 0.0 0.3 0.0 1.3 0.9 0.2 0.0 0.3 0.3 0.0 0.1 0.0 0.1 1.0 3.8 0.0 0.0 2.8 1.8 3.1 0.0 1.3 0.1 0.6 0.0 0.3 0.3 0.0 0.0 0.4 1.6 1.0 0.0 0.0 0.6 0.0 2.8 2.9 5.9 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.1 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 4.8 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 4.4 1.0 IL15 "IL-15, MGC9721" ENSG00000164136 "Interleukin 15" P40933 4 141636599-141733987 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "monocytes: 96.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 15.5;Karpas-707: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB004457, HPA037738" Approved Supported "Nucleoplasm,Nuclear speckles" "Secreted to blood" NA NA 182000 "Nucleoplasm, Nuclear speckles" "CAB004457: AB_2124575, HPA037738: AB_2675640" "unprognostic (1.10e-2)" "unprognostic (1.53e-1)" "unprognostic (1.04e-2)" "unprognostic (8.57e-2)" "unprognostic (8.77e-3)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (2.90e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (5.20e-2)" "unprognostic (1.74e-2)" "unprognostic (3.75e-2)" "unprognostic (1.09e-1)" "unprognostic (4.03e-2)" "unprognostic (3.29e-2)" "unprognostic (1.54e-1)" 7.7 3.7 1.1 21.3 1.5 2.9 9.2 1.8 2.2 6.0 8.8 0.8 2.2 6.3 11.3 7.4 5.6 4.6 9.9 9.3 1.1 1.5 6.9 3.7 14.4 18.8 2.3 1.6 3.2 3.1 0.5 4.5 9.9 2.1 7.7 5.7 5.9 6.9 3.6 9.1 3.2 14.2 7.1 2.6 17.0 5.3 2.6 2.0 9.8 18.1 5.9 11.0 9.8 16.9 3.7 4.6 8.1 14.0 2.6 4.5 4.4 2.4 5.2 0.2 0.5 0.8 4.7 1.3 5.6 5.2 5.8 4.7 2.8 6.8 2.3 7.3 4.8 5.0 3.6 0.1 3.0 3.2 15.5 1.4 0.4 13.7 0.4 3.9 1.6 1.1 1.7 1.2 3.8 0.4 11.9 3.7 1.8 3.8 15.2 3.7 0.8 3.4 0.3 2.6 1.8 1.6 0.9 13.4 0.3 7.6 0.6 0.5 1.3 2.4 3.7 2.7 0.6 0.9 0.2 5.5 5.9 3.8 1.7 3.4 10.7 1.3 0.7 6.3 0.6 2.1 8.1 14.0 0.8 2.5 12.4 4.5 3.7 2.9 2.2 4.6 3.4 1.2 1.3 1.0 2.6 12.5 0.1 1.5 4.4 1.1 1.5 1.8 2.2 1.1 1.5 2.3 1.6 2.1 2.0 0.0 3.2 10.4 2.8 5.5 0.3 2.4 0.0 4.0 7.9 5.2 0.0 1.0 0.0 8.1 4.0 11.3 3.9 0.0 12.2 1.8 7.2 4.3 0.0 1.7 4.9 0.0 0.0 11.6 18.3 1.5 2.6 19.3 8.5 96.4 4.7 15.1 14.3 3.5 1.1 8.4 0.5 6.5 3.1 0.5 0.7 3.0 0.2 6.4 2.3 2.1 IQCK "FLJ36575, MGC35048" ENSG00000174628 "IQ motif containing K" Q8N0W5 16 19716456-19858467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 107.1;Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 96.8;Spermatocytes: 80.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026792, HPA048786" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA026792: AB_1853889, HPA048786: AB_2680520" "unprognostic (4.21e-2)" "unprognostic (3.19e-1)" "unprognostic (6.29e-3)" "unprognostic (2.04e-2)" "unprognostic (3.70e-1)" "unprognostic (4.07e-2)" "unprognostic (1.69e-1)" "unprognostic (8.51e-2)" "unprognostic (1.58e-1)" "unprognostic (9.68e-3)" "unprognostic (1.17e-1)" "unprognostic (5.13e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" 5.5 4.8 9.3 2.8 11.4 1.1 7.8 3.7 7.1 10.1 3.7 13.9 19.4 5.1 6.3 19.9 2.5 25.2 7.5 4.8 10.4 11.2 11.2 3.0 5.3 2.3 8.3 8.9 8.9 5.7 20.7 14.6 4.4 12.1 5.4 4.2 9.3 8.2 22.4 4.0 3.3 2.7 5.3 8.5 2.6 5.1 27.2 7.9 1.1 21.0 3.2 1.9 5.7 3.5 1.5 1.0 0.0 3.8 0.1 3.0 1.0 2.6 7.2 9.2 6.1 2.8 9.1 0.6 0.0 4.6 4.3 3.4 0.4 5.0 0.3 5.1 2.5 2.7 3.0 2.0 3.5 3.0 1.1 1.9 0.1 1.9 3.5 9.0 1.7 0.1 5.1 3.0 5.5 1.3 4.8 4.6 4.5 2.7 0.8 2.7 8.8 1.6 1.0 2.8 2.8 6.7 5.5 0.7 0.5 10.8 1.9 8.5 3.6 3.7 1.3 5.6 1.8 3.7 0.9 3.1 0.9 1.0 4.9 0.9 0.2 0.5 0.0 5.6 0.2 1.8 0.0 0.7 0.0 1.4 3.8 2.5 1.5 1.6 2.3 0.4 0.6 3.0 1.5 0.0 0.1 3.5 1.0 1.2 1.0 9.3 11.4 3.7 7.1 10.4 11.2 8.3 8.9 12.1 7.9 14.9 3.2 0.8 9.3 5.5 41.5 0.8 20.4 107.1 17.0 43.6 108.0 4.2 39.7 39.8 32.8 16.9 2.7 0.0 25.9 2.1 10.0 6.5 0.0 1.5 4.9 3.2 5.2 9.2 2.7 25.2 16.7 2.6 16.9 1.0 4.3 25.1 23.3 0.0 17.0 27.5 96.8 6.5 9.2 80.7 34.9 4.4 3.4 1.0 5.8 4.3 JDP2 JUNDM2 ENSG00000140044 "Jun dimerization protein 2" Q8WYK2 14 75427716-75474111 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 71.9;Muller glia cells: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 11.0;granulocytes: 6.9;monocytes: 10.5" "Cell line enhanced" "Detected in many" "HHSteC: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059511 Supported Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA059511: AB_2684046" "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "prognostic unfavorable (8.58e-5)" "unprognostic (1.64e-2)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.99e-2)" "unprognostic (2.81e-1)" "unprognostic (5.06e-2)" "unprognostic (1.91e-1)" "unprognostic (3.25e-2)" "unprognostic (1.86e-1)" "unprognostic (8.11e-3)" "unprognostic (2.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.13e-1)" "unprognostic (9.30e-3)" 27.0 14.4 11.2 19.3 12.5 46.0 59.6 10.6 15.1 16.3 15.3 13.7 6.5 15.3 12.7 10.5 17.1 14.8 21.3 20.7 13.5 9.0 9.7 14.3 24.8 13.2 14.0 8.7 21.8 15.8 7.4 10.1 12.0 11.2 13.9 8.1 16.6 19.5 11.4 13.3 15.2 22.4 17.8 15.7 39.7 15.8 4.7 11.8 1.4 20.7 18.7 9.7 14.2 60.4 11.0 2.1 6.9 10.5 0.1 0.2 1.1 4.4 3.9 0.7 7.8 24.7 18.4 26.8 13.8 15.0 9.0 11.4 9.5 3.9 3.5 7.0 26.2 1.6 17.4 4.9 4.7 3.9 4.7 0.5 4.8 7.3 3.4 50.8 6.8 0.3 32.4 28.3 3.7 9.1 3.5 0.4 4.0 0.6 6.8 8.1 21.7 0.3 11.2 2.7 8.6 2.5 2.4 0.1 9.5 4.3 2.4 0.6 3.1 14.2 20.4 15.8 9.2 19.5 14.9 1.8 11.4 17.7 0.7 2.0 5.7 1.6 8.3 3.4 25.8 5.6 0.1 4.1 3.8 0.0 7.0 0.0 11.0 0.2 0.0 2.1 5.1 0.0 0.0 6.9 0.1 10.5 1.8 0.2 1.1 11.2 12.5 10.6 15.1 13.5 9.0 14.0 8.7 11.2 11.8 11.9 31.0 5.6 5.5 14.5 14.3 16.9 12.7 6.7 7.9 8.7 9.8 1.6 0.0 2.3 0.3 11.3 14.9 0.0 5.7 4.7 22.2 3.7 2.3 7.4 8.9 7.9 5.2 11.1 71.9 0.2 16.7 9.4 11.8 2.8 12.7 43.2 6.9 8.6 15.6 2.2 30.5 6.5 7.1 0.1 0.4 7.9 0.2 0.0 8.0 9.1 KCNK13 "K2p13.1, THIK-1, THIK1" ENSG00000152315 "Potassium two pore domain channel subfamily K member 13" Q9HB14 14 90061765-90185857 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.3;parathyroid gland: 14.3;testis: 13.2" "Cell type enhanced" "Detected in some" 24 "Hofbauer cells: 5.6;Kupffer cells: 2.5;Macrophages: 5.3;monocytes: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 7 "dendritic cells: 3.8;monocytes: 1.5" "Cell line enhanced" "Detected in some" "GAMG: 2.4;RT4: 4.2;SuSa: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003514 Approved Approved "Nuclear speckles,Cell Junctions" NA NA "Nuclear speckles, Cell Junctions" "HPA003514: AB_2666978" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (6.17e-2)" "unprognostic (6.31e-2)" "unprognostic (2.56e-1)" "unprognostic (5.55e-2)" "unprognostic (3.56e-2)" "unprognostic (3.98e-2)" "unprognostic (2.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-2)" "unprognostic (1.97e-1)" "unprognostic (2.04e-2)" "unprognostic (6.32e-2)" "unprognostic (1.46e-1)" "unprognostic (5.65e-2)" 0.8 1.1 2.9 2.2 3.5 0.1 0.4 0.2 4.2 0.4 0.6 4.0 0.0 0.6 0.3 1.5 0.3 0.4 0.5 2.7 2.9 2.4 4.8 0.7 0.7 1.6 6.3 1.4 0.4 2.7 14.3 0.6 1.2 3.6 0.4 0.7 0.1 1.1 0.7 0.1 0.1 0.7 0.4 8.3 1.1 0.5 13.2 5.4 0.7 2.7 0.0 0.6 0.8 0.1 0.0 3.8 0.0 1.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.9 0.0 0.0 0.8 1.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.4 4.2 1.8 0.5 0.0 1.8 1.2 7.1 0.0 1.6 0.0 0.0 2.1 0.0 0.6 0.6 1.8 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 2.9 3.5 0.2 4.2 2.9 2.4 6.3 1.4 3.6 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 2.5 0.6 0.0 5.3 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.1 0.0 0.0 0.1 KCTD20 "C6orf69, dJ108K11.3, MGC14254" ENSG00000112078 "Potassium channel tetramerization domain containing 20" Q7Z5Y7 6 36442767-36491143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030092 Approved Approved "Nuclear speckles,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear speckles" "HPA030092: AB_10601437" "unprognostic (2.17e-1)" "unprognostic (2.02e-1)" "unprognostic (5.20e-3)" "unprognostic (2.43e-2)" "unprognostic (1.00e-3)" "unprognostic (5.03e-3)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.63e-1)" "unprognostic (1.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (1.18e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (9.31e-4)" "unprognostic (2.94e-2)" 34.3 23.1 18.4 22.8 17.6 20.1 39.0 15.7 21.4 22.2 20.7 18.7 22.4 12.0 25.5 23.1 24.6 22.0 25.1 21.0 16.3 17.1 16.2 29.7 20.5 26.2 18.0 14.4 25.6 12.7 15.7 16.1 21.7 16.5 17.5 16.0 17.9 16.2 19.2 20.4 24.6 17.6 30.8 17.3 24.2 16.6 10.2 13.3 31.6 13.6 18.1 24.9 21.5 18.3 6.2 14.0 19.4 14.4 6.4 8.5 10.9 11.0 5.0 14.7 28.1 20.2 13.0 7.1 13.5 18.7 14.7 16.5 13.0 6.3 37.4 12.2 21.9 8.4 10.3 19.2 9.8 24.5 26.6 10.6 21.3 8.0 13.7 9.4 20.6 14.8 13.1 10.1 11.2 7.2 9.8 15.0 19.9 32.8 21.4 13.8 9.7 23.3 7.8 5.4 8.8 4.6 23.2 16.7 21.0 8.0 12.5 3.5 20.8 11.8 12.0 35.9 15.2 16.5 20.5 17.1 40.0 13.7 11.8 16.7 16.9 39.3 27.1 6.9 28.4 40.7 19.4 14.4 9.2 7.5 13.1 8.5 6.2 5.9 6.2 14.0 5.1 6.2 6.1 10.6 6.4 7.2 7.6 6.9 10.9 18.4 17.6 15.7 21.4 16.3 17.1 18.0 14.4 16.5 13.3 35.7 21.3 25.3 14.7 44.5 17.2 13.2 33.1 21.4 23.9 15.7 9.8 22.6 1.7 14.7 0.4 31.4 13.2 70.0 12.3 15.4 34.9 16.2 52.0 41.2 23.8 14.3 14.6 49.1 52.1 1.5 29.4 33.6 32.1 32.5 15.2 17.9 16.3 14.0 50.2 16.1 9.5 19.4 53.6 5.2 26.0 55.5 19.2 29.9 15.1 27.3 KIAA0100 "BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488" ENSG00000007202 KIAA0100 Q14667 17 28614440-28645454 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042781 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted - unknown location" No No "Nuclear speckles, Cytosol" "HPA042781: AB_10797020" "unprognostic (1.91e-1)" "unprognostic (1.03e-2)" "unprognostic (3.47e-2)" "unprognostic (5.26e-3)" "unprognostic (2.43e-1)" "unprognostic (6.89e-2)" "prognostic unfavorable (3.47e-5)" "unprognostic (4.99e-2)" "unprognostic (3.04e-1)" "unprognostic (3.03e-3)" "unprognostic (2.40e-2)" "unprognostic (2.53e-1)" "unprognostic (4.24e-3)" "unprognostic (7.58e-2)" "unprognostic (5.84e-2)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 27.7 31.2 22.3 21.3 34.7 21.9 26.3 28.1 40.1 20.0 24.0 28.2 20.9 15.5 24.7 21.6 25.4 24.0 20.1 21.4 22.0 22.4 38.1 30.7 24.1 26.3 23.1 19.6 25.6 24.6 48.0 27.0 32.7 35.6 22.7 28.5 22.1 27.0 23.3 40.7 25.0 27.9 28.4 21.4 26.4 22.8 24.8 18.6 26.3 28.6 20.2 26.6 22.7 18.8 2.9 7.2 3.5 3.0 2.0 3.3 1.3 19.6 37.6 19.1 18.1 34.8 20.8 13.9 18.4 24.6 22.6 21.3 25.8 9.0 27.4 22.2 33.6 23.6 26.3 28.0 27.3 27.4 30.3 26.2 21.8 29.8 14.1 15.0 38.0 37.9 21.2 21.2 30.5 23.3 17.6 32.2 19.6 20.5 8.9 20.5 28.2 27.7 18.1 8.3 35.7 13.9 21.3 21.4 17.9 13.6 35.4 18.8 14.5 23.2 63.6 15.5 24.8 38.0 26.6 29.7 17.3 19.1 23.1 34.7 8.4 9.7 17.7 19.7 24.7 20.1 0.8 3.0 3.5 3.0 2.5 3.3 2.9 1.5 2.7 3.3 1.7 1.8 1.8 1.8 2.0 2.7 7.2 1.7 1.3 22.3 34.7 28.1 40.1 22.0 22.4 23.1 19.6 35.6 18.6 14.9 19.1 3.9 6.3 9.2 31.3 27.1 15.3 12.0 12.5 12.2 27.5 10.4 5.0 8.4 12.4 10.5 22.7 23.3 9.4 8.0 8.9 11.1 8.1 28.0 9.4 27.0 11.6 21.5 29.7 18.3 8.6 15.0 10.1 14.4 15.6 12.6 9.2 8.6 6.0 13.8 22.8 0.0 7.8 16.9 20.9 9.7 38.1 8.6 16.1 11.2 KIAA0556 "JBTS26, KATNIP" ENSG00000047578 KIAA0556 O60303 16 27550133-27780369 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 33.6;Ciliated cells: 36.1;Cone photoreceptor cells: 64.8;Rod photoreceptor cells: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.0" "Group enriched" "Detected in all" 4 "granulocytes: 11.0;NK-cells: 5.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035089, HPA035090" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA035089: AB_10671509, HPA035090: AB_10601129" "unprognostic (1.81e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" "unprognostic (3.65e-3)" "unprognostic (7.76e-2)" "prognostic favorable (3.00e-4)" "unprognostic (2.72e-2)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (2.94e-1)" "unprognostic (2.12e-1)" "unprognostic (1.47e-3)" "unprognostic (2.98e-1)" "unprognostic (2.11e-1)" "unprognostic (1.50e-3)" "unprognostic (1.45e-1)" 6.1 6.2 7.1 8.7 10.9 7.9 6.8 6.3 10.8 8.4 8.2 12.0 13.2 6.5 15.1 13.1 11.2 38.6 7.5 7.0 7.1 6.7 9.7 5.0 8.2 5.6 6.5 7.3 8.2 11.7 14.9 19.0 6.8 8.6 11.9 9.8 11.8 9.8 9.7 4.1 11.0 7.9 8.4 9.3 7.9 12.1 22.8 8.4 8.7 20.9 5.0 11.1 7.6 9.0 1.4 1.5 11.0 2.0 5.5 1.8 0.4 5.4 11.2 6.3 5.9 9.6 8.8 10.5 7.4 8.0 6.6 9.0 9.8 9.1 4.6 10.6 10.5 12.8 9.1 8.0 9.5 13.2 21.4 5.6 3.6 11.3 5.7 5.7 4.9 9.3 9.3 8.4 14.4 15.6 8.5 12.9 5.3 5.8 3.9 9.3 12.5 5.4 6.0 3.8 7.0 4.6 7.7 7.7 5.0 12.1 7.6 8.1 5.2 7.4 6.7 4.1 9.2 14.9 4.3 11.1 8.4 5.4 6.5 6.4 5.3 4.5 5.0 9.7 4.8 7.5 9.5 2.0 3.8 0.8 1.3 0.8 0.9 0.4 1.4 1.3 1.4 1.8 0.3 11.0 5.5 0.5 1.5 1.5 0.4 7.1 10.9 6.3 10.8 7.1 6.7 6.5 7.3 8.6 8.4 6.0 1.9 2.9 4.8 1.3 33.6 4.5 0.0 36.1 9.1 1.8 64.8 2.5 0.0 3.0 11.2 3.5 5.9 0.0 3.2 2.2 2.7 6.5 0.0 0.8 2.3 3.2 11.6 3.1 1.8 12.0 2.3 3.2 5.0 2.8 3.3 6.5 3.6 3.5 1.1 1.7 54.4 0.0 2.0 9.9 4.9 1.3 1.8 3.3 3.3 4.4 KTI12 "MGC20419, SBBI81, TOT4" ENSG00000198841 "KTI12 chromatin associated homolog" Q96EK9 1 52032103-52033816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031203, HPA031204, HPA031205" Approved Approved "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles, Cytoplasmic bodies" "HPA031203: AB_2732464, HPA031204: AB_10600110, HPA031205: AB_10611380" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (1.19e-3)" "unprognostic (3.36e-3)" "unprognostic (4.18e-1)" "unprognostic (1.83e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.74e-1)" "unprognostic (2.94e-1)" "unprognostic (3.72e-2)" "unprognostic (4.06e-2)" "unprognostic (8.08e-3)" "unprognostic (6.59e-2)" "unprognostic (3.36e-3)" "unprognostic (2.39e-1)" "unprognostic (3.59e-2)" "unprognostic (1.64e-2)" 14.9 14.6 5.9 9.9 7.4 22.1 9.7 8.1 9.3 7.8 8.4 6.7 7.2 7.4 10.5 7.6 8.1 10.6 10.9 8.1 5.6 7.6 14.1 14.1 6.4 11.9 5.4 5.9 16.1 10.7 4.3 11.0 15.5 5.5 9.6 6.3 9.1 6.4 7.7 9.4 7.3 10.0 8.9 3.9 12.2 9.5 10.6 4.8 15.4 14.5 9.2 11.3 9.7 10.5 19.4 27.7 9.7 15.2 13.4 19.9 11.7 9.2 9.2 3.6 8.7 12.6 10.6 11.6 9.4 11.7 13.9 11.9 10.2 4.6 10.7 10.7 9.8 20.8 10.6 12.8 11.2 9.7 10.8 14.3 11.0 10.4 9.9 8.8 15.8 11.0 10.0 8.6 11.1 6.0 6.1 9.4 9.5 16.4 5.7 11.6 7.3 11.5 17.6 7.2 8.1 10.4 11.1 10.1 14.3 13.2 6.7 6.6 9.5 9.1 16.2 16.9 8.7 3.1 24.9 7.0 11.4 7.0 13.6 17.7 19.9 16.5 16.6 12.5 16.8 8.2 7.8 13.9 9.7 14.8 15.2 16.3 19.4 16.7 17.9 18.4 15.2 19.9 14.0 2.9 13.4 11.4 27.7 16.2 11.7 5.9 7.4 8.1 9.3 5.6 7.6 5.4 5.9 5.5 4.8 3.0 6.1 10.0 11.8 6.4 6.0 2.4 10.2 2.7 3.4 3.5 0.0 10.5 5.0 10.1 0.8 6.9 2.0 0.0 9.4 16.1 9.3 5.5 5.8 5.3 8.7 9.5 2.4 10.4 3.8 0.5 10.6 6.0 5.0 12.6 3.4 8.0 9.5 3.5 9.6 8.3 4.4 19.4 12.3 16.8 7.0 6.5 15.3 10.0 4.7 11.2 LHPP HDHD2B ENSG00000107902 "Phospholysine phosphohistidine inorganic pyrophosphate phosphatase" Q9H008 10 124461834-124617888 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 106.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 103.7;Late spermatids: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009163, HPA009269" Enhanced Supported "Nuclear speckles,Cytosol" NA NA 880000 "Nuclear speckles, Cytosol" "HPA009163: AB_1079250, HPA009269: AB_1079249" "unprognostic (3.46e-2)" "unprognostic (1.23e-2)" "unprognostic (4.78e-2)" "unprognostic (3.89e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (5.77e-3)" "unprognostic (2.02e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-1)" "unprognostic (6.42e-2)" "unprognostic (5.55e-2)" "unprognostic (1.79e-3)" "unprognostic (2.52e-1)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" 9.6 14.2 37.3 6.0 34.0 6.9 7.9 11.9 34.2 12.3 13.6 29.7 8.2 17.9 7.5 11.0 12.7 8.1 8.3 9.8 43.0 31.5 18.6 33.8 6.6 8.2 62.7 19.3 5.5 12.2 6.6 5.6 7.2 20.5 6.9 6.7 6.7 13.3 10.6 6.5 8.9 15.7 8.1 106.0 8.2 12.4 14.2 19.5 7.1 20.5 3.6 11.2 8.7 5.7 24.7 20.0 13.3 16.1 3.9 17.2 12.9 14.8 7.4 3.0 7.6 11.7 9.6 8.0 5.5 11.2 3.5 6.4 1.3 13.8 14.7 12.8 8.2 3.8 16.2 0.9 2.9 3.6 3.3 10.6 10.8 2.4 6.8 12.0 2.1 17.5 7.1 12.6 3.4 8.3 10.2 5.5 13.3 5.3 5.9 4.3 14.7 7.1 6.9 5.3 6.3 4.2 7.6 3.3 18.8 7.5 1.9 1.7 9.1 3.8 14.1 5.0 4.3 10.7 0.3 2.6 5.4 8.0 4.5 1.4 4.9 1.5 4.7 4.9 4.2 1.2 4.6 16.1 13.3 9.5 13.5 12.4 23.7 11.1 10.1 20.0 24.7 13.7 9.6 2.7 3.9 14.9 7.5 17.2 12.9 37.3 34.0 11.9 25.0 43.0 31.5 62.7 19.3 20.5 19.5 3.0 15.0 15.6 9.1 6.5 6.2 12.0 15.3 18.7 12.5 7.0 0.0 44.1 28.2 4.0 103.7 1.6 23.3 0.0 2.1 20.7 9.3 7.6 10.4 53.3 22.8 11.1 9.1 7.4 13.2 124.0 5.5 9.2 16.9 14.4 17.3 6.9 3.5 25.9 9.9 58.6 6.4 12.9 5.1 28.8 10.2 4.6 20.3 7.2 19.6 11.1 LIMK1 LIMK ENSG00000106683 "LIM domain kinase 1" P53667 7 74082933-74122525 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.2" "Cell type enhanced" "Detected in many" 6 "B-cells: 22.9;Hofbauer cells: 25.0;Horizontal cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-87 MG: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028516, HPA073571" Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA028516: AB_10601751, HPA073571: " "unprognostic (1.45e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (4.95e-5)" "unprognostic (2.77e-2)" "unprognostic (1.40e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (7.79e-6)" "unprognostic (1.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-1)" "unprognostic (3.32e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (6.63e-8)" "unprognostic (4.14e-2)" "unprognostic (7.00e-2)" "unprognostic (3.84e-2)" "unprognostic (5.79e-2)" 8.8 8.6 31.6 18.2 18.6 6.3 7.4 14.3 44.1 11.5 6.6 7.1 6.6 6.9 7.3 5.3 6.4 6.0 10.8 6.3 26.8 32.9 5.2 2.6 12.5 22.0 33.4 22.2 12.1 8.1 4.0 7.2 8.0 45.2 6.1 4.7 4.8 18.1 9.6 10.9 6.8 7.2 7.6 10.8 18.4 7.8 10.4 6.5 4.3 7.5 3.7 18.1 14.1 7.2 4.6 8.6 3.8 7.7 6.9 2.4 3.1 17.0 13.3 10.2 16.9 13.5 18.3 7.4 10.6 10.2 8.6 9.6 7.7 16.9 10.6 4.8 13.0 28.9 10.3 3.8 6.5 3.3 18.3 6.7 7.8 4.5 8.8 15.5 5.9 28.7 18.1 5.9 6.9 3.6 26.0 12.8 7.7 5.2 3.4 10.7 14.9 5.1 10.7 19.3 6.0 8.4 7.4 15.8 6.6 9.6 3.7 4.0 9.3 6.8 16.4 8.5 11.7 5.2 5.4 15.2 13.7 12.8 35.4 17.0 3.8 4.3 19.4 50.9 4.3 9.3 0.1 6.5 3.8 2.4 7.7 1.8 4.6 0.6 1.5 8.6 2.4 0.2 0.7 0.7 6.9 4.7 0.8 0.4 3.1 31.6 18.6 14.3 44.1 26.8 32.9 33.4 22.2 45.2 6.5 3.0 2.4 22.9 4.6 2.6 5.6 2.7 7.6 2.7 3.4 1.8 2.0 2.2 0.0 6.6 0.6 3.0 0.9 0.0 5.6 5.4 7.5 5.1 5.7 1.1 25.0 33.4 2.4 2.5 10.7 1.5 6.6 14.1 3.3 10.0 2.1 3.1 10.2 2.9 5.6 1.5 3.1 0.0 2.1 1.9 12.4 2.8 3.1 10.1 2.5 6.2 LMNA "CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1" ENSG00000160789 "Lamin A/C" P02545 1 156082573-156140089 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease mutation, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "granulocytes: 1139.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 10.4;memory CD4 T-cell: 8.9;myeloid DC: 34.8;T-reg: 35.4" "Group enriched" "Detected in all" 8 "dendritic cells: 34.8;granulocytes: 10.4;T-cells: 35.4" "Cell line enhanced" "Detected in many" "WM-115: 137.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004022, HPA006523, HPA006660, HPA012078" Supported Supported "Nucleoplasm,Nuclear speckles" NA NA 3200000 "Nucleoplasm, Nuclear speckles" "CAB004022: AB_2136278, HPA006523: , HPA006660: AB_1079231, HPA012078: " "unprognostic (2.22e-2)" "unprognostic (1.89e-1)" "unprognostic (1.04e-2)" "unprognostic (5.75e-2)" "unprognostic (7.43e-3)" "unprognostic (1.47e-1)" "unprognostic (5.23e-3)" "unprognostic (3.27e-2)" "unprognostic (8.33e-2)" "unprognostic (5.90e-2)" "unprognostic (5.10e-2)" "unprognostic (6.34e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-1)" "unprognostic (2.89e-1)" "unprognostic (3.08e-2)" "unprognostic (1.44e-2)" 64.0 37.3 7.4 51.4 11.8 21.3 88.6 9.0 10.8 62.8 32.6 21.9 27.2 28.6 69.1 52.3 62.2 40.1 77.7 62.5 8.8 7.5 25.9 26.6 51.8 39.6 15.7 11.2 60.3 30.9 15.2 17.4 73.3 18.1 34.0 15.2 32.7 37.5 26.4 36.3 68.7 29.9 63.0 10.3 22.4 36.7 30.2 12.9 9.4 31.5 140.0 35.6 46.4 51.2 1.1 34.8 10.4 3.5 1.7 35.4 6.4 59.1 58.7 6.5 17.4 32.9 57.1 20.0 64.0 81.5 48.3 33.4 14.8 58.6 0.5 38.0 98.4 24.9 69.3 9.5 49.6 12.6 20.1 5.6 18.7 47.2 34.3 29.7 3.2 55.2 34.1 21.6 39.2 27.0 25.0 43.1 0.0 10.0 4.5 52.9 46.7 0.1 10.3 4.8 68.6 74.8 0.2 22.7 17.3 47.8 28.4 6.6 13.3 43.2 46.9 59.4 10.0 39.6 15.4 76.8 46.1 29.3 56.9 51.6 4.4 1.2 1.2 75.3 3.1 137.4 10.4 3.5 0.1 1.2 0.8 1.0 1.1 8.9 3.4 34.8 0.0 0.1 0.3 0.8 1.7 0.1 0.3 35.4 6.4 7.4 11.8 9.0 10.8 8.8 7.5 15.7 11.2 18.1 12.9 244.2 393.4 23.4 924.2 542.3 8.1 85.2 119.8 93.7 315.1 153.5 45.2 422.7 92.9 335.7 28.0 269.0 358.5 46.7 313.5 336.4 599.3 268.8 1139.0 91.5 324.9 12.7 414.0 194.0 35.3 30.8 267.2 305.5 814.9 19.0 337.1 35.8 392.9 289.2 270.1 93.5 18.0 200.5 784.5 74.2 30.2 526.5 569.5 18.5 345.1 767.5 LPAR1 "edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1" ENSG00000198121 "Lysophosphatidic acid receptor 1" Q92633 9 110873263-111038458 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4" "Cell type enhanced" "Detected in many" 12 "Fibroblasts: 45.6;Leydig cells: 35.9;Peritubular cells: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.5;eosinophil: 15.6" "Group enriched" "Detected in many" 6 "granulocytes: 15.6;monocytes: 7.5" "Cell line enhanced" "Detected in many" "ASC diff: 98.3;ASC TERT1: 57.4;BJ hTERT+: 69.5;HSkMC: 41.7" "Low region specificity" "Detected in all" HPA050667 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA050667: " "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (4.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.17e-2)" "unprognostic (2.10e-1)" "unprognostic (1.40e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (4.29e-3)" "unprognostic (2.12e-2)" "unprognostic (5.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.97e-3)" "unprognostic (1.65e-1)" 16.3 9.5 55.8 12.0 56.2 0.3 14.8 4.7 30.9 43.7 12.3 71.4 3.4 9.4 12.1 12.3 10.6 10.1 9.8 8.5 55.6 30.6 5.7 1.9 7.3 10.5 59.4 17.0 8.9 4.6 1.1 2.3 25.7 29.1 9.4 12.8 3.5 5.6 17.2 3.3 6.9 10.2 14.0 69.8 9.5 6.5 4.8 49.4 0.1 6.2 3.2 11.3 15.4 17.8 0.0 1.9 15.6 7.5 1.8 0.0 1.6 1.8 3.5 5.0 0.0 98.3 57.4 0.0 24.5 69.5 17.2 7.8 0.4 0.3 0.0 0.0 25.3 3.1 7.3 0.0 19.1 14.2 0.0 0.6 0.0 0.2 0.0 26.6 0.0 0.0 41.7 1.1 8.5 16.2 10.3 0.3 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.9 0.0 19.8 0.0 3.7 0.0 3.9 3.3 0.1 1.2 0.5 0.0 0.0 1.0 1.7 0.0 0.0 8.1 0.2 5.8 0.0 0.2 0.0 0.0 1.2 0.0 8.9 0.9 7.5 15.6 0.0 2.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 1.8 1.1 0.1 0.0 1.6 55.8 56.2 4.7 29.5 55.6 30.6 59.4 17.0 29.1 49.4 0.0 0.6 0.0 10.4 11.6 0.0 0.8 0.0 2.7 10.3 0.0 0.0 0.5 1.7 1.3 1.0 1.7 5.1 0.0 2.5 0.3 45.6 9.6 0.0 0.0 3.3 0.0 0.0 3.1 3.3 1.5 35.9 2.5 13.5 12.6 3.7 1.1 1.7 0.0 66.4 0.0 0.0 0.0 7.2 0.0 2.4 8.2 0.7 0.0 4.0 5.5 MAGEA4 "CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336" ENSG00000147381 "MAGE family member A4" P43358 X 151912509-151925170 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "placenta: 12.1;testis: 23.5" "Cell type enriched" "Detected in some" 7 "Spermatogonia: 190.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 62.8;AN3-CA: 39.2;HMC-1: 74.8;U-2 OS: 20.0;U-266/84: 116.4" "HPA021942, CAB040535" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB040535: , HPA021942: AB_1853490" "unprognostic (7.90e-3)" "unprognostic (6.66e-3)" "unprognostic (5.39e-1)" "unprognostic (1.36e-1)" "unprognostic (5.81e-2)" "unprognostic (2.94e-2)" "unprognostic (4.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.8 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 20.0 0.0 0.3 15.9 116.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 23.4 190.5 0.0 27.6 0.0 0.0 0.0 MAMDC2 MGC21981 ENSG00000165072 "MAM domain containing 2" Q7Z304 9 70043581-70226970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 37.9;Leydig cells: 89.5;Peritubular cells: 77.1;Sertoli cells: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 4 "NK-cell: 2.6" "Lineage enriched" "Detected in single" 4 "NK-cells: 2.6" "Cell line enhanced" "Detected in some" "ASC diff: 23.0;HHSteC: 24.0;LHCN-M2: 29.9;TIME: 28.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021814, HPA022249" Uncertain Approved "Nuclear speckles,Plasma membrane" "Secreted in other tissues" NA NA "Nuclear speckles, Plasma membrane" "HPA021814: AB_1853508, HPA022249: AB_2139157" "unprognostic (1.88e-1)" "unprognostic (3.16e-3)" "unprognostic (2.21e-3)" "unprognostic (2.71e-2)" "unprognostic (4.30e-2)" "unprognostic (8.49e-2)" "unprognostic (1.27e-2)" "unprognostic (8.25e-2)" "unprognostic (5.91e-2)" "unprognostic (3.65e-2)" "unprognostic (1.92e-1)" "unprognostic (3.67e-1)" "unprognostic (3.03e-2)" "unprognostic (4.23e-3)" "unprognostic (2.35e-1)" "prognostic unfavorable (7.78e-4)" "unprognostic (2.79e-3)" 9.0 4.3 0.6 11.1 0.5 0.0 14.7 0.6 0.8 32.3 27.7 0.3 9.1 4.3 40.7 33.7 31.6 28.7 44.9 13.5 0.6 0.6 2.0 1.0 42.4 2.3 0.7 0.8 35.5 2.4 1.0 0.8 2.6 1.3 13.9 6.6 16.1 5.4 10.8 15.5 5.0 14.2 46.3 2.6 12.0 10.7 20.0 0.0 0.3 6.8 24.6 6.1 36.4 27.5 0.0 0.3 0.0 0.0 2.6 0.6 0.0 0.1 0.0 0.2 0.0 23.0 7.8 0.7 4.5 2.0 1.0 1.9 0.0 0.5 0.0 0.3 0.8 0.6 3.6 0.0 0.3 0.9 0.0 0.0 0.0 7.4 0.0 24.0 0.0 0.0 1.4 0.2 0.6 0.4 8.2 1.9 0.0 0.0 0.2 29.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.6 2.8 10.1 0.0 0.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 28.7 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.6 0.5 0.6 0.8 0.6 0.6 0.7 0.8 1.3 0.0 0.0 1.0 0.0 0.4 5.5 0.4 3.1 0.0 0.0 0.0 3.5 3.9 0.1 0.0 0.0 37.9 2.9 0.0 0.0 0.2 5.7 21.0 0.1 1.1 0.0 2.6 0.0 0.0 0.0 0.0 9.1 89.5 0.7 10.1 0.0 0.0 15.4 0.3 0.0 77.1 0.3 0.2 38.8 25.0 0.3 0.4 4.3 0.2 0.0 0.0 0.0 MAPK12 "ERK6, p38gamma, PRKM12, SAPK-3, SAPK3" ENSG00000188130 "Mitogen-activated protein kinase 12" P53778 22 50245450-50261825 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "skeletal muscle: 104.2" "Cell type enhanced" "Detected in many" 8 "Ito cells: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 31 "NK-cell: 3.0" "Lineage enriched" "Detected in single" 31 "NK-cells: 3.0" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 35.4" "Low region specificity" "Detected in all" "CAB025483, HPA054562" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB025483: , HPA054562: AB_2682524" "unprognostic (3.68e-2)" "unprognostic (1.72e-1)" "unprognostic (4.53e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (6.35e-3)" "unprognostic (3.90e-3)" "unprognostic (3.16e-2)" "unprognostic (6.02e-2)" "unprognostic (5.70e-2)" "unprognostic (3.48e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.00e-6)" "unprognostic (2.57e-1)" "unprognostic (8.88e-2)" "unprognostic (1.11e-2)" "unprognostic (4.28e-3)" 3.0 1.6 4.5 2.1 4.5 1.0 1.8 9.0 7.0 2.1 1.4 2.1 1.6 2.0 5.4 5.1 3.3 2.9 2.4 5.1 3.9 3.6 2.5 1.0 2.1 2.0 3.5 5.7 3.0 1.4 1.2 7.0 2.3 2.6 2.9 1.1 2.2 1.4 3.7 104.2 0.9 1.5 4.2 2.6 1.6 1.5 1.6 2.4 0.0 1.3 10.8 1.1 2.4 1.9 0.0 0.0 0.0 0.0 3.0 0.0 0.0 10.4 6.4 2.5 7.5 5.7 6.3 3.5 8.0 6.9 13.4 8.5 9.3 3.3 19.6 10.9 8.8 8.0 7.0 11.1 1.6 2.6 5.6 15.6 12.8 19.5 11.5 18.1 12.0 25.4 13.5 2.9 3.0 0.0 7.3 15.2 1.8 11.3 18.2 6.2 5.7 0.0 16.0 7.5 3.5 10.5 18.3 6.7 19.9 7.9 1.4 8.6 2.9 6.2 0.2 9.9 1.9 3.4 14.0 7.9 13.9 12.5 3.0 5.0 4.2 3.2 10.5 3.5 11.3 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 4.5 4.5 9.0 7.0 3.9 3.6 3.5 5.7 2.6 2.4 0.0 5.6 1.3 0.4 0.7 5.1 7.8 2.5 1.4 0.0 0.0 0.0 0.3 1.7 0.4 0.3 9.5 0.0 0.0 0.0 1.8 2.8 3.0 10.4 1.0 4.9 1.6 1.7 22.1 2.8 1.3 6.1 0.8 0.0 1.0 0.0 5.1 0.6 0.0 3.5 6.5 1.7 6.5 2.4 0.2 9.7 0.5 0.3 1.0 0.2 0.0 MAPK14 "CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15" ENSG00000112062 "Mitogen-activated protein kinase 14" Q16539 6 36027677-36111236 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 32.1;neutrophil: 12.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 32.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010285, CAB040578, HPA051825" Approved Supported "Nuclear speckles,Cytosol" NA NA 7100000 "Nuclear speckles" Cytosol "CAB010285: AB_632140, CAB040578: , HPA051825: " "unprognostic (6.76e-3)" "unprognostic (6.28e-2)" "unprognostic (6.30e-3)" "unprognostic (3.30e-3)" "unprognostic (6.98e-2)" "unprognostic (4.04e-2)" "unprognostic (8.10e-2)" "unprognostic (1.93e-1)" "unprognostic (2.20e-3)" "unprognostic (8.39e-2)" "unprognostic (6.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.47e-2)" "unprognostic (3.66e-3)" "unprognostic (6.66e-2)" "unprognostic (3.25e-1)" "unprognostic (1.58e-1)" 21.5 20.6 11.7 18.4 15.5 49.9 20.7 26.5 18.1 22.0 20.5 12.5 11.9 16.9 38.8 12.1 24.0 18.9 16.0 16.4 9.3 9.5 16.0 29.8 21.5 29.0 12.0 11.3 17.7 18.5 15.0 27.2 27.3 10.2 23.4 18.3 17.0 16.7 16.5 21.2 25.6 22.5 26.0 10.6 35.5 18.2 11.1 10.3 34.1 20.9 17.6 20.8 25.0 30.0 2.3 4.0 32.1 4.9 3.0 2.8 2.1 18.5 10.2 11.0 17.7 25.1 25.0 24.2 19.4 25.3 23.0 24.0 24.9 9.6 15.0 19.3 21.3 11.0 13.3 18.1 16.8 24.1 16.9 14.5 34.7 14.5 20.8 13.8 21.9 21.0 17.6 16.4 16.6 16.5 19.2 26.1 26.0 19.2 18.9 15.7 8.8 22.4 26.3 6.7 11.4 10.2 26.7 17.9 13.9 16.2 25.6 8.3 7.0 17.5 13.1 20.3 14.1 15.4 40.9 18.3 20.7 12.0 13.0 17.7 9.3 21.2 15.1 9.4 43.2 16.9 32.1 4.9 3.0 2.4 3.5 2.8 1.5 2.2 2.6 4.0 2.3 2.5 2.4 12.3 3.0 4.7 1.9 2.6 2.1 11.7 15.5 26.5 18.1 9.3 9.5 12.0 11.3 10.2 10.3 29.8 11.5 18.2 10.6 14.2 19.3 23.5 7.6 16.0 19.4 17.4 29.5 38.2 1.7 12.1 2.6 20.2 25.7 0.0 9.9 14.8 20.9 9.0 20.7 39.4 22.3 11.1 16.1 21.5 58.1 3.7 22.7 30.0 10.1 19.8 22.5 12.2 17.6 20.3 25.1 14.0 24.3 12.9 11.5 6.3 7.7 16.7 20.0 23.5 15.6 8.8 MAPT "DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau" ENSG00000186868 "Microtubule associated protein tau" P10636 17 45894382-46028334 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Alzheimer disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 89.9;skeletal muscle: 43.7" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 300.5;Early spermatids: 153.8;Horizontal cells: 341.7;Late spermatids: 194.8;Muller glia cells: 139.1" "Group enriched" "Detected in many" 11 "breast cancer: 9.5;glioma: 13.3;prostate cancer: 3.0;renal cancer: 4.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 27.9;SCLC-21H: 10.1;T-47d: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000151, HPA048895, HPA069524, HPA069570, CAB072344" Enhanced Supported "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155" "unprognostic (1.78e-3)" "unprognostic (7.51e-2)" "unprognostic (3.71e-2)" "unprognostic (8.40e-5)" "unprognostic (1.40e-1)" "unprognostic (1.31e-2)" "unprognostic (4.06e-5)" "unprognostic (6.04e-2)" "unprognostic (2.19e-2)" "unprognostic (3.49e-2)" "unprognostic (3.88e-3)" "unprognostic (2.65e-1)" "unprognostic (1.72e-3)" "unprognostic (6.53e-2)" "unprognostic (3.43e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" 3.8 7.1 28.9 2.4 31.2 2.1 8.8 40.1 89.9 2.4 2.7 21.4 1.7 2.5 2.6 2.3 6.4 2.5 2.8 6.5 28.7 29.7 15.3 2.2 2.4 2.3 22.6 35.2 2.3 2.8 8.5 8.8 5.2 29.1 5.1 2.5 2.2 8.1 5.3 43.7 4.6 2.8 2.5 13.6 2.2 2.3 6.5 27.7 0.0 2.3 3.1 2.3 3.2 0.8 0.0 0.0 0.3 0.1 0.5 1.7 0.1 0.8 0.3 0.2 2.6 0.0 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 1.3 0.1 0.0 27.9 1.4 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 1.6 0.2 1.4 0.0 4.2 0.5 0.1 0.0 0.4 1.1 0.0 2.3 2.8 0.0 3.6 10.1 4.7 1.0 0.0 1.0 0.6 12.7 0.0 0.0 0.2 0.3 0.6 0.1 0.5 0.2 0.0 0.2 0.5 0.3 0.0 0.1 0.3 0.8 0.0 0.6 0.0 0.4 1.2 0.0 0.0 0.9 0.9 0.0 0.5 0.1 0.0 1.7 0.1 28.9 31.2 40.1 46.3 28.7 29.7 22.6 35.2 29.1 27.7 0.0 9.8 0.8 1.1 0.9 300.5 32.3 0.0 0.0 0.0 1.8 60.9 0.1 6.6 0.4 153.8 1.3 0.0 0.0 0.4 8.0 1.9 2.9 4.6 0.5 0.3 341.7 0.0 0.6 0.3 194.8 2.6 1.3 5.0 1.0 0.0 139.1 0.6 0.0 2.5 44.6 24.8 0.0 4.1 11.4 5.9 2.9 0.2 0.0 0.1 0.5 MED17 "CRSP6, CRSP77, DRIP80, SRB4, TRAP80" ENSG00000042429 "Mediator complex subunit 17" Q9NVC6 11 93784227-93814963 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA046619 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA046619: " "prognostic unfavorable (4.94e-4)" "unprognostic (2.92e-1)" "unprognostic (2.72e-3)" "unprognostic (1.38e-1)" "unprognostic (6.71e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.48e-3)" "unprognostic (7.73e-2)" "unprognostic (1.41e-1)" "unprognostic (4.59e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-1)" "unprognostic (2.22e-1)" "unprognostic (5.56e-3)" "unprognostic (1.48e-1)" 9.0 7.4 5.8 9.9 8.0 9.5 9.2 13.9 10.7 10.7 10.2 9.0 9.4 4.3 12.1 7.5 7.9 10.4 7.3 11.5 6.3 5.4 6.4 4.6 8.2 8.1 9.5 7.3 13.8 9.9 5.4 13.1 9.5 6.1 8.2 4.9 8.0 9.4 6.6 9.3 10.2 14.0 7.7 7.7 13.9 12.1 7.9 8.8 20.7 7.8 5.5 9.8 11.2 11.6 10.5 6.8 10.8 5.7 10.2 8.5 5.1 3.0 1.0 2.6 5.5 3.2 0.4 5.1 6.7 2.3 4.5 2.8 5.3 6.3 5.0 11.3 0.6 1.3 9.4 2.4 1.4 1.2 6.0 2.7 5.6 3.4 1.5 1.7 9.3 9.5 1.3 3.3 3.3 2.2 1.1 1.8 1.3 4.9 3.0 2.7 0.8 11.2 2.7 4.8 0.7 0.8 8.6 7.6 4.1 2.7 2.1 9.1 11.7 5.6 4.6 2.8 0.7 7.0 2.3 6.0 7.0 5.6 9.3 5.8 4.6 9.1 3.6 1.8 6.6 7.9 4.9 4.6 10.8 6.4 5.7 7.6 10.5 8.2 8.0 6.0 9.0 8.5 4.8 4.7 10.2 3.3 6.8 8.1 5.1 5.8 8.0 13.9 7.9 6.3 5.4 9.5 7.3 6.1 8.8 6.0 9.4 35.0 34.7 26.8 21.7 12.1 12.7 18.7 14.8 7.0 15.7 32.8 1.7 12.8 0.7 13.4 11.5 0.0 8.5 22.7 17.1 21.5 10.4 6.8 12.9 14.3 25.7 13.5 13.7 2.2 14.7 12.1 13.5 11.8 11.2 17.1 9.7 14.1 20.1 1.5 35.0 64.7 19.8 24.7 15.4 22.5 28.5 20.3 13.8 32.7 MKX "C10orf48, IRXL1, MGC39616" ENSG00000150051 "Mohawk homeobox" Q8IYA7 10 27672875-27746060 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 21.3;prostate: 24.3" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 3.4;Ciliated cells: 6.7;Club cells: 2.3;Peritubular cells: 6.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "myeloid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "BJ: 19.3;BJ hTERT+: 11.1;BJ hTERT+ SV40 Large T+: 12.7;BJ hTERT+ SV40 Large T+ RasG12V: 8.7;fHDF/TERT166: 55.2;SiHa: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006927 Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA006927: AB_1853981" "unprognostic (2.04e-1)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.23e-2)" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (8.37e-2)" "unprognostic (2.16e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (7.62e-2)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (6.38e-3)" 3.7 3.2 1.6 1.4 2.1 0.3 3.0 2.6 5.9 4.9 4.3 1.4 0.9 0.5 1.8 3.4 1.8 7.1 2.7 0.8 1.4 2.5 0.6 1.9 1.2 0.5 2.7 1.4 21.3 1.0 0.3 13.9 0.3 6.7 24.3 1.5 2.9 0.9 7.7 0.5 1.0 0.7 10.6 2.7 0.8 3.4 1.3 0.1 0.0 4.5 0.5 0.3 8.7 1.6 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 19.3 11.1 12.7 8.7 0.0 0.0 0.0 0.0 55.2 0.5 0.0 0.1 0.0 3.4 0.0 1.2 0.0 3.5 0.0 0.5 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 1.2 0.0 2.4 0.3 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 8.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 2.6 5.9 1.4 2.5 2.7 1.4 6.7 0.1 0.0 3.4 0.0 0.0 0.0 0.1 1.4 0.0 6.7 2.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.7 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 MNS1 "FLJ11222, SPATA40" ENSG00000138587 "Meiosis specific nuclear structural 1" Q8NEH6 15 56421544-56465137 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;testis: 36.4" "Group enriched" "Detected in many" 5 "Ciliated cells: 285.0;Early spermatids: 279.9;Spermatocytes: 128.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039975, HPA040382" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA039975: AB_10793858, HPA040382: AB_10794740" "unprognostic (7.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.19e-1)" "unprognostic (5.07e-2)" "unprognostic (2.25e-1)" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.13e-2)" "unprognostic (2.05e-2)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-3)" "unprognostic (8.20e-3)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.71e-2)" 1.6 1.4 3.2 2.7 4.9 3.2 2.6 35.2 6.7 4.3 2.0 2.1 0.6 2.0 3.2 5.4 2.4 17.6 2.9 2.1 4.1 4.0 7.9 1.8 2.9 1.2 2.1 4.9 4.0 2.1 0.8 10.7 1.4 11.4 3.8 1.9 1.1 1.8 1.7 1.2 1.3 1.8 1.9 3.2 1.3 1.9 36.4 2.4 3.3 2.6 1.4 1.1 1.6 2.2 0.1 0.8 0.0 0.4 0.0 0.0 0.0 19.2 4.5 2.4 7.1 2.0 4.3 0.4 4.7 2.7 5.6 11.9 6.4 9.3 10.8 6.0 2.0 8.1 7.6 2.9 2.7 11.4 0.0 1.2 13.9 5.0 1.1 0.7 4.7 1.5 1.7 0.1 11.3 1.6 2.3 1.0 4.2 3.1 0.0 4.7 2.5 0.1 5.9 0.7 10.0 2.7 9.0 14.2 0.1 5.4 3.8 18.7 5.7 7.8 2.4 8.2 0.6 5.7 7.3 0.4 7.6 8.7 7.3 11.4 2.2 7.1 0.2 8.5 11.2 8.7 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 3.2 4.9 35.2 6.7 4.1 4.0 2.1 4.9 11.4 2.4 0.0 6.6 0.8 7.2 3.0 9.7 5.2 5.1 285.0 42.1 33.2 23.6 0.5 10.0 7.1 279.9 1.4 0.0 0.0 1.7 3.1 10.3 2.0 0.0 0.0 5.6 14.3 1.2 7.4 1.0 16.7 11.8 3.0 0.0 1.0 0.7 12.0 1.2 0.0 8.1 9.1 31.9 0.0 3.6 128.6 20.6 1.3 0.5 0.0 3.7 0.9 NAMPT "PBEF, PBEF1" ENSG00000105835 "Nicotinamide phosphoribosyltransferase" P43490 7 106248285-106286326 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Biological rhythms, Pyridine nucleotide biosynthesis" "Cytokine, Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 597.4;Macrophages: 479.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 18 "neutrophil: 143.5" "Lineage enriched" "Detected in many" 20 "granulocytes: 143.5" "Cell line enhanced" "Detected in all" "U-87 MG: 110.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034349, HPA047776, HPA057722" Approved Approved "Nuclear speckles,Cell Junctions" "Secreted to blood" NA NA 2140000 410000 "Nuclear speckles" "Cell Junctions" "CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: " "unprognostic (2.87e-1)" "prognostic unfavorable (4.78e-4)" "unprognostic (5.90e-3)" "unprognostic (1.63e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (8.81e-4)" "unprognostic (2.15e-1)" "unprognostic (2.74e-2)" "unprognostic (2.74e-1)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (3.02e-1)" "prognostic unfavorable (2.49e-6)" "unprognostic (6.83e-2)" "unprognostic (6.96e-2)" "unprognostic (7.76e-2)" "unprognostic (6.44e-3)" 67.3 22.2 8.1 113.6 18.1 110.4 52.6 7.8 12.9 11.6 18.2 2.9 9.5 9.3 9.9 13.5 53.4 27.8 28.1 84.4 13.4 6.3 13.5 92.9 48.9 117.5 10.3 5.2 27.3 18.3 5.5 10.0 23.9 29.2 17.4 10.5 8.2 32.9 14.3 41.0 12.9 14.1 44.9 59.1 41.1 26.4 11.9 7.1 6.2 13.5 40.7 13.2 48.8 26.4 0.8 2.0 143.5 7.3 1.0 1.5 1.3 19.2 12.9 4.6 7.8 19.7 23.0 7.6 6.1 34.6 12.4 21.9 7.6 11.7 16.1 14.7 6.8 37.2 15.2 8.6 18.4 27.2 9.5 9.2 6.5 5.5 5.9 73.7 12.6 12.1 21.9 21.1 22.2 26.0 18.6 39.5 8.0 13.6 62.0 14.8 10.1 12.6 5.3 9.0 12.2 10.4 6.0 6.6 35.5 11.8 18.2 9.5 5.2 8.6 18.8 21.8 13.4 6.0 3.6 33.6 18.5 14.3 26.5 11.2 42.7 24.2 23.3 110.0 14.3 27.4 8.1 2.3 3.5 0.4 5.6 0.7 0.8 0.5 0.6 2.0 0.7 0.8 0.4 143.5 1.0 7.3 0.8 1.5 1.3 8.1 18.1 7.8 12.9 13.4 6.3 10.3 5.2 29.2 7.1 122.1 246.8 48.1 258.1 184.4 22.1 87.9 163.1 104.4 177.5 40.1 11.8 23.8 39.7 250.8 6.3 173.0 92.2 0.0 120.5 44.2 117.9 276.9 178.5 597.4 98.8 38.1 24.1 141.8 340.8 4.5 37.4 479.6 153.5 65.9 46.4 19.5 161.8 35.1 29.4 36.0 28.4 25.8 234.9 14.9 57.9 181.7 21.2 41.5 63.9 273.8 NCAPG2 "CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB" ENSG00000146918 "Non-SMC condensin II complex subunit G2" Q86XI2 7 158631311-158704829 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.1" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026631, HPA049637" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA026631: AB_1845983, HPA049637: " "unprognostic (2.73e-2)" "unprognostic (1.77e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (7.94e-4)" "unprognostic (1.66e-1)" "prognostic favorable (1.91e-4)" "prognostic unfavorable (3.00e-5)" "unprognostic (5.33e-3)" "prognostic unfavorable (3.21e-4)" "unprognostic (7.79e-2)" "prognostic unfavorable (8.50e-4)" "unprognostic (5.19e-2)" "prognostic unfavorable (4.06e-5)" "unprognostic (2.58e-3)" "unprognostic (1.28e-1)" "unprognostic (8.21e-2)" "unprognostic (7.37e-2)" 5.9 4.0 4.4 8.6 4.2 20.1 5.4 9.0 5.1 4.4 6.6 5.8 3.5 4.2 5.1 5.1 9.9 3.7 3.1 4.0 4.3 3.5 3.3 3.9 4.4 11.4 6.2 4.2 4.4 4.4 6.0 5.8 6.9 4.9 4.5 7.7 3.9 5.3 4.2 4.5 6.5 5.5 4.6 6.2 6.1 5.3 14.6 5.1 39.1 3.6 7.6 13.0 4.8 5.5 1.8 2.8 6.9 5.4 6.1 9.3 2.5 30.0 16.0 19.5 12.5 2.9 4.8 7.7 22.0 14.2 27.3 30.6 14.1 15.8 18.6 13.8 9.0 29.0 15.5 16.2 10.1 36.5 19.8 12.0 16.8 19.9 11.1 1.3 20.7 19.0 2.0 1.1 22.2 6.4 5.0 15.1 21.8 20.6 28.0 25.0 32.0 34.4 14.0 19.2 17.1 13.0 20.2 20.5 17.7 6.7 13.5 21.3 16.5 27.2 10.6 6.0 13.0 9.6 13.5 7.9 18.7 14.3 50.4 35.3 18.5 13.6 22.6 19.8 26.5 35.4 6.9 1.0 1.2 6.5 1.4 9.3 1.8 6.6 4.5 2.8 1.2 2.2 2.4 0.6 6.1 5.4 1.4 8.3 2.5 4.4 4.2 9.0 5.1 4.3 3.5 6.2 4.2 4.9 5.1 6.0 1.0 1.5 1.1 3.5 3.8 3.4 2.5 8.1 6.8 1.8 0.0 2.6 0.0 2.3 9.3 2.2 0.4 0.0 2.9 8.4 2.7 0.9 1.1 2.1 6.1 7.9 0.0 4.3 2.7 4.0 2.6 4.7 1.7 2.8 1.7 1.9 1.6 0.0 3.9 1.1 2.8 6.5 4.1 40.1 15.6 1.8 2.2 5.1 1.8 2.3 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 161.6" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 2033.2;Hepatocytes: 1436.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "HPA063737: AB_2685109" "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favorable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 38.3 48.3 47.8 22.4 43.1 30.2 22.1 30.9 53.6 12.4 39.7 13.4 28.1 36.4 14.8 39.2 23.2 15.9 20.0 142.2 38.4 35.7 51.2 64.6 28.1 24.9 40.6 36.0 16.5 48.5 9.9 30.6 13.2 41.8 19.3 26.9 22.9 54.1 35.9 161.6 12.6 32.9 25.9 31.3 19.3 29.4 10.0 26.4 11.9 21.6 48.9 21.3 17.1 16.3 61.7 98.6 116.1 93.9 45.1 70.1 95.0 27.1 55.1 44.7 28.8 29.3 21.9 20.5 33.5 18.9 19.9 18.4 33.2 46.3 24.5 31.2 18.7 29.1 34.0 25.6 27.2 18.0 38.6 58.5 47.5 86.5 39.5 23.3 37.5 27.2 27.0 16.5 20.8 18.4 47.1 17.7 47.1 25.8 50.5 27.2 102.8 37.0 33.6 22.6 103.1 67.5 33.1 42.5 36.4 49.6 67.3 29.9 21.7 65.6 40.0 42.6 39.3 59.8 58.6 39.5 12.7 24.1 25.3 22.3 40.0 62.3 54.5 38.2 27.8 26.2 58.1 93.9 67.8 43.7 63.5 50.2 61.7 64.7 49.8 82.6 52.0 65.4 60.4 116.1 45.1 58.1 98.6 70.1 95.0 47.8 43.1 30.9 53.6 38.4 35.7 40.6 36.0 41.8 26.4 154.9 246.4 237.3 88.1 114.4 72.8 2033.2 565.6 282.4 178.6 369.9 37.3 225.4 988.2 197.4 98.7 145.0 655.0 280.4 371.9 86.0 164.5 117.3 207.1 1436.2 359.0 52.4 305.2 426.6 707.7 29.0 243.1 282.3 315.5 296.6 433.5 108.9 268.5 512.0 226.7 864.5 130.9 219.9 185.4 133.6 144.5 153.9 172.1 204.2 467.2 90.1 NEUROG3 "Atoh5, bHLHa7, Math4B, ngn3" ENSG00000122859 "Neurogenin 3" Q9Y4Z2 10 69571698-69573238 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.5;intestine: 8.4" "Group enriched" "Detected in some" 49 "Cardiomyocytes: 4.8;Intestinal endocrine cells: 5.1" "Cancer enhanced" "Detected in some" "stomach cancer: 1.4" "Region enriched" "Detected in single" 20 "hippocampal formation: 7.5" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;memory B-cell: 1.1" "Group enriched" "Detected in many" 7 "B-cells: 1.1;T-cells: 2.1" "Cell line enriched" "Detected in some" 5 "THP-1: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA039785 Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA039785: AB_10795114" "unprognostic (1.22e-2)" "unprognostic (7.33e-2)" "unprognostic (3.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (5.85e-5)" "unprognostic (4.58e-2)" "unprognostic (4.19e-1)" 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 7.6 0.0 0.0 8.0 0.0 0.0 0.9 0.0 1.8 0.0 7.5 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.1 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.3 7.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NFATC4 NFAT3 ENSG00000100968 "Nuclear factor of activated T cells 4" Q14934 14 24365673-24379604 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 22.4;Leydig cells: 16.1;Sertoli cells: 25.8;Smooth muscle cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 19.3;BJ hTERT+: 24.9;hTERT-RPE1: 21.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA031641, CAB032859, HPA076526" Uncertain Supported "Nuclear speckles,Cytosol" No No "Nuclear speckles, Cytosol" "CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: AB_2686805" "unprognostic (3.51e-1)" "unprognostic (5.61e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (8.08e-2)" "unprognostic (1.67e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.39e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (1.81e-6)" "unprognostic (1.47e-2)" "unprognostic (1.07e-1)" "unprognostic (1.35e-1)" "unprognostic (4.19e-2)" 9.0 11.3 4.3 5.5 6.7 0.4 10.9 4.2 5.1 28.2 14.0 3.3 8.9 3.4 19.0 11.4 9.1 13.8 21.6 7.8 4.9 1.3 6.4 0.9 5.6 3.3 8.0 4.1 33.1 2.7 8.4 8.6 14.0 6.3 14.8 3.9 9.3 4.0 13.5 4.6 6.9 5.9 20.9 2.8 4.2 7.7 9.6 3.1 1.5 11.0 5.9 5.8 22.3 14.7 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 13.2 19.3 0.0 8.6 24.9 11.7 10.3 0.0 7.2 7.3 0.2 12.4 0.8 0.0 3.5 0.1 7.1 0.0 0.3 5.6 9.0 0.0 6.4 0.0 0.0 13.9 0.1 7.1 0.0 21.8 9.1 2.3 1.8 0.0 2.2 0.4 0.0 0.8 1.1 0.5 0.0 0.5 0.8 0.9 0.0 0.1 1.5 6.1 0.0 1.7 2.8 4.6 5.2 2.2 5.2 10.9 2.3 10.2 0.0 5.3 0.7 5.1 2.2 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 6.7 4.2 5.1 4.9 1.3 8.0 4.1 6.3 3.1 3.0 7.2 0.8 1.0 3.9 0.4 5.2 0.0 0.0 5.7 0.0 0.0 0.4 0.0 1.8 2.4 3.8 0.4 0.0 0.2 0.5 22.4 0.6 0.0 0.0 0.6 0.0 7.5 1.8 0.0 4.0 16.1 0.0 6.8 0.0 4.7 11.3 0.8 0.0 7.1 0.0 1.6 25.8 25.5 13.4 2.2 3.0 0.5 0.0 1.3 2.1 NFKBIZ "FLJ34463, INAP, MAIL" ENSG00000144802 "NFKB inhibitor zeta" Q9BYH8 3 101827991-101861022 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 116.9" "Cell type enhanced" "Detected in many" 5 "granulocytes: 368.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 20.0" "Group enriched" "Detected in many" 4 "granulocytes: 15.8;monocytes: 20.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 31.5;RPTEC TERT1: 31.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA010547, HPA075363" Enhanced Supported "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA010547: AB_1854442, HPA075363: AB_2686745" "unprognostic (2.20e-2)" "unprognostic (1.11e-2)" "unprognostic (6.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-2)" "unprognostic (1.62e-1)" "unprognostic (9.22e-2)" "unprognostic (5.96e-2)" "unprognostic (1.40e-1)" "unprognostic (8.82e-2)" "prognostic unfavorable (4.30e-8)" "unprognostic (2.69e-1)" "unprognostic (8.90e-2)" "unprognostic (3.30e-1)" "unprognostic (8.52e-3)" 26.4 4.4 2.2 35.5 3.4 116.9 46.9 2.4 2.0 17.4 23.7 3.6 5.5 16.8 21.3 13.0 22.1 39.5 31.5 17.3 2.8 1.9 13.8 26.8 29.6 21.3 4.4 0.3 18.2 15.7 2.4 7.2 18.8 5.0 16.3 10.4 10.9 37.4 8.1 9.8 21.0 18.5 17.9 5.2 21.5 16.8 7.1 3.3 3.3 26.5 30.8 23.8 18.7 20.0 3.2 3.8 15.8 20.0 0.5 4.1 1.1 2.8 2.2 1.5 1.9 4.4 7.7 2.4 11.4 31.5 5.1 4.8 2.7 3.4 5.2 14.6 3.1 15.7 9.0 1.1 4.9 13.1 15.3 1.0 5.0 3.9 1.4 6.9 0.3 0.3 5.3 7.7 13.5 6.2 12.5 3.7 0.2 0.8 10.9 7.2 3.5 0.1 2.9 2.6 0.9 6.7 0.6 6.9 0.7 31.5 18.4 0.7 0.9 1.9 2.3 12.2 3.4 2.8 2.1 4.7 8.2 8.2 3.0 3.7 9.2 3.2 3.6 14.9 1.0 1.1 4.9 3.6 1.0 1.0 8.3 1.1 1.9 1.4 1.0 2.4 3.2 4.1 2.7 15.8 0.5 20.0 3.8 0.7 1.1 2.2 3.4 2.4 2.0 2.8 1.9 4.4 0.3 5.0 3.3 80.4 236.3 41.4 30.7 250.1 8.8 17.3 45.9 72.3 110.3 62.8 2.0 14.6 0.0 152.4 3.7 112.8 123.3 0.0 113.5 33.8 98.5 56.9 368.8 58.2 52.3 9.5 70.7 47.9 91.7 1.1 18.7 186.1 67.4 68.5 64.5 19.2 152.1 109.7 0.7 1.9 7.4 19.4 108.2 0.0 0.6 220.1 21.4 55.3 73.5 38.8 NLRP12 "CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2" ENSG00000142405 "NLR family pyrin domain containing 12" P59046 19 53793603-53824394 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 22.8;bone marrow: 11.0;lung: 6.5;lymphoid tissue: 13.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 9.0;Club cells: 6.8;granulocytes: 7.0;Kupffer cells: 12.3;Macrophages: 6.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 22.8;neutrophil: 15.0" "Group enriched" "Detected in many" 4 "granulocytes: 22.8;monocytes: 8.7" "Group enriched" "Detected in some" 4 "HMC-1: 7.7;THP-1: 6.7;U-87 MG: 7.3;U-937: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042099, HPA042981" Approved Uncertain "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA042099: , HPA042981: AB_10795712" "unprognostic (6.92e-2)" "unprognostic (3.11e-1)" "unprognostic (6.66e-3)" "unprognostic (9.82e-2)" "unprognostic (1.81e-4)" "unprognostic (3.90e-2)" "unprognostic (5.79e-2)" "unprognostic (6.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-5)" "unprognostic (1.63e-1)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (1.46e-2)" "unprognostic (4.48e-1)" 1.9 0.3 0.2 4.2 0.6 11.0 0.4 0.2 0.2 0.9 0.3 0.1 0.9 0.3 0.7 0.7 0.6 1.0 0.5 3.3 0.2 0.2 0.5 0.5 6.5 13.5 0.6 0.3 1.0 0.3 0.1 0.2 1.1 0.8 0.3 0.1 0.5 1.7 0.0 0.2 0.2 0.3 1.4 0.5 10.2 0.4 1.0 0.6 0.3 0.3 0.4 0.2 1.1 1.4 0.0 3.6 22.8 8.7 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.6 7.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 6.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 7.3 6.1 0.0 22.8 8.7 11.0 0.0 2.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 15.0 0.0 1.5 0.0 0.0 2.1 0.2 0.6 0.2 0.2 0.2 0.2 0.6 0.3 0.8 0.6 6.0 9.0 0.0 0.7 0.3 0.8 0.4 0.0 4.0 6.8 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.4 0.7 7.0 0.0 2.4 0.0 0.0 0.0 12.3 0.0 0.3 6.1 1.7 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.6 NME8 "CILD6, NM23-H8, SPTRX2, TXNDC3" ENSG00000086288 "NME/NM23 family member 8" Q8N427 7 37848597-37900401 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 7.9;bone marrow: 13.4;testis: 11.3" "Group enriched" "Detected in some" 5 "Early spermatids: 33.4;Late spermatids: 14.1" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 1.7;HMC-1: 2.5;NB-4: 3.7;NTERA-2: 3.5;THP-1: 3.2;U-937: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016416, HPA019259, HPA029572" Enhanced Supported "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "CAB016416: , HPA019259: AB_1858475, HPA029572: " "unprognostic (7.44e-3)" "unprognostic (2.32e-2)" "unprognostic (9.11e-2)" "unprognostic (2.97e-2)" "unprognostic (6.05e-2)" "unprognostic (1.20e-2)" "unprognostic (6.56e-2)" "unprognostic (4.22e-2)" "unprognostic (7.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (2.34e-2)" "unprognostic (8.13e-8)" "unprognostic (5.90e-2)" "unprognostic (3.36e-1)" "unprognostic (1.49e-1)" "unprognostic (1.86e-1)" 0.1 0.0 0.1 0.5 0.1 13.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.2 0.2 0.1 0.1 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.8 1.9 0.1 11.3 0.0 0.2 0.0 0.0 0.0 7.9 3.8 1.9 0.2 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 1.9 1.5 0.7 0.4 0.0 0.0 0.1 1.3 1.5 0.0 0.0 0.7 3.8 0.2 0.0 7.9 0.0 0.8 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.8 0.0 0.0 0.0 3.0 14.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 3.8 0.0 0.0 NR2F6 "EAR-2, ERBAL2" ENSG00000160113 "Nuclear receptor subfamily 2 group F member 6" P10588 19 17231883-17245940 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 123.8;Hepatocytes: 131.0;Horizontal cells: 143.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 59.1;EFO-21: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079917 Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles" Cytosol "CAB079917: AB_2635238" "unprognostic (1.48e-1)" "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (3.07e-1)" "unprognostic (3.67e-1)" "unprognostic (7.20e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (6.62e-2)" "unprognostic (9.68e-2)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (7.28e-3)" "unprognostic (1.37e-3)" 10.0 8.0 5.4 9.3 5.6 1.1 15.2 6.9 7.4 9.0 23.4 4.7 10.9 26.0 7.9 26.3 16.8 7.7 11.3 14.8 4.6 5.9 17.7 49.3 10.0 2.8 4.8 4.7 9.8 23.5 7.0 8.6 26.5 4.0 10.5 8.2 8.0 13.4 10.3 20.2 9.4 36.2 6.6 2.4 5.0 26.8 9.7 4.5 1.7 13.8 9.3 6.7 10.7 11.5 2.7 1.8 1.6 1.1 7.4 6.5 1.3 19.4 11.7 6.4 11.6 2.5 2.8 59.1 11.0 4.0 4.8 4.1 7.9 17.2 4.6 34.6 4.9 2.8 9.7 4.8 6.3 2.1 6.1 28.0 4.2 7.5 14.2 5.6 2.0 5.9 3.7 7.3 2.2 3.6 5.0 2.9 2.1 9.9 1.1 2.0 10.4 1.7 7.4 17.6 14.6 18.2 3.5 4.0 3.9 6.6 12.7 5.1 14.8 6.1 21.5 12.4 6.5 11.9 6.4 4.8 3.4 8.3 6.5 8.7 6.6 2.3 3.3 4.2 3.0 4.1 0.0 1.1 1.6 2.7 0.0 2.4 0.5 3.9 2.5 1.8 2.7 6.5 2.2 0.2 7.4 0.1 0.8 3.5 1.3 5.4 5.6 6.9 7.4 4.6 5.9 4.8 4.7 4.0 4.5 8.9 18.5 4.7 14.9 9.4 63.1 33.0 33.1 10.7 11.4 24.4 72.6 54.8 24.9 20.6 7.8 12.6 123.8 0.0 41.6 54.2 11.1 17.2 1.1 131.0 13.7 143.0 44.1 17.8 2.9 4.1 16.4 3.3 10.1 1.8 71.7 40.3 40.0 73.0 17.7 29.4 53.0 6.5 15.5 1.0 7.7 9.3 66.7 2.9 56.2 14.1 OIP5 "CT86, hMIS18beta, MIS18B" ENSG00000104147 "Opa interacting protein 5" O43482 15 41309268-41332621 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.7;testis: 41.7" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 19.9;Spermatocytes: 82.8;Spermatogonia: 66.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA052271, HPA059602" Enhanced Supported "Nuclear speckles,Vesicles" NA Yes "Nuclear speckles" Vesicles "HPA052271: AB_2681780, HPA059602: AB_2684079" "unprognostic (5.17e-2)" "unprognostic (7.26e-2)" "unprognostic (3.07e-1)" "unprognostic (1.59e-2)" "unprognostic (6.94e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.79e-4)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (9.34e-5)" "unprognostic (5.51e-2)" "unprognostic (0.00e+0)" "unprognostic (3.84e-2)" "unprognostic (2.02e-1)" "unprognostic (5.75e-2)" "unprognostic (2.86e-2)" 1.3 2.1 0.5 3.8 0.8 7.5 0.7 1.5 1.1 1.1 3.4 0.7 2.3 3.0 0.6 0.6 4.6 0.6 1.3 1.9 0.9 0.4 1.1 1.1 1.0 4.3 0.6 0.4 1.2 0.6 0.0 0.3 1.6 0.5 0.5 3.1 0.2 1.2 1.3 8.3 2.5 3.1 0.6 0.8 2.7 1.4 41.7 0.7 16.7 0.5 6.3 4.0 0.7 1.5 2.5 7.7 1.1 1.3 1.9 5.9 1.7 13.3 7.1 14.1 10.3 0.7 0.9 13.4 8.3 3.8 9.9 10.7 12.7 6.6 8.0 7.3 3.0 15.6 20.9 14.3 6.4 7.9 17.2 16.5 16.9 20.8 13.1 0.1 18.4 9.5 0.3 1.3 5.6 5.9 2.1 8.4 16.8 23.1 15.4 6.6 6.4 10.8 13.7 12.8 19.9 15.5 13.3 11.8 12.0 4.4 6.2 22.4 7.5 13.7 14.0 3.8 5.9 13.9 10.5 4.1 10.2 15.8 10.2 14.7 7.4 32.4 28.3 3.0 22.5 14.7 0.0 0.8 1.1 0.6 1.3 1.5 2.1 1.8 1.6 1.4 2.5 2.6 1.7 0.0 1.9 0.8 7.7 5.9 1.7 0.5 0.8 1.5 1.1 0.9 0.4 0.6 0.4 0.5 0.7 0.0 0.3 0.0 0.6 3.7 0.0 0.2 0.0 0.0 2.3 0.0 0.0 7.1 0.0 0.5 5.5 0.1 0.9 0.0 0.3 19.9 1.5 0.3 1.1 0.8 6.5 0.0 0.0 0.0 0.6 9.2 0.9 1.6 0.0 1.0 1.7 0.6 0.1 0.0 1.1 0.2 0.2 6.5 0.9 82.8 66.8 2.0 3.2 0.7 3.0 0.1 OTX1 ENSG00000115507 "Orthodenticle homeobox 1" P32242 2 63050057-63057836 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.3;retina: 18.9;salivary gland: 19.6;skin 1: 14.3" "Cell type enhanced" "Detected in some" 21 "Basal keratinocytes: 1.4;Ciliated cells: 6.7;Club cells: 2.3;Suprabasal keratinocytes: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 113 "neutrophil: 11.3" "Lineage enriched" "Detected in single" 113 "granulocytes: 11.3" "Cell line enriched" "Detected in many" 9 "THP-1: 34.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB012341, HPA052122" Uncertain Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "CAB012341: AB_2157155, HPA052122: AB_2681736" "unprognostic (2.25e-2)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-3)" "unprognostic (2.32e-1)" "unprognostic (1.67e-2)" "unprognostic (6.92e-3)" "unprognostic (3.66e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (2.26e-3)" "unprognostic (1.71e-1)" "unprognostic (0.00e+0)" "unprognostic (4.64e-2)" "unprognostic (2.31e-1)" "unprognostic (3.80e-4)" "unprognostic (3.67e-3)" 0.5 0.4 8.2 0.4 4.3 0.4 1.1 0.2 7.2 0.4 0.4 5.8 0.0 0.6 0.4 0.4 1.4 0.5 0.5 0.4 9.0 1.4 0.4 0.5 0.8 0.4 2.0 3.4 0.6 0.6 0.4 0.1 0.4 0.1 2.3 0.4 18.9 19.6 0.4 0.4 14.3 0.4 0.4 0.1 0.6 1.0 0.9 4.4 0.0 0.4 4.4 5.6 0.6 0.2 0.0 0.0 11.3 0.0 0.0 0.0 0.0 1.5 0.8 2.8 1.7 0.0 0.1 3.9 0.0 0.2 0.2 0.2 2.8 1.5 0.1 0.5 0.0 0.7 2.0 1.8 1.2 0.3 0.7 1.6 1.8 1.4 3.2 0.0 1.2 1.3 0.0 0.5 0.0 0.5 0.5 0.0 1.7 1.5 0.0 0.1 1.3 1.6 2.9 0.0 1.4 1.0 1.5 2.4 0.4 0.7 0.5 0.3 0.4 1.1 0.1 0.9 0.0 0.6 34.7 0.1 0.6 1.1 0.0 0.6 1.0 0.7 2.6 0.2 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 8.2 4.3 0.2 7.2 9.0 1.4 2.0 3.4 0.1 4.4 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.0 6.7 2.3 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 2.3 0.1 0.0 0.0 0.0 PABPN1 "OPMD, PAB2, PABP2" ENSG00000100836 "Poly(A) binding protein nuclear 1" Q86U42 14 23321289-23326185 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000637 Supported Approved "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553" "unprognostic (5.11e-3)" "unprognostic (2.65e-2)" "unprognostic (7.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.88e-2)" "unprognostic (1.47e-1)" "unprognostic (1.95e-3)" "prognostic favorable (9.66e-4)" "unprognostic (5.88e-2)" "prognostic unfavorable (2.41e-7)" "unprognostic (1.52e-2)" "unprognostic (1.31e-2)" "unprognostic (1.07e-1)" "unprognostic (8.25e-3)" 41.1 46.0 67.4 39.8 73.7 57.1 34.0 79.5 80.2 36.1 42.2 39.4 51.2 55.1 55.3 67.7 38.3 43.2 43.4 35.3 64.4 44.7 46.6 47.1 33.2 46.4 62.4 45.8 48.6 35.2 44.8 54.0 40.6 60.3 46.2 52.8 39.4 42.3 45.2 46.6 53.7 55.9 50.2 47.4 46.0 41.4 54.1 69.3 53.5 51.0 29.6 54.6 33.3 46.5 11.4 15.6 13.1 9.8 12.0 9.0 2.8 25.7 28.9 64.0 50.6 30.1 33.8 41.7 26.8 26.5 36.7 35.2 34.6 48.6 46.2 14.4 33.8 41.2 41.0 71.4 37.0 51.1 39.5 27.2 35.7 41.4 89.5 33.7 55.4 49.1 39.3 37.2 27.3 32.2 55.8 40.1 40.1 33.4 36.3 35.0 49.1 58.1 67.8 70.1 32.3 33.1 58.2 24.8 27.9 41.5 53.6 44.3 34.6 34.4 32.0 27.2 45.5 24.2 40.2 33.8 25.7 32.8 25.1 34.0 43.4 30.0 54.9 15.2 45.5 29.8 13.1 9.8 8.9 7.3 7.0 5.9 8.7 7.3 6.3 7.6 11.4 9.0 8.5 11.9 12.0 7.7 15.6 7.9 2.8 67.4 73.7 79.5 80.2 64.4 44.7 62.4 45.8 60.3 69.3 32.8 49.6 74.5 72.7 140.2 113.5 11.8 99.3 25.4 35.2 120.4 137.4 57.9 11.6 47.7 43.5 69.2 70.8 23.3 49.1 55.5 69.1 73.0 23.1 97.3 54.7 73.1 155.0 58.3 81.4 34.5 75.1 76.0 50.6 58.7 95.5 69.4 49.3 88.5 56.3 31.1 80.6 71.1 69.2 26.5 29.2 157.2 52.5 43.6 98.9 93.2 PAGE3 "CT16.6, GAGED1, PAGE-3" ENSG00000204279 "PAGE family member 3" Q5JUK9 X 55258412-55264846 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 111 "testis: 11.1" "Group enriched" "Detected in some" 54 "Early spermatids: 91.5;Late spermatids: 208.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.0;PC-3: 1.9" "HPA045032, HPA062248" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA045032: , HPA062248: AB_2684725" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 208.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.8 1.6 0.0 0.0 0.0 0.0 0.0 PCBP1 "hnRNP-E1, hnRNP-X, HNRPE1, HNRPX" ENSG00000169564 "Poly(rC) binding protein 1" Q15365 2 70087454-70089203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Viral RNA replication" "DNA-binding, Ribonucleoprotein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037113, HPA043803, HPA068497" Approved Enhanced "Nuclear speckles,Cytoplasmic bodies" No No 12000000 "Nuclear speckles" "Cytoplasmic bodies" "CAB037113: AB_1840915, HPA043803: AB_2678676, HPA068497: AB_2685996" "unprognostic (1.63e-1)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" "unprognostic (7.08e-2)" "unprognostic (5.37e-1)" "unprognostic (1.63e-2)" "unprognostic (8.33e-2)" "unprognostic (9.94e-3)" "unprognostic (2.01e-1)" "unprognostic (2.70e-1)" "unprognostic (6.65e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.71e-5)" "unprognostic (3.85e-2)" "unprognostic (9.25e-2)" "unprognostic (1.22e-1)" "unprognostic (5.90e-2)" 52.7 57.6 34.4 49.7 36.7 79.5 149.6 33.3 39.9 38.8 47.2 32.4 45.7 41.1 54.1 39.3 55.6 39.3 45.4 55.1 34.0 31.2 41.6 69.5 46.3 77.8 43.5 29.8 42.3 88.3 42.8 30.5 52.7 37.5 36.3 31.2 29.6 47.9 42.0 149.0 41.5 39.6 59.7 39.1 52.0 43.2 31.6 42.1 91.0 43.8 59.9 48.4 49.6 148.0 15.1 29.2 49.6 32.1 31.6 30.3 28.9 61.0 63.1 54.6 42.6 58.9 45.2 88.0 45.9 42.5 45.6 38.3 73.1 41.2 84.2 23.7 52.1 49.3 54.8 64.0 66.8 46.8 60.0 49.4 67.2 38.7 111.6 66.5 55.6 64.8 39.3 43.7 37.5 52.4 34.2 57.8 22.8 68.8 62.4 57.1 76.0 71.6 83.6 55.1 58.1 41.8 58.0 59.8 84.3 61.9 63.3 51.9 41.8 37.7 77.4 54.2 40.3 46.0 50.6 53.0 42.8 53.8 36.2 57.8 83.1 85.3 85.4 45.3 77.3 52.6 12.6 30.8 45.5 30.3 32.1 27.8 15.1 23.7 26.0 29.2 14.4 24.2 26.9 49.6 31.6 26.7 21.0 27.7 28.9 34.4 36.7 33.3 39.9 34.0 31.2 43.5 29.8 37.5 42.1 142.9 126.1 207.0 259.8 429.9 61.2 0.3 191.1 77.6 87.6 186.7 21.6 344.0 230.5 178.2 24.5 194.4 308.0 280.4 172.1 388.1 237.1 214.9 113.0 353.2 342.4 55.6 171.4 230.2 473.7 20.0 172.3 379.2 285.1 245.3 179.1 119.4 191.5 189.4 175.3 361.9 37.4 168.1 288.4 83.0 70.6 477.1 588.2 233.9 170.9 314.6 PCLO "ACZ, DKFZp779G1236, KIAA0559" ENSG00000186472 "Piccolo presynaptic cytomatrix protein" Q9Y6V0 7 82754013-83162930 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 95.6;Cone photoreceptor cells: 123.7;Horizontal cells: 81.0;Intestinal endocrine cells: 57.6;Rod photoreceptor cells: 84.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "REH: 62.4;U-2 OS: 71.7" "Low region specificity" "Detected in all" "HPA015858, HPA029579, CAB079012" Approved Supported Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles, Plasma membrane" "CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044" "unprognostic (1.32e-2)" "unprognostic (1.99e-1)" "unprognostic (9.33e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (4.49e-3)" "unprognostic (6.14e-2)" "unprognostic (4.61e-2)" "unprognostic (1.82e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" "unprognostic (4.79e-6)" "unprognostic (5.15e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-5)" "unprognostic (6.62e-5)" 3.1 7.9 8.8 0.8 26.3 0.4 4.7 50.3 19.4 3.2 3.9 1.6 0.4 2.9 1.0 7.3 2.3 2.0 1.9 2.2 9.8 5.7 8.2 0.6 1.8 0.6 4.6 12.6 1.9 4.0 11.4 19.2 1.0 9.1 4.9 3.5 3.6 2.5 5.0 0.6 2.6 2.4 0.7 5.3 1.1 2.9 4.5 4.4 0.0 8.4 0.0 0.8 1.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 1.9 0.1 1.4 0.5 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.4 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.2 1.1 62.4 1.0 0.0 0.4 0.2 1.2 0.8 0.0 0.6 0.1 0.3 0.8 0.1 0.0 0.0 71.7 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.8 26.3 50.3 19.4 9.8 5.7 4.6 12.6 9.1 4.4 8.9 14.1 0.0 8.3 2.3 95.6 24.6 20.4 9.4 18.2 1.8 123.7 0.9 6.6 4.6 9.0 4.1 14.6 0.0 4.4 0.3 0.4 5.3 0.0 0.0 1.3 81.0 57.6 0.0 0.0 5.6 2.6 0.0 0.0 0.0 12.3 17.5 2.5 14.4 6.0 16.7 84.6 0.0 0.3 3.9 13.8 3.0 0.6 0.0 7.7 4.8 PCP2 "GPSM4, MGC41903" ENSG00000174788 "Purkinje cell protein 2" Q8IVA1 19 7631611-7633748 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 45.5;retina: 20.2;testis: 80.7" "Cell type enriched" "Detected in many" 5 "Late spermatids: 3770.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 14 "cerebellum: 45.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 9.1;Karpas-707: 4.6;NB-4: 18.4" "Region enriched" "Detected in some" 43 "cerebellum: 2422.3" "Region enriched" "Detected in some" 18 "cerebellum: 135.0" HPA057428 Approved "Nuclear speckles,Vesicles" Yes NA "Nuclear speckles" Vesicles "HPA057428: AB_2683436" "prognostic favorable (7.93e-4)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.43e-2)" "unprognostic (1.49e-1)" "unprognostic (1.79e-4)" "unprognostic (1.19e-1)" "unprognostic (4.88e-5)" "unprognostic (1.11e-1)" "unprognostic (6.23e-2)" "unprognostic (9.15e-3)" "unprognostic (6.01e-2)" "unprognostic (1.36e-2)" "unprognostic (8.17e-2)" "unprognostic (1.18e-1)" "unprognostic (8.70e-2)" "prognostic favorable (2.76e-5)" 0.5 0.4 0.5 0.5 0.5 1.9 3.3 45.5 0.6 1.0 0.5 0.5 0.5 0.6 0.5 2.0 0.5 1.3 1.2 0.5 0.5 0.0 2.5 1.0 1.2 1.4 0.5 0.5 0.5 1.6 0.3 0.5 0.5 3.2 2.0 0.0 20.2 10.6 1.0 0.5 4.2 0.5 0.5 1.9 1.1 0.9 80.7 0.5 0.5 1.9 0.5 0.6 0.5 0.5 1.0 1.7 2.6 0.3 0.7 1.2 5.2 1.8 0.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 1.7 0.8 1.2 0.0 0.0 1.4 0.0 0.2 0.0 0.8 0.6 2.8 2.5 0.1 0.0 0.3 9.1 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.2 4.6 0.0 0.3 0.4 18.4 0.4 0.3 0.0 0.8 0.2 0.7 0.9 0.1 0.1 0.0 1.5 1.6 0.0 0.4 4.0 3.4 0.2 0.0 0.6 0.4 0.1 1.6 0.6 0.2 0.0 2.1 0.0 0.0 0.3 0.0 0.9 0.1 1.2 0.4 0.5 0.5 0.5 1.0 0.8 1.0 2.6 0.7 0.0 1.7 0.2 5.2 0.5 0.5 45.5 0.6 0.5 0.0 0.5 0.5 3.2 0.5 0.0 2.9 0.0 0.8 0.7 166.8 0.0 0.0 0.0 2.3 5.2 21.6 0.2 8.3 0.6 765.5 0.0 0.6 0.0 0.2 0.0 0.0 1.2 1.1 0.0 0.4 22.3 0.0 0.0 1.2 3770.2 9.8 1.0 1.7 1.8 0.2 24.5 0.5 0.0 12.4 0.3 79.8 19.4 0.0 11.1 6.4 1.0 0.0 1.5 0.5 0.6 PDZK1IP1 "DD96, MAP17, SPAP" ENSG00000162366 "PDZK1 interacting protein 1" Q13113 1 47183593-47191044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "kidney: 281.3" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 4006.8" "Cancer enhanced" "Detected in all" "renal cancer: 340.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "EFO-21: 31.5;RPTEC TERT1: 104.5" "Not detected" "Not detected" HPA014907 Enhanced Approved "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA014907: AB_1855166" "unprognostic (2.97e-1)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "prognostic unfavorable (6.92e-4)" "unprognostic (8.14e-3)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.65e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (3.45e-4)" "unprognostic (2.64e-2)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (1.75e-3)" "unprognostic (1.89e-1)" 2.7 1.2 0.6 2.4 0.6 3.9 4.1 0.6 0.6 9.2 9.1 0.6 0.6 2.2 1.3 4.8 30.4 2.9 23.9 0.7 0.5 0.0 281.3 1.6 7.2 0.5 0.6 0.5 2.3 16.8 0.0 0.6 3.2 0.6 2.1 3.4 0.8 33.9 12.4 0.7 19.9 9.5 0.5 0.5 0.7 9.0 1.4 0.6 1.1 1.0 18.3 18.5 4.1 8.3 0.1 0.5 2.1 1.1 0.2 0.3 42.4 11.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.6 0.0 31.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 104.5 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.1 0.2 0.0 0.5 0.3 42.4 0.6 0.6 0.6 0.6 0.5 0.0 0.6 0.5 0.6 0.6 71.5 39.6 6.7 11.1 12.6 0.0 0.0 359.2 6.7 34.2 221.6 0.0 0.0 351.5 818.0 0.0 1.6 60.9 140.2 656.9 0.0 0.9 37.3 10.4 1.0 0.2 0.0 38.1 2.5 0.3 0.0 3.1 1.5 8.5 21.6 123.8 0.5 959.8 81.8 0.0 4006.8 0.0 0.0 2.3 0.0 0.1 47.2 0.7 1.5 119.5 16.8 PLRG1 "Cwc1, PRL1, Prp46, PRPF46, TANGO4" ENSG00000171566 "Pleiotropic regulator 1" O43660 4 154535006-154550435 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035931, HPA035932, HPA061486" Supported Enhanced "Nuclear membrane,Nuclear speckles" NA NA "Nuclear speckles" "Nuclear membrane" "HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536" "unprognostic (6.51e-2)" "unprognostic (5.66e-3)" "unprognostic (6.10e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (1.61e-2)" "unprognostic (2.17e-2)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (2.88e-1)" "unprognostic (1.24e-1)" "unprognostic (1.74e-2)" "prognostic favorable (8.20e-5)" "unprognostic (2.92e-1)" "unprognostic (9.84e-3)" "unprognostic (1.64e-2)" "unprognostic (1.97e-1)" 20.2 18.1 23.3 14.9 30.9 17.5 25.2 29.3 28.6 22.7 19.5 24.7 16.7 15.6 24.4 19.3 24.4 22.8 16.0 16.2 22.9 22.2 26.0 34.9 17.1 20.4 28.9 24.3 23.9 14.2 28.2 21.9 17.8 29.4 18.4 22.7 13.3 19.4 23.3 23.0 16.5 22.1 29.2 32.5 19.1 16.8 13.3 25.9 22.0 24.8 22.3 31.5 18.3 16.5 25.2 25.2 23.2 30.9 34.0 28.8 23.7 23.9 19.6 25.4 27.1 30.1 26.1 21.4 30.8 37.8 42.2 34.5 23.1 21.2 26.1 15.8 36.6 27.8 17.7 33.1 41.2 46.9 26.3 16.5 31.4 15.6 22.3 30.8 31.2 26.4 28.0 38.3 49.8 39.2 25.4 36.1 28.9 32.0 33.6 36.6 17.1 23.9 14.9 19.2 19.1 21.4 23.8 13.2 15.8 29.2 15.4 14.8 16.7 18.8 20.3 29.4 25.1 19.5 21.9 23.2 25.2 28.6 22.2 27.4 17.6 22.8 32.9 23.7 15.1 33.5 23.2 19.4 15.2 23.7 22.5 28.2 25.2 24.8 25.6 25.2 19.2 26.6 24.8 5.2 34.0 30.9 24.8 28.8 23.7 23.3 30.9 29.3 28.6 22.9 22.2 28.9 24.3 29.4 25.9 23.8 14.9 29.0 28.9 14.4 27.4 22.1 12.7 37.5 14.8 21.0 11.8 43.2 13.3 39.6 14.7 21.9 18.7 0.0 30.4 31.8 28.3 15.4 45.0 25.5 30.6 58.8 26.0 17.2 20.6 1.3 25.9 20.4 13.5 38.7 14.1 29.8 28.6 20.9 32.9 29.0 19.5 19.4 21.7 22.8 29.6 15.2 37.1 28.8 19.1 20.2 POLDIP3 "KIAA1649, PDIP3, PDIP46, SKAR" ENSG00000100227 "DNA polymerase delta interacting protein 3" Q9BY77 22 42583721-42614962 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 116.8;Late spermatids: 271.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018419, HPA048790" Approved Enhanced "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA018419: AB_1856928, HPA048790: AB_2680522" "unprognostic (2.00e-1)" "unprognostic (1.55e-1)" "unprognostic (1.32e-1)" "unprognostic (7.05e-3)" "prognostic favorable (7.79e-4)" "unprognostic (2.82e-1)" "unprognostic (1.17e-2)" "unprognostic (5.44e-2)" "unprognostic (8.16e-2)" "unprognostic (4.49e-3)" "unprognostic (2.48e-1)" "unprognostic (5.96e-2)" "prognostic favorable (3.36e-4)" "unprognostic (3.73e-2)" "unprognostic (3.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.19e-1)" 17.7 24.5 25.8 22.9 31.6 43.8 25.3 30.9 33.2 28.4 23.2 36.2 23.4 19.2 31.3 27.8 28.1 41.4 28.8 20.6 25.9 19.2 24.4 19.7 25.1 24.4 38.0 24.9 71.5 24.1 27.7 24.4 30.8 27.4 27.5 22.5 24.0 28.1 27.0 23.8 28.5 21.2 27.2 24.5 26.9 28.0 28.2 38.3 37.9 33.5 17.4 33.2 21.2 27.0 22.2 33.0 22.7 28.5 20.9 26.8 27.0 17.4 17.9 40.4 18.8 18.3 21.0 25.9 20.1 17.1 31.1 23.2 20.9 12.1 29.6 13.0 23.8 14.7 20.3 42.0 23.0 24.3 14.2 31.0 23.5 21.0 21.6 17.0 36.5 24.1 14.6 26.3 22.8 23.8 26.0 21.8 22.5 25.1 19.7 24.4 19.5 30.4 26.5 22.3 22.9 16.9 38.7 36.8 20.0 25.8 11.3 13.3 11.4 24.4 21.3 21.5 24.8 19.6 26.9 19.8 19.7 23.9 13.3 20.2 19.2 23.4 27.5 16.0 22.7 27.7 18.1 28.5 22.7 25.7 26.5 26.8 22.2 23.0 21.8 33.0 22.2 25.6 22.5 16.6 20.9 22.7 16.9 23.7 27.0 25.8 31.6 30.9 33.2 25.9 19.2 38.0 24.9 27.4 38.3 17.9 13.7 27.3 20.7 17.4 29.4 10.4 15.3 14.7 13.6 19.2 19.6 31.6 18.3 25.3 116.8 15.7 18.8 23.3 21.6 31.9 16.3 27.2 24.2 15.3 20.0 23.8 18.4 16.0 20.8 271.9 20.1 18.4 18.6 49.5 13.5 17.7 21.5 17.5 23.3 15.1 14.4 45.3 20.2 20.9 35.0 15.4 43.6 25.4 16.9 19.7 POLI "RAD30B, RAD3OB" ENSG00000101751 "DNA polymerase iota" Q9UNA4 18 54269404-54321266 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 68.1;Spermatocytes: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012000, HPA064696" Enhanced Supported "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA012000: AB_1847786, HPA064696: AB_2685325" "unprognostic (1.64e-1)" "unprognostic (5.79e-3)" "unprognostic (9.72e-3)" "unprognostic (4.92e-2)" "unprognostic (3.04e-1)" "unprognostic (4.46e-2)" "unprognostic (1.31e-1)" "unprognostic (1.05e-2)" "unprognostic (4.04e-3)" "unprognostic (2.22e-2)" "unprognostic (2.07e-3)" "unprognostic (1.30e-3)" "unprognostic (1.55e-1)" "unprognostic (4.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (6.99e-2)" 16.5 11.1 10.2 9.5 14.0 5.2 15.8 9.6 14.7 12.9 9.9 13.4 13.7 6.6 13.2 13.1 6.6 10.3 8.3 9.1 8.7 7.6 12.9 6.4 9.0 7.4 10.9 9.0 16.4 11.8 17.6 21.3 17.4 15.3 12.7 7.7 9.6 11.3 14.7 7.2 8.2 7.6 10.9 12.0 8.2 9.0 30.5 10.9 17.3 27.3 1.5 7.0 12.7 10.5 9.9 10.3 10.9 10.7 7.9 12.7 7.1 7.6 2.8 21.0 12.7 7.1 13.9 6.8 6.3 13.6 7.3 12.2 2.1 7.3 3.6 2.1 9.2 7.4 6.3 4.9 7.3 8.2 8.7 2.4 4.5 3.1 5.3 11.6 7.2 3.8 15.1 11.1 6.3 13.3 16.6 15.4 6.0 3.1 10.3 12.2 6.0 5.1 6.4 7.2 2.0 3.1 3.3 4.3 9.0 8.3 10.2 9.9 10.1 4.5 4.0 6.7 14.2 14.7 3.3 7.4 13.8 3.8 2.0 5.2 8.4 1.9 5.2 9.8 6.5 10.0 5.4 10.7 10.9 8.3 5.7 7.7 8.6 8.8 8.6 10.3 9.9 12.7 7.6 6.7 7.9 5.8 8.1 9.8 7.1 10.2 14.0 9.6 14.7 8.7 7.6 10.9 9.0 15.3 10.9 23.8 16.0 4.5 7.9 2.3 15.1 9.5 2.5 24.1 10.3 5.2 9.8 26.3 8.3 7.9 68.1 6.0 2.0 0.0 5.4 14.9 7.1 3.8 12.7 5.8 7.9 3.2 5.8 10.4 8.4 12.8 18.4 6.1 6.8 6.4 4.7 18.8 5.6 2.9 17.0 12.5 20.8 32.3 8.0 70.7 28.2 2.3 23.3 4.4 3.9 2.4 POLR2D RBP4 ENSG00000144231 "RNA polymerase II subunit D" O15514 2 127843551-127858157 "Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.4" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034694, HPA046092" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA034694: AB_2674284, HPA046092: AB_10963049" "unprognostic (3.57e-2)" "unprognostic (3.76e-2)" "unprognostic (2.59e-1)" "unprognostic (2.54e-2)" "unprognostic (2.77e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.91e-4)" "unprognostic (2.51e-1)" "unprognostic (7.95e-3)" "unprognostic (2.64e-3)" "unprognostic (1.97e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (3.66e-2)" "unprognostic (6.57e-2)" "unprognostic (1.17e-1)" "unprognostic (2.38e-1)" 8.2 9.4 8.1 8.9 9.1 17.9 7.9 9.3 12.6 6.9 7.7 12.3 6.9 6.3 7.5 6.2 9.8 7.7 7.6 7.3 7.8 6.3 6.3 13.5 7.2 11.8 9.9 7.5 10.3 17.4 7.4 9.4 10.2 8.7 7.2 9.9 7.3 7.6 6.5 21.9 8.9 7.8 9.8 8.8 11.1 7.8 46.4 9.9 16.7 6.3 9.1 16.8 8.0 7.2 16.7 20.6 11.4 22.1 16.7 21.0 14.3 18.4 12.1 22.5 15.7 8.4 9.2 18.1 17.7 8.4 21.4 19.2 27.3 15.3 28.7 15.3 11.9 12.2 9.8 32.3 15.3 33.2 16.8 17.6 28.4 12.1 25.0 9.8 30.4 15.8 6.5 11.5 28.5 16.4 5.9 13.9 21.1 39.5 25.8 12.2 14.7 30.2 13.8 31.5 19.4 14.0 29.1 23.8 25.9 7.1 12.7 14.0 18.7 11.9 14.8 14.9 17.6 16.6 21.1 14.0 18.6 26.2 10.5 20.4 30.5 49.4 51.7 16.2 15.2 18.2 5.7 15.8 11.4 19.4 21.5 18.1 16.7 15.6 16.9 20.6 15.1 21.0 17.8 5.0 16.7 22.1 13.5 13.9 14.3 8.1 9.1 9.3 12.6 7.8 6.3 9.9 7.5 8.7 9.9 3.0 9.4 14.9 17.2 9.6 14.8 9.0 10.2 8.1 12.5 12.2 7.9 26.9 10.0 17.6 54.9 9.5 7.0 23.3 15.2 23.1 10.3 13.9 18.4 14.9 19.4 31.8 8.1 9.2 9.1 142.9 16.4 11.5 8.5 25.2 10.6 11.8 13.4 10.5 17.3 8.7 12.9 12.9 14.1 61.1 55.3 8.8 22.3 13.8 13.4 14.0 PPIG "CARS-Cyp, SCAF10, SRCyp" ENSG00000138398 "Peptidylprolyl isomerase G" Q13427 2 169584340-169641406 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021788, HPA057469" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA021788: AB_1847408, HPA057469: AB_2683445" "unprognostic (2.70e-1)" "unprognostic (2.17e-1)" "unprognostic (2.40e-1)" "unprognostic (2.04e-3)" "unprognostic (4.17e-2)" "unprognostic (3.49e-2)" "unprognostic (1.55e-3)" "unprognostic (3.66e-2)" "unprognostic (2.15e-3)" "unprognostic (3.15e-3)" "unprognostic (2.47e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (4.56e-4)" "unprognostic (5.23e-2)" "unprognostic (3.29e-1)" "unprognostic (3.41e-2)" "unprognostic (3.39e-2)" 26.2 25.3 28.5 23.8 45.3 39.2 26.7 45.0 40.7 33.1 27.1 14.6 26.0 25.3 27.1 28.1 29.4 24.3 21.2 24.2 30.0 20.3 26.0 41.1 25.5 30.4 27.7 35.9 29.5 22.8 39.4 56.7 26.0 38.0 29.3 23.9 13.8 28.6 28.8 27.8 24.5 30.8 31.9 39.7 29.7 24.1 19.8 33.7 24.1 28.4 22.6 29.9 37.4 27.6 36.4 23.7 41.7 24.7 18.7 29.6 13.3 19.5 9.3 26.3 14.4 14.6 17.9 24.8 22.4 16.8 16.5 17.1 25.4 22.6 33.7 20.6 16.1 20.7 18.8 20.6 18.3 24.5 23.4 16.6 50.7 13.9 30.9 14.1 47.7 22.6 15.0 20.7 22.4 25.2 15.7 18.1 20.6 48.9 28.2 18.8 15.8 35.2 29.3 37.7 15.9 9.5 32.4 26.3 32.9 20.4 29.4 23.0 15.2 24.0 17.9 24.3 21.1 16.7 27.6 20.8 21.6 16.5 14.4 18.3 16.4 23.6 47.1 15.9 25.6 19.7 20.7 20.0 29.9 20.3 20.1 23.2 27.6 27.0 23.8 14.9 36.4 29.6 23.7 41.7 18.7 24.7 23.7 22.9 13.3 28.5 45.3 45.0 40.7 30.0 20.3 27.7 35.9 38.0 33.7 205.4 160.5 152.0 169.4 134.5 178.8 130.1 61.1 132.5 155.8 89.0 51.1 146.0 68.0 90.9 6.8 121.2 97.1 70.0 90.5 147.9 117.4 133.0 172.3 157.2 134.3 208.2 100.6 106.2 118.2 8.4 131.5 135.1 104.6 124.4 115.6 123.1 82.2 108.7 137.9 99.6 103.2 161.7 154.6 225.0 148.0 150.9 171.9 152.4 132.6 136.1 PPP1R16B "ANKRD4, KIAA0823, TIMAP" ENSG00000101445 "Protein phosphatase 1 regulatory subunit 16B" Q96T49 20 38805705-38923024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.4;lymphoid tissue: 35.0" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 35.0;Ito cells: 32.5;monocytes: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 22.7;HMC-1: 24.5;HUVEC TERT2: 14.5;U-266/70: 39.9;U-266/84: 16.0;U-698: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049571, HPA079512" Approved Supported "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA049571: , HPA079512: " "unprognostic (2.62e-2)" "prognostic favorable (2.11e-4)" "unprognostic (2.67e-3)" "unprognostic (3.35e-3)" "unprognostic (2.19e-1)" "prognostic favorable (7.87e-5)" "unprognostic (1.13e-1)" "unprognostic (4.17e-2)" "unprognostic (4.31e-2)" "unprognostic (6.28e-2)" "unprognostic (4.09e-3)" "unprognostic (4.77e-2)" "unprognostic (3.45e-2)" "unprognostic (8.53e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.90e-2)" 11.2 3.2 26.3 15.9 44.4 13.0 4.4 19.7 35.1 3.6 4.5 25.6 0.0 3.6 3.5 1.9 3.3 5.8 5.3 4.9 25.5 9.1 24.4 2.6 7.3 30.1 15.0 18.8 1.6 1.5 1.2 1.8 3.7 10.9 2.1 5.1 1.6 2.3 2.3 3.4 1.8 9.2 6.8 18.6 14.4 4.9 1.2 15.1 5.1 3.2 0.5 35.0 7.5 3.7 8.4 4.9 3.5 1.3 3.9 5.2 1.6 0.0 0.3 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.7 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.5 0.1 1.7 0.0 0.0 0.0 0.1 24.5 0.0 0.0 0.0 0.0 0.0 14.5 3.1 0.3 4.8 0.0 0.0 2.8 3.8 3.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 8.1 0.0 0.0 0.0 0.3 0.0 1.2 2.2 0.0 0.3 0.0 0.0 39.9 16.0 15.6 0.0 0.0 0.0 0.0 0.3 3.5 5.2 0.7 2.8 8.4 3.7 5.1 1.1 5.4 2.2 3.0 0.0 3.9 1.3 4.9 3.7 1.6 26.3 44.4 19.7 35.1 25.5 9.1 15.0 18.8 10.9 15.1 3.0 4.8 8.3 0.0 0.9 1.2 15.2 0.0 4.0 2.3 0.0 0.0 0.0 0.0 0.0 1.0 14.6 0.0 0.0 0.0 0.0 0.5 0.0 3.5 0.0 0.1 35.0 0.0 32.5 3.0 0.6 0.0 2.4 8.5 35.1 0.0 0.2 0.0 0.0 0.0 10.8 0.2 0.0 0.3 0.0 0.2 1.1 0.0 15.0 0.0 0.1 PPP1R8 "ard-1, ARD1, NIPP-1, NIPP1, PRO2047" ENSG00000117751 "Protein phosphatase 1 regulatory subunit 8" Q12972 1 27830778-27851676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027406, HPA027417, HPA027452" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490" "unprognostic (5.61e-2)" "unprognostic (2.55e-1)" "unprognostic (4.42e-3)" "unprognostic (3.76e-2)" "unprognostic (2.00e-2)" "unprognostic (9.09e-3)" "prognostic unfavorable (2.19e-5)" "unprognostic (4.82e-2)" "unprognostic (2.14e-3)" "unprognostic (2.20e-1)" "unprognostic (3.16e-2)" "unprognostic (9.16e-2)" "unprognostic (6.26e-2)" "unprognostic (8.08e-2)" "unprognostic (2.91e-2)" "unprognostic (4.86e-2)" "unprognostic (2.58e-2)" 18.0 14.5 28.6 15.5 37.0 23.2 19.4 23.1 29.7 18.9 16.0 18.2 12.0 13.3 24.0 15.6 19.6 19.4 14.6 16.2 23.4 17.7 13.9 14.8 17.6 28.6 24.6 25.7 24.6 18.5 14.2 18.9 17.4 24.4 15.3 18.0 11.7 15.1 19.5 17.8 17.8 15.1 21.8 24.6 16.9 14.3 21.4 25.6 20.7 17.9 9.4 24.6 18.6 16.0 11.9 9.7 17.0 11.4 14.0 16.5 14.9 21.1 15.0 32.7 21.2 20.6 21.6 18.8 22.8 24.0 39.1 31.7 16.8 24.4 30.3 16.1 25.9 15.2 19.1 38.4 21.3 28.4 25.4 23.4 39.5 20.4 24.7 20.8 36.3 28.1 18.8 23.3 35.4 31.7 17.6 23.1 26.0 33.4 20.7 23.2 13.8 39.6 21.4 40.4 18.7 17.5 32.5 27.1 28.8 21.0 19.5 22.9 20.9 28.0 21.9 27.0 17.5 19.2 22.9 19.0 19.3 17.6 30.2 21.1 19.2 29.3 38.3 18.8 47.4 24.6 17.0 10.0 9.1 14.0 10.0 16.5 11.6 11.6 15.8 9.7 11.9 12.8 12.1 5.9 14.0 11.4 7.3 11.4 14.9 28.6 37.0 23.1 29.7 23.4 17.7 24.6 25.7 24.4 25.6 14.9 7.7 28.1 17.4 15.3 22.6 11.5 7.6 18.7 20.5 5.2 2.0 41.6 26.6 24.8 26.4 14.6 12.6 0.0 22.4 34.1 19.0 13.0 25.4 15.8 23.1 7.9 11.1 20.3 14.3 18.7 22.2 16.9 10.1 40.5 14.5 19.8 24.7 16.1 15.9 19.9 13.9 25.8 16.4 27.9 40.2 12.3 36.7 24.5 15.3 17.4 PRKAA1 AMPKa1 ENSG00000132356 "Protein kinase AMP-activated catalytic subunit alpha 1" Q13131 5 40759379-40798374 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 230.0;Late spermatids: 337.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005050, HPA035409, HPA064946" Supported Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB005050: AB_562037, HPA035409: AB_2674613, HPA064946: AB_2685390" "unprognostic (2.07e-1)" "unprognostic (1.41e-2)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (3.97e-1)" "unprognostic (1.05e-1)" "unprognostic (3.51e-2)" "unprognostic (7.53e-2)" "unprognostic (1.66e-2)" "unprognostic (2.88e-1)" "unprognostic (3.34e-3)" "unprognostic (2.63e-1)" "unprognostic (2.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.10e-2)" 40.6 15.7 9.4 15.9 16.1 29.0 26.2 14.3 17.7 30.2 24.0 19.9 18.9 21.7 23.5 20.9 22.5 20.4 21.3 15.0 10.5 11.7 35.9 40.7 24.8 16.7 12.2 8.5 28.8 20.6 25.3 20.0 16.8 35.7 26.1 22.3 20.0 23.2 17.9 18.5 16.6 32.6 20.7 14.1 25.1 22.1 29.3 11.4 21.4 28.0 20.5 22.9 32.5 17.9 8.4 6.5 15.9 8.9 10.8 12.6 6.5 11.4 11.9 9.6 12.7 23.7 24.8 9.1 19.6 20.0 14.7 13.2 11.2 14.9 6.7 9.1 20.0 19.2 9.3 8.8 17.8 27.7 19.8 8.0 13.4 27.6 8.9 19.6 12.7 14.2 22.8 8.7 19.6 20.3 16.3 21.6 8.7 6.3 19.6 21.9 5.5 11.8 10.0 4.2 11.7 14.4 9.9 20.5 9.9 22.5 19.5 8.3 8.4 34.3 22.8 11.6 5.4 12.0 10.6 23.1 26.5 14.3 15.2 15.9 7.8 6.1 8.1 16.6 27.7 14.1 14.1 6.6 12.7 10.0 8.1 12.6 8.4 9.4 9.4 6.5 7.7 11.5 10.0 15.9 10.8 8.9 2.0 11.3 6.5 9.4 16.1 14.3 17.7 10.5 11.7 12.2 8.5 35.7 11.4 38.7 27.4 25.1 20.8 21.4 19.2 15.3 43.3 22.7 28.4 45.4 33.4 10.9 6.6 24.4 230.0 32.8 33.8 0.0 39.5 11.7 23.6 34.6 17.4 73.6 17.7 14.3 20.3 36.2 21.5 337.0 28.1 24.1 33.7 36.1 27.4 15.4 29.5 31.7 24.4 26.4 25.7 0.0 33.0 20.4 16.8 28.5 15.6 28.8 30.2 28.0 PRKAA2 "AMPK, AMPKa2, PRKAA" ENSG00000162409 "Protein kinase AMP-activated catalytic subunit alpha 2" P54646 1 56645322-56715335 "Enzymes, Predicted membrane proteins, Transporters" "Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 39.1;skeletal muscle: 40.2" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 309.5;Rod photoreceptor cells: 106.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.0" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044540 Approved Supported "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA044540: AB_2678977" "unprognostic (4.17e-3)" "unprognostic (1.62e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (4.80e-4)" "unprognostic (9.35e-2)" "unprognostic (1.92e-3)" "prognostic unfavorable (5.30e-4)" "unprognostic (7.30e-2)" "unprognostic (3.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-1)" "unprognostic (8.64e-2)" "prognostic favorable (4.95e-5)" "unprognostic (1.30e-2)" "unprognostic (4.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.85e-1)" 2.4 2.1 3.7 1.2 6.3 0.7 4.1 7.2 8.1 2.2 5.5 1.2 2.4 1.2 3.0 3.2 6.3 3.5 2.6 39.1 4.2 2.9 14.5 1.4 2.0 0.8 2.4 6.2 2.5 2.6 10.4 2.6 1.2 5.0 4.6 2.2 6.0 4.5 3.5 40.2 1.4 2.1 7.2 1.9 1.9 3.2 1.7 0.8 0.0 4.0 12.3 0.8 4.4 2.1 0.2 0.0 1.0 0.1 0.1 0.1 0.0 0.0 3.7 2.0 0.0 0.7 0.5 2.3 1.8 1.4 2.4 4.2 3.7 4.7 0.0 0.6 0.6 7.4 0.0 7.7 0.0 7.1 0.0 8.5 0.0 6.9 5.2 0.0 0.0 0.1 0.6 0.0 3.5 0.3 5.7 0.8 1.9 0.0 0.0 1.0 0.1 0.0 0.0 5.5 0.0 5.4 0.0 0.0 0.0 13.9 1.2 2.0 5.4 5.7 0.1 0.0 6.2 3.2 0.0 0.0 1.5 2.3 2.7 6.2 0.0 0.0 0.0 4.5 0.0 1.1 0.5 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 3.7 6.3 7.2 8.1 4.2 2.9 2.4 6.2 5.0 0.8 8.9 3.7 0.0 5.9 0.8 39.3 309.5 22.9 10.7 15.9 47.1 47.1 0.8 46.4 9.1 2.3 11.7 1.0 0.0 4.1 0.3 3.5 15.6 2.3 6.4 0.1 25.4 13.8 3.7 0.0 1.9 6.4 0.9 5.0 0.0 7.7 16.8 6.7 0.0 27.6 74.2 106.6 6.5 21.2 7.2 2.8 0.4 0.3 0.0 5.2 11.2 PRKN "AR-JP, PARK2, parkin, PDJ" ENSG00000185345 "Parkin RBR E3 ubiquitin protein ligase" O60260 6 161347420-162727771 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 41.8" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 7.4;Distal tubular cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 3.7;HEL: 9.2;Karpas-707: 5.9;RPMI-8226: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016257, HPA036012" Enhanced Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB016257: AB_628104, HPA036012: AB_2732471" "unprognostic (9.23e-2)" "unprognostic (3.29e-2)" "unprognostic (6.48e-2)" "unprognostic (2.69e-3)" "unprognostic (9.85e-2)" "unprognostic (5.85e-2)" "unprognostic (7.07e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-2)" "unprognostic (1.03e-3)" "unprognostic (8.16e-2)" "prognostic favorable (6.75e-12)" "unprognostic (9.93e-2)" "unprognostic (1.51e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-1)" 6.8 7.1 7.9 2.3 12.2 1.5 4.2 7.2 13.4 5.3 4.3 6.3 4.6 2.8 7.8 4.4 6.1 3.4 4.3 17.7 9.2 6.2 17.4 3.6 2.6 3.0 5.8 5.2 6.4 3.0 5.6 8.6 2.0 5.5 4.0 2.4 8.3 3.5 4.8 41.8 4.0 3.3 6.6 5.9 2.7 3.5 10.3 6.8 0.6 3.8 4.7 2.7 4.9 2.1 4.6 1.2 4.2 0.8 1.8 4.6 1.3 0.1 0.3 1.3 3.7 0.9 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.2 0.0 0.9 0.0 0.2 0.2 0.0 0.4 0.6 9.2 0.2 0.0 0.9 0.2 0.1 3.2 0.1 0.0 0.5 0.6 0.0 0.4 0.4 5.9 1.0 0.5 0.1 0.1 0.2 0.6 0.9 0.0 0.0 5.9 0.7 0.1 1.0 2.5 0.0 0.0 0.3 1.2 0.0 0.6 0.0 0.1 0.3 0.1 0.3 0.8 0.1 0.0 0.1 0.2 2.2 2.8 0.8 4.2 2.1 0.5 3.5 1.5 2.0 2.2 1.2 4.6 4.4 4.6 1.5 1.8 0.4 0.3 0.2 1.3 7.9 12.2 7.2 11.7 9.2 6.2 5.8 5.2 5.5 6.8 8.9 7.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 0.4 16.6 0.8 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PRPF18 hPrp18 ENSG00000165630 "Pre-mRNA processing factor 18" Q99633 10 13586927-13630868 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037599, HPA047950" Supported Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA037599: AB_10795137, HPA047950: AB_2680221" "unprognostic (5.82e-2)" "unprognostic (7.86e-3)" "unprognostic (4.07e-2)" "unprognostic (1.20e-2)" "unprognostic (3.00e-2)" "unprognostic (6.36e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (6.12e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-3)" "unprognostic (2.82e-2)" "unprognostic (2.20e-1)" "unprognostic (8.09e-2)" "unprognostic (1.63e-1)" 21.7 20.4 22.8 21.1 21.3 40.5 22.6 29.3 22.9 18.5 18.5 15.9 25.3 18.3 20.8 32.1 20.7 15.6 17.1 19.5 17.1 14.8 22.8 23.5 17.9 17.9 17.2 21.4 18.4 19.8 20.1 40.8 20.2 21.6 16.4 20.5 9.8 22.3 28.5 34.1 20.9 20.1 20.9 21.9 17.4 18.6 19.4 22.0 25.6 26.2 16.0 20.7 18.0 21.9 20.0 19.9 30.3 25.0 27.0 25.8 11.6 16.7 12.6 11.2 9.6 15.7 15.4 14.1 19.6 9.8 21.5 20.7 11.9 25.8 14.1 11.1 17.9 9.6 14.0 14.8 16.2 25.0 20.7 14.7 16.4 10.8 9.3 18.8 12.8 19.8 11.8 26.4 18.7 9.2 13.1 20.8 20.6 16.9 19.0 19.5 17.3 23.8 8.8 10.6 16.5 6.3 17.1 13.7 17.4 14.2 7.2 7.9 19.7 15.4 11.1 16.6 14.4 17.2 21.0 17.6 13.4 15.8 21.7 14.6 18.7 20.0 20.1 19.8 16.2 9.1 16.9 20.4 25.9 21.6 18.1 18.6 20.0 19.7 18.5 19.9 18.2 21.0 25.8 30.3 27.0 25.0 17.4 23.6 11.6 22.8 21.3 29.3 22.9 17.1 14.8 17.2 21.4 21.6 22.0 17.9 21.9 26.2 18.8 40.5 13.3 8.1 17.8 34.8 30.7 21.0 9.8 26.7 34.9 26.2 15.5 20.1 20.0 23.3 25.4 33.7 18.6 14.4 25.5 22.9 22.9 20.6 12.1 12.3 20.4 12.0 16.4 20.6 23.6 32.5 18.8 16.0 28.3 28.1 12.4 36.6 19.9 19.4 18.9 113.0 28.5 40.9 34.9 39.2 17.5 21.0 PRPS2 ENSG00000101911 "Phosphoribosyl pyrophosphate synthetase 2" P11908 X 12791355-12824222 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 138.1;testis: 109.7" "Group enriched" "Detected in many" 21 "Leydig cells: 1325.5;Peritubular cells: 1875.4;Sertoli cells: 614.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051269, HPA067599, CAB070417" Enhanced Approved "Nuclear speckles,Vesicles" NA NA Vesicles "Nuclear speckles" "CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869" "unprognostic (7.50e-2)" "prognostic favorable (1.90e-4)" "unprognostic (2.09e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-2)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (4.75e-2)" "unprognostic (6.98e-2)" "unprognostic (2.64e-3)" "unprognostic (4.44e-3)" "unprognostic (1.81e-1)" "unprognostic (7.83e-2)" "unprognostic (2.20e-1)" "unprognostic (1.50e-1)" "unprognostic (1.35e-1)" "unprognostic (2.04e-1)" 5.4 20.8 4.0 10.2 8.7 6.1 6.1 3.7 11.5 18.7 13.3 5.7 44.4 4.1 17.0 21.7 9.6 9.6 13.2 3.3 4.0 3.5 10.8 9.0 5.4 10.7 2.7 7.7 75.3 19.9 20.1 2.4 3.2 2.9 14.9 10.2 4.4 11.1 138.1 1.5 10.3 6.3 12.2 3.9 7.6 14.3 109.7 3.1 26.2 7.8 5.5 10.9 15.1 10.2 21.9 17.7 10.5 12.5 15.0 22.7 16.7 31.3 20.8 7.2 13.1 8.9 10.6 4.1 15.6 8.6 17.3 16.9 14.7 25.2 9.2 7.1 7.5 14.8 23.8 14.0 17.1 20.4 24.7 30.1 11.3 17.1 13.6 8.3 22.3 11.7 10.2 11.5 12.9 17.1 8.9 7.0 26.8 8.3 12.9 14.6 21.6 34.0 10.3 15.4 25.5 28.1 18.2 31.1 23.5 10.4 26.1 14.0 9.4 18.9 0.7 11.8 10.4 18.8 10.1 6.5 13.7 9.9 49.9 16.6 30.3 11.1 21.9 14.3 11.3 21.4 10.5 12.5 5.6 11.7 12.4 13.6 18.0 17.0 11.1 17.7 21.9 22.7 15.3 5.5 15.0 7.7 12.6 14.0 16.7 4.0 8.7 3.7 11.5 4.0 3.5 2.7 7.7 2.9 3.1 3.0 5.4 25.1 40.7 56.8 0.6 1.6 5.1 21.4 5.7 52.4 0.0 0.6 61.3 17.7 9.4 10.8 8.4 23.3 33.8 5.7 24.8 42.5 27.6 13.9 22.0 0.0 20.9 11.6 18.7 23.3 1325.5 24.5 38.8 20.8 26.7 0.3 28.8 5.8 1875.4 8.7 0.0 614.4 21.7 4.9 5.8 38.1 0.3 29.3 48.2 31.1 PSKH1 ENSG00000159792 "Protein serine kinase H1" P11801 16 67893272-67929678 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053927, HPA062763" Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA053927: AB_2682312, HPA062763: " "unprognostic (2.57e-2)" "unprognostic (8.91e-3)" "unprognostic (1.88e-1)" "unprognostic (5.79e-2)" "unprognostic (3.26e-1)" "unprognostic (3.89e-1)" "unprognostic (1.64e-1)" "unprognostic (1.29e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-2)" "unprognostic (9.85e-3)" "unprognostic (8.32e-2)" "prognostic favorable (4.28e-10)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (4.15e-2)" "unprognostic (3.90e-3)" 14.3 18.3 13.6 14.0 16.6 4.8 15.1 13.3 13.3 11.0 14.7 17.7 24.0 14.0 19.2 14.6 17.7 20.2 19.3 17.8 12.2 8.4 18.8 15.1 13.1 10.4 16.2 12.7 21.2 35.3 33.2 13.0 9.8 16.1 14.3 11.4 16.2 19.0 14.8 19.9 14.0 15.2 16.3 11.3 12.8 19.1 31.7 15.0 12.5 14.9 12.9 8.6 14.8 18.7 4.0 5.2 4.5 5.8 5.2 5.6 3.5 7.4 13.3 15.2 16.7 23.6 12.0 9.8 9.0 13.7 9.6 8.5 10.0 10.8 7.0 13.7 15.1 7.6 11.3 8.7 9.2 3.2 2.7 9.8 8.0 9.9 12.7 16.2 7.6 4.8 22.0 16.1 11.3 11.9 12.9 13.9 13.3 12.2 3.0 9.9 16.6 10.3 4.9 14.5 8.1 8.3 15.9 5.8 14.5 11.2 9.3 13.2 15.7 27.9 7.6 9.1 6.3 14.0 13.9 12.2 10.8 3.8 9.0 4.5 9.2 4.9 15.2 13.0 5.1 11.8 0.0 4.3 4.5 5.6 5.8 3.8 4.0 3.9 5.3 5.2 3.5 3.4 4.3 2.7 5.2 3.6 3.8 2.3 3.5 13.6 16.6 13.3 13.3 12.2 8.4 16.2 12.7 16.1 15.0 0.0 2.2 5.1 2.5 1.0 10.7 1.7 7.6 4.0 2.3 5.2 5.9 5.2 10.0 5.5 10.8 2.9 8.1 0.0 6.5 4.0 3.9 3.5 5.8 7.7 4.1 6.4 10.4 4.3 5.6 16.9 4.4 1.2 5.0 3.6 6.3 8.2 6.9 3.5 7.4 6.3 6.7 12.9 4.7 3.5 5.7 1.4 4.9 3.1 6.3 1.4 PSMD13 "p40.5, Rpn9" ENSG00000185627 "Proteasome 26S subunit, non-ATPase 13" Q9UNM6 11 236546-252984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038691, HPA038692" Approved Approved "Nuclear speckles,Cytosol" NA NA 49000 "Nuclear speckles" Cytosol "HPA038691: AB_2676153, HPA038692: AB_10671749" "unprognostic (1.32e-2)" "unprognostic (7.98e-2)" "unprognostic (9.19e-2)" "prognostic favorable (5.74e-4)" "unprognostic (2.24e-2)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.76e-5)" "unprognostic (7.54e-3)" "unprognostic (2.94e-1)" "unprognostic (1.90e-1)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.52e-13)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" 24.2 17.9 18.4 20.9 21.3 29.1 28.6 22.1 25.6 24.0 23.6 19.2 20.0 15.6 25.3 20.3 26.8 20.6 19.1 31.8 19.6 20.4 23.4 34.9 23.0 29.8 17.1 19.1 18.1 26.5 15.1 18.0 31.7 21.8 24.0 19.5 16.8 20.9 21.1 56.5 25.5 20.5 21.3 17.0 26.9 18.8 21.2 12.9 32.8 23.3 30.0 27.0 20.5 17.9 20.8 33.5 25.1 32.6 26.4 26.6 39.0 31.1 18.6 22.2 22.9 22.4 20.4 12.8 21.4 30.4 47.0 34.7 16.4 42.1 29.6 20.9 26.1 17.1 29.5 28.0 32.3 37.4 23.8 21.3 13.1 7.2 11.3 25.0 31.9 27.8 18.0 23.2 23.4 20.3 11.5 42.6 21.2 33.1 23.1 35.9 12.3 26.6 19.6 29.7 15.4 27.0 20.6 21.8 20.9 27.5 8.3 18.0 14.2 15.7 16.8 16.6 12.1 10.3 19.8 27.9 13.8 13.2 7.0 25.0 21.0 24.2 38.4 24.8 25.6 22.8 22.2 31.4 20.5 23.5 30.6 26.3 20.8 24.1 23.6 33.5 18.5 21.3 23.3 25.1 26.4 32.6 22.7 26.6 39.0 18.4 21.3 22.1 25.6 19.6 20.4 17.1 19.1 21.8 12.9 44.7 33.8 60.3 44.1 31.8 40.7 42.3 58.6 57.6 36.4 29.6 29.5 145.8 69.6 99.0 33.5 47.1 60.8 23.3 114.2 117.3 41.0 50.8 65.8 52.5 89.1 35.0 46.1 53.4 49.4 36.2 63.6 57.7 43.9 94.6 55.5 65.1 96.7 55.4 56.3 59.8 35.5 84.1 46.4 67.4 79.3 33.9 172.1 62.3 58.8 45.6 PSMD8 "HIP6, HYPF, Nin1p, p31, Rpn12, S14" ENSG00000099341 "Proteasome 26S subunit, non-ATPase 8" P48556 19 38374536-38383824 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 704.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006702, CAB021101" Supported Approved "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "CAB021101: AB_10061018, HPA006702: AB_1079710" "unprognostic (9.50e-2)" "unprognostic (7.02e-2)" "unprognostic (1.70e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.59e-1)" "unprognostic (5.54e-3)" "unprognostic (1.94e-3)" "unprognostic (5.03e-2)" "unprognostic (2.85e-2)" "unprognostic (1.73e-2)" "unprognostic (4.61e-1)" "unprognostic (8.79e-2)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.28e-1)" "unprognostic (2.08e-2)" "unprognostic (2.58e-3)" "unprognostic (4.84e-2)" 53.0 35.1 30.0 23.9 35.6 32.9 43.0 28.1 49.4 26.5 31.8 25.8 30.1 31.5 30.9 40.9 39.1 32.5 28.0 75.3 32.2 29.3 40.9 71.1 28.8 28.8 27.1 37.0 24.4 48.2 30.6 29.2 56.6 30.0 33.6 32.9 24.6 32.6 29.7 157.1 42.2 33.2 34.5 25.0 27.6 28.9 55.8 21.4 38.1 35.4 50.1 33.9 28.3 27.1 40.4 60.8 32.0 68.1 38.8 65.6 68.7 60.5 96.6 38.1 43.4 62.1 50.0 20.0 44.1 60.2 68.0 71.1 66.2 36.5 42.7 46.1 58.7 41.8 21.1 63.6 54.8 61.5 70.3 42.0 46.4 31.9 40.8 80.4 46.7 41.3 50.4 54.8 58.5 78.0 37.6 53.3 52.0 57.8 48.1 74.7 60.3 44.1 26.3 29.6 89.7 52.8 46.0 61.2 33.9 48.1 50.5 39.9 40.6 45.8 59.3 42.8 37.1 30.9 44.1 39.2 52.0 48.1 54.4 64.6 48.7 56.2 57.0 78.2 48.1 57.7 32.0 55.2 29.2 46.1 59.9 39.1 40.4 40.4 44.2 60.8 37.0 33.6 32.6 20.8 38.8 68.1 42.3 65.6 68.7 30.0 35.6 28.1 49.4 32.2 29.3 27.1 37.0 30.0 21.4 62.5 58.2 119.9 188.9 182.9 97.2 223.0 73.9 99.0 68.2 76.8 51.1 304.9 295.1 231.4 321.4 92.0 206.5 70.0 232.9 276.1 132.4 178.0 91.2 110.9 262.3 73.1 140.2 70.6 89.4 704.4 109.6 143.2 189.0 308.4 120.9 153.3 230.1 154.3 110.7 228.8 89.3 148.8 173.9 203.2 136.5 185.6 476.9 127.8 132.9 185.9 PUS7L DKFZP434G1415 ENSG00000129317 "Pseudouridylate synthase 7 like" Q9H0K6 12 43718993-43758817 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056203, HPA058750" Uncertain Approved "Nucleoli,Nuclear speckles" NA NA "Nuclear speckles" Nucleoli "HPA056203: AB_2683064, HPA058750: AB_2683807" "unprognostic (3.41e-3)" "unprognostic (1.03e-1)" "unprognostic (2.51e-3)" "unprognostic (1.83e-1)" "unprognostic (3.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.87e-4)" "unprognostic (1.11e-1)" "unprognostic (8.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.49e-1)" "unprognostic (2.54e-2)" "unprognostic (1.80e-3)" "unprognostic (1.32e-1)" "unprognostic (2.56e-1)" "unprognostic (2.50e-2)" "unprognostic (9.27e-2)" 8.0 7.0 14.9 9.1 18.5 6.1 10.6 20.3 16.6 9.2 7.3 3.7 8.3 7.3 7.3 7.9 9.7 6.1 7.7 6.9 14.2 9.0 9.3 7.9 5.4 10.4 8.3 12.6 10.2 9.5 12.7 21.7 7.7 11.5 8.3 9.1 2.7 8.4 9.4 6.1 7.2 7.6 6.3 12.1 9.2 7.6 5.6 11.3 13.0 11.6 6.1 11.3 8.6 8.3 6.6 5.2 8.6 4.3 5.1 6.9 3.4 6.4 4.9 4.3 2.5 3.0 10.8 7.7 5.6 4.8 7.6 5.9 17.4 4.7 14.9 7.2 6.9 4.4 5.9 6.2 5.7 13.1 4.6 3.9 10.9 5.5 6.5 3.7 17.4 7.1 4.5 4.3 7.9 8.3 7.1 5.5 8.8 18.9 6.6 17.7 2.6 8.9 4.5 7.9 0.0 5.2 8.5 10.2 8.9 3.3 5.0 7.3 2.4 7.0 7.6 3.0 5.4 9.0 4.9 4.0 7.8 5.1 9.0 8.9 5.8 9.9 15.1 7.2 28.8 2.6 8.6 4.3 4.8 5.0 3.8 6.2 4.4 5.4 5.3 4.4 6.6 4.8 6.9 3.1 5.1 3.1 5.2 2.1 3.4 14.9 18.5 20.3 16.6 14.2 9.0 8.3 12.6 11.5 11.3 8.9 12.1 29.0 16.6 10.3 66.3 11.7 12.7 5.3 14.8 24.4 64.8 29.4 34.9 17.4 1.7 17.6 11.0 0.0 20.2 20.3 20.3 16.9 16.2 18.3 17.8 41.3 18.6 17.2 23.4 2.1 18.7 16.6 11.8 12.6 22.4 37.1 15.1 14.0 25.1 17.7 103.5 19.4 16.6 23.6 34.3 9.7 20.3 25.4 28.5 8.7 R3HCC1L "C10orf28, GIDRP86, PSORT" ENSG00000166024 "R3H domain and coiled-coil containing 1 like" Q7Z5L2 10 98134624-98244897 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037367 Enhanced Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA037367: AB_10696930" "unprognostic (3.00e-1)" "unprognostic (2.55e-2)" "unprognostic (1.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.67e-2)" "unprognostic (7.04e-2)" "unprognostic (1.15e-3)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (6.00e-2)" "unprognostic (1.55e-1)" "unprognostic (1.74e-3)" "unprognostic (7.39e-2)" "unprognostic (3.12e-1)" "unprognostic (1.49e-1)" "unprognostic (1.43e-2)" 14.5 8.2 9.5 14.9 12.9 19.1 13.0 16.4 11.4 11.1 12.9 8.9 10.3 8.0 11.4 13.0 12.0 8.0 7.7 8.1 10.2 6.2 9.6 10.8 10.9 13.8 11.9 5.4 9.3 10.1 15.6 20.7 14.4 11.8 13.7 13.1 12.9 12.0 9.5 10.0 14.1 15.0 10.1 16.7 13.2 9.4 25.2 12.5 17.1 11.0 6.9 15.7 11.5 16.0 10.2 6.0 18.6 12.9 10.2 13.9 5.5 10.6 7.0 10.7 9.4 9.2 9.8 8.9 12.1 16.9 11.9 13.2 9.5 7.7 15.1 6.5 7.2 6.7 12.2 10.7 7.3 13.5 11.3 7.3 8.9 5.5 10.6 11.3 12.1 10.9 8.9 8.4 10.4 15.5 10.5 7.6 9.5 7.7 9.4 9.2 10.2 9.5 12.6 7.7 5.1 9.2 9.8 12.2 6.1 8.6 6.3 3.7 7.9 6.2 4.6 23.6 14.3 8.3 7.7 8.4 8.0 8.5 8.9 9.0 9.6 10.1 25.8 11.4 12.7 5.8 10.7 6.9 18.6 9.9 9.4 8.8 10.2 10.2 10.0 5.3 9.5 9.0 8.8 8.5 10.2 12.9 6.0 13.9 5.5 9.5 12.9 16.4 11.4 10.2 6.2 11.9 5.4 11.8 12.5 14.9 13.7 6.5 4.8 3.0 6.2 7.7 10.2 17.4 7.9 7.0 5.9 7.9 5.0 6.5 18.2 6.2 10.2 0.0 6.0 8.3 4.5 5.3 16.2 3.9 6.2 4.8 5.8 3.1 9.8 9.4 4.9 9.1 11.8 10.0 10.6 6.2 7.5 5.8 5.3 2.9 13.3 0.0 5.1 40.0 22.6 3.3 10.9 7.5 7.6 7.1 RAD52 ENSG00000002016 "RAD52 homolog, DNA repair protein" P43351 12 912077-990053 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028957 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA028957: AB_2672842" "unprognostic (4.53e-1)" "unprognostic (8.08e-3)" "unprognostic (4.68e-2)" "unprognostic (5.27e-2)" "unprognostic (7.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.82e-3)" "unprognostic (1.88e-1)" "unprognostic (2.80e-2)" "unprognostic (8.43e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-1)" "prognostic unfavorable (2.22e-6)" "unprognostic (1.54e-1)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (3.74e-2)" 7.4 8.5 12.4 8.1 15.1 5.0 10.0 18.8 15.9 12.6 11.7 14.5 13.6 9.4 12.5 14.2 8.2 11.0 9.0 7.8 14.3 7.3 9.9 10.5 6.9 8.9 15.0 9.6 17.6 11.4 9.6 15.6 8.5 15.0 10.5 11.7 9.5 8.4 11.0 16.5 14.9 10.4 12.8 17.0 10.3 8.8 6.8 20.9 9.4 14.6 4.3 9.7 9.7 13.3 7.0 9.6 7.4 3.8 4.0 6.0 1.4 3.1 12.2 9.5 10.7 10.4 7.8 10.2 6.3 5.9 7.0 7.0 11.7 11.2 10.0 2.0 6.3 6.1 9.4 7.2 4.2 6.2 13.4 6.4 11.1 11.7 8.1 5.9 11.9 3.4 4.5 7.5 7.4 22.7 14.0 5.9 9.8 7.4 5.7 6.7 6.6 8.1 11.9 12.4 7.9 7.9 8.3 9.3 3.7 7.3 5.7 3.4 3.9 8.1 8.8 4.5 14.6 8.2 5.8 5.8 9.8 11.9 7.7 6.6 2.2 3.4 10.4 5.1 5.0 3.6 7.4 3.4 2.0 4.6 2.9 6.0 4.8 4.9 4.0 4.4 7.0 5.7 5.2 2.8 4.0 3.8 9.6 4.4 1.4 12.4 15.1 18.8 15.9 14.3 7.3 15.0 9.6 15.0 20.9 3.0 5.1 0.0 1.1 1.5 3.7 3.1 0.0 1.4 4.5 3.5 2.0 3.6 1.7 1.9 3.2 3.0 4.0 0.0 1.4 2.2 2.2 1.3 5.7 2.1 2.3 3.2 1.7 0.6 1.0 4.5 0.6 2.2 0.0 2.8 2.3 1.9 0.6 2.9 0.7 1.4 2.3 6.5 3.1 4.6 4.1 0.9 1.7 1.3 2.9 0.9 RBM41 FLJ11016 ENSG00000089682 "RNA binding motif protein 41" Q96IZ5 X 107064420-107118823 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042881 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA042881: AB_10794536" "unprognostic (1.07e-2)" "unprognostic (1.55e-1)" "unprognostic (4.10e-1)" "unprognostic (3.39e-2)" "unprognostic (1.39e-1)" "unprognostic (2.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-2)" "unprognostic (1.98e-2)" "unprognostic (2.19e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" "unprognostic (2.80e-2)" "unprognostic (1.92e-1)" 10.0 10.3 9.2 9.1 10.8 5.0 9.5 23.7 14.2 13.4 11.9 10.1 8.2 12.7 12.2 11.5 11.1 12.4 7.6 8.8 8.7 6.8 11.8 13.7 8.3 8.9 9.7 9.4 9.7 10.6 21.0 14.1 12.0 11.6 10.8 11.2 9.0 10.7 9.0 14.6 11.6 15.5 11.2 14.2 11.5 8.2 15.6 12.8 12.2 15.7 8.0 9.9 12.4 9.8 6.3 4.8 10.6 7.0 8.6 6.3 3.4 14.4 11.6 7.5 6.0 5.0 8.7 8.7 8.6 8.5 6.3 8.6 7.7 12.1 7.9 16.3 6.2 11.1 12.0 10.8 8.0 9.7 9.8 16.0 9.7 21.0 9.4 5.6 9.8 7.6 6.1 15.9 7.7 7.7 8.9 9.5 7.5 16.7 11.1 7.6 7.0 8.3 5.6 11.0 8.0 13.3 6.7 6.3 6.8 9.4 9.2 6.2 9.8 10.7 7.7 6.9 10.7 7.1 5.1 9.2 8.9 5.2 10.5 6.7 5.2 9.6 8.9 5.0 4.5 6.6 10.6 7.0 10.6 6.3 3.7 3.9 6.3 5.5 6.3 4.7 6.3 4.1 2.8 1.0 8.6 3.7 4.8 4.9 3.4 9.2 10.8 23.7 14.2 8.7 6.8 9.7 9.4 11.6 12.8 11.9 14.2 10.3 5.1 4.6 20.6 20.4 7.6 14.7 6.8 7.0 25.5 7.0 1.7 12.0 4.0 5.8 11.8 23.3 6.9 4.6 6.2 5.2 12.7 7.8 5.7 11.1 7.5 6.2 7.9 1.3 13.3 10.5 5.0 6.4 9.0 10.5 10.6 10.5 11.0 6.9 20.7 0.0 9.5 6.8 7.2 6.5 3.8 10.1 11.0 5.5 RBM6 "3G2, DEF-3, DEF3, g16, NY-LU-12" ENSG00000004534 "RNA binding motif protein 6" P78332 3 49940007-50100045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026272, HPA027164" Enhanced Approved "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA026272: AB_1847592, HPA027164: AB_1847593" "unprognostic (3.81e-3)" "unprognostic (2.13e-1)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (4.53e-2)" "unprognostic (2.88e-2)" "unprognostic (1.40e-2)" "unprognostic (7.97e-3)" "unprognostic (8.84e-3)" "unprognostic (5.09e-2)" "prognostic favorable (1.41e-4)" "unprognostic (4.31e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (7.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.45e-1)" "prognostic favorable (5.13e-5)" 24.4 30.2 30.2 51.3 37.1 30.0 25.1 49.4 41.1 31.2 31.0 28.9 38.5 30.3 51.4 34.3 21.8 28.8 32.6 25.3 32.1 19.8 29.2 30.6 26.8 39.8 38.1 26.0 42.6 35.9 41.9 36.9 21.9 30.5 40.1 29.8 25.6 28.1 38.3 25.3 35.9 32.4 36.7 40.9 42.6 28.0 29.7 38.0 24.9 32.6 21.9 35.9 25.1 36.6 12.8 9.9 14.7 8.6 7.3 15.6 5.9 9.7 6.2 25.4 16.9 26.0 14.3 9.0 16.5 14.3 14.6 15.4 10.7 11.1 50.1 9.7 16.4 14.9 8.1 21.7 14.5 18.6 20.1 8.1 23.2 14.2 13.9 14.8 24.4 24.1 13.3 18.0 16.5 18.6 27.0 18.4 13.1 19.0 12.6 13.9 9.3 22.9 36.2 20.3 12.1 11.4 8.8 10.9 12.8 14.4 19.0 10.1 18.2 15.1 10.9 10.3 23.6 8.5 19.3 17.0 14.6 17.4 11.9 16.7 17.4 41.2 30.2 8.4 20.5 14.3 14.7 8.6 5.0 15.6 4.7 12.1 12.8 10.2 8.5 8.8 11.9 10.5 11.5 6.1 7.3 7.7 9.9 6.7 5.9 30.2 37.1 49.4 41.1 32.1 19.8 38.1 26.0 30.5 38.0 53.6 75.9 98.3 36.2 48.0 117.7 27.5 35.7 52.2 50.0 59.3 96.2 29.5 10.0 26.7 26.1 51.5 48.5 23.3 24.1 24.9 50.1 43.0 40.6 28.4 24.2 87.4 45.4 47.3 59.4 17.2 60.7 54.9 57.3 40.5 32.6 52.2 32.6 31.6 57.0 10.3 141.3 45.3 50.9 108.1 28.1 39.5 30.3 54.2 31.0 31.9 RBP7 CRBPIV ENSG00000162444 "Retinol binding protein 7" Q96R05 1 9997206-10016020 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 68.1;breast: 210.2" "Group enriched" "Detected in many" 5 "Endothelial cells: 121.4;Kupffer cells: 402.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 54.1;intermediate monocyte: 23.4;neutrophil: 60.6" "Group enriched" "Detected in many" 30 "granulocytes: 60.6;monocytes: 54.1" "Cell line enhanced" "Detected in some" "EFO-21: 10.5;SK-MEL-30: 7.1;T-47d: 26.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA034749 Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA034749: AB_10602084" "unprognostic (1.93e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (9.59e-2)" "unprognostic (2.31e-1)" "unprognostic (6.28e-2)" "unprognostic (1.39e-2)" "unprognostic (1.85e-1)" "unprognostic (1.05e-3)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (7.90e-2)" "unprognostic (5.07e-2)" "unprognostic (2.38e-2)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (1.61e-2)" 68.1 3.7 3.8 3.0 11.4 7.5 210.2 2.1 5.5 4.3 10.9 8.7 2.7 0.5 6.4 4.5 7.2 2.4 14.7 29.7 5.3 2.8 7.6 2.5 2.5 4.5 7.6 3.0 2.6 3.7 14.7 3.5 4.4 6.2 4.7 1.2 3.5 4.8 2.7 5.9 6.6 2.0 4.4 8.9 21.5 3.0 2.6 5.2 1.2 11.3 1.8 1.4 4.5 17.5 0.0 1.8 60.6 54.1 0.0 0.1 15.0 0.0 0.6 0.2 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.8 1.8 2.4 0.0 10.5 1.0 0.0 0.0 0.0 0.8 3.4 0.0 2.5 0.0 0.1 0.9 1.2 0.0 0.0 0.0 1.6 1.6 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 4.4 0.0 0.0 0.0 0.5 0.0 0.1 0.4 1.9 0.1 7.1 2.9 26.8 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 54.1 0.4 0.0 23.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 60.6 0.0 11.1 0.3 0.1 15.0 3.8 11.4 2.1 5.5 5.3 2.8 7.6 3.0 6.2 5.2 0.0 2.2 11.2 7.8 18.3 0.0 17.6 10.2 1.4 1.2 1.8 0.0 4.5 19.9 1.3 2.6 121.4 0.0 0.0 2.3 2.2 8.2 19.2 3.5 1.3 54.6 0.0 0.0 49.7 402.1 4.7 5.8 23.1 20.3 0.0 0.0 1.3 3.7 0.0 0.7 0.7 1.1 0.0 5.3 1.2 1.5 15.4 5.1 1.3 0.4 4.3 RCAN3 DSCR1L2 ENSG00000117602 "RCAN family member 3" Q9UKA8 1 24502351-24541040 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.0" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 73.6;Intestinal endocrine cells: 78.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 37.0" "Group enriched" "Detected in many" 4 "MAIT T-cell: 5.6;memory CD4 T-cell: 14.0;memory CD8 T-cell: 5.0;naive CD4 T-cell: 19.2;naive CD8 T-cell: 9.9;T-reg: 19.2" "Lineage enriched" "Detected in many" 7 "T-cells: 19.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034533, HPA064289" Enhanced Approved "Nucleoli fibrillar center,Nuclear speckles" NA NA "Nuclear speckles" "Nucleoli fibrillar center" "HPA034533: AB_10601481, HPA064289: AB_2685232" "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (4.01e-2)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "unprognostic (4.20e-3)" "unprognostic (3.41e-3)" "unprognostic (3.66e-2)" "unprognostic (6.42e-2)" "unprognostic (2.47e-1)" "unprognostic (1.72e-3)" "unprognostic (7.44e-2)" "unprognostic (3.52e-3)" "unprognostic (9.83e-2)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "unprognostic (4.71e-2)" 3.2 1.5 2.7 15.8 4.0 4.7 7.6 37.0 3.7 3.9 5.0 7.6 3.2 5.2 3.2 7.7 12.6 11.2 6.5 3.1 3.3 7.8 5.3 2.1 8.1 27.2 5.5 1.9 2.0 15.0 5.5 15.0 7.0 7.6 27.7 5.2 6.1 17.4 4.8 1.6 10.0 6.7 2.6 7.9 7.9 13.2 2.6 2.9 17.2 11.7 8.6 23.2 6.0 6.3 2.8 1.5 1.4 0.9 1.9 19.2 4.2 10.5 8.3 0.1 2.6 2.3 5.3 9.6 7.2 3.9 5.7 5.4 2.4 14.1 7.9 6.6 12.1 4.2 10.0 7.5 9.1 6.2 7.6 4.5 0.8 2.2 7.2 1.4 2.6 7.0 1.9 6.8 1.9 3.0 5.0 1.2 9.9 1.1 0.3 2.6 3.5 6.9 4.0 11.1 8.2 6.1 2.8 0.1 0.2 4.3 9.1 22.6 5.6 5.7 7.5 22.2 5.2 7.7 5.4 8.2 6.8 8.2 0.4 4.9 10.7 12.8 10.1 2.8 10.8 7.9 1.4 0.9 1.1 0.7 0.5 5.6 2.6 14.0 5.0 1.5 2.8 19.2 9.9 0.3 1.9 0.2 1.1 19.2 4.2 2.7 4.0 37.0 3.7 3.3 7.8 5.5 1.9 7.6 2.9 17.9 14.1 12.6 24.9 12.6 37.2 5.9 15.3 73.6 18.2 19.2 60.9 2.9 11.6 18.2 0.9 7.5 6.5 0.0 24.5 9.2 6.2 52.5 16.1 1.1 8.7 23.8 78.8 7.4 7.9 0.0 1.7 18.6 28.7 34.3 13.5 9.4 32.0 11.2 1.1 0.7 32.8 0.0 8.1 0.5 12.8 19.1 4.5 35.7 11.0 21.8 RFPL1 RNF78 ENSG00000128250 "Ret finger protein like 1" O75677 22 29438583-29442455 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 20.4" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 6.5;Ito cells: 12.9;Kupffer cells: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 11.2;HMC-1: 4.3;Karpas-707: 4.7;SH-SY5Y: 5.8;SiHa: 2.8;THP-1: 5.3" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (4.54e-1)" "unprognostic (6.63e-8)" "unprognostic (3.14e-3)" "unprognostic (1.89e-1)" 0.0 3.3 0.2 0.1 0.7 0.0 0.0 0.4 20.4 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 1.9 0.0 0.1 0.4 2.8 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 4.5 0.0 0.0 0.0 0.4 1.6 0.9 0.0 1.8 0.0 1.2 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 11.2 0.7 0.0 1.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 5.8 2.8 0.0 0.0 0.3 0.0 5.3 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.2 1.2 0.8 0.0 0.6 1.0 0.9 1.6 0.1 1.1 0.0 0.0 1.8 0.0 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 12.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFPL2 RNF79 ENSG00000128253 "Ret finger protein like 2" O75678 22 32190435-32203477 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 7.9;prostate: 10.8" "Cell type enriched" "Detected in single" 4 "Glandular cells: 3.1" "Cancer enriched" "Detected in single" 15 "prostate cancer: 5.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.5;OE19: 1.1;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2" "HPA046608, HPA048320, HPA072380" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA046608: , HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (3.81e-2)" "unprognostic (4.05e-2)" "unprognostic (8.29e-2)" "unprognostic (9.66e-3)" "unprognostic (2.54e-1)" "unprognostic (9.90e-2)" "unprognostic (2.59e-1)" "unprognostic (6.02e-3)" "unprognostic (2.22e-2)" "unprognostic (3.44e-2)" "unprognostic (8.64e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.04e-4)" "unprognostic (6.02e-2)" "unprognostic (3.28e-2)" "unprognostic (5.62e-7)" "unprognostic (3.50e-2)" 0.1 0.3 2.3 0.2 3.9 1.1 0.1 2.7 7.9 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 3.1 5.6 0.2 0.5 0.1 0.4 1.9 0.1 0.1 0.1 0.0 0.1 10.8 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.5 0.0 0.8 0.0 1.2 0.2 0.0 2.5 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.4 0.0 0.3 0.0 1.1 0.0 1.0 0.1 0.0 0.0 0.2 1.8 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.1 0.8 0.0 1.2 1.2 0.5 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFPL3 RNF120 ENSG00000128276 "Ret finger protein like 3" O75679 22 32354885-32361161 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.4" "Cell type enriched" "Detected in single" 7 "Early spermatids: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 3.8;NB-4: 4.8;U-266/70: 5.6;U-266/84: 5.5" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (1.63e-1)" "unprognostic (9.90e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (1.97e-1)" "unprognostic (3.25e-2)" "unprognostic (4.31e-2)" "unprognostic (1.90e-1)" "unprognostic (6.32e-2)" 0.0 0.0 0.3 0.0 0.3 1.0 0.0 0.7 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.4 0.2 0.6 0.5 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.3 1.1 0.2 0.0 0.1 0.5 0.0 23.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 1.1 0.2 0.1 0.8 2.4 0.7 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.3 2.4 1.1 0.1 0.1 0.0 1.5 0.5 0.0 0.0 0.0 0.0 1.4 0.0 1.8 0.1 1.8 0.0 0.9 1.4 4.8 0.2 0.3 0.1 2.4 0.5 0.6 0.0 0.4 1.8 0.5 0.1 0.4 1.3 0.6 0.0 0.4 0.0 0.0 0.9 0.4 0.0 5.6 5.5 0.1 0.1 1.7 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 RMI2 "BLAP18, C16orf75, MGC24665" ENSG00000175643 "RecQ mediated genome instability 2" Q96E14 16 11249619-11351762 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.7;testis: 29.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 100.7;Peritubular cells: 40.0;Spermatogonia: 42.9;Syncytiotrophoblasts: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;T-cells: 3.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA040995 Uncertain Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles" Cytosol "HPA040995: AB_10795531" "unprognostic (2.76e-1)" "prognostic favorable (5.69e-5)" "unprognostic (1.17e-1)" "unprognostic (3.09e-3)" "unprognostic (1.69e-2)" "unprognostic (1.80e-3)" "prognostic unfavorable (2.77e-5)" "unprognostic (3.98e-1)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (3.44e-3)" "unprognostic (3.89e-1)" "unprognostic (2.18e-1)" "unprognostic (5.50e-2)" "unprognostic (3.68e-2)" "unprognostic (3.60e-3)" "unprognostic (1.03e-1)" 1.0 1.8 4.2 18.0 5.1 4.8 2.8 0.7 4.1 2.8 7.3 1.0 0.4 4.3 2.5 3.2 11.8 1.0 2.6 1.9 2.5 1.5 3.1 2.3 2.9 17.9 1.6 5.6 3.6 1.6 0.7 1.1 13.2 1.2 2.6 9.0 0.8 2.9 1.7 1.1 8.7 5.6 1.1 1.4 4.2 4.0 29.6 1.2 31.7 1.4 2.8 20.4 3.6 4.5 6.5 0.6 0.9 0.0 0.3 3.0 0.3 19.2 12.9 25.4 10.8 1.1 5.5 10.6 11.2 8.9 10.6 17.7 4.9 22.9 26.7 9.7 5.2 12.0 11.3 10.8 10.7 17.3 5.2 10.1 14.6 7.6 32.6 0.4 5.6 6.6 1.2 2.1 4.6 4.4 4.2 5.8 11.8 20.1 21.3 5.5 22.2 19.3 26.2 21.3 26.9 5.1 23.5 27.4 28.5 6.3 12.5 14.6 11.6 9.5 15.9 8.3 15.3 27.0 8.4 1.8 8.5 8.0 16.3 1.6 5.8 9.6 31.7 7.9 18.5 15.7 0.0 0.0 0.9 0.6 0.0 0.0 6.5 0.2 0.0 0.4 2.5 1.8 0.7 0.2 0.3 0.0 0.6 3.0 0.3 4.2 5.1 0.7 4.1 2.5 1.5 1.6 5.6 1.2 1.2 0.0 0.3 4.9 6.4 6.1 0.1 0.8 5.1 0.0 2.3 7.0 0.0 100.7 5.0 2.3 2.2 0.7 1.1 23.3 0.4 27.0 2.6 1.6 0.0 0.8 15.8 0.0 2.4 1.3 1.0 4.3 14.7 3.4 3.3 1.8 5.9 0.0 1.1 3.5 40.0 0.0 0.5 32.3 0.9 31.4 42.9 4.6 39.9 0.0 7.0 2.8 RREB1 HNT ENSG00000124782 "Ras responsive element binding protein 1" Q92766 6 7107597-7251980 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001756, HPA034843" Approved Supported "Nucleoli fibrillar center,Nuclear speckles" NA NA "Nuclear speckles" "Nucleoli fibrillar center" "HPA001756: AB_1856477, HPA034843: AB_2674357" "unprognostic (1.69e-1)" "unprognostic (3.16e-2)" "unprognostic (2.93e-1)" "unprognostic (5.05e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-3)" "unprognostic (2.53e-1)" "unprognostic (1.32e-2)" "unprognostic (2.45e-2)" "unprognostic (6.51e-2)" "unprognostic (3.31e-2)" "unprognostic (1.16e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (9.54e-2)" "unprognostic (2.92e-1)" 17.4 13.3 3.4 17.9 3.6 24.1 15.9 1.4 3.3 15.8 16.8 3.6 13.5 9.7 18.5 16.3 26.6 9.4 19.1 8.5 3.8 2.1 12.7 18.5 14.4 15.9 4.2 1.8 12.5 26.4 14.6 11.2 15.9 4.6 13.7 8.3 15.2 23.6 18.5 30.5 16.5 20.3 14.5 5.2 20.0 9.6 10.6 4.4 12.8 15.9 17.1 24.9 12.5 17.5 3.0 7.8 8.6 3.6 5.2 2.3 2.0 7.0 6.7 5.6 6.5 5.2 3.4 23.1 2.7 3.9 3.1 4.3 10.4 5.5 3.3 5.9 5.2 3.6 5.1 8.1 8.7 3.5 4.7 6.5 13.1 4.7 13.1 7.2 7.2 10.0 5.8 7.1 5.0 7.6 2.2 4.2 7.9 23.0 0.0 3.5 8.4 4.3 20.2 2.6 5.1 5.9 6.8 6.9 5.3 5.3 13.4 1.6 1.4 6.1 8.9 5.8 9.1 6.7 16.9 6.5 6.2 4.0 4.4 3.6 2.3 2.5 5.1 1.8 6.0 5.0 6.0 3.6 8.6 2.2 3.1 1.7 3.0 1.3 1.4 2.4 1.6 2.3 2.1 2.8 5.2 3.2 7.8 0.8 2.0 3.4 3.6 1.4 3.3 3.8 2.1 4.2 1.8 4.6 4.4 23.8 26.6 13.7 15.3 27.9 0.6 21.6 33.1 12.0 20.5 34.9 66.8 22.4 6.6 13.6 33.8 23.2 42.6 0.0 14.2 29.1 17.1 24.7 9.3 56.8 29.4 0.0 30.5 36.2 57.4 3.6 18.4 36.8 21.9 10.8 34.2 11.7 19.0 28.8 18.0 15.8 27.5 51.8 10.2 7.9 14.3 30.4 38.3 16.7 40.3 46.8 RSBN1L "FLJ42526, FLJ45813, MGC71764" ENSG00000187257 "Round spermatid basic protein 1 like" Q6PCB5 7 77696443-77783022 "Cancer-related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 337.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 31.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 31.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020406, HPA020413" Approved Supported "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA020406: AB_1856488, HPA020413: AB_2253910" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (2.41e-1)" "unprognostic (1.72e-1)" "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (2.43e-2)" "prognostic favorable (3.74e-4)" "unprognostic (1.27e-2)" "unprognostic (3.78e-2)" "unprognostic (1.25e-1)" "unprognostic (9.02e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-3)" "unprognostic (1.53e-3)" 12.9 10.6 15.0 22.1 14.6 9.5 15.5 28.7 17.0 22.8 23.5 8.9 12.1 11.1 17.2 13.6 15.0 14.2 13.4 10.6 12.4 10.3 12.0 14.9 15.7 18.2 11.1 11.0 19.2 14.9 19.5 16.2 12.2 11.8 18.8 15.1 13.9 14.0 15.4 13.6 11.7 14.9 18.0 11.0 20.7 14.3 29.8 13.8 34.5 21.1 6.7 18.0 23.6 28.2 7.2 7.0 31.5 4.0 3.0 5.2 1.2 9.0 7.0 11.7 20.5 8.2 10.5 5.7 6.7 7.3 9.6 11.0 8.6 16.2 18.6 2.6 6.9 12.1 7.9 15.8 8.7 13.8 10.1 8.5 14.8 11.0 8.4 6.9 18.1 14.0 7.5 6.4 8.8 9.7 7.3 7.9 12.4 20.1 19.6 9.9 10.4 15.5 18.3 8.3 11.7 6.3 16.2 11.7 19.5 6.0 11.9 13.8 14.4 10.2 18.6 7.3 12.4 11.3 9.7 7.5 14.4 13.3 8.6 10.2 8.8 9.3 29.9 6.8 16.9 9.4 9.1 4.0 6.4 5.2 2.9 3.9 5.4 4.5 3.8 2.2 7.2 4.3 4.7 31.5 3.0 3.2 7.0 4.5 1.2 15.0 14.6 28.7 17.0 12.4 10.3 11.1 11.0 11.8 13.8 53.6 44.7 77.1 91.4 69.9 234.2 15.9 38.2 69.6 80.8 52.4 221.9 45.1 33.2 32.4 254.3 67.5 45.0 0.0 43.8 30.0 64.1 42.7 68.2 48.3 38.0 149.4 74.4 43.0 41.9 50.1 94.0 54.7 60.8 45.1 68.1 88.8 31.9 58.5 112.4 18.0 337.1 71.1 85.6 98.9 156.4 65.7 32.4 99.1 57.8 72.2 RTEL1 "bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL" ENSG00000258366 "Regulator of telomere elongation helicase 1" Q9NZ71 20 63657810-63696253 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA020622, HPA067329, HPA078328" Approved "Nuclear speckles,Nuclear bodies" NA NA "Nuclear speckles, Nuclear bodies" "HPA020622: AB_2732425, HPA067329: AB_2685823, HPA078328: AB_2732380" "unprognostic (3.63e-2)" "unprognostic (8.08e-3)" "unprognostic (4.80e-2)" "unprognostic (1.12e-1)" "unprognostic (4.27e-1)" "unprognostic (9.30e-3)" "unprognostic (2.59e-1)" "unprognostic (3.64e-2)" "unprognostic (3.30e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (9.50e-2)" "unprognostic (8.77e-3)" "unprognostic (1.17e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" "unprognostic (8.84e-2)" 8.4 14.3 9.4 11.5 12.4 14.2 7.9 25.6 11.8 9.1 11.1 11.2 10.9 9.8 15.4 7.4 7.0 9.5 9.3 6.2 8.0 6.9 7.1 7.2 8.9 7.8 7.5 12.1 10.6 17.8 7.2 18.2 9.8 8.2 10.2 4.8 10.2 12.9 10.2 10.2 8.2 10.1 8.8 4.4 11.6 10.4 17.6 8.9 9.1 11.9 4.9 9.5 9.3 9.0 1.7 3.6 0.0 3.3 0.4 3.0 2.4 5.3 7.3 5.2 10.1 1.1 1.2 9.7 11.0 2.9 17.2 4.5 14.5 4.5 7.1 5.7 3.3 6.5 9.9 3.6 7.2 4.1 3.5 7.3 8.8 12.6 13.8 3.8 8.6 16.1 1.5 4.0 4.2 5.3 3.3 5.8 12.7 10.8 6.8 3.8 5.7 13.3 11.1 5.1 4.5 15.3 10.7 4.9 7.3 2.8 6.5 10.4 6.3 6.1 18.0 1.4 2.5 4.7 9.7 7.7 19.5 6.4 6.7 8.4 6.3 2.6 4.5 4.7 6.1 6.7 0.0 2.7 0.0 3.0 3.3 1.6 0.9 1.7 2.0 3.6 1.7 2.9 1.1 0.0 0.4 2.6 3.2 1.4 2.4 9.4 12.4 25.6 11.8 8.0 6.9 7.5 12.1 8.2 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 RTL6 "dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3" ENSG00000188636 "Retrotransposon Gag like 6" Q6ICC9 22 44492572-44498298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 13.4;Collecting duct cells: 12.2;Ductal cells: 6.3;Exocrine glandular cells: 5.6;Pancreatic endocrine cells: 6.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005697 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA005697: AB_1079244" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (1.57e-1)" "unprognostic (9.64e-3)" "unprognostic (5.40e-2)" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.57e-2)" "unprognostic (1.65e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" 11.6 14.1 19.3 7.7 17.4 3.2 10.2 16.2 30.0 13.6 12.2 14.7 15.2 9.7 17.8 14.2 9.4 19.1 12.4 16.7 17.1 16.1 10.9 4.9 10.4 6.3 16.9 11.4 22.6 12.1 18.9 9.9 5.9 11.9 11.5 10.4 9.2 7.7 16.3 15.5 3.7 9.2 19.0 16.5 7.9 10.7 12.6 9.5 14.4 11.6 7.2 5.3 11.8 10.2 0.2 1.1 0.1 1.4 0.9 4.5 2.1 7.0 9.8 12.7 16.9 10.0 8.1 3.3 9.3 11.1 13.1 10.4 3.2 4.2 0.0 5.9 17.4 9.9 6.1 8.5 9.2 8.2 3.3 16.7 0.0 18.9 0.0 12.4 0.9 4.7 8.8 9.0 12.0 9.3 18.0 11.7 11.3 3.9 0.0 8.9 12.4 22.3 2.0 7.8 7.8 10.5 6.1 6.7 0.0 11.3 8.2 13.7 16.0 15.2 7.4 9.4 6.4 7.4 9.9 12.0 10.3 14.0 13.6 7.4 4.4 1.7 0.0 15.4 2.3 15.4 0.0 1.4 0.1 4.3 0.6 4.5 0.0 2.5 3.6 1.1 0.2 1.0 2.5 0.0 0.9 0.8 0.1 0.4 2.1 19.3 17.4 16.2 27.8 17.1 16.1 16.9 11.4 11.9 9.5 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 13.4 4.5 12.2 0.0 2.2 0.0 6.3 0.0 0.0 0.0 0.0 5.6 2.6 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.8 0.0 0.0 6.2 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 RUNDC1 DKFZp761H0421 ENSG00000198863 "RUN domain containing 1" Q96C34 17 42980565-42993690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023726 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023726: AB_2184078" "unprognostic (4.24e-2)" "unprognostic (1.26e-1)" "unprognostic (9.39e-2)" "prognostic favorable (6.93e-5)" "unprognostic (9.78e-2)" "unprognostic (1.22e-1)" "unprognostic (6.40e-2)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (3.84e-2)" "unprognostic (1.22e-1)" "unprognostic (1.53e-3)" "unprognostic (2.87e-3)" "unprognostic (1.25e-1)" "unprognostic (1.12e-2)" "unprognostic (4.77e-3)" 7.3 11.0 23.4 8.7 23.1 8.4 14.7 18.6 24.6 13.0 12.9 7.9 12.2 9.0 12.3 17.9 9.0 20.9 9.5 8.7 17.2 13.0 12.1 6.6 9.6 9.3 9.2 16.9 7.7 14.2 17.7 17.2 6.7 12.2 17.9 11.0 8.9 11.1 12.9 14.5 9.1 10.0 12.3 7.5 10.7 13.9 11.9 12.5 9.6 14.5 4.4 10.4 12.7 8.1 5.6 7.5 10.0 5.2 1.4 2.6 1.2 11.3 20.0 8.1 10.9 13.9 8.4 8.7 11.0 11.5 15.8 11.9 12.6 6.6 7.7 10.0 10.9 10.8 14.3 10.3 11.1 17.7 8.6 16.3 5.1 11.3 12.0 8.9 11.0 11.0 6.2 13.7 14.0 9.3 12.7 8.4 8.5 9.8 4.9 9.1 8.3 13.6 7.9 9.1 16.3 12.7 9.9 11.4 7.6 13.3 15.3 11.8 11.0 8.7 8.3 9.1 12.5 16.0 12.4 6.9 14.5 9.0 8.5 13.1 11.7 11.2 6.7 10.3 5.9 9.0 5.0 3.3 10.0 1.9 5.2 2.4 4.6 2.3 1.6 2.5 5.6 2.3 2.5 7.6 1.4 3.6 7.5 2.6 1.2 23.4 23.1 18.6 24.6 17.2 13.0 9.2 16.9 12.2 12.5 41.7 48.0 16.4 9.9 13.4 18.8 12.2 20.4 20.1 22.7 5.2 21.6 8.9 18.3 10.8 7.7 6.6 17.5 0.0 8.4 6.0 6.8 16.2 10.5 5.8 7.2 36.5 18.4 8.0 7.9 2.5 9.2 11.3 3.3 10.0 13.2 14.5 8.7 17.5 13.4 10.3 33.5 19.4 8.1 19.7 13.6 12.8 4.6 11.4 13.6 14.4 S1PR2 "AGR16, DFNB68, EDG5, Gpcr13, H218" ENSG00000267534 "Sphingosine-1-phosphate receptor 2" O95136 19 10221433-10231331 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 75.1;Early spermatids: 83.7;Late spermatids: 119.0;Syncytiotrophoblasts: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 23.7" "Group enriched" "Detected in many" 7 "granulocytes: 23.7;T-cells: 7.4" "Cell line enhanced" "Detected in many" "BEWO: 14.6;Daudi: 25.8;U-266/70: 19.3;U-698: 27.9;WM-115: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014255, HPA014307" Approved Uncertain "Nuclear speckles,Golgi apparatus" NA NA "Golgi apparatus" "Nuclear speckles" "HPA014255: , HPA014307: AB_1847989" "unprognostic (5.38e-3)" "unprognostic (1.83e-3)" "unprognostic (1.20e-1)" "unprognostic (1.26e-2)" "unprognostic (3.31e-2)" "unprognostic (1.05e-3)" "unprognostic (8.50e-2)" "unprognostic (8.71e-2)" "unprognostic (2.84e-1)" "unprognostic (1.70e-1)" "unprognostic (7.40e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.91e-2)" "unprognostic (4.56e-2)" "unprognostic (3.11e-1)" "unprognostic (8.09e-2)" 17.1 2.3 1.4 13.7 1.3 0.9 7.2 0.9 1.5 13.3 4.1 1.7 3.9 1.8 8.3 9.2 6.4 7.9 6.5 6.1 1.3 1.5 2.4 9.5 11.2 10.6 1.3 0.0 12.9 2.6 3.9 2.2 31.3 1.7 9.8 2.5 3.2 9.4 5.7 3.4 4.0 3.9 8.7 1.7 2.2 4.2 21.8 1.0 2.0 3.3 6.3 15.6 8.0 12.0 0.3 1.6 23.7 1.9 2.1 7.4 1.2 1.4 0.2 1.7 3.4 9.4 11.5 14.6 2.1 4.4 1.0 2.0 0.9 0.8 25.8 2.5 4.0 1.1 0.8 0.6 1.0 0.7 2.6 1.3 0.6 0.6 0.6 3.1 0.7 0.6 6.3 0.5 1.9 0.6 2.7 0.1 1.3 0.6 5.6 0.6 1.2 0.3 1.2 1.7 0.4 0.8 1.8 0.7 0.9 0.8 1.2 1.2 2.3 1.2 0.7 1.8 1.4 0.6 0.6 0.2 3.5 1.1 7.9 0.6 19.3 9.1 27.9 1.3 1.3 19.1 23.7 1.9 0.4 4.9 1.5 5.9 0.2 6.2 4.6 1.6 0.3 2.6 2.6 0.5 2.1 0.6 0.2 7.4 1.2 1.4 1.3 0.9 1.3 1.3 1.5 1.3 0.0 1.7 1.0 0.0 1.4 0.0 3.5 0.0 0.6 0.4 0.0 0.0 1.2 1.8 2.0 75.1 0.0 3.1 83.7 1.5 0.0 0.0 2.7 13.9 15.8 4.2 0.0 5.9 12.5 0.0 2.4 4.9 0.6 119.0 20.4 4.8 0.0 4.6 0.1 7.1 2.3 0.0 12.4 0.5 0.4 12.9 2.0 1.2 1.1 0.0 57.2 1.5 0.0 2.6 SART1 "Ara1, HAF, SNRNP110, Snu66" ENSG00000175467 "SART1, U4/U6.U5 tri-snRNP-associated protein 1" O43290 11 65961689-65979828 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Allergen, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031188, HPA031189, HPA031190" Supported Enhanced "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289" "unprognostic (2.93e-2)" "unprognostic (1.13e-2)" "unprognostic (1.09e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-1)" "unprognostic (6.99e-2)" "unprognostic (2.52e-3)" "unprognostic (8.15e-2)" "unprognostic (8.97e-2)" "unprognostic (2.10e-1)" "unprognostic (2.11e-2)" "unprognostic (3.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (4.24e-2)" 22.3 17.5 26.4 25.0 27.8 50.7 21.7 28.5 27.2 21.4 19.6 17.7 20.9 22.7 26.3 17.4 19.0 20.3 20.7 19.5 23.8 16.8 15.8 18.2 19.0 26.2 23.0 25.7 26.8 28.4 22.5 19.2 22.4 25.2 18.1 12.0 15.9 27.1 27.2 34.6 26.2 19.9 27.9 29.2 29.2 20.3 20.4 25.6 24.0 20.5 19.1 19.0 20.6 41.3 5.9 5.8 12.1 5.3 4.1 8.1 2.7 22.2 27.0 12.4 16.6 12.2 9.7 19.0 17.4 12.3 20.1 13.2 19.5 15.6 25.4 20.0 15.0 24.3 22.0 15.6 15.9 10.2 20.4 15.4 29.4 19.2 18.0 18.3 25.3 24.7 12.2 12.1 18.6 16.7 8.0 12.4 19.1 18.5 18.1 11.5 40.3 32.6 36.5 21.1 12.0 25.9 35.8 18.0 26.7 8.3 14.9 14.0 19.9 16.4 16.9 20.1 6.0 18.9 20.7 18.5 25.2 24.9 24.7 24.2 27.7 21.6 22.3 20.9 12.9 21.2 2.0 4.5 12.1 7.1 5.3 6.0 5.9 8.0 7.4 5.8 5.4 5.9 6.6 6.3 4.1 3.1 4.9 8.1 2.7 26.4 27.8 28.5 27.2 23.8 16.8 23.0 25.7 25.2 25.6 6.0 7.8 27.2 18.9 20.1 17.6 7.5 17.8 10.7 9.1 15.7 9.8 28.9 5.0 19.2 6.3 17.4 27.1 23.3 25.3 26.5 18.4 15.6 32.3 13.0 26.1 15.9 12.0 15.4 22.1 5.9 34.2 27.3 16.9 38.7 18.6 20.4 22.2 20.1 31.1 13.4 20.5 32.3 25.8 24.4 26.6 19.1 37.9 24.6 20.2 15.3 SERPINB13 "headpin, HUR7, hurpin, PI13" ENSG00000197641 "Serpin family B member 13" Q9UIV8 18 63586989-63604639 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1" "Group enriched" "Detected in some" 11 "Ciliated cells: 8.1;Club cells: 29.6;Urothelial cells: 8.5" "Cancer enhanced" "Detected in many" "cervical cancer: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 132 "HaCaT: 65.6;hTCEpi: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052630, HPA057129" Enhanced Approved "Nuclear speckles,Cytosol" NA NA 59000 "Nuclear speckles, Cytosol" "HPA052630: AB_2681891, HPA057129: AB_2683347" "unprognostic (3.49e-2)" "unprognostic (3.73e-1)" "unprognostic (1.11e-1)" "unprognostic (7.27e-2)" "unprognostic (2.28e-1)" "unprognostic (4.29e-2)" "unprognostic (2.81e-1)" "unprognostic (6.04e-3)" 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.1 37.7 0.1 0.0 0.0 0.1 3.1 0.1 70.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 10.9 0.1 0.2 5.7 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.0 0.1 107.2 54.2 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 8.1 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 8.5 SETD2 "FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A" ENSG00000181555 "SET domain containing 2" Q9BYW2 3 47016429-47163967 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042451 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA042451: AB_10806239" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (6.08e-2)" "unprognostic (1.01e-1)" "unprognostic (3.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.40e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (6.19e-2)" "unprognostic (2.45e-1)" "unprognostic (7.84e-2)" "prognostic favorable (7.99e-6)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (8.79e-2)" "unprognostic (5.43e-2)" 13.2 10.5 12.2 15.2 15.4 20.0 11.7 22.4 16.4 13.4 14.0 9.1 12.9 9.5 15.8 7.5 10.8 11.4 8.7 8.8 10.6 6.8 11.4 10.3 10.4 11.8 11.7 9.5 16.0 13.4 21.4 16.3 10.7 11.3 12.4 10.9 7.7 12.7 14.8 27.6 12.5 11.5 11.9 9.8 13.8 10.4 12.8 12.8 23.2 15.8 5.5 12.8 16.1 15.5 4.8 2.6 6.0 2.3 7.1 3.9 1.0 11.6 9.2 15.4 7.9 9.3 10.7 6.5 10.7 10.4 12.6 11.5 9.7 7.6 25.7 6.7 14.8 12.3 7.1 16.7 10.2 17.1 14.7 6.6 26.4 15.3 7.5 7.0 19.7 15.3 9.2 9.9 12.4 15.4 10.2 11.6 13.3 16.9 9.7 10.3 6.1 14.5 2.6 11.7 5.6 7.7 9.6 15.0 13.3 6.4 15.3 6.7 10.6 18.1 7.1 6.7 11.5 7.5 14.7 14.8 13.9 10.4 11.8 17.1 12.5 13.9 26.0 8.0 11.3 8.1 2.4 2.2 5.2 3.9 2.3 2.4 3.7 2.4 3.0 2.5 4.8 3.5 3.0 6.0 7.1 1.9 2.6 1.0 1.0 12.2 15.4 22.4 16.4 10.6 6.8 11.7 9.5 11.3 12.8 44.7 53.3 20.6 20.5 29.7 33.4 58.5 22.9 66.9 80.8 10.4 39.3 16.3 10.0 17.4 24.0 29.3 26.5 0.0 19.3 10.1 20.8 25.9 55.6 26.7 14.3 25.4 21.2 23.4 27.2 20.8 28.1 21.6 16.9 20.8 27.8 21.7 20.0 17.5 31.1 9.3 37.0 12.9 21.7 78.1 18.9 31.1 15.4 27.7 24.8 34.2 SF3A1 "Prp21, PRPF21, SAP114, SF3a120" ENSG00000099995 "Splicing factor 3a subunit 1" Q15459 22 30331988-30356947 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000690, HPA030083" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA 19000 "Nucleoplasm, Nuclear speckles" "HPA000690: AB_1079933, HPA030083: AB_10602183" "unprognostic (8.61e-2)" "unprognostic (1.60e-1)" "unprognostic (3.21e-2)" "unprognostic (7.54e-2)" "unprognostic (5.06e-3)" "unprognostic (1.79e-1)" "unprognostic (5.54e-3)" "unprognostic (3.30e-1)" "unprognostic (3.83e-1)" "unprognostic (2.59e-1)" "unprognostic (2.58e-1)" "unprognostic (3.26e-1)" "prognostic favorable (1.16e-4)" "unprognostic (2.25e-1)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" "unprognostic (1.13e-1)" 32.6 30.2 23.3 37.3 25.6 44.6 35.0 33.6 37.3 29.2 26.4 24.8 27.7 26.1 36.3 23.0 32.2 29.4 30.7 26.2 21.5 16.6 24.9 29.7 28.5 48.2 23.5 26.1 45.7 31.4 44.4 27.2 25.9 19.6 27.2 24.5 29.7 31.8 33.1 45.5 36.3 29.5 27.6 18.7 34.6 29.1 78.4 25.7 50.9 32.9 26.6 34.9 32.7 42.6 13.2 10.6 16.2 13.7 12.1 16.6 8.3 26.4 18.6 25.6 24.8 15.2 13.7 30.6 21.0 13.4 22.9 17.1 24.6 17.7 33.1 14.5 14.8 18.1 25.5 32.4 22.3 25.2 30.0 28.4 30.9 23.1 20.1 13.8 61.9 34.4 13.7 15.8 28.9 23.6 13.0 16.4 18.0 34.1 34.7 16.6 15.2 30.1 14.1 42.3 20.4 15.6 43.0 32.1 26.8 13.1 29.4 26.6 24.3 26.7 16.3 24.2 17.8 19.9 20.4 22.9 29.4 26.2 20.9 38.7 26.9 32.4 33.5 22.6 23.0 30.2 7.6 9.8 15.0 13.5 11.3 13.7 12.8 13.5 14.4 10.6 13.2 15.3 13.7 16.2 12.1 13.7 6.4 16.6 8.3 23.3 25.6 33.6 37.3 21.5 16.6 23.5 26.1 19.6 25.7 53.6 60.9 28.0 23.1 23.2 17.9 26.6 35.7 48.2 37.5 29.6 15.7 28.2 14.9 22.6 85.6 29.2 25.3 46.7 25.3 33.8 23.4 23.0 50.8 23.6 34.7 25.4 24.1 28.3 35.7 91.2 32.5 26.1 16.9 63.1 29.8 24.6 24.5 31.6 35.3 14.6 17.4 45.3 23.9 54.7 41.0 23.8 28.9 30.5 28.2 22.2 SF3A3 "PRP9, PRPF9, SAP61, SF3a60" ENSG00000183431 "Splicing factor 3a subunit 3" Q12874 1 37956975-37990921 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032054, HPA032055" Supported Supported "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA032054: AB_10602184, HPA032055: AB_2674130" "unprognostic (1.56e-1)" "unprognostic (1.21e-1)" "unprognostic (7.08e-3)" "unprognostic (6.19e-3)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "prognostic unfavorable (2.11e-8)" "unprognostic (1.34e-1)" "unprognostic (2.74e-2)" "unprognostic (5.74e-3)" "unprognostic (9.18e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (2.52e-3)" "unprognostic (8.39e-2)" "unprognostic (2.24e-1)" "unprognostic (3.68e-2)" 7.0 6.4 5.3 6.3 5.9 13.6 7.6 7.4 5.5 6.3 6.5 4.3 9.4 8.7 6.8 7.7 4.1 4.3 4.8 4.9 5.9 6.2 6.1 8.4 5.3 8.7 6.7 6.4 5.7 5.6 6.1 7.2 5.9 7.2 15.3 7.7 5.9 7.7 4.3 7.9 6.2 5.8 6.3 10.3 6.2 6.1 23.6 19.0 10.6 20.6 18.7 27.8 20.6 15.9 12.2 22.1 18.8 13.8 12.8 26.7 15.6 14.3 27.5 22.3 20.0 17.0 30.4 13.7 15.2 10.7 13.8 28.0 22.8 33.8 13.9 27.3 38.6 19.5 17.3 12.7 46.9 18.7 12.1 16.0 28.4 18.8 12.6 19.0 23.7 34.0 12.0 19.8 10.7 24.7 27.1 54.5 16.6 19.0 29.5 37.9 21.9 12.6 16.7 19.3 14.3 20.0 9.3 16.5 20.6 11.0 18.6 17.0 14.4 15.8 13.2 30.9 11.5 16.3 31.0 13.9 43.2 17.9 10.6 15.3 9.8 21.8 18.9 21.2 20.4 25.8 22.0 19.0 23.6 27.8 23.6 2.0 18.7 20.6 11.8 26.3 20.6 47.6 31.2 43.1 32.7 42.0 34.1 19.8 7.6 28.1 44.3 21.0 21.6 48.1 33.2 40.0 18.5 30.6 15.5 0.0 33.5 56.8 32.4 19.1 40.5 20.8 45.1 25.4 15.0 21.5 25.3 10.0 36.8 36.9 37.1 107.4 22.3 37.9 31.9 7.0 50.9 23.7 34.2 38.8 34.7 116.5 59.6 36.5 27.6 38.9 28.3 25.9 SFMBT2 KIAA1617 ENSG00000198879 "Scm like with four mbt domains 2" Q5VUG0 10 7158624-7411486 "Predicted intracellular proteins" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.7" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 76.6;Rod photoreceptor cells: 33.6;T-cells: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 16.4;REH: 14.7;RPMI-8226: 13.8;SH-SY5Y: 11.3;THP-1: 17.6;U-937: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035447, HPA035448, HPA070388" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA035447: AB_2674628, HPA035448: AB_10669904, HPA070388: " "unprognostic (4.36e-2)" "unprognostic (2.29e-2)" "unprognostic (4.36e-2)" "unprognostic (1.42e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-3)" "unprognostic (4.65e-1)" "unprognostic (4.56e-1)" "unprognostic (1.03e-1)" "unprognostic (6.51e-2)" "unprognostic (5.57e-2)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (1.26e-1)" "unprognostic (9.17e-3)" "unprognostic (5.37e-3)" "unprognostic (7.29e-2)" 3.0 4.2 9.6 5.9 11.7 6.1 6.2 6.6 13.7 2.5 2.8 26.7 1.1 2.0 4.3 3.7 2.3 3.7 3.6 3.9 12.6 6.9 2.7 1.1 4.1 7.2 14.6 7.4 11.2 3.8 10.1 6.6 3.7 10.8 6.5 3.4 3.9 4.6 3.6 3.9 1.2 3.5 3.4 10.6 9.0 2.9 1.5 9.7 2.0 7.8 1.1 6.2 3.7 4.1 0.1 5.4 1.7 7.4 1.3 1.8 0.4 0.0 3.4 0.2 0.0 0.0 0.2 3.2 0.1 0.0 0.0 0.0 0.0 0.9 5.3 0.0 0.1 0.0 1.6 6.0 0.0 0.0 0.3 5.4 0.0 8.9 0.0 0.4 5.8 0.7 0.8 0.2 0.0 0.2 0.0 0.0 7.3 9.0 16.4 0.0 2.3 4.6 9.1 1.1 0.0 0.0 14.7 1.8 13.8 0.0 0.5 1.3 11.3 0.0 0.0 0.0 1.5 0.8 17.6 0.0 0.0 1.8 0.2 0.1 7.0 10.1 0.0 0.7 11.1 0.1 0.1 0.4 1.7 1.4 3.8 0.8 0.1 0.5 0.9 0.7 0.1 1.8 1.1 0.2 1.3 7.4 5.4 0.0 0.4 9.6 11.7 6.6 13.7 12.6 6.9 14.6 7.4 10.8 9.7 0.0 6.9 6.7 1.2 1.3 5.8 9.6 2.5 1.4 1.2 0.0 76.6 5.9 0.0 0.4 0.1 6.7 0.0 0.0 0.2 2.0 1.7 9.3 4.6 0.5 14.1 0.0 4.1 7.4 11.5 0.4 4.6 9.2 5.0 9.0 0.0 12.9 0.2 0.0 2.1 0.1 33.6 0.0 1.0 0.4 3.6 1.1 3.7 24.1 0.0 0.6 SHPK "CARKL, SHK" ENSG00000197417 Sedoheptulokinase Q9UHJ6 17 3608262-3636322 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024361, HPA064939" Enhanced Approved "Nucleoplasm,Nuclear speckles" NA NA 150000 "Nucleoplasm, Nuclear speckles" "HPA024361: AB_1846030, HPA064939: AB_2685388" "unprognostic (1.75e-2)" "unprognostic (1.51e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (3.57e-3)" "unprognostic (1.54e-2)" "unprognostic (1.95e-2)" "unprognostic (3.01e-2)" "unprognostic (1.56e-1)" "unprognostic (3.64e-2)" "unprognostic (1.08e-2)" "unprognostic (1.42e-1)" "unprognostic (3.82e-2)" "unprognostic (6.75e-2)" "unprognostic (1.55e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" 8.9 12.9 7.6 6.2 10.6 5.9 8.9 17.3 12.3 8.8 14.1 14.9 8.8 18.5 10.7 6.1 11.6 7.6 5.3 5.9 7.0 5.5 14.3 26.7 6.3 5.3 12.0 4.5 10.2 13.7 11.8 6.2 8.6 9.8 7.4 8.6 12.3 8.9 9.4 7.5 12.1 22.8 5.1 6.7 6.1 9.7 5.2 13.0 7.7 7.7 4.0 7.6 7.5 9.6 5.2 7.1 5.1 4.8 6.4 7.5 5.4 5.3 10.9 11.6 7.4 4.8 4.9 6.4 3.6 3.2 7.0 4.2 18.7 5.0 6.3 8.0 6.9 6.6 10.4 15.4 11.6 5.1 10.1 15.0 6.9 9.3 13.4 5.8 5.9 9.8 8.2 5.6 7.8 5.3 6.0 13.2 5.0 9.1 8.1 6.8 9.5 7.6 4.6 5.8 12.3 7.3 10.5 6.1 10.1 10.0 6.9 3.3 8.9 13.1 12.1 3.6 7.4 10.8 3.5 9.4 10.8 5.1 10.3 8.7 2.7 3.5 4.2 11.7 5.4 5.4 3.3 4.7 5.1 4.6 4.8 4.7 5.2 4.2 3.7 6.5 4.0 7.5 4.7 0.9 6.4 4.1 7.1 3.6 5.4 7.6 10.6 17.3 12.3 7.0 5.5 12.0 4.5 9.8 13.0 0.0 2.7 1.5 0.8 0.0 5.4 0.8 7.6 1.4 1.2 5.2 15.7 8.1 1.7 2.9 0.4 2.2 10.5 0.0 4.1 8.6 0.9 1.9 0.0 14.8 6.9 14.3 3.4 1.8 1.3 0.0 3.7 2.5 0.0 3.6 5.9 3.1 4.3 5.8 2.5 6.5 15.6 0.0 0.8 0.6 1.2 0.4 4.7 1.0 5.5 1.7 SIRT7 ENSG00000187531 "Sirtuin 7" Q9NRC8 17 81911939-81921323 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "eosinophil: 17.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027284, HPA028246, CAB037261, HPA053669" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "CAB037261: AB_1079989, HPA027284: , HPA028246: , HPA053669: AB_2682224" "unprognostic (8.15e-3)" "unprognostic (3.24e-2)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.46e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (1.97e-5)" "unprognostic (3.03e-1)" "unprognostic (2.10e-1)" "unprognostic (2.46e-2)" "unprognostic (2.79e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.69e-7)" "unprognostic (4.34e-3)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (2.16e-2)" 6.2 5.9 6.7 10.1 12.8 22.6 6.4 17.0 11.4 8.2 12.9 7.0 9.0 14.3 5.5 4.6 28.8 7.2 10.6 3.9 6.7 2.6 7.9 9.8 7.9 11.3 11.0 6.6 4.8 18.7 4.9 7.8 8.8 7.6 7.1 6.7 3.7 12.7 7.0 5.3 15.7 15.3 5.1 5.7 14.1 18.4 8.9 8.8 8.3 6.7 7.3 16.4 8.3 12.3 3.9 1.8 17.4 3.4 1.3 2.6 1.2 15.3 12.8 1.6 5.6 4.2 4.0 10.3 7.8 6.6 9.2 8.7 11.0 12.3 6.9 6.1 4.3 5.8 11.1 6.3 4.8 3.0 5.9 13.6 6.0 6.2 17.3 12.8 7.8 12.4 4.0 15.2 8.8 7.3 3.8 6.8 3.8 6.4 3.4 4.3 12.1 8.3 11.1 4.0 23.9 13.3 5.6 3.3 6.4 8.9 10.1 6.7 8.8 9.0 21.7 10.0 3.2 9.0 18.7 5.3 4.1 9.1 7.7 14.1 5.7 1.8 5.0 10.1 10.7 6.7 3.0 2.3 17.4 2.6 3.4 0.9 3.3 2.0 2.1 1.2 3.9 1.8 0.6 3.8 1.3 2.6 1.8 1.0 1.2 6.7 12.8 17.0 11.4 6.7 2.6 11.0 6.6 7.6 8.8 11.9 9.8 27.4 19.4 33.8 22.2 4.0 20.4 16.0 3.4 17.4 53.0 25.1 8.3 18.8 17.0 15.3 59.6 0.0 12.0 29.1 12.9 25.0 11.5 14.7 23.3 28.6 19.5 14.1 19.8 9.1 13.3 24.8 23.6 45.9 28.5 19.3 36.4 49.1 9.6 10.5 35.9 0.0 17.5 37.1 38.4 48.6 41.2 44.8 31.8 44.5 SLC25A12 Aralar ENSG00000115840 "Solute carrier family 25 member 12" O75746 2 171784370-171999859 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 84.7" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035333, HPA035334" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA035333: AB_10603028, HPA035334: AB_2674577" "unprognostic (3.24e-2)" "unprognostic (2.52e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (2.65e-2)" "unprognostic (7.27e-2)" "unprognostic (4.21e-3)" "unprognostic (5.23e-2)" "unprognostic (1.39e-1)" "unprognostic (4.96e-2)" "unprognostic (7.76e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.91e-8)" "unprognostic (8.64e-3)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (2.70e-1)" 6.4 6.7 8.8 6.2 18.2 2.9 9.2 17.9 25.0 10.6 12.2 5.7 5.2 4.2 10.4 7.1 11.5 6.9 5.9 42.4 9.9 13.4 10.7 1.9 5.2 6.5 10.4 12.4 10.0 3.5 16.4 14.7 4.7 15.2 10.6 10.0 11.0 21.7 14.8 84.7 7.6 5.7 14.3 7.1 5.6 9.0 4.3 6.2 5.8 10.1 23.8 8.4 10.0 6.7 6.4 3.6 5.1 4.6 6.6 8.1 2.9 7.2 5.3 5.6 13.0 16.7 18.9 0.1 9.2 15.7 12.6 12.1 2.8 6.8 22.9 6.1 10.8 9.8 9.1 11.8 11.6 15.8 14.0 11.1 10.0 7.7 6.7 6.4 20.0 10.0 16.5 11.5 14.6 4.2 6.8 13.0 9.1 6.9 10.5 8.0 4.4 14.1 8.4 4.5 6.1 7.5 14.7 8.1 11.9 13.2 6.3 7.9 2.5 5.8 13.7 7.3 3.8 5.0 5.9 8.9 10.5 4.6 11.6 6.3 14.2 9.1 23.2 14.5 10.6 7.1 5.1 3.0 1.6 6.5 3.9 7.3 6.4 4.5 6.8 3.6 3.9 6.3 8.1 0.2 6.6 4.6 0.6 4.5 2.9 8.8 18.2 17.9 25.0 9.9 13.4 10.4 12.4 15.2 6.2 0.0 6.0 1.5 11.2 6.2 25.4 94.4 0.0 13.4 22.7 17.4 23.6 6.0 16.6 1.5 2.5 7.0 5.6 23.3 2.9 1.2 7.0 4.3 10.4 0.2 4.0 35.0 13.8 8.6 7.3 1.7 11.5 5.4 15.1 6.4 7.0 18.3 1.3 3.5 23.0 10.9 22.1 12.9 11.8 3.2 9.0 6.8 1.0 8.7 7.4 4.6 SLC9C2 "MGC43026, SLC9A11" ENSG00000162753 "Solute carrier family 9 member C2 (putative)" Q5TAH2 1 173500464-173603094 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 24.9" "Cell type enhanced" "Detected in some" 13 "Club cells: 2.3;Cone photoreceptor cells: 5.9;Early spermatids: 4.2;Late spermatids: 2.3;Spermatocytes: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.7" "Group enriched" "Detected in some" 4 "BEWO: 1.8;THP-1: 3.7" "Low region specificity" "Detected in all" "HPA059122, HPA079529" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA059122: , HPA079529: " "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (8.52e-2)" "unprognostic (5.88e-3)" "unprognostic (3.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-3)" "unprognostic (1.19e-1)" "unprognostic (4.21e-2)" "unprognostic (4.92e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-6)" "unprognostic (1.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.98e-1)" "unprognostic (1.81e-1)" 0.4 0.1 0.3 0.0 1.3 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.5 0.0 0.1 0.4 0.0 1.7 0.0 0.1 0.5 0.3 0.2 0.0 0.4 0.1 0.0 0.4 0.8 0.3 0.1 0.4 0.5 0.5 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.1 0.3 1.0 0.3 24.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 1.3 0.0 1.6 0.5 0.3 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.0 5.9 0.1 0.0 0.0 4.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.1 0.0 0.0 0.0 SLU7 9G8 ENSG00000164609 "SLU7 homolog, splicing factor" O95391 5 160401641-160421711 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035907, HPA058120" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA035907: AB_10671717, HPA058120: AB_2683612" "unprognostic (3.70e-2)" "unprognostic (7.18e-2)" "unprognostic (1.86e-2)" "unprognostic (9.96e-3)" "unprognostic (8.01e-2)" "unprognostic (3.52e-1)" "unprognostic (3.38e-3)" "unprognostic (3.76e-2)" "unprognostic (2.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.93e-1)" "unprognostic (7.69e-2)" "prognostic favorable (1.98e-4)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" 19.4 18.9 25.7 14.1 30.7 32.9 22.0 30.4 32.9 18.0 16.2 14.2 14.2 12.9 18.1 21.4 17.8 14.6 14.8 19.3 23.7 23.6 19.4 19.0 18.1 19.4 25.7 28.1 17.5 15.4 18.4 21.6 18.5 28.4 17.5 16.8 10.3 18.6 16.6 33.8 17.7 17.0 18.6 26.2 20.6 17.8 20.3 25.8 21.4 26.0 20.2 23.5 20.6 17.7 18.4 13.2 33.5 20.1 20.6 17.9 12.2 12.4 15.8 13.5 19.2 17.9 19.0 17.5 17.6 25.7 19.5 23.6 20.9 15.2 20.3 18.0 18.8 19.3 13.9 11.9 19.5 24.6 32.7 17.4 15.0 21.6 13.4 18.0 25.4 18.6 20.4 18.3 17.8 20.4 19.8 13.3 18.4 13.6 19.0 17.4 11.0 12.4 16.2 9.9 12.7 14.2 10.6 28.2 20.0 17.1 20.3 16.5 22.7 20.6 18.9 31.0 11.8 25.3 24.1 16.9 19.0 9.8 13.7 18.6 21.2 24.3 18.1 27.4 16.9 17.8 24.7 13.2 22.5 17.4 14.8 16.3 18.4 16.3 17.1 12.1 16.6 17.9 17.1 33.5 20.6 20.1 13.2 17.4 12.2 25.7 30.7 30.4 32.9 23.7 23.6 25.7 28.1 28.4 25.8 62.5 60.3 40.4 39.5 39.8 70.1 58.4 20.4 78.9 52.4 24.4 23.6 32.7 43.1 43.6 85.1 35.9 28.4 46.7 48.7 33.2 36.4 32.9 45.1 21.5 33.8 54.0 37.9 28.3 41.9 21.3 44.3 49.1 62.4 61.3 33.0 50.0 45.3 35.3 44.6 29.3 44.2 45.3 40.1 47.9 42.8 36.3 78.7 48.4 28.0 42.3 SMC4 "CAP-C, hCAP-C, SMC4L1" ENSG00000113810 "Structural maintenance of chromosomes 4" Q9NTJ3 3 160399274-160434962 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.2" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 332.4;Spermatogonia: 238.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029449, CAB055509" Approved Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles, Cytosol" "CAB055509: , HPA029449: AB_10603891" "unprognostic (2.63e-1)" "unprognostic (1.01e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.54e-2)" "unprognostic (2.18e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (4.20e-5)" "prognostic unfavorable (9.00e-4)" "prognostic unfavorable (8.05e-7)" "unprognostic (3.03e-2)" "unprognostic (4.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" 4.8 5.5 3.0 25.4 4.4 15.1 4.0 3.1 3.2 5.3 10.1 1.7 5.3 6.5 5.2 4.9 19.3 4.6 7.0 5.7 2.4 1.7 4.4 6.3 7.9 16.5 3.1 1.3 4.7 4.2 1.7 10.8 7.4 2.6 4.4 6.9 2.7 5.7 6.9 5.9 4.6 7.0 6.2 3.1 13.1 5.7 20.7 3.2 70.2 5.1 7.6 14.3 7.8 6.3 8.8 6.1 30.5 7.6 7.8 15.8 4.8 63.3 11.7 26.7 12.3 5.1 5.2 12.3 31.6 14.9 36.6 31.7 14.8 36.5 40.1 18.5 13.0 24.3 36.6 30.3 15.3 58.8 53.1 21.1 38.8 20.1 4.7 2.8 25.7 31.8 2.6 2.2 19.3 15.8 13.3 15.5 17.1 22.3 46.7 21.8 11.4 31.5 6.4 15.7 15.7 27.6 32.0 41.9 29.1 6.8 7.9 16.1 16.7 24.1 22.3 11.0 13.1 26.8 19.2 14.6 23.4 19.6 21.3 57.6 31.2 31.8 73.2 16.8 26.4 25.9 30.5 3.2 12.1 6.7 4.7 6.5 8.8 10.5 8.0 3.5 7.2 6.7 6.0 5.7 7.8 7.6 6.1 15.8 4.8 3.0 4.4 3.1 3.2 2.4 1.7 3.1 1.3 2.6 3.2 98.3 146.6 24.2 16.6 36.2 14.2 31.9 22.9 32.1 44.3 33.2 7.9 29.7 3.3 18.2 26.7 45.6 21.1 116.8 12.6 126.9 41.4 11.7 76.3 15.6 51.1 0.0 28.9 39.3 26.0 21.5 23.3 45.4 16.9 37.9 24.6 9.8 11.3 20.1 45.3 6.2 24.1 129.4 30.3 332.4 238.9 31.1 28.5 48.4 46.6 17.6 SNRPB2 "Msl1, U2B''" ENSG00000125870 "Small nuclear ribonucleoprotein polypeptide B2" P08579 20 16729961-16742563 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 82.5" "Low region specificity" "Detected in all" "HPA050814, HPA076104" Supported Supported "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA050814: AB_2681245, HPA076104: AB_2732301" "unprognostic (4.73e-2)" "unprognostic (1.78e-1)" "unprognostic (4.02e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (8.45e-2)" "unprognostic (8.36e-2)" "prognostic unfavorable (6.03e-7)" "unprognostic (4.23e-2)" "unprognostic (5.94e-2)" "unprognostic (1.65e-2)" "unprognostic (2.73e-2)" "unprognostic (4.06e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.14e-2)" "unprognostic (1.77e-1)" 27.1 29.4 30.8 29.9 31.5 46.6 32.4 23.2 33.3 25.1 28.6 18.3 19.5 24.7 33.5 37.9 25.4 28.2 22.8 30.9 31.0 29.7 45.4 30.2 24.7 39.9 28.7 33.0 33.4 21.5 19.7 41.9 35.2 25.5 25.9 28.1 16.9 23.0 25.5 34.7 18.4 30.1 31.8 30.8 36.0 27.0 24.3 28.3 40.8 33.1 31.1 35.7 34.1 22.7 21.2 29.8 29.0 24.5 19.8 30.6 18.1 16.2 16.0 21.1 13.1 10.6 13.3 23.5 16.1 13.5 17.6 17.3 18.3 18.4 26.1 12.6 13.7 26.9 15.3 16.6 18.8 25.2 8.5 13.9 24.1 5.3 33.7 12.4 28.1 16.6 13.2 12.6 16.0 12.6 13.1 16.4 17.9 19.8 11.9 17.9 16.9 32.1 34.1 18.8 82.5 21.5 18.5 25.3 18.3 17.0 11.0 11.2 32.1 11.9 32.9 79.2 16.3 20.8 23.0 13.9 16.1 16.0 14.4 26.4 10.5 21.5 29.1 7.6 16.8 34.7 26.5 19.5 29.0 19.3 24.3 24.8 21.2 24.5 21.8 20.5 19.6 21.5 23.5 8.4 19.8 24.5 29.8 30.6 18.1 30.8 31.5 23.2 33.3 31.0 29.7 28.7 33.0 25.5 28.3 41.7 50.5 143.6 137.9 79.1 29.0 59.3 107.0 71.0 58.0 89.0 0.0 243.3 182.4 155.3 65.1 101.3 71.8 70.0 147.1 239.3 108.5 97.4 130.4 123.8 197.4 46.1 89.6 143.6 159.1 15.7 159.9 140.9 104.6 180.3 95.5 72.9 145.9 94.3 146.3 288.9 20.2 97.0 116.0 149.2 137.1 83.9 315.1 173.0 100.5 144.0 SOCS6 "CIS4, Cish4, HSPC060, SOCS4, SSI4, STAI4, STATI4" ENSG00000170677 "Suppressor of cytokine signaling 6" O14544 18 70288901-70330200 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 6.0;myeloid DC: 6.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" CAB010189 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB010189: AB_661195" "unprognostic (1.76e-3)" "unprognostic (6.83e-3)" "unprognostic (8.90e-3)" "unprognostic (4.52e-2)" "unprognostic (1.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.07e-1)" "unprognostic (7.93e-2)" "unprognostic (5.83e-2)" "unprognostic (1.75e-1)" "unprognostic (6.90e-2)" "unprognostic (8.19e-2)" "prognostic favorable (1.02e-4)" "unprognostic (1.02e-1)" "unprognostic (1.52e-1)" "unprognostic (4.11e-2)" "unprognostic (1.80e-2)" 9.1 8.8 12.7 5.1 16.3 10.2 12.8 13.8 11.6 15.0 14.6 20.1 9.8 14.1 12.9 6.7 17.7 11.8 12.6 9.8 12.8 7.8 8.9 26.1 8.8 2.8 21.4 10.1 10.6 12.4 18.1 7.2 21.1 14.9 8.7 13.5 14.3 17.3 7.8 17.7 8.4 20.4 13.3 20.3 4.2 12.7 6.1 18.0 2.5 10.8 10.3 7.5 10.6 11.8 0.5 6.3 4.6 6.0 1.5 1.1 1.7 10.2 22.6 9.6 6.6 9.2 10.8 10.8 22.0 13.6 13.4 10.2 8.4 17.4 1.1 2.0 20.4 16.3 12.1 7.0 7.2 13.1 0.0 4.2 7.7 8.0 12.9 10.9 4.1 8.7 8.7 8.7 11.6 9.8 13.4 6.7 0.9 4.5 5.3 9.1 4.9 3.6 3.1 6.2 6.5 9.7 4.2 9.3 1.9 8.3 8.4 4.5 11.1 11.3 12.6 10.2 7.3 3.7 7.3 8.2 14.8 7.5 3.0 8.8 0.0 0.0 2.8 16.5 0.3 9.9 0.0 6.0 4.6 0.4 1.2 0.2 0.5 0.8 0.1 6.3 0.0 1.1 0.6 0.0 1.5 0.1 0.6 0.0 1.7 12.7 16.3 13.8 11.6 12.8 7.8 21.4 10.1 14.9 18.0 23.8 13.4 1.3 12.4 10.4 10.4 18.0 22.9 24.1 29.6 10.4 5.9 20.5 10.0 16.1 1.1 12.2 38.4 0.0 16.2 12.8 12.9 15.0 30.1 27.7 21.4 35.0 28.3 8.6 5.7 1.8 10.6 14.7 25.3 8.2 25.7 6.5 22.4 23.7 12.0 17.4 4.7 0.0 11.3 1.2 11.3 10.5 57.2 2.2 23.0 30.4 SOX7 ENSG00000171056 "SRY-box 7" Q9BT81 8 10723768-10730512 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.2" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 57.2;Basal keratinocytes: 54.4;Endothelial cells: 70.1;Ito cells: 42.4;Suprabasal keratinocytes: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 9.4;hTCEpi: 17.4;HUVEC TERT2: 20.3;TIME: 5.4" "Low region specificity" "Detected in many" HPA009065 Approved Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA009065: AB_1857390" "unprognostic (1.21e-1)" "unprognostic (1.08e-1)" "unprognostic (1.15e-3)" "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.65e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-1)" "unprognostic (8.74e-2)" "unprognostic (7.26e-2)" "unprognostic (7.44e-2)" "unprognostic (1.09e-1)" "unprognostic (7.71e-3)" "unprognostic (2.45e-3)" "unprognostic (2.38e-1)" "unprognostic (5.41e-3)" "unprognostic (4.84e-3)" 17.4 1.8 3.5 3.4 3.3 0.7 7.0 1.7 4.2 16.0 3.4 2.1 1.0 0.8 7.1 6.8 19.7 3.0 6.1 12.5 2.6 2.2 3.0 7.4 37.2 2.9 2.6 1.5 2.6 4.5 2.7 4.2 26.4 3.6 5.8 2.2 7.6 7.1 5.0 12.5 11.7 2.1 4.2 3.0 2.2 2.2 1.9 3.2 0.6 4.7 22.7 14.5 8.8 23.1 1.9 0.3 0.8 0.4 0.2 1.2 0.1 4.5 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.5 9.4 2.8 3.4 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.2 0.1 17.4 0.0 3.6 0.0 20.3 0.0 0.4 0.2 0.0 0.1 0.1 0.1 1.3 0.7 2.6 0.9 0.0 0.0 0.0 1.7 0.5 2.7 1.7 0.0 0.0 1.2 0.0 0.0 5.4 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.5 0.4 0.1 0.2 0.2 1.2 1.9 0.3 0.1 0.1 0.3 0.2 0.4 0.8 0.2 0.1 0.3 0.1 0.1 3.5 3.3 1.7 4.2 2.6 2.2 2.6 1.5 3.6 3.2 0.0 18.1 2.7 57.2 54.4 1.1 2.8 2.5 2.7 3.4 0.0 3.9 4.1 0.0 0.1 0.2 70.1 0.0 0.0 0.2 0.2 2.8 12.5 3.5 4.5 0.5 0.0 0.0 42.4 1.5 0.0 0.9 1.1 3.3 0.0 0.1 0.5 0.2 0.0 0.4 0.0 2.4 0.0 4.1 2.6 1.5 35.5 10.4 0.0 0.4 20.7 SPATA45 "C1orf227, LOC149643" ENSG00000185523 "Spermatogenesis associated 45" Q537H7 1 212830141-212847649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 4.4;pancreas: 4.4;testis: 14.2" "Group enriched" "Detected in some" 23 "Early spermatids: 131.3;Late spermatids: 94.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 4.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA049921 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA049921: AB_2680953" "unprognostic (1.17e-1)" "unprognostic (2.83e-2)" "unprognostic (4.71e-1)" "unprognostic (2.06e-1)" "unprognostic (4.05e-2)" "unprognostic (6.14e-2)" "unprognostic (4.39e-4)" "unprognostic (1.07e-2)" "unprognostic (1.70e-1)" "unprognostic (3.12e-3)" "unprognostic (1.64e-2)" "unprognostic (3.14e-1)" "unprognostic (2.06e-2)" "unprognostic (6.14e-3)" "unprognostic (1.32e-2)" "unprognostic (9.50e-2)" "unprognostic (2.67e-3)" 0.1 0.1 0.4 0.0 0.3 0.1 0.3 0.1 0.2 0.1 0.2 0.0 0.3 0.9 0.0 0.9 0.4 0.1 0.3 0.3 0.2 0.4 0.4 0.8 0.4 0.1 4.4 0.0 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.5 0.5 0.1 14.2 0.3 0.4 0.0 0.1 2.8 0.7 4.4 0.9 0.5 1.2 0.5 0.4 4.0 0.9 2.6 0.8 2.1 2.6 0.4 0.0 0.8 1.2 0.8 0.6 0.9 0.1 0.0 1.7 0.3 1.7 0.0 1.0 3.7 0.0 0.0 0.0 2.1 1.2 0.0 1.7 1.5 0.0 0.4 0.0 0.0 0.0 1.7 0.0 1.8 2.3 2.5 0.2 0.9 0.6 0.8 1.4 2.1 0.2 0.0 2.1 0.4 0.9 2.7 1.6 0.0 0.0 0.9 0.6 1.3 0.0 0.9 0.1 1.9 1.1 1.1 1.7 4.4 0.3 1.6 1.1 0.0 0.4 4.4 0.7 0.9 0.9 0.3 0.1 0.0 0.7 2.8 0.6 1.2 2.4 0.5 0.7 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 0.0 5.0 0.0 131.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 94.9 1.4 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.9 1.5 0.0 0.0 0.0 0.0 0.0 SREK1 "DKFZp564B176, SFRS12, SRrp508, SRrp86" ENSG00000153914 "Splicing regulatory glutamic acid and lysine rich protein 1" Q8WXA9 5 66139971-66183615 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037673, HPA037674, HPA059332" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA037673: AB_2675598, HPA037674: AB_10671376, HPA059332: AB_2683983" "unprognostic (1.38e-1)" "unprognostic (2.51e-1)" "unprognostic (6.16e-2)" "unprognostic (1.52e-1)" "unprognostic (9.40e-2)" "prognostic favorable (2.54e-4)" "unprognostic (1.29e-2)" "unprognostic (7.67e-2)" "unprognostic (5.66e-3)" "unprognostic (2.19e-1)" "unprognostic (2.66e-2)" "unprognostic (5.48e-2)" "prognostic unfavorable (5.77e-4)" "unprognostic (1.63e-1)" "unprognostic (3.08e-1)" "unprognostic (6.76e-2)" "unprognostic (6.69e-2)" 11.1 13.4 12.8 15.6 14.5 38.0 16.3 24.2 14.7 12.9 10.1 8.9 17.3 10.9 18.5 15.9 9.6 13.6 10.6 8.2 12.4 13.3 10.6 10.5 12.5 12.7 11.1 12.0 12.2 14.3 23.4 30.3 12.2 11.4 12.2 10.7 11.9 12.4 16.5 11.9 20.2 12.6 13.7 11.3 14.9 11.0 11.0 11.4 19.5 14.3 9.8 9.5 10.6 10.5 6.5 6.0 8.5 5.6 7.7 6.0 2.8 5.1 6.3 8.9 5.3 4.2 7.9 8.8 6.0 3.5 3.3 3.5 9.3 6.0 7.7 7.7 4.6 4.4 6.9 4.5 6.0 5.8 5.4 10.2 7.3 16.2 6.8 3.7 6.6 8.6 4.6 6.0 4.0 4.5 6.9 5.2 4.5 6.6 5.6 3.5 5.0 6.9 15.5 4.7 2.1 3.2 9.3 4.1 5.5 5.7 9.3 10.5 7.1 5.7 2.7 4.9 6.9 6.8 8.6 5.5 5.3 3.2 7.2 6.1 6.0 4.1 8.7 5.2 10.7 5.7 8.5 5.6 5.2 5.0 3.9 5.4 6.2 4.7 6.0 4.2 6.5 5.6 5.6 4.1 7.7 3.7 6.0 4.4 2.8 12.8 14.5 24.2 13.8 12.4 13.3 11.1 12.0 11.4 11.4 86.4 149.8 64.8 77.1 58.6 59.7 64.9 66.2 132.5 117.2 43.6 110.0 73.9 31.5 45.7 31.9 85.0 41.6 70.0 48.3 73.9 67.2 73.1 94.7 57.6 44.0 63.5 74.7 58.3 48.5 44.8 77.3 55.5 40.5 37.9 43.9 86.7 44.4 37.0 72.2 27.8 96.5 45.3 63.8 65.4 57.5 60.6 100.9 61.0 47.2 68.6 STK17A DRAK1 ENSG00000164543 "Serine/threonine kinase 17a" Q9UEE5 7 43582758-43626786 "Enzymes, Plasma proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 43.3" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 549.3;Urothelial cells: 279.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA018138, HPA037979" Uncertain Supported "Nuclear speckles,Plasma membrane" Yes No "Nuclear speckles" "Plasma membrane" "HPA018138: AB_2669784, HPA037979: AB_10795247" "unprognostic (1.81e-3)" "unprognostic (1.08e-2)" "unprognostic (2.67e-1)" "unprognostic (5.41e-2)" "unprognostic (5.11e-2)" "unprognostic (3.35e-2)" "unprognostic (1.03e-2)" "unprognostic (9.15e-3)" "unprognostic (2.07e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (2.99e-3)" "unprognostic (3.76e-2)" "unprognostic (3.08e-1)" "unprognostic (1.97e-3)" "unprognostic (3.66e-1)" 7.1 10.1 6.1 43.3 8.2 20.2 8.4 7.9 7.2 4.8 9.3 3.7 2.0 6.1 5.3 4.2 10.1 4.7 8.6 17.7 5.7 5.6 6.7 8.1 15.2 36.6 6.6 2.6 7.3 14.3 1.5 6.3 37.2 5.7 6.2 5.3 3.6 8.6 3.4 10.7 4.8 12.3 5.8 5.3 27.8 11.0 9.0 2.8 30.1 7.3 6.8 37.7 10.3 8.1 10.8 1.4 11.5 0.9 12.7 11.4 2.9 4.4 5.5 5.0 3.4 6.3 8.3 2.1 15.9 17.3 8.7 8.9 4.8 3.2 7.1 25.1 13.3 17.8 9.1 3.8 21.2 12.2 17.5 4.3 6.3 4.1 5.9 4.7 10.8 4.2 6.8 25.0 11.5 10.6 34.5 16.3 7.7 7.4 24.4 10.0 2.0 17.6 5.0 7.7 2.6 18.1 6.1 3.2 14.0 15.2 3.3 2.7 6.1 7.2 3.3 4.6 10.7 3.8 5.5 16.3 19.0 7.2 11.2 17.8 14.8 7.3 10.2 19.3 9.6 30.2 0.7 0.4 11.5 5.8 0.2 5.8 10.8 6.1 9.7 0.3 10.1 11.4 10.2 6.4 12.7 0.9 1.4 3.2 2.9 6.1 8.2 7.9 5.9 5.7 5.6 6.6 2.6 5.7 2.8 113.2 27.8 121.1 549.3 161.6 3.0 25.4 5.1 52.2 81.9 19.2 9.8 44.4 28.2 110.3 36.3 19.4 29.1 0.0 82.8 19.7 31.9 134.1 39.1 7.7 15.8 0.0 6.9 16.5 16.2 8.8 5.5 19.9 33.7 55.1 27.8 8.1 75.9 56.1 2.5 9.7 25.2 6.5 55.6 45.1 29.6 118.9 55.8 186.8 10.0 279.4 TAB1 MAP3K7IP1 ENSG00000100324 "TGF-beta activated kinase 1 (MAP3K7) binding protein 1" Q15750 22 39399741-39437060 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032328, HPA039988, HPA057104" Approved Enhanced "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB032328: AB_2281637, HPA039988: AB_2676787, HPA057104: AB_2683338" "unprognostic (1.76e-1)" "unprognostic (1.79e-2)" "unprognostic (7.88e-2)" "unprognostic (6.73e-3)" "unprognostic (9.23e-3)" "unprognostic (4.30e-2)" "unprognostic (6.44e-2)" "unprognostic (1.79e-2)" "unprognostic (4.93e-2)" "unprognostic (7.05e-2)" "unprognostic (1.63e-1)" "unprognostic (7.35e-2)" "unprognostic (7.80e-3)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" 12.2 14.9 18.3 13.6 20.8 13.6 12.5 24.7 28.1 16.9 16.2 32.0 10.9 16.9 18.8 10.7 13.6 17.9 19.2 18.9 17.9 15.7 12.4 14.8 13.7 15.8 22.7 18.8 26.7 19.5 16.3 12.5 13.8 15.9 16.9 9.1 19.6 21.6 19.1 27.8 17.3 15.7 14.3 17.2 17.2 14.4 11.9 20.6 13.0 13.3 10.9 13.0 16.8 14.3 5.9 8.2 6.1 8.7 5.2 7.6 6.3 12.0 12.5 12.7 14.5 13.5 11.5 11.3 10.1 12.6 15.5 14.7 11.5 8.7 18.2 8.0 9.8 8.6 14.7 12.9 14.8 6.2 14.1 20.6 8.0 15.3 11.3 11.8 15.0 15.4 11.5 13.2 11.7 12.8 11.8 11.3 11.1 14.5 12.5 7.7 7.8 11.5 12.5 8.9 19.0 12.8 20.8 18.2 18.1 11.9 12.9 11.3 8.4 14.3 17.8 12.5 8.3 14.5 16.5 9.6 10.8 17.3 8.3 8.2 19.8 12.7 13.2 12.8 10.6 10.5 1.4 8.7 6.1 7.6 7.2 6.2 5.9 4.6 6.1 8.2 5.9 7.5 6.7 1.3 5.2 6.7 3.8 4.6 6.3 18.3 20.8 24.7 28.1 17.9 15.7 22.7 18.8 15.9 20.6 3.0 4.1 4.9 2.8 1.8 52.3 6.5 5.1 2.7 3.4 3.5 17.7 10.3 0.0 5.2 1.3 4.5 4.2 0.0 3.4 7.1 4.7 2.4 4.7 4.2 6.1 27.0 10.9 3.1 5.6 2.4 7.2 3.9 5.0 8.2 4.5 11.8 4.8 4.3 8.5 4.2 18.2 6.5 4.7 7.1 8.9 2.9 4.7 8.2 5.6 1.3 TAB3 MAP3K7IP3 ENSG00000157625 "TGF-beta activated kinase 1 and MAP3K7 binding protein 3" Q8N5C8 X 30827442-30975084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034980, HPA034981" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA034980: AB_10602708, HPA034981: AB_2674394" "unprognostic (4.39e-1)" "unprognostic (2.22e-1)" "unprognostic (3.04e-2)" "unprognostic (1.73e-1)" "unprognostic (6.35e-2)" "unprognostic (2.95e-3)" "unprognostic (1.49e-2)" "unprognostic (1.73e-2)" "unprognostic (3.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.51e-1)" "prognostic favorable (8.45e-4)" "unprognostic (5.91e-2)" "unprognostic (1.25e-1)" "unprognostic (9.12e-2)" "unprognostic (2.75e-1)" 6.1 8.0 5.9 6.6 6.9 10.1 6.5 9.1 9.2 7.6 6.5 4.2 17.9 5.2 40.3 7.4 13.2 9.2 10.6 6.9 6.1 5.3 16.9 23.3 8.0 8.1 6.7 6.6 11.3 17.3 25.0 9.4 39.3 9.1 12.9 6.7 9.3 11.5 15.0 8.8 8.1 7.4 9.6 5.2 7.1 8.4 26.7 3.6 8.3 7.7 14.5 15.6 6.6 7.9 1.0 0.6 0.8 1.1 3.9 1.0 0.4 23.2 5.6 5.8 5.9 4.5 6.9 6.1 7.2 9.1 4.9 5.5 6.3 20.0 10.5 4.4 8.3 9.4 12.1 8.9 18.4 7.1 18.1 8.5 9.8 6.6 15.4 3.9 10.3 7.7 4.9 11.1 8.3 21.4 8.5 8.0 8.1 11.2 8.6 6.3 11.2 8.2 5.2 6.9 4.2 9.5 5.3 10.2 7.8 8.2 6.8 4.8 6.9 8.1 12.3 15.6 11.3 10.5 4.1 7.7 5.4 8.0 27.1 6.6 11.3 8.6 10.4 8.5 4.9 7.6 0.2 0.5 0.8 0.7 1.1 0.9 0.8 1.0 0.4 0.6 1.0 1.0 1.0 0.8 3.9 0.8 0.3 0.6 0.4 5.9 6.9 9.1 9.2 6.1 5.3 6.7 6.6 9.1 3.6 11.9 10.4 5.4 6.5 8.0 6.5 10.6 17.8 16.0 7.9 10.4 11.8 12.7 3.3 8.3 0.8 7.7 7.4 23.3 5.9 4.2 5.1 13.1 13.9 24.2 6.8 11.1 6.9 8.6 13.8 0.9 10.0 10.2 5.0 7.2 12.3 6.0 7.7 8.7 15.2 10.2 19.1 0.0 3.1 3.7 1.7 8.8 18.8 6.9 9.3 9.9 TAF5L PAF65B ENSG00000135801 "TATA-box binding protein associated factor 5 like" O75529 1 229593111-229626047 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067941 Supported "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA067941: AB_2685929" "unprognostic (3.41e-1)" "unprognostic (1.34e-1)" "unprognostic (3.39e-2)" "unprognostic (1.93e-1)" "unprognostic (7.46e-2)" "unprognostic (1.94e-1)" "unprognostic (2.91e-1)" "unprognostic (2.36e-1)" "unprognostic (1.63e-1)" "unprognostic (6.84e-2)" "unprognostic (5.17e-3)" "unprognostic (8.16e-3)" "unprognostic (1.91e-3)" "unprognostic (3.21e-1)" "unprognostic (2.99e-1)" "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" 19.5 8.3 13.0 14.4 12.8 23.0 25.6 13.5 14.7 12.1 15.3 14.7 9.9 12.7 15.8 10.6 15.0 14.1 16.3 12.9 10.5 9.0 9.5 18.6 13.6 15.7 12.1 8.0 12.2 10.4 12.7 11.6 25.0 12.9 15.7 15.8 9.2 13.3 12.3 24.9 10.1 17.0 16.5 12.8 15.6 13.8 8.5 10.5 15.9 13.5 11.9 15.3 17.1 13.2 1.1 1.6 0.2 1.3 2.1 2.6 0.8 16.5 9.6 13.8 11.5 9.5 10.0 35.8 11.2 13.5 14.1 13.2 12.9 13.6 18.7 12.0 12.1 9.2 14.2 15.2 13.8 13.6 13.9 21.8 14.6 9.8 8.1 10.7 19.3 17.0 11.1 13.5 13.9 12.0 5.5 13.7 19.8 19.4 17.3 13.2 8.0 21.8 10.4 19.5 18.7 7.6 19.4 15.5 19.2 9.8 15.4 13.9 16.9 9.6 13.3 15.4 5.3 15.8 20.2 11.8 11.8 14.4 15.5 23.6 9.2 7.0 21.4 8.9 11.7 18.5 0.0 1.1 0.2 2.1 1.2 2.6 1.1 2.2 1.7 1.6 1.0 2.2 1.9 0.2 2.1 1.3 0.7 1.9 0.8 13.0 12.8 13.5 14.7 10.5 9.0 12.1 8.0 12.9 10.5 3.0 6.5 2.2 3.8 5.0 5.7 6.3 7.6 4.0 9.1 3.5 11.8 9.7 1.7 3.6 2.1 6.3 9.1 0.0 7.2 29.3 4.8 5.8 0.0 12.1 8.4 6.4 11.5 6.7 6.9 2.9 4.4 6.8 5.0 10.0 10.6 3.2 5.6 7.0 3.9 2.8 8.3 12.9 6.2 6.5 2.2 4.5 8.7 5.1 8.3 7.0 TAP2 "ABCB3, D6S217E, PSF2, RING11" ENSG00000204267 "Transporter 2, ATP binding cassette subfamily B member" Q03519 6 32821833-32838780 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "monocytes: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.6;U-251 MG: 28.3" HPA001312 Approved Supported "Nuclear speckles,Endoplasmic reticulum" NA NA 14000 "Endoplasmic reticulum" "Nuclear speckles" "HPA001312: AB_1080206" "unprognostic (2.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.51e-4)" "unprognostic (1.90e-1)" "prognostic unfavorable (5.22e-8)" "unprognostic (5.32e-1)" "unprognostic (4.17e-2)" "unprognostic (2.35e-1)" "unprognostic (4.71e-2)" 12.8 8.4 6.5 22.5 6.9 14.7 9.5 6.3 7.3 8.8 15.0 7.6 3.3 15.3 9.6 5.9 17.4 7.9 11.5 7.7 5.2 6.0 10.8 19.0 18.0 14.0 7.1 6.3 9.7 6.1 2.6 5.8 5.7 7.9 8.2 11.9 7.9 12.1 5.2 5.8 9.6 28.0 7.0 6.1 24.9 7.7 3.3 6.9 25.9 14.7 7.1 20.1 23.6 10.7 0.9 2.8 4.9 5.4 2.9 4.1 1.9 7.9 0.0 0.0 2.3 2.2 3.1 0.0 0.5 1.6 6.2 8.5 2.1 16.3 15.5 3.1 4.0 11.2 8.3 7.1 28.6 2.5 10.5 0.9 1.8 6.1 0.7 1.0 0.0 12.3 0.3 0.4 8.4 13.1 0.0 4.0 0.0 8.6 5.2 0.0 0.6 2.0 1.0 0.3 0.6 4.0 8.4 0.0 5.9 5.2 0.1 0.1 0.0 7.7 16.4 1.6 0.3 0.8 0.0 2.3 8.8 2.0 2.3 28.3 8.1 13.4 14.5 8.1 10.9 1.6 1.7 2.0 1.8 4.1 5.4 2.0 0.9 1.2 2.7 2.0 0.6 1.0 0.6 4.9 2.9 4.1 2.8 1.9 1.9 6.5 6.9 6.3 7.3 5.2 6.0 7.1 6.3 7.9 6.9 0.0 6.9 28.3 12.0 0.0 4.5 2.4 2.5 2.7 6.8 14.0 2.0 1.2 1.7 33.7 0.0 28.7 19.3 0.0 28.6 35.6 4.1 11.3 4.7 5.8 22.4 17.5 3.5 16.0 12.3 0.0 5.2 14.5 0.0 92.8 18.4 18.9 27.4 13.9 5.6 4.7 4.8 0.0 7.5 0.4 1.2 0.0 1.4 24.5 10.3 14.8 TBC1D12 KIAA0608 ENSG00000108239 "TBC1 domain family member 12" O60347 10 94402504-94535930 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.2" "Group enriched" "Detected in many" 13 "B-cells: 1.4;dendritic cells: 2.2;monocytes: 1.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038277, HPA038645" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA038277: AB_10672584, HPA038645: AB_10672650" "unprognostic (7.23e-3)" "unprognostic (1.58e-2)" "prognostic favorable (1.79e-5)" "unprognostic (7.83e-2)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" "unprognostic (1.21e-2)" "unprognostic (7.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-1)" "unprognostic (2.27e-2)" "unprognostic (9.43e-2)" "unprognostic (3.71e-1)" "unprognostic (1.29e-1)" "unprognostic (1.12e-1)" 6.9 4.9 8.9 4.0 18.1 1.2 8.1 7.5 14.8 5.3 8.4 39.2 7.1 6.2 5.6 4.0 4.7 4.3 5.1 4.4 12.4 8.5 5.8 4.1 5.2 3.0 25.5 8.7 5.8 7.1 16.8 3.2 7.8 23.1 6.0 9.7 5.9 3.6 6.5 4.3 5.7 6.9 6.0 41.6 5.6 4.2 10.9 21.3 0.2 4.3 1.5 3.5 5.7 4.9 1.4 2.2 0.0 1.1 0.0 0.1 0.2 7.6 3.4 4.5 6.7 6.3 7.7 5.9 5.0 10.3 5.6 5.3 13.6 3.4 0.0 3.0 7.3 5.5 4.3 5.4 3.7 7.2 0.0 6.1 2.4 3.1 4.3 4.8 0.0 1.9 5.2 4.7 5.9 7.6 9.5 6.0 0.0 3.5 8.0 9.0 4.2 0.0 0.0 1.4 5.5 3.6 0.0 5.8 4.0 5.0 3.4 1.9 4.5 5.0 4.3 4.0 4.3 9.4 4.6 5.9 3.9 5.4 6.3 3.9 5.7 5.4 0.0 3.9 0.0 2.1 0.0 1.1 0.0 0.0 0.7 0.0 0.5 0.0 0.0 2.2 1.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 8.9 18.1 7.5 13.4 12.4 8.5 25.5 8.7 23.1 21.3 8.9 4.0 4.5 4.9 17.3 17.2 4.8 2.5 2.7 4.5 8.7 9.8 14.8 0.0 5.2 13.8 10.5 13.6 0.0 4.4 10.7 13.8 9.3 5.7 3.4 16.5 7.9 8.1 9.2 18.7 7.4 7.8 18.3 15.1 10.8 7.6 8.1 6.2 10.5 9.9 5.2 26.8 12.9 11.8 44.7 10.8 16.8 20.4 0.0 11.2 7.6 TBC1D8 "AD3, GRAMD8, HBLP1, VRP" ENSG00000204634 "TBC1 domain family member 8" O95759 2 101007617-101252866 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 76.0;skeletal muscle: 66.3" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 32.5;Ciliated cells: 41.5;Glandular cells: 38.4;monocytes: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 16.6;non-classical monocyte: 20.6" "Lineage enriched" "Detected in many" 5 "monocytes: 20.6" "Cell line enhanced" "Detected in many" "ASC diff: 36.7;ASC TERT1: 26.1;BJ hTERT+: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015211, HPA037496" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "CAB015211: , HPA037496: AB_2675507" "unprognostic (1.82e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (4.25e-3)" "unprognostic (3.98e-1)" "unprognostic (2.12e-2)" "unprognostic (1.08e-2)" "unprognostic (2.74e-1)" "unprognostic (5.80e-2)" "unprognostic (2.38e-1)" "unprognostic (8.53e-2)" "unprognostic (1.82e-1)" "unprognostic (2.25e-2)" "unprognostic (8.02e-2)" "unprognostic (1.26e-1)" "unprognostic (6.73e-2)" "unprognostic (7.98e-3)" 14.4 4.0 3.0 5.5 4.2 7.3 14.1 10.1 5.1 7.6 19.6 2.2 52.8 4.3 7.8 12.2 8.4 13.2 12.0 24.1 4.8 2.7 8.9 12.8 11.8 6.8 3.0 3.8 5.1 27.5 3.9 8.5 4.4 6.1 25.7 3.8 6.7 15.1 76.0 66.3 15.2 22.7 7.7 5.0 11.3 13.3 11.3 2.8 3.3 5.3 8.3 8.0 8.7 8.6 0.6 4.0 0.2 20.6 0.0 0.3 1.8 2.0 12.8 1.0 3.7 36.7 26.1 10.5 1.2 22.5 0.9 1.1 4.5 3.3 0.9 11.5 0.9 18.0 6.5 2.1 9.9 0.6 0.6 1.9 0.6 4.3 15.6 2.5 0.1 11.0 12.1 9.4 1.2 9.4 0.7 13.1 1.8 0.2 1.1 1.1 5.6 1.1 6.4 2.8 1.4 13.8 2.5 3.2 0.2 7.5 13.7 8.1 3.9 1.7 3.1 4.4 1.8 0.9 9.4 10.8 0.5 1.9 1.9 0.8 2.1 0.1 0.0 4.7 3.2 3.3 0.0 5.1 0.2 0.1 16.6 0.2 0.2 0.1 0.1 2.8 0.6 0.3 0.2 0.2 0.0 20.6 4.0 0.1 1.8 3.0 4.2 10.1 5.1 4.8 2.7 3.0 3.8 6.1 2.8 3.0 2.9 0.0 32.5 3.7 5.8 10.6 20.4 41.5 20.5 5.2 3.9 3.9 0.0 5.9 4.8 4.9 1.3 0.0 2.6 2.5 2.3 38.4 6.9 5.0 3.6 1.6 2.9 7.4 11.2 8.6 2.8 12.2 5.0 33.3 1.7 0.9 2.8 0.6 1.8 0.7 3.6 6.5 4.2 1.4 1.9 5.5 2.9 0.0 0.9 24.3 TBXA2R ENSG00000006638 "Thromboxane A2 receptor" P21731 19 3594506-3606840 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "Ito cells: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 12.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 11.9;U-2197: 8.6;U-937: 7.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA077366 Supported "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA077366: AB_2686836" "unprognostic (1.59e-1)" "unprognostic (3.86e-2)" "unprognostic (1.21e-2)" "unprognostic (1.74e-1)" "unprognostic (8.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.52e-2)" "unprognostic (2.17e-3)" "unprognostic (8.41e-2)" "unprognostic (6.25e-2)" "prognostic favorable (7.17e-4)" "unprognostic (3.89e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (4.32e-2)" "unprognostic (9.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.02e-1)" 8.7 11.8 1.4 3.9 1.6 2.1 3.9 0.5 1.6 13.5 3.8 1.7 3.9 2.6 7.4 4.8 8.0 4.7 6.0 6.8 2.4 1.5 10.1 18.4 6.7 7.3 1.4 1.9 8.3 2.2 2.5 1.7 10.6 2.7 3.6 1.4 5.0 1.7 4.2 3.1 1.8 4.4 6.5 2.1 14.9 3.7 3.4 1.9 2.2 3.9 3.2 1.8 6.8 9.6 12.6 0.3 3.2 0.4 3.1 9.6 3.9 0.1 0.2 0.2 4.1 0.9 2.2 0.7 3.0 0.8 2.3 1.8 0.1 0.3 0.1 4.4 1.2 2.3 0.1 0.9 0.0 0.9 0.2 1.0 2.9 11.9 0.3 1.2 0.0 5.3 1.1 0.0 3.0 0.0 1.7 0.9 0.0 4.5 0.4 0.4 0.2 0.2 1.5 0.1 0.1 2.6 0.1 0.0 0.2 0.0 0.1 0.2 1.7 0.2 0.4 0.1 0.3 1.8 5.1 2.6 4.8 1.1 8.6 2.8 0.2 0.3 0.2 4.0 7.4 1.1 2.9 0.4 0.2 2.6 0.2 0.3 1.8 0.8 2.3 0.0 12.6 4.6 9.6 3.2 3.1 0.2 0.3 0.2 3.9 1.4 1.6 0.5 1.6 2.4 1.5 1.4 1.9 2.7 1.9 0.0 0.0 1.3 0.1 0.5 0.4 0.8 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.1 2.3 0.1 0.0 0.0 0.7 0.0 0.0 35.0 1.2 0.0 0.3 0.0 1.7 0.0 0.0 0.3 0.1 0.0 0.7 0.0 0.1 0.0 3.1 0.1 1.3 0.5 0.1 0.0 0.0 0.0 TCEAL2 "my048, MY0876G05, WEX1" ENSG00000184905 "Transcription elongation factor A like 2" Q9H3H9 X 102125688-102127711 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 84.0;ovary: 46.5" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 143.3;Distal tubular cells: 59.7;Horizontal cells: 92.2;Muller glia cells: 150.4" "Cancer enhanced" "Detected in many" "glioma: 22.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 17 "T-cells: 2.1" "Group enriched" "Detected in some" 4 "HAP1: 7.4;SCLC-21H: 8.1;U-2 OS: 14.6" HPA076317 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA076317: AB_2686794" "unprognostic (2.34e-3)" "unprognostic (1.35e-2)" "unprognostic (7.59e-3)" "unprognostic (3.84e-3)" "unprognostic (2.07e-1)" "unprognostic (4.57e-2)" "unprognostic (4.27e-2)" "unprognostic (2.80e-2)" "unprognostic (3.47e-1)" "unprognostic (3.26e-1)" "unprognostic (7.07e-3)" "unprognostic (1.43e-1)" "unprognostic (1.56e-2)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.04e-1)" "unprognostic (4.11e-3)" 2.4 19.6 34.1 2.6 44.6 1.1 2.4 40.9 84.0 5.8 7.0 8.5 1.8 3.1 19.5 8.6 5.3 7.3 6.4 5.1 30.0 37.9 8.2 1.3 4.4 1.6 25.4 26.5 46.5 3.7 2.8 38.3 1.1 30.1 19.4 3.8 6.6 16.4 21.6 1.2 1.7 3.2 14.0 16.1 2.9 4.2 19.7 9.6 0.0 25.6 0.0 2.1 4.3 2.6 0.1 0.1 0.0 0.1 0.0 2.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 1.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 14.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.8 0.1 1.7 0.0 0.1 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.1 0.4 34.1 44.6 40.9 41.8 30.0 37.9 25.4 26.5 30.1 9.6 6.0 12.3 0.0 55.7 1.6 143.3 4.6 0.0 0.0 22.7 29.6 5.9 0.0 59.7 0.1 2.9 8.7 0.0 0.0 0.3 0.1 5.3 42.5 2.3 0.0 0.0 92.2 0.0 3.7 0.0 7.5 6.1 1.0 6.8 1.0 0.0 150.4 1.6 0.0 5.3 0.5 40.9 6.5 17.0 1.7 1.1 1.1 0.0 0.0 0.0 6.3 TCF12 "bHLHb20, HEB, HsT17266, HTF4" ENSG00000140262 "Transcription factor 12" Q99081 15 56918623-57299281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 89.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004432, HPA065827" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "CAB004432: AB_671267, HPA065827: AB_2685564" "unprognostic (1.19e-1)" "unprognostic (1.11e-1)" "unprognostic (8.26e-2)" "unprognostic (1.65e-1)" "unprognostic (2.07e-3)" "unprognostic (1.11e-1)" "unprognostic (6.63e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (7.83e-2)" "unprognostic (7.26e-3)" "unprognostic (5.57e-3)" "prognostic unfavorable (5.24e-5)" "unprognostic (2.03e-1)" "unprognostic (2.93e-1)" "unprognostic (3.15e-2)" "unprognostic (1.41e-1)" 20.9 14.3 24.9 12.6 37.5 10.9 18.4 32.7 41.8 48.2 16.5 33.6 14.0 16.0 28.1 15.0 14.8 28.2 21.4 15.7 28.4 16.4 17.0 14.4 17.3 13.7 33.9 15.3 26.2 12.5 29.2 15.7 19.1 27.9 26.3 17.9 14.7 20.1 17.5 18.1 16.0 15.8 25.8 25.3 13.6 17.3 14.7 41.3 89.4 17.0 9.6 15.8 23.3 21.2 11.8 15.9 16.0 19.3 12.2 17.6 10.2 6.5 12.3 54.1 17.4 24.7 21.7 9.5 13.5 23.7 12.0 15.9 7.9 5.3 9.0 11.1 20.4 8.6 7.9 21.1 9.7 15.3 11.8 7.9 18.0 13.3 9.5 17.0 11.3 9.5 19.0 17.6 11.0 29.2 16.0 21.4 40.5 20.1 11.3 16.2 2.2 26.7 6.3 14.6 6.8 5.3 36.5 62.8 8.4 16.5 12.2 11.0 32.0 14.5 5.3 13.1 18.0 8.2 22.3 16.4 19.3 14.8 8.2 19.6 6.5 11.6 15.0 10.8 22.1 23.1 16.0 11.2 8.7 15.0 14.3 12.4 10.8 12.2 13.6 15.9 11.8 14.1 12.7 1.3 12.2 19.3 6.6 17.6 10.2 24.9 37.5 32.7 26.9 28.4 16.4 33.9 15.3 27.9 41.3 50.6 15.8 14.2 18.0 23.7 12.8 14.5 20.4 16.0 27.3 15.7 33.4 8.5 11.6 15.2 19.4 27.4 15.8 0.0 10.3 12.7 31.5 19.7 22.0 16.0 23.5 12.7 8.6 22.7 34.0 15.6 23.9 26.0 13.5 10.0 16.5 26.9 13.8 17.5 32.5 13.6 25.1 45.3 20.6 18.9 12.5 29.5 10.9 16.0 16.4 15.6 THAP4 CGI-36 ENSG00000176946 "THAP domain containing 4" Q8WY91 2 241584405-241637449 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "DNA-binding, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 189.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044982, HPA053448" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA044982: AB_10959786, HPA053448: AB_2682154" "unprognostic (3.17e-2)" "unprognostic (1.70e-2)" "unprognostic (6.56e-2)" "unprognostic (1.36e-2)" "unprognostic (8.35e-2)" "unprognostic (7.23e-2)" "unprognostic (1.16e-3)" "unprognostic (3.61e-2)" "unprognostic (7.56e-2)" "unprognostic (2.18e-1)" "unprognostic (3.24e-1)" "unprognostic (2.21e-1)" "prognostic favorable (1.46e-4)" "unprognostic (2.57e-1)" "unprognostic (1.78e-1)" "unprognostic (5.06e-1)" "unprognostic (1.07e-1)" 11.9 11.5 19.3 13.0 22.5 13.3 26.3 13.8 27.5 12.8 21.3 13.5 10.8 23.7 12.7 19.1 23.6 15.3 16.9 52.4 15.4 18.1 38.2 25.1 13.6 11.9 18.3 11.7 16.7 25.0 30.9 15.0 11.2 15.6 17.1 15.4 12.5 19.7 17.4 55.8 18.5 20.4 13.7 11.3 10.3 18.5 22.7 11.4 16.0 19.0 26.1 15.7 19.4 18.3 14.3 13.9 22.9 12.7 12.5 30.2 9.8 15.3 19.3 11.7 21.6 15.7 16.5 18.3 10.1 15.6 17.5 15.5 17.5 14.4 13.7 5.9 18.1 20.0 17.8 23.4 25.8 6.6 10.3 27.4 14.1 13.3 49.8 21.0 16.7 9.9 16.9 20.5 18.6 25.9 12.1 16.1 22.0 24.1 4.8 13.3 30.1 17.0 40.7 20.0 15.7 16.4 19.5 16.3 18.4 36.2 20.5 27.8 18.3 8.5 27.9 23.1 7.5 13.8 19.7 14.0 18.6 13.0 17.6 20.5 11.3 6.6 14.1 14.3 14.3 14.2 15.4 9.3 22.9 17.5 10.8 18.5 13.8 19.4 16.2 9.7 14.3 18.7 14.9 6.5 12.5 12.7 13.9 30.2 9.8 19.3 22.5 13.8 27.5 15.4 18.1 18.3 11.7 15.6 11.4 17.9 14.2 19.1 33.6 17.7 10.1 47.6 35.7 21.4 26.1 38.4 3.9 20.4 189.0 35.2 14.5 15.5 59.6 0.0 24.5 22.1 17.9 31.3 6.9 31.1 15.9 7.9 27.6 13.5 11.0 4.8 16.7 12.4 11.8 18.0 46.5 9.0 25.0 37.4 18.4 59.2 5.1 32.3 17.5 19.3 21.1 22.6 23.0 10.2 47.2 39.1 THEM6 "C8orf55, DSCD75" ENSG00000130193 "Thioesterase superfamily member 6" Q8WUY1 8 142727203-142736927 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 28.9;RT4: 40.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023255 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted - unknown location" NA NA "Nuclear speckles, Cytosol" "HPA023255: AB_1845782" "unprognostic (6.20e-3)" "unprognostic (2.21e-1)" "unprognostic (9.10e-2)" "unprognostic (5.33e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-2)" "unprognostic (1.74e-2)" "unprognostic (6.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.44e-1)" "unprognostic (4.91e-2)" "unprognostic (6.76e-2)" "prognostic favorable (6.66e-7)" "unprognostic (7.02e-3)" "unprognostic (3.55e-2)" "unprognostic (2.39e-2)" "prognostic favorable (4.49e-4)" 11.9 13.9 9.4 5.6 13.4 6.0 21.6 9.0 20.7 10.8 11.8 12.8 16.6 14.4 5.6 7.1 14.9 12.5 15.0 12.6 10.7 11.5 16.7 35.2 11.0 7.4 8.8 11.7 4.5 30.7 13.4 10.0 10.7 11.6 9.8 6.7 10.0 18.5 15.3 11.3 11.7 14.3 4.8 9.3 8.7 15.1 3.0 7.5 10.3 14.4 15.6 10.6 19.7 7.9 6.5 3.8 4.5 7.4 8.4 14.6 7.5 9.9 8.3 1.2 8.7 4.1 1.4 6.1 5.1 4.3 7.9 5.5 5.0 15.0 4.2 11.8 1.9 2.9 23.2 3.7 11.1 1.3 3.4 10.2 3.2 4.7 10.1 4.5 1.8 3.4 2.0 4.0 1.5 2.2 1.6 6.7 6.0 1.5 2.1 1.3 28.9 7.5 0.4 2.0 18.7 27.1 8.8 0.9 9.6 9.4 40.7 19.6 7.7 7.9 23.7 6.5 1.2 11.6 1.5 3.8 3.4 2.5 9.8 0.9 1.4 1.9 1.8 3.5 9.1 4.2 4.5 4.0 2.0 9.7 7.4 14.6 4.6 10.3 12.5 3.8 6.5 12.5 11.5 0.5 8.4 7.1 2.9 9.1 7.5 9.4 13.4 9.0 20.7 10.7 11.5 8.8 11.7 11.6 7.5 8.9 4.3 2.7 7.4 3.2 9.8 5.3 12.7 0.0 3.4 17.4 5.9 12.1 5.0 10.2 1.7 8.1 19.3 0.0 10.2 9.4 4.1 8.0 0.0 18.1 10.2 15.9 30.6 11.6 1.2 12.4 2.6 2.6 5.0 1.8 12.9 14.6 8.4 3.5 3.9 12.3 11.5 0.0 4.2 2.3 7.2 6.8 2.9 8.5 20.4 21.1 THOC6 "fSAP35, MGC2655, WDR58" ENSG00000131652 "THO complex 6" Q86W42 16 3024027-3027755 "Disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transport" "Developmental protein, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 98.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052953 Uncertain Supported "Nucleoplasm,Nuclear speckles" No No "Nucleoplasm, Nuclear speckles" "HPA052953: AB_2681997" "unprognostic (2.07e-2)" "unprognostic (4.13e-3)" "unprognostic (1.70e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" "unprognostic (2.91e-1)" "unprognostic (7.82e-3)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (4.40e-4)" "unprognostic (3.59e-1)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (9.43e-2)" 10.5 12.0 7.8 14.6 8.2 16.7 12.8 7.0 9.8 10.0 13.7 9.1 11.9 15.5 15.7 8.6 13.7 10.4 19.3 9.5 7.0 5.6 12.9 17.5 12.4 15.5 11.0 4.8 13.2 20.7 11.8 13.2 28.0 9.0 15.1 8.6 7.2 16.6 11.0 17.0 20.6 17.6 10.5 6.5 16.9 10.5 9.0 6.8 27.3 12.7 19.4 17.9 10.0 11.6 17.8 34.5 5.0 24.4 14.3 16.4 16.3 12.8 20.9 15.2 16.0 7.8 9.0 26.8 3.9 9.2 9.3 13.8 13.8 15.2 24.3 13.0 6.6 6.9 17.7 16.5 12.6 5.1 21.5 21.2 13.2 19.3 20.1 13.3 19.2 29.0 9.0 15.3 11.3 28.3 11.8 8.6 14.1 19.1 13.1 4.6 30.0 10.8 35.7 27.3 7.4 9.0 29.3 11.4 28.4 9.7 6.5 31.3 14.8 11.3 17.9 7.2 6.9 12.8 21.0 7.1 9.7 22.6 10.9 14.3 9.5 8.0 29.5 2.5 13.2 9.7 0.8 24.4 5.0 14.8 23.7 14.9 15.3 13.7 14.3 34.5 17.8 16.0 16.4 1.8 14.3 13.1 29.1 14.2 16.3 7.8 8.2 7.0 9.8 7.0 5.6 11.0 4.8 9.0 6.8 17.9 9.0 19.5 75.5 60.7 3.6 2.8 10.2 4.0 9.1 17.4 2.0 92.0 29.9 28.5 4.9 9.0 19.6 0.0 20.6 98.4 42.7 41.2 11.5 9.2 45.3 3.2 24.8 7.4 23.0 2.2 13.8 29.1 23.6 44.1 22.9 3.0 19.1 27.5 11.3 22.4 2.0 6.5 38.1 0.9 24.8 39.3 64.5 17.5 41.3 38.7 THOC7 "FLJ23445, fSAP24, NIF3L1BP1" ENSG00000163634 "THO complex 7" Q6I9Y2 3 63833870-63863903 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 147.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044143 Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA044143: AB_10794892" "unprognostic (4.33e-2)" "unprognostic (9.68e-2)" "unprognostic (1.75e-2)" "unprognostic (1.30e-1)" "unprognostic (2.26e-2)" "unprognostic (2.86e-1)" "unprognostic (1.20e-3)" "unprognostic (3.53e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-2)" "unprognostic (2.86e-2)" "unprognostic (9.90e-2)" "unprognostic (3.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.18e-2)" "unprognostic (4.25e-2)" "unprognostic (2.31e-1)" 24.3 28.5 41.1 19.7 34.7 29.0 33.3 20.6 37.6 24.6 29.6 14.8 24.1 27.7 22.2 24.6 43.6 18.7 27.2 36.1 38.5 28.3 30.5 32.5 17.2 25.9 33.9 35.2 21.1 35.6 18.0 23.8 42.0 33.7 24.6 30.4 14.8 30.4 22.8 52.9 27.0 34.9 31.1 27.2 20.4 21.5 24.6 15.5 34.4 21.3 43.0 27.6 28.4 22.8 25.4 31.4 32.2 24.8 27.6 32.1 17.7 19.8 12.2 14.1 3.4 18.9 25.8 13.4 17.6 18.3 20.6 20.8 14.6 22.0 23.8 7.5 22.6 20.6 11.7 15.7 27.6 28.9 24.3 11.5 21.3 16.0 16.9 19.8 29.6 10.5 18.6 23.3 17.7 31.4 20.3 22.6 16.0 16.2 23.2 25.0 147.5 25.9 26.9 17.8 43.0 9.8 18.9 13.3 32.4 35.7 19.1 7.0 16.3 15.2 21.4 23.8 14.4 13.7 41.2 16.2 15.0 16.1 18.6 31.0 15.2 22.3 28.9 18.7 38.0 19.6 32.2 21.9 17.1 22.2 24.8 30.7 25.4 27.6 30.0 31.4 17.4 23.8 24.8 13.1 27.6 20.7 28.9 32.1 17.7 41.1 34.7 20.6 37.6 38.5 28.3 33.9 35.2 33.7 15.5 83.4 45.5 85.5 64.3 54.7 49.8 132.7 66.2 89.7 81.9 80.3 17.7 145.0 175.8 128.4 54.2 60.1 73.9 93.5 108.7 140.5 54.4 56.4 52.1 76.8 98.6 46.1 53.0 41.1 67.5 71.0 82.3 73.9 64.1 181.3 101.8 52.7 119.8 91.2 67.1 197.6 51.9 51.8 72.2 202.6 43.2 62.6 178.5 55.5 119.9 83.0 TMEM259 "ASBABP1, C19orf6, MBRL, MGC4022" ENSG00000182087 "Transmembrane protein 259" Q4ZIN3 19 1009648-1021179 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042669, HPA054801" Approved Approved "Nuclear speckles,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear speckles" "HPA042669: AB_10794916, HPA054801: AB_2682604" "unprognostic (1.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "prognostic favorable (1.01e-4)" "unprognostic (4.12e-2)" "unprognostic (6.87e-3)" "unprognostic (2.77e-2)" "unprognostic (1.23e-1)" "unprognostic (2.20e-1)" "unprognostic (2.74e-1)" "unprognostic (4.85e-3)" "unprognostic (4.07e-2)" "unprognostic (4.81e-2)" "prognostic favorable (8.92e-6)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (4.10e-3)" 39.5 39.2 35.7 42.3 39.2 46.4 36.9 54.8 44.3 35.4 41.0 46.1 33.9 43.7 39.6 27.4 37.0 34.8 38.6 43.9 34.8 26.1 37.1 59.2 40.5 44.6 44.1 30.0 38.4 59.0 43.5 55.7 47.9 40.1 41.1 23.3 47.8 49.0 36.2 39.3 62.3 42.9 30.1 27.5 61.8 48.5 36.0 40.2 38.0 47.6 24.9 45.4 37.9 37.0 3.8 6.7 2.5 5.2 2.5 5.5 3.0 36.1 23.3 16.2 18.4 20.0 19.4 28.6 30.8 26.8 25.5 27.5 21.4 20.4 25.1 30.3 23.2 12.0 41.4 16.3 30.2 11.3 32.0 27.5 14.7 28.8 23.5 35.5 28.2 37.4 25.9 30.9 20.4 25.6 24.3 22.1 25.6 24.8 50.8 16.9 15.8 30.9 25.9 24.0 18.4 19.2 35.2 12.3 31.7 20.1 34.1 22.5 23.6 19.5 24.8 21.1 13.7 24.3 36.7 25.6 25.5 14.6 35.6 32.0 72.1 27.0 27.8 30.0 23.2 25.2 0.9 3.9 2.2 5.5 3.5 4.1 3.8 3.2 5.5 6.0 3.4 3.5 3.9 2.5 2.5 5.2 6.7 3.2 3.0 35.7 39.2 54.8 44.3 34.8 26.1 44.1 30.0 40.1 40.2 29.8 50.0 37.4 47.9 55.4 118.9 11.8 33.1 5.3 18.2 62.8 92.3 47.3 10.0 22.9 16.0 38.2 90.7 0.0 29.5 40.4 37.6 50.4 15.0 43.3 44.1 98.5 38.6 31.3 21.9 8.9 39.4 40.7 42.2 27.9 67.4 75.8 34.5 56.2 32.2 18.2 165.0 32.3 46.0 45.3 38.1 56.8 68.9 41.5 49.9 59.1 TOR1B "DQ1, MGC4386" ENSG00000136816 "Torsin family 1 member B" O14657 9 129803153-129811281 "Predicted intracellular proteins" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013403, HPA013697, CAB022709" Approved Uncertain "Nuclear speckles,Cytosol" "Intracellular and membrane" NA NA "Nuclear speckles" Cytosol "CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196" "unprognostic (2.91e-3)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-2)" "unprognostic (1.75e-1)" "unprognostic (5.73e-3)" "unprognostic (1.95e-1)" "unprognostic (7.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.13e-2)" "unprognostic (2.07e-3)" "unprognostic (4.09e-2)" "unprognostic (1.23e-1)" "unprognostic (5.40e-3)" "unprognostic (1.69e-3)" 14.2 14.4 9.7 13.8 12.2 14.0 18.4 23.6 11.9 11.3 22.5 10.5 11.6 12.3 14.0 8.2 13.5 10.5 15.0 13.3 11.7 11.5 11.8 35.3 13.0 10.8 9.4 9.0 10.8 21.1 13.3 13.6 20.0 10.6 12.9 25.8 10.8 12.8 13.7 13.5 13.0 18.1 14.2 8.9 12.4 14.9 19.5 8.3 16.8 16.4 10.0 11.9 14.9 18.0 4.6 6.2 17.2 14.6 7.3 12.3 8.4 5.3 12.3 5.1 13.7 25.9 19.4 12.0 19.2 12.5 13.2 13.1 10.1 12.2 3.8 12.2 18.8 20.6 21.8 5.6 7.9 13.6 13.9 5.9 3.3 10.4 7.1 11.1 6.3 14.9 11.0 13.9 18.8 9.3 9.8 11.7 10.1 11.5 8.9 12.3 14.9 8.6 9.9 10.8 25.1 9.7 3.5 9.0 11.5 10.1 5.6 7.1 8.3 12.4 14.3 7.6 9.7 20.6 6.2 10.7 25.0 11.9 29.7 16.4 6.5 24.2 3.2 13.7 8.2 16.9 6.3 11.5 17.2 12.2 14.6 12.3 3.9 9.5 10.5 6.2 4.6 7.1 7.1 14.2 7.3 8.5 3.8 9.1 8.4 9.7 12.2 23.6 11.9 11.7 11.5 9.4 9.0 10.6 8.3 8.9 3.7 4.5 5.2 5.8 2.5 5.1 5.1 5.3 1.2 5.2 3.9 9.7 0.0 8.8 9.2 6.7 8.0 0.0 12.2 15.2 8.5 9.2 4.6 13.5 10.8 6.4 18.4 11.6 4.3 10.9 4.0 7.6 3.3 12.6 15.5 4.8 10.0 3.5 5.3 3.0 2.5 19.4 9.5 10.3 7.0 4.6 12.7 10.0 10.7 10.1 U2AF2 U2AF65 ENSG00000063244 "U2 small nuclear RNA auxiliary factor 2" P26368 19 55654146-55674715 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010910, HPA041943, HPA043562" Supported Supported Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555" "unprognostic (2.37e-1)" "unprognostic (2.22e-1)" "unprognostic (3.12e-1)" "unprognostic (9.60e-2)" "unprognostic (6.94e-2)" "unprognostic (4.01e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (9.46e-2)" "unprognostic (1.36e-2)" "unprognostic (8.00e-2)" "unprognostic (3.33e-2)" "unprognostic (4.25e-3)" "unprognostic (2.19e-2)" "unprognostic (4.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.08e-2)" 32.1 39.3 40.0 51.9 40.0 68.2 34.1 53.4 44.1 39.6 43.7 41.2 37.0 46.2 45.0 32.5 47.9 43.6 35.4 33.8 35.0 29.4 36.5 39.1 35.6 59.6 41.1 33.7 51.4 38.3 37.7 48.1 42.9 31.5 36.8 29.7 35.9 36.4 39.5 33.3 42.7 43.0 34.7 32.4 58.1 37.4 104.4 41.4 68.4 42.0 34.0 50.4 36.3 42.9 3.0 4.1 5.5 4.0 1.4 3.0 1.7 44.2 72.7 44.5 36.5 21.1 21.4 48.0 35.9 33.8 61.8 60.2 42.2 42.2 53.6 29.2 30.4 30.6 36.3 55.2 50.0 27.5 40.3 92.3 44.9 32.5 38.7 34.3 51.0 51.5 29.1 30.3 46.1 30.5 23.2 35.5 36.3 53.5 34.6 31.2 41.6 70.8 44.9 49.0 38.3 57.9 77.3 28.7 42.8 33.9 51.9 52.9 41.1 39.4 37.3 22.7 26.0 36.4 54.0 30.3 54.4 39.5 25.0 75.8 31.5 42.6 63.6 24.2 50.6 46.2 0.2 2.6 2.2 3.0 4.0 2.6 2.1 2.7 2.4 2.4 3.0 2.2 2.0 5.5 1.4 2.6 4.1 2.9 1.7 40.0 40.0 53.4 44.1 35.0 29.4 41.1 33.7 31.5 41.4 3.0 7.8 30.2 34.6 40.3 39.4 2.0 28.1 2.7 10.3 26.2 29.5 50.4 16.6 27.1 3.6 25.3 37.1 0.0 20.6 50.3 29.4 26.5 34.5 24.6 32.5 33.4 43.7 25.2 23.2 5.2 41.1 28.1 18.6 39.7 38.5 23.8 24.5 21.0 32.2 19.6 49.8 0.0 31.7 23.3 28.8 34.4 60.1 33.7 38.2 39.4 UBAP2L "KIAA0144, NICE-4" ENSG00000143569 "Ubiquitin associated protein 2 like" Q14157 1 154220179-154271510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 107.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035068 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA035068: AB_10696366" "unprognostic (3.14e-2)" "unprognostic (1.50e-1)" "unprognostic (8.82e-2)" "unprognostic (2.93e-3)" "unprognostic (3.98e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (4.65e-5)" "unprognostic (1.97e-2)" "unprognostic (5.10e-3)" "unprognostic (9.01e-2)" "unprognostic (1.67e-1)" "unprognostic (6.96e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (7.40e-3)" "unprognostic (9.14e-2)" "unprognostic (2.69e-1)" "unprognostic (3.72e-1)" 33.8 33.0 39.1 34.8 47.5 32.7 32.3 34.3 46.6 31.2 31.3 32.9 25.5 20.6 40.6 30.3 36.1 34.8 28.3 36.9 38.3 25.2 26.7 23.9 35.1 34.1 26.5 39.5 42.7 25.0 42.1 40.6 43.9 30.5 29.2 25.8 31.2 31.8 32.8 53.2 36.8 25.3 36.6 30.2 30.5 27.4 37.5 30.2 34.6 33.8 26.6 38.5 37.9 32.4 18.3 24.3 17.6 26.5 24.6 20.6 18.3 42.5 41.1 40.3 31.7 28.7 32.9 34.6 49.1 35.5 44.7 31.1 44.1 33.2 53.3 51.1 41.1 21.2 37.1 52.8 36.2 39.4 46.9 45.2 57.6 42.6 36.8 27.1 60.0 34.2 31.3 15.8 40.3 25.8 28.0 35.2 20.9 52.4 25.9 35.0 46.4 46.8 22.5 75.0 31.3 39.1 33.7 31.8 47.1 27.9 49.9 41.2 49.8 56.5 53.1 21.4 46.3 53.4 41.6 56.5 27.7 29.4 34.0 46.6 56.8 61.1 72.6 29.7 33.0 41.4 8.8 19.2 13.2 17.5 25.1 19.1 15.6 16.4 15.7 24.3 18.3 19.1 20.6 17.6 24.6 26.5 11.4 14.7 18.3 39.1 47.5 34.3 46.6 38.3 25.2 26.5 39.5 30.5 30.2 23.8 33.4 27.4 15.2 16.4 18.0 33.7 10.2 26.8 37.5 17.4 7.9 42.0 14.9 26.8 78.5 19.4 11.8 0.0 23.4 31.4 24.6 14.5 24.3 17.8 30.9 14.3 22.4 28.3 22.4 107.3 19.8 23.2 18.6 20.8 19.9 17.4 24.0 11.5 21.2 11.9 20.2 12.9 20.8 25.7 41.7 17.9 65.1 14.6 19.9 18.0 UBE3B ENSG00000151148 "Ubiquitin protein ligase E3B" Q7Z3V4 12 109477402-109536705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041012 Approved Approved "Nuclear speckles,Mitochondria" NA NA "Nuclear speckles" Mitochondria "HPA041012: AB_10964435" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (7.12e-2)" "unprognostic (7.37e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (4.92e-2)" "unprognostic (7.19e-2)" "unprognostic (2.93e-1)" "unprognostic (4.46e-3)" "unprognostic (9.39e-2)" "unprognostic (1.23e-1)" "prognostic favorable (2.49e-5)" "unprognostic (3.35e-1)" "unprognostic (3.35e-2)" "unprognostic (2.87e-1)" "unprognostic (1.26e-1)" 14.5 19.3 17.2 12.9 21.2 9.2 15.3 19.7 27.8 14.4 17.3 23.3 14.0 14.6 17.4 16.2 20.1 19.3 13.9 28.6 14.6 11.6 19.8 16.4 15.5 13.1 18.6 13.9 18.4 20.3 25.5 15.1 16.8 15.8 17.5 21.2 20.7 15.7 17.4 34.0 21.6 16.3 18.6 15.2 17.0 17.3 24.5 18.3 18.2 21.1 17.6 15.9 19.5 19.6 15.9 14.5 22.4 16.7 14.3 18.2 11.4 10.4 16.5 13.0 9.4 22.2 17.9 11.4 13.8 15.8 16.8 11.3 17.3 10.7 6.5 10.3 22.6 14.3 13.5 13.1 17.7 16.2 14.3 9.3 12.4 10.8 15.6 14.2 10.1 10.4 20.3 16.5 16.2 19.5 25.4 18.1 15.5 13.6 6.2 19.1 16.3 6.9 14.8 13.3 11.7 19.9 11.5 12.2 12.7 14.4 18.8 12.1 22.4 16.1 21.9 10.7 15.9 22.4 10.8 16.5 20.8 6.0 10.6 9.8 13.9 11.5 11.5 20.7 8.5 17.2 22.4 15.3 14.3 15.9 16.7 15.7 15.9 15.3 11.2 14.5 12.9 12.9 17.1 19.5 14.3 13.6 13.5 18.2 11.4 17.2 21.2 19.7 27.8 14.6 11.6 18.6 13.9 15.8 18.3 11.9 10.8 6.7 10.0 4.5 20.4 32.1 10.2 14.7 14.8 15.7 31.4 15.7 10.0 16.0 11.8 13.5 15.1 23.3 13.2 9.3 8.4 15.1 9.2 16.0 11.1 20.6 8.6 12.9 17.1 24.6 11.5 11.0 10.1 14.4 15.8 16.7 18.8 10.5 9.2 17.7 25.0 6.5 8.5 9.6 12.7 6.4 19.8 10.9 13.8 12.2 UFC1 HSPC155 ENSG00000143222 "Ubiquitin-fold modifier conjugating enzyme 1" Q9Y3C8 1 161152776-161158856 "Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027481, HPA028722" Enhanced Approved "Nuclear speckles,Cytosol" NA NA 180000 "Nuclear speckles" Cytosol "HPA027481: AB_10599850, HPA028722: AB_10601674" "unprognostic (2.16e-1)" "unprognostic (6.17e-2)" "unprognostic (1.83e-1)" "unprognostic (8.25e-3)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-3)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (3.40e-2)" "unprognostic (5.04e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (2.62e-6)" "unprognostic (3.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.13e-1)" "unprognostic (6.22e-2)" 34.2 38.6 52.6 25.4 54.7 35.1 45.6 21.1 41.8 35.4 37.3 27.8 47.7 36.9 31.5 57.2 40.6 69.9 40.8 36.0 42.5 45.9 56.1 55.2 32.0 29.8 46.3 35.6 48.7 85.5 39.3 40.6 54.2 34.4 44.0 46.8 29.2 63.6 40.3 34.3 36.1 48.6 35.8 34.4 39.1 39.1 22.2 33.9 38.9 50.2 38.9 38.9 37.9 33.4 41.1 43.6 22.4 33.0 40.9 54.1 48.0 22.4 20.8 18.4 23.1 24.7 39.7 38.8 22.9 27.0 21.9 19.4 27.2 46.1 31.2 38.5 31.8 15.1 11.7 15.4 22.0 16.3 26.5 42.2 19.0 31.0 32.6 24.5 41.9 48.6 33.8 35.7 27.3 18.9 37.3 38.1 31.8 31.5 22.9 27.9 27.1 19.4 38.3 33.8 67.0 22.9 23.8 13.4 43.4 42.4 27.4 21.2 33.7 20.0 66.3 26.3 31.0 25.3 78.0 28.5 16.3 15.9 15.6 33.4 39.9 51.0 28.2 25.8 26.7 20.6 22.4 32.8 20.4 39.0 33.0 47.2 41.1 41.8 41.5 40.4 31.0 36.7 39.5 6.0 40.9 24.0 43.6 54.1 48.0 52.6 54.7 21.1 41.8 42.5 45.9 46.3 35.6 34.4 33.9 65.5 68.2 142.4 148.8 88.7 59.5 99.6 142.7 566.1 94.4 99.5 39.3 208.4 373.0 191.0 103.8 125.8 138.7 140.2 332.6 317.7 97.7 152.4 116.6 83.9 213.1 44.5 196.3 79.8 133.0 302.8 97.2 153.3 124.9 257.9 166.3 88.5 242.7 175.4 85.6 257.5 52.6 64.7 102.4 96.2 34.8 105.8 361.2 152.3 163.7 181.2 UNC45A "GC-UNC45, SMAP-1" ENSG00000140553 "Unc-45 myosin chaperone A" Q9H3U1 15 90930180-90954093 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Myogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039228 Approved Supported "Nuclear speckles,Cytosol" NA NA 21000000 "Nuclear speckles" Cytosol "HPA039228: AB_2676402" "unprognostic (1.46e-1)" "unprognostic (3.83e-2)" "unprognostic (4.51e-2)" "unprognostic (1.97e-1)" "unprognostic (2.68e-2)" "unprognostic (1.70e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (2.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (1.98e-1)" "unprognostic (9.85e-2)" "prognostic favorable (7.46e-7)" "unprognostic (9.30e-2)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-2)" 19.1 21.0 10.1 14.4 10.1 11.9 20.6 21.8 14.6 20.3 27.6 10.7 23.2 13.0 29.7 15.5 24.9 20.4 24.8 12.8 9.5 7.3 16.2 15.9 15.2 13.2 11.9 12.3 22.1 19.4 25.8 14.1 22.8 11.5 23.8 10.9 15.3 20.2 29.6 6.9 26.6 16.9 35.8 9.7 15.7 22.4 18.4 10.8 18.0 20.8 12.6 16.9 33.2 30.4 10.1 12.0 12.1 11.9 10.8 14.5 9.8 15.3 31.2 12.9 11.3 35.5 16.4 11.5 17.4 15.0 23.8 19.1 24.9 20.4 18.1 23.5 21.9 13.7 34.0 21.9 22.4 11.2 20.0 32.0 34.9 32.7 17.7 20.1 8.6 23.7 20.3 27.5 23.3 17.1 22.9 32.2 14.5 15.3 14.9 17.8 24.7 11.0 7.4 17.4 28.2 15.8 22.0 19.7 19.2 16.2 36.5 18.3 16.6 23.4 23.5 21.7 16.2 21.3 17.9 31.6 20.3 14.6 17.1 18.2 14.3 19.7 8.5 19.9 20.2 20.6 12.1 9.0 5.4 14.5 8.3 14.0 10.1 11.9 11.2 12.0 8.3 10.0 9.1 1.8 10.8 11.9 10.7 10.5 9.8 10.1 10.1 21.8 14.6 9.5 7.3 11.9 12.3 11.5 10.8 20.8 21.9 23.1 21.9 14.4 22.5 11.2 35.7 9.4 21.6 17.4 17.7 45.4 11.6 29.7 18.8 21.2 22.6 0.0 15.8 18.5 21.6 16.1 28.8 12.4 24.1 17.5 35.5 16.0 15.4 22.0 27.3 15.4 18.6 37.9 15.4 20.7 19.8 25.9 48.4 16.6 30.0 32.3 30.1 18.4 6.0 16.4 38.7 21.0 18.3 20.6 YLPM1 "C14orf170, PPP1R169, ZAP" ENSG00000119596 "YLP motif containing 1" P49750 14 74763366-74859435 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048070, HPA061123" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA048070: AB_2680247, HPA061123: AB_2684435" "unprognostic (2.17e-1)" "unprognostic (3.32e-2)" "unprognostic (3.95e-1)" "unprognostic (2.98e-1)" "unprognostic (3.79e-2)" "unprognostic (7.64e-2)" "unprognostic (3.22e-3)" "unprognostic (8.74e-2)" "unprognostic (3.60e-2)" "unprognostic (2.56e-1)" "unprognostic (7.83e-3)" "unprognostic (6.63e-2)" "prognostic favorable (6.08e-7)" "unprognostic (1.09e-2)" "unprognostic (2.41e-1)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" 17.2 19.0 28.9 21.7 33.4 26.1 21.0 51.4 32.6 18.6 15.4 24.9 18.8 13.1 23.8 20.6 17.4 20.6 15.9 15.8 24.2 18.2 15.7 14.0 16.4 20.8 24.1 24.8 31.3 21.0 30.9 30.5 19.8 22.5 20.0 17.2 18.8 20.6 22.8 20.7 23.0 16.5 17.7 21.2 18.9 16.2 28.8 27.6 24.7 22.5 8.7 20.6 22.4 18.7 5.5 7.8 3.3 3.9 5.4 4.6 3.0 19.2 21.4 23.5 4.5 16.9 16.5 12.7 13.4 13.7 13.6 13.7 18.8 13.9 28.9 10.0 15.1 9.7 17.5 20.3 13.9 21.6 17.4 11.7 20.9 13.6 12.8 9.1 15.9 16.0 14.4 9.3 15.3 11.6 16.1 18.5 16.1 16.5 13.8 16.7 19.8 18.3 12.9 14.0 11.9 18.0 27.7 23.4 10.1 10.8 27.8 17.2 16.9 21.5 13.3 5.1 15.7 15.9 10.6 27.7 16.5 21.1 11.8 16.8 16.9 16.3 31.9 14.3 11.7 12.3 0.7 3.4 3.3 3.8 3.9 4.2 4.4 3.2 3.2 3.1 5.5 4.6 4.6 2.7 5.4 3.1 7.8 2.7 3.0 28.9 33.4 51.4 32.6 24.2 18.2 24.1 24.8 22.5 27.6 23.8 29.3 17.9 9.5 17.6 43.2 36.4 17.8 38.8 30.7 8.7 39.3 17.3 1.7 12.8 28.4 22.5 12.1 0.0 13.5 12.1 17.6 15.9 16.3 16.0 16.1 49.3 19.7 20.3 19.1 12.5 31.4 16.6 5.0 15.4 17.9 27.2 14.2 10.5 45.6 11.8 28.3 19.4 15.1 59.1 47.3 20.5 13.2 17.0 19.4 10.5 ZBTB8A "BOZF1, FLJ90065, ZBTB8, ZNF916A" ENSG00000160062 "Zinc finger and BTB domain containing 8A" Q96BR9 1 32539427-32605939 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 33.2;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031768, HPA031769, HPA031770" Approved Approved "Nuclear speckles,Focal adhesion sites" NA NA "Nuclear speckles, Focal adhesion sites" "HPA031768: AB_10610568, HPA031769: AB_2674036, HPA031770: AB_2674037" "unprognostic (1.71e-1)" "unprognostic (1.98e-1)" "unprognostic (1.01e-1)" "unprognostic (7.40e-2)" "unprognostic (7.21e-2)" "unprognostic (2.85e-2)" "unprognostic (9.45e-5)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (7.83e-3)" "unprognostic (4.23e-3)" "unprognostic (1.78e-1)" "unprognostic (8.10e-2)" "unprognostic (2.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.47e-1)" "unprognostic (3.15e-2)" 8.8 4.9 4.4 3.2 5.0 2.3 19.1 11.1 5.9 13.6 6.2 4.8 12.2 3.8 12.7 8.6 7.2 7.8 5.7 6.9 4.4 3.4 5.7 4.4 14.0 1.9 3.3 4.5 8.6 10.9 10.7 8.9 5.5 7.9 7.8 6.2 6.9 9.9 11.4 10.3 4.8 4.2 15.4 5.2 2.7 6.4 6.2 3.5 1.8 11.2 6.6 3.0 9.1 7.6 1.6 2.1 4.1 1.0 2.6 1.0 0.5 6.6 1.9 7.8 8.4 5.6 7.5 5.9 6.7 5.3 6.3 6.4 0.8 5.4 5.4 4.6 7.2 2.8 5.2 7.7 5.3 5.6 1.4 5.2 0.3 6.6 2.9 7.2 1.2 0.4 5.0 7.6 4.6 12.1 6.3 7.0 4.9 1.1 3.9 6.3 6.8 3.6 0.6 7.1 3.3 2.8 6.6 11.4 4.3 3.9 6.9 6.6 6.0 9.3 4.7 8.9 4.3 6.1 3.1 7.2 8.4 6.9 11.5 4.8 7.1 3.4 4.2 5.8 1.4 3.5 4.1 1.0 0.8 0.8 0.6 1.0 0.8 0.7 0.7 0.7 1.6 0.8 0.9 3.8 2.6 0.8 2.1 0.6 0.5 4.4 5.0 11.1 5.9 4.4 3.4 3.3 4.5 7.9 3.5 14.9 14.4 1.5 6.3 3.7 10.5 3.6 5.1 4.0 4.5 7.0 21.6 2.5 1.7 5.7 3.8 12.8 3.5 0.0 4.5 5.1 10.1 7.2 2.3 3.6 1.4 6.4 4.7 20.3 4.0 3.9 18.4 4.8 3.3 1.0 4.5 4.1 5.0 3.5 33.2 2.4 8.7 32.3 11.3 0.9 4.3 3.3 1.3 2.5 8.7 5.4 ZC2HC1C "C14orf140, FAM164C" ENSG00000119703 "Zinc finger C2HC-type containing 1C" Q53FD0 14 75064170-75079987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 75.7" "Group enriched" "Detected in many" 8 "Ciliated cells: 48.2;Early spermatids: 103.8;Late spermatids: 150.0;Spermatocytes: 54.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA050928, HPA065062" Enhanced Approved "Nuclear speckles,Mitochondria" No No "Nuclear speckles" Mitochondria "HPA050928: AB_2681277, HPA065062: AB_2732728" "unprognostic (8.01e-2)" "unprognostic (2.01e-2)" "unprognostic (9.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.97e-3)" "unprognostic (6.00e-2)" "unprognostic (8.94e-2)" "unprognostic (1.20e-2)" "unprognostic (3.71e-3)" "unprognostic (3.22e-2)" "unprognostic (1.09e-3)" "unprognostic (2.26e-1)" "prognostic favorable (4.63e-13)" "unprognostic (4.69e-3)" "unprognostic (7.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.81e-1)" 0.7 2.1 2.3 0.5 5.3 0.2 1.3 1.8 3.4 1.5 2.0 2.3 4.6 2.5 1.0 18.2 1.3 8.2 1.5 2.9 3.0 3.0 4.3 6.8 2.2 0.1 2.3 2.3 0.8 3.6 5.2 10.9 3.3 4.7 1.0 1.8 1.2 2.3 5.7 3.0 1.1 1.9 1.0 1.9 0.6 1.2 75.7 2.3 0.6 5.9 0.5 0.4 1.2 0.4 1.6 0.6 0.8 0.3 3.8 3.8 0.8 6.0 4.7 1.0 5.3 0.3 0.3 2.8 0.5 2.1 2.7 1.2 7.7 11.1 5.6 4.3 0.5 3.7 2.4 0.0 0.1 1.9 5.9 0.6 1.4 1.6 2.7 3.7 0.1 3.7 1.1 0.6 3.4 0.1 3.1 1.6 0.4 8.0 2.5 1.3 1.3 0.6 0.7 1.7 3.5 3.3 0.1 0.3 2.7 6.0 0.4 9.7 2.3 3.5 3.1 2.8 1.0 4.4 1.8 0.8 1.7 1.9 2.9 1.1 5.6 8.3 2.9 2.4 1.0 0.9 0.8 0.3 0.8 1.9 0.0 0.5 1.6 1.6 0.5 0.3 0.8 0.7 0.8 0.4 3.8 0.2 0.6 3.8 0.8 2.3 5.3 1.8 3.4 3.0 3.0 2.3 2.3 4.7 2.3 6.0 8.9 0.9 1.5 1.5 4.4 5.6 5.1 48.2 10.3 10.4 9.8 1.9 3.3 3.2 103.8 1.7 2.6 0.0 1.2 1.0 1.3 2.0 1.1 3.9 1.4 11.1 5.1 1.8 1.0 150.0 2.8 0.9 3.3 1.0 3.1 3.1 1.5 0.0 2.5 5.7 8.4 6.5 0.5 54.1 5.3 0.6 4.2 0.0 3.3 0.8 ZCCHC4 "FLJ23024, HSPC052, ZGRF4" ENSG00000168228 "Zinc finger CCHC-type containing 4" Q9H5U6 4 25312785-25370383 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035575, HPA035576" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles, Golgi apparatus" "HPA035575: AB_2674682, HPA035576: AB_10671516" "unprognostic (5.52e-1)" "unprognostic (1.54e-1)" "unprognostic (2.94e-2)" "unprognostic (3.06e-2)" "unprognostic (1.87e-2)" "unprognostic (5.84e-2)" "unprognostic (2.80e-3)" "unprognostic (1.71e-1)" "unprognostic (3.00e-1)" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (1.85e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.59e-2)" "unprognostic (1.07e-2)" 11.5 10.3 9.7 14.6 12.8 8.1 12.4 13.1 12.4 11.3 9.5 12.8 12.5 8.9 14.6 10.4 9.1 11.7 8.0 10.6 9.0 6.5 9.3 8.8 8.7 11.5 13.7 7.0 15.4 9.4 12.7 11.6 10.7 9.8 10.9 10.0 11.6 10.0 10.3 16.6 10.4 10.4 13.5 10.0 12.4 9.1 11.2 10.9 15.0 11.3 7.6 11.1 11.0 12.7 6.5 4.4 2.4 3.8 6.5 7.5 3.9 3.9 2.4 8.1 3.6 6.4 8.1 7.2 10.0 10.7 11.8 13.7 3.8 10.4 6.5 2.8 6.1 11.7 3.1 7.8 7.3 16.5 1.5 4.2 6.0 5.4 6.4 8.1 9.7 4.4 6.3 8.2 11.2 8.8 7.0 5.6 10.1 10.7 3.3 9.9 2.9 10.0 12.9 11.1 6.4 5.3 6.8 12.4 3.9 6.3 4.1 7.6 5.2 4.3 3.6 6.4 8.3 5.3 5.9 4.4 9.9 4.1 6.4 13.3 6.5 8.1 9.5 10.7 9.5 9.5 2.4 3.2 1.0 5.3 3.8 7.5 6.0 6.8 6.4 4.4 6.5 6.7 7.3 1.8 6.5 3.6 3.5 6.5 3.9 9.7 12.8 13.1 12.4 9.0 6.5 13.7 7.0 9.8 10.9 0.0 4.3 1.4 3.6 3.3 3.9 4.5 0.0 10.7 6.8 0.0 2.0 5.0 3.3 3.2 1.1 4.1 2.6 0.0 2.0 4.0 3.2 1.9 1.1 2.4 4.6 3.2 2.4 3.1 5.2 0.0 3.7 4.4 3.3 2.8 4.1 4.8 2.7 3.7 4.9 3.7 4.5 0.0 5.2 6.0 7.7 3.0 3.1 5.7 3.8 2.0 ZDHHC15 "DHHC15, FLJ31812, MRX91" ENSG00000102383 "Zinc finger DHHC-type containing 15" Q96MV8 X 75368427-75523502 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Cardiomyocytes: 6.9;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 5.7;K-562: 3.6;LHCN-M2: 4.0;MOLT-4: 4.2;NTERA-2: 3.7;RH-30: 5.8;RPTEC TERT1: 3.2;SH-SY5Y: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003618 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA003618: AB_2217686" "unprognostic (8.28e-2)" "unprognostic (1.73e-1)" "unprognostic (8.05e-2)" "unprognostic (1.62e-5)" "unprognostic (1.64e-2)" "unprognostic (1.00e-1)" "unprognostic (4.00e-4)" "unprognostic (1.96e-2)" "unprognostic (3.19e-1)" "unprognostic (8.70e-2)" "unprognostic (3.77e-3)" "unprognostic (1.40e-1)" "unprognostic (4.78e-13)" "unprognostic (2.60e-3)" "unprognostic (1.17e-2)" "unprognostic (1.09e-1)" "unprognostic (9.67e-4)" 3.0 5.4 4.9 1.5 6.8 1.1 5.3 6.2 9.9 5.8 3.4 3.9 2.4 1.3 6.5 3.7 3.2 4.5 3.3 5.4 5.9 8.7 5.3 1.2 4.1 1.6 4.8 5.3 8.5 4.7 5.0 8.7 0.7 7.0 4.0 2.3 5.4 12.7 6.9 1.6 2.8 1.8 5.2 6.4 2.9 2.1 2.6 3.1 2.0 6.6 2.1 1.5 2.6 3.1 0.3 0.4 0.7 0.2 0.5 1.6 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.6 3.6 0.1 4.0 0.0 4.2 0.1 3.7 0.0 0.0 0.0 5.8 0.0 3.2 0.0 1.6 4.8 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.5 1.0 0.0 0.7 2.9 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.1 0.3 0.6 0.0 0.0 0.2 1.6 1.1 0.7 0.5 0.1 0.4 0.0 0.3 4.9 6.8 6.2 9.6 5.9 8.7 4.8 5.3 7.0 3.1 6.0 1.9 0.0 1.4 3.5 3.7 6.9 2.5 0.0 2.3 5.2 3.9 0.0 0.0 0.7 0.0 2.1 0.0 0.0 0.6 0.0 0.9 1.0 1.1 0.0 0.1 0.0 1.7 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.3 0.3 0.0 3.5 1.0 2.1 6.5 1.4 0.1 0.4 3.1 0.0 0.0 0.0 0.3 ZIM2 ZNF656 ENSG00000269699 "Zinc finger imprinted 2" Q9NZV7 19 56774552-56840729 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;ovary: 35.4" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 24.1;Horizontal cells: 9.5;Late spermatids: 24.5;Spermatogonia: 18.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.4;Hep G2: 9.8;NTERA-2: 2.8;RH-30: 2.9;U-2 OS: 2.1;U-266/84: 2.0" HPA071856 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA071856: AB_2686460" "unprognostic (9.01e-4)" "unprognostic (8.77e-2)" "unprognostic (5.09e-2)" "unprognostic (4.60e-2)" "unprognostic (2.45e-2)" "unprognostic (3.01e-1)" "unprognostic (2.33e-1)" "unprognostic (8.68e-3)" "unprognostic (4.12e-1)" "unprognostic (1.00e-1)" 1.6 13.1 8.5 1.6 44.0 1.4 2.5 8.2 19.1 2.2 1.7 4.8 0.0 1.6 3.2 1.2 1.7 2.8 1.4 2.6 8.1 6.5 2.0 1.7 1.4 1.5 3.0 13.7 35.4 1.5 1.8 21.1 18.3 18.2 2.0 1.5 0.1 3.7 2.0 1.3 1.4 1.8 2.2 3.9 1.7 1.5 11.4 6.1 0.0 2.2 0.0 2.0 1.9 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 44.0 8.2 19.1 8.1 6.5 3.0 13.7 18.2 6.1 0.0 0.0 0.0 0.0 0.1 3.8 0.8 0.0 0.0 0.0 0.0 0.0 4.6 1.7 0.0 24.1 0.0 0.0 0.0 0.0 0.9 0.4 0.1 0.0 0.0 0.5 9.5 0.0 0.0 0.0 24.5 1.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.4 0.0 2.4 0.0 0.0 7.5 18.3 0.1 8.2 0.0 0.0 0.0 ZKSCAN7 "FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39" ENSG00000196345 "Zinc finger with KRAB and SCAN domains 7" Q9P0L1 3 44555193-44594173 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 13.1;Late spermatids: 11.0;Spermatocytes: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 6.6;NTERA-2: 5.1;SH-SY5Y: 8.0;SuSa: 5.0" "Low region specificity" "Detected in all" "HPA048312, HPA049906, HPA071850" Uncertain Supported "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA048312: AB_2680352, HPA049906: AB_2680946, HPA071850: AB_2686458" "unprognostic (3.31e-2)" "unprognostic (4.49e-2)" "unprognostic (7.25e-2)" "unprognostic (5.78e-3)" "unprognostic (3.41e-2)" "unprognostic (1.21e-3)" "unprognostic (2.18e-1)" "unprognostic (2.31e-2)" "unprognostic (3.45e-2)" "unprognostic (1.06e-1)" "unprognostic (4.22e-4)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-1)" "unprognostic (7.17e-3)" 3.4 6.0 5.7 6.3 3.9 1.9 5.3 9.9 6.1 6.1 3.9 6.0 6.1 2.0 6.9 9.5 2.9 6.4 5.3 4.8 5.6 3.9 4.5 4.6 5.1 5.1 4.4 3.4 13.0 6.7 6.8 18.2 3.4 4.1 6.6 3.5 7.2 3.7 5.8 4.3 2.2 3.8 7.2 3.9 4.8 3.7 18.6 4.4 12.1 6.0 1.9 4.8 5.5 5.9 3.7 2.5 2.0 1.2 2.4 3.4 1.2 0.0 0.0 4.6 6.6 1.3 0.7 0.0 2.2 1.9 2.3 2.7 0.0 0.1 0.1 0.8 1.5 0.8 0.0 0.0 1.4 2.9 0.0 0.0 0.2 1.4 1.7 4.1 0.0 0.0 3.2 1.5 1.3 0.0 0.0 0.6 0.1 0.0 0.1 3.5 0.0 0.0 0.0 5.1 0.0 0.0 0.0 2.1 0.0 1.3 0.6 3.1 8.0 0.1 0.2 0.0 5.0 0.0 3.1 0.7 1.4 0.5 1.8 0.0 0.2 0.1 0.0 0.3 0.0 1.1 2.0 1.2 1.6 3.4 0.5 1.0 1.3 2.1 2.6 1.0 3.7 1.6 3.2 1.6 2.4 1.1 2.5 2.1 1.2 5.7 3.9 9.9 6.1 5.6 3.9 4.4 3.4 4.1 4.4 0.0 0.3 0.0 0.6 0.1 5.0 3.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.6 13.1 0.6 0.0 0.0 0.4 0.0 0.9 0.3 0.0 1.0 0.9 3.2 2.9 0.0 0.0 11.0 0.9 0.2 0.0 1.0 0.0 4.1 0.9 0.0 2.5 0.6 4.0 0.0 0.3 9.4 3.4 0.4 0.1 0.7 0.4 0.1 ZMYND15 DKFZp434N127 ENSG00000141497 "Zinc finger MYND-type containing 15" Q9H091 17 4740015-4746119 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.6" "Group enriched" "Detected in many" 6 "Early spermatids: 141.0;monocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.1;non-classical monocyte: 1.5" "Group enriched" "Detected in many" 11 "granulocytes: 1.1;monocytes: 1.5" "Cell line enhanced" "Detected in some" "A-431: 5.1;CAPAN-2: 4.8;HaCaT: 3.9;T-47d: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA023286 Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023286: AB_1859076" "unprognostic (2.30e-3)" "unprognostic (1.63e-2)" "unprognostic (1.61e-2)" "unprognostic (7.49e-3)" "unprognostic (3.62e-2)" "unprognostic (7.86e-2)" "unprognostic (4.97e-2)" "unprognostic (1.59e-2)" "unprognostic (1.33e-2)" "unprognostic (3.49e-1)" "unprognostic (6.72e-3)" "unprognostic (4.02e-1)" "unprognostic (5.47e-2)" "unprognostic (4.62e-2)" "unprognostic (9.24e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" 3.6 1.6 2.3 2.9 2.0 0.9 2.0 0.7 2.7 1.3 1.0 5.1 1.4 5.2 1.8 4.5 1.2 1.5 3.8 3.8 3.6 1.8 2.4 3.5 6.1 4.9 3.7 1.7 0.9 4.7 12.5 1.8 1.5 3.4 1.9 1.0 4.2 3.8 2.7 0.4 1.8 3.9 1.2 4.8 6.2 2.4 25.6 2.9 0.7 1.4 0.7 0.8 1.6 0.9 0.0 0.1 1.1 1.5 0.0 0.0 0.2 5.1 0.9 0.0 2.5 0.1 0.2 0.4 0.1 1.4 1.3 3.1 2.3 4.8 0.0 0.2 0.0 0.6 3.9 0.9 0.4 0.1 0.5 1.7 0.0 0.5 1.3 0.8 0.1 1.4 0.2 0.6 0.2 0.2 0.7 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.7 0.6 0.6 0.0 0.1 1.4 1.6 2.3 0.0 3.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 1.5 0.0 0.0 0.2 2.3 2.0 0.7 2.7 3.6 1.8 3.7 1.7 3.4 2.9 0.0 1.3 0.0 5.2 0.8 0.1 0.6 0.0 0.0 1.2 1.8 0.0 0.0 0.0 1.4 141.0 0.3 4.0 0.0 3.5 0.0 0.3 5.3 0.0 0.2 5.0 0.0 1.2 3.7 7.6 15.1 0.6 10.7 1.7 36.9 2.6 1.4 2.6 0.6 2.1 0.7 0.2 0.0 0.5 0.7 1.2 0.6 0.0 0.0 0.6 7.4 ZNF160 "F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18" ENSG00000170949 "Zinc finger protein 160" Q9HCG1 19 53066606-53103436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 28.8" HPA023599 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023599: AB_2218442" "unprognostic (1.18e-2)" "unprognostic (4.75e-2)" "unprognostic (1.16e-2)" "unprognostic (9.46e-2)" "unprognostic (4.90e-2)" "unprognostic (8.31e-3)" "unprognostic (2.65e-5)" "unprognostic (5.20e-2)" "unprognostic (4.11e-3)" "unprognostic (2.03e-1)" "unprognostic (3.12e-2)" "unprognostic (6.03e-3)" "unprognostic (2.71e-3)" "unprognostic (2.87e-1)" "unprognostic (4.63e-1)" "unprognostic (1.71e-1)" "prognostic favorable (2.67e-5)" 17.7 28.0 15.7 18.5 19.9 8.1 17.2 26.4 20.0 16.3 15.5 21.6 14.1 9.6 22.7 17.2 11.0 15.5 16.8 13.8 14.5 8.9 19.7 13.2 17.3 12.8 22.5 15.2 25.9 12.7 20.9 18.2 16.1 18.8 15.1 13.3 9.9 14.3 19.3 10.2 13.1 12.1 17.4 19.6 31.5 13.2 15.2 22.4 19.0 29.5 7.5 12.5 18.0 15.0 9.1 4.3 10.7 5.9 17.5 11.2 5.4 5.6 5.1 7.1 10.8 11.9 8.4 12.1 6.2 8.4 5.0 8.1 4.4 3.6 6.5 5.4 5.7 6.7 4.2 6.6 6.4 10.1 4.8 8.1 10.0 3.8 2.4 6.5 0.0 6.9 10.4 6.6 5.4 7.7 12.8 5.4 7.7 5.0 0.0 9.5 3.9 8.3 6.2 6.6 1.5 8.3 5.3 7.5 5.0 7.9 28.8 6.0 7.8 0.0 5.0 0.9 23.7 5.3 5.8 10.3 14.1 5.1 4.1 4.5 3.7 15.4 9.3 2.5 2.5 6.7 9.0 3.1 10.7 7.1 4.2 10.3 8.4 7.3 9.5 4.3 9.1 11.2 8.7 6.5 17.5 5.9 4.1 7.3 5.4 15.7 19.9 26.4 20.0 14.5 8.9 22.5 15.2 18.8 22.4 20.8 29.1 11.9 8.4 3.5 21.1 18.3 17.8 10.7 14.8 8.7 27.5 7.4 5.0 5.9 25.5 16.1 8.1 0.0 5.9 6.7 7.1 9.0 17.4 4.3 5.6 44.5 8.1 36.2 10.0 8.1 10.0 9.5 1.7 2.8 6.8 12.0 6.4 7.0 13.4 4.7 17.9 12.9 10.0 7.9 7.6 3.4 8.7 20.0 5.1 9.8 ZNF165 "CT53, ZSCAN7" ENSG00000197279 "Zinc finger protein 165" P49910 6 28080975-28089563 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.9" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 113.2;Intestinal endocrine cells: 51.6;Syncytiotrophoblasts: 66.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 8.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 18.7;GAMG: 14.0" "Low region specificity" "Detected in all" HPA007247 Approved "Nuclear speckles,Microtubules" NA NA "Nuclear speckles, Microtubules" "HPA007247: AB_2797217" "unprognostic (1.85e-1)" "unprognostic (2.01e-3)" "unprognostic (1.12e-2)" "unprognostic (2.43e-3)" "unprognostic (1.45e-1)" "unprognostic (4.32e-3)" "unprognostic (3.42e-1)" "unprognostic (2.09e-1)" "unprognostic (1.93e-2)" "prognostic favorable (2.10e-4)" "unprognostic (1.18e-3)" "unprognostic (1.29e-2)" "prognostic favorable (1.19e-5)" "unprognostic (1.10e-1)" "unprognostic (2.40e-1)" "unprognostic (2.18e-1)" "prognostic favorable (9.82e-5)" 0.4 0.8 1.2 2.1 1.7 0.7 2.2 1.3 2.4 1.5 2.6 0.9 7.9 2.0 1.1 6.3 2.5 1.8 0.6 0.8 1.7 1.1 3.5 2.7 2.6 0.9 0.8 0.3 0.7 5.4 3.1 7.7 6.2 4.0 1.2 3.6 0.6 2.5 1.3 0.4 1.0 3.4 0.4 0.5 1.0 2.2 23.9 0.5 1.2 3.1 1.4 2.5 1.2 1.2 8.6 4.2 1.6 0.6 0.2 1.7 0.5 10.5 0.7 0.7 0.5 0.3 0.5 18.7 0.4 0.5 0.8 0.7 7.3 7.9 1.0 3.1 0.2 14.0 4.1 1.7 5.2 0.6 0.2 2.9 0.3 1.2 7.9 0.3 1.8 1.4 0.3 2.9 0.6 7.8 0.5 0.2 0.6 1.8 0.3 0.5 3.0 0.3 2.0 1.5 9.6 0.9 1.3 0.6 6.1 4.3 5.2 7.8 0.6 0.8 9.3 0.7 2.1 4.3 0.3 0.1 0.5 0.8 0.3 0.7 2.6 7.0 2.7 0.3 2.0 0.3 0.0 0.3 1.6 0.7 0.6 1.5 6.0 0.9 0.5 1.2 8.6 1.7 1.3 1.1 0.2 0.2 4.2 0.4 0.5 1.2 1.7 1.3 2.4 1.7 1.1 0.8 0.3 4.0 0.5 6.0 9.5 11.5 12.9 7.6 0.8 0.5 2.5 17.4 6.8 3.5 0.0 6.9 3.3 13.6 113.2 0.9 23.8 0.0 10.7 7.5 0.6 4.0 0.0 0.0 1.3 0.0 51.6 0.0 0.6 7.2 0.9 1.5 5.0 2.8 4.7 1.2 17.1 10.5 2.1 1.4 2.4 0.0 1.3 12.3 2.7 10.3 66.6 1.3 5.6 36.9 ZNF250 "MGC9718, ZFP647, ZNF647" ENSG00000196150 "Zinc finger protein 250" P15622 8 144876497-144902168 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020853 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA020853: AB_1859152" "unprognostic (1.16e-3)" "unprognostic (9.56e-2)" "unprognostic (2.63e-1)" "unprognostic (2.60e-3)" "unprognostic (1.03e-1)" "unprognostic (5.95e-3)" "unprognostic (3.73e-3)" "unprognostic (2.72e-2)" "unprognostic (6.27e-2)" "unprognostic (7.37e-2)" "unprognostic (4.94e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.43e-7)" "unprognostic (2.23e-1)" "unprognostic (6.79e-2)" "unprognostic (5.82e-2)" "prognostic favorable (8.26e-4)" 6.5 7.0 8.4 9.4 10.0 4.5 21.2 33.0 11.1 13.8 9.0 8.6 7.3 9.2 15.8 11.4 9.1 10.7 7.2 7.1 6.3 7.6 10.5 5.6 9.3 5.9 9.3 9.5 16.4 8.6 12.5 14.7 10.0 10.0 10.6 6.8 10.4 8.8 12.4 10.6 14.8 9.1 12.2 6.5 8.3 6.9 6.1 9.2 9.7 19.9 6.0 8.8 12.7 12.0 12.2 7.5 6.4 5.9 6.1 12.7 5.0 4.8 3.7 13.1 11.1 7.6 5.4 4.7 5.7 6.3 9.0 8.0 2.3 3.5 12.9 9.9 6.6 3.6 6.3 6.5 6.8 6.5 3.7 8.0 10.5 13.4 3.6 3.7 2.0 3.9 4.0 9.2 7.0 8.3 8.6 4.9 8.0 8.5 10.9 8.2 8.9 12.5 4.8 3.7 5.8 10.9 15.2 6.0 5.6 9.2 3.9 13.0 10.3 11.1 4.1 5.0 5.5 5.9 5.7 5.0 10.0 8.9 8.0 5.1 5.7 4.4 7.6 4.9 7.0 4.2 4.6 5.9 6.4 12.7 3.3 9.8 12.2 9.4 7.3 7.5 11.0 11.1 9.2 3.3 6.1 4.2 3.2 12.4 5.0 8.4 10.0 33.0 11.1 6.3 7.6 9.3 9.5 10.0 9.2 11.9 4.0 0.9 2.7 4.8 7.4 3.6 2.5 5.3 2.3 5.2 0.0 1.9 3.3 6.6 5.1 5.0 2.0 0.0 1.6 1.2 5.6 1.6 2.3 2.4 1.5 7.9 4.1 4.9 2.8 2.4 3.7 4.1 5.0 1.8 1.6 3.6 2.8 0.0 4.9 1.9 9.8 12.9 4.1 6.3 4.3 4.8 1.6 5.3 3.4 2.0 ZNF286B "ZNF286C, ZNF286L, ZNF590" ENSG00000249459 "Zinc finger protein 286B" P0CG31 17 18658429-18682262 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 5.8;Cholangiocytes: 5.1" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA068125 Uncertain Approved "Nuclear speckles,Cytosol" No No "Nuclear speckles" Cytosol "HPA068125: AB_2685960" "unprognostic (3.15e-1)" "unprognostic (1.23e-1)" "unprognostic (3.81e-1)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.78e-2)" "unprognostic (1.47e-3)" "unprognostic (3.20e-1)" "unprognostic (5.52e-3)" "unprognostic (1.97e-1)" "unprognostic (1.05e-4)" "unprognostic (1.50e-1)" "unprognostic (9.20e-4)" "unprognostic (1.16e-1)" "unprognostic (3.82e-1)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" 0.7 0.9 1.4 1.2 1.4 0.8 1.5 6.5 2.8 2.0 1.2 0.3 3.4 1.8 2.3 1.9 1.1 0.8 1.5 1.8 1.6 0.2 0.7 1.2 1.4 5.4 0.6 1.3 1.4 1.0 1.4 1.4 0.8 1.4 2.9 1.4 0.9 1.9 1.5 1.3 1.2 1.1 1.0 1.6 1.4 1.7 3.0 0.9 1.1 1.7 3.2 4.2 1.0 3.0 2.6 5.1 5.1 2.0 3.3 4.0 2.7 0.8 1.3 1.1 6.1 0.3 4.2 1.6 2.2 1.2 3.4 5.5 2.0 2.7 1.8 5.8 2.7 2.0 1.0 2.5 0.0 2.4 3.6 2.0 5.9 2.9 2.5 3.0 5.0 1.8 0.4 2.8 1.1 6.3 1.9 2.1 1.8 0.8 3.0 7.7 0.1 1.0 0.9 2.9 9.1 4.1 1.3 2.3 11.0 3.7 1.2 2.9 1.6 6.1 4.4 4.2 2.0 2.5 0.2 1.6 1.3 3.7 1.1 0.8 0.5 3.4 0.9 3.0 2.1 3.2 3.8 0.7 3.0 3.9 4.2 0.9 3.2 1.7 0.9 3.5 1.0 3.0 0.0 0.5 0.6 5.8 1.6 1.2 5.1 0.0 0.0 1.8 2.0 0.9 0.0 1.2 0.6 2.5 0.0 0.0 1.1 1.4 3.6 0.6 1.1 0.4 0.4 0.0 0.0 4.3 1.2 0.2 2.0 0.5 1.7 0.0 0.8 0.5 1.3 0.8 1.4 0.6 0.5 0.0 1.0 1.9 2.5 4.0 0.6 0.8 0.6 0.4 ZNF304 ENSG00000131845 "Zinc finger protein 304" Q9HCX3 19 57351307-57359898 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ito cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050531 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA050531: AB_2681160" "unprognostic (4.44e-1)" "unprognostic (1.73e-3)" "unprognostic (5.63e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (9.72e-2)" "unprognostic (2.86e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.95e-4)" "unprognostic (1.54e-1)" "unprognostic (1.28e-3)" "unprognostic (5.97e-2)" "prognostic favorable (1.52e-7)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (4.31e-1)" "unprognostic (9.00e-3)" 8.5 11.3 8.5 7.8 13.5 6.0 10.8 20.1 12.0 7.7 8.5 7.7 7.2 4.2 9.3 12.6 8.8 8.9 7.1 10.6 7.1 7.0 7.6 5.6 8.7 11.8 8.8 11.0 11.7 5.2 16.4 9.6 9.0 8.6 9.7 5.2 7.4 8.1 10.9 8.5 9.9 7.1 8.8 6.7 11.0 6.8 6.9 8.6 11.1 11.7 9.9 11.4 9.2 6.1 5.5 3.9 5.7 5.6 5.9 6.1 3.8 5.6 2.8 6.9 8.7 5.7 5.4 4.3 5.6 8.7 6.5 14.8 0.0 2.6 4.6 3.6 6.5 3.4 2.0 3.9 7.5 9.6 1.5 18.4 7.4 7.3 3.9 4.1 4.0 4.6 6.6 10.0 6.2 8.8 6.9 4.1 10.5 2.2 0.0 6.8 1.5 8.5 2.3 4.6 0.0 8.9 5.5 11.1 5.9 4.6 12.1 5.5 5.9 5.9 4.6 4.0 6.5 5.6 5.9 4.6 9.3 5.5 2.8 6.0 7.5 6.4 6.9 5.7 0.1 4.7 5.7 2.8 2.3 3.3 2.3 6.1 5.5 5.6 4.6 3.9 4.6 4.7 4.8 0.2 5.9 5.6 2.1 4.4 3.8 8.5 13.5 20.1 12.0 7.1 7.0 8.8 11.0 8.6 8.6 0.0 0.3 2.0 0.6 5.7 6.0 4.0 7.6 6.7 5.7 0.0 0.0 1.5 1.7 1.4 0.3 3.7 0.4 0.0 0.9 0.7 1.3 1.4 0.0 2.1 1.3 3.2 0.0 9.2 1.9 0.6 1.7 1.4 3.3 0.0 1.5 1.0 0.8 0.0 2.1 1.3 2.3 0.0 2.0 1.6 4.2 4.8 0.9 2.5 0.9 1.0 ZNF337 dJ694B14.1 ENSG00000130684 "Zinc finger protein 337" Q9Y3M9 20 25674215-25696841 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044303, HPA064219" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA044303: AB_2678890, HPA064219: AB_2685215" "unprognostic (2.14e-1)" "unprognostic (2.19e-2)" "unprognostic (1.65e-2)" "unprognostic (1.80e-1)" "unprognostic (1.30e-1)" "unprognostic (5.81e-3)" "unprognostic (4.54e-3)" "unprognostic (6.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.34e-2)" "unprognostic (3.15e-2)" "unprognostic (9.36e-4)" "prognostic unfavorable (2.87e-6)" "unprognostic (1.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.93e-2)" "unprognostic (8.82e-3)" 10.4 9.8 11.7 9.0 14.3 10.8 13.6 49.5 14.8 17.9 14.6 16.1 13.3 7.0 19.8 19.4 9.6 18.0 9.0 8.4 10.9 9.8 9.4 6.9 13.5 12.3 15.1 14.2 23.1 8.4 20.3 19.0 9.3 11.2 16.6 10.9 11.0 8.6 17.2 11.9 12.9 11.1 15.4 9.4 13.4 8.7 7.0 14.9 19.0 12.2 6.0 11.0 14.3 26.1 3.8 3.9 4.8 3.9 5.3 9.6 3.8 7.8 14.4 11.5 8.0 9.4 11.9 9.7 6.8 6.1 5.4 6.7 2.9 7.4 10.0 6.5 6.2 11.1 12.9 7.7 22.2 7.3 3.6 6.1 6.2 9.3 12.5 8.3 5.5 6.7 11.1 19.9 6.2 18.4 13.8 8.3 13.2 5.4 8.9 10.3 8.8 15.0 10.1 3.1 4.4 10.2 9.4 10.8 4.9 5.5 8.7 9.4 10.0 7.0 11.0 9.2 14.8 6.4 7.7 11.0 11.5 6.1 7.6 8.9 12.5 6.7 3.6 5.5 4.7 9.2 0.0 2.4 4.8 7.2 3.9 7.9 3.8 6.0 6.8 3.9 3.2 8.4 9.6 0.1 5.3 2.2 3.9 3.9 3.8 11.7 14.3 49.5 14.8 10.9 9.8 15.1 14.2 11.2 14.9 6.0 12.5 1.5 4.6 1.8 8.8 0.8 5.1 22.7 17.0 3.5 2.0 2.8 3.3 3.3 0.8 4.6 1.1 0.0 2.7 1.9 3.1 3.9 4.7 2.9 2.7 6.4 5.2 3.1 4.8 0.0 6.6 1.6 1.7 2.8 4.3 9.2 2.6 0.0 5.3 1.7 13.0 0.0 3.1 5.6 9.6 2.0 1.9 4.8 2.4 1.5 ZNF527 KIAA1829 ENSG00000189164 "Zinc finger protein 527" Q8NB42 19 37371061-37393066 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 11.8;Rod photoreceptor cells: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037740, HPA037741" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA037740: AB_10672284, HPA037741: AB_2675642" "unprognostic (4.36e-2)" "unprognostic (5.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-2)" "unprognostic (1.30e-2)" "unprognostic (9.26e-2)" "unprognostic (8.70e-3)" "unprognostic (6.47e-3)" "unprognostic (1.91e-1)" "unprognostic (6.05e-4)" "unprognostic (8.34e-3)" "unprognostic (8.92e-2)" "unprognostic (6.83e-2)" "unprognostic (1.44e-2)" "unprognostic (1.52e-3)" "unprognostic (3.17e-4)" 6.0 6.3 6.7 4.7 10.2 6.6 8.5 10.2 13.0 7.8 6.8 9.3 2.7 3.4 9.6 6.0 5.5 6.1 4.3 7.1 8.0 5.7 7.3 5.9 5.2 7.2 6.8 9.1 10.8 6.4 10.2 13.5 5.4 9.8 6.9 7.4 8.2 5.8 7.6 10.1 5.0 5.0 9.5 5.8 6.7 5.1 7.2 7.5 6.7 7.6 4.8 7.3 6.9 7.2 6.3 2.6 6.8 2.5 4.7 6.8 3.9 3.9 4.4 4.0 4.8 4.1 6.9 2.4 4.0 3.6 4.1 5.2 3.6 1.0 3.6 5.0 3.8 3.4 1.1 6.9 3.6 5.0 6.8 2.7 4.4 4.7 0.9 4.8 7.2 4.8 4.9 4.0 4.7 8.2 4.3 3.6 6.1 1.8 2.5 4.4 1.4 5.6 1.6 2.3 4.8 1.5 4.6 6.1 4.9 2.6 3.8 5.1 2.7 6.4 2.0 2.0 4.0 4.7 4.9 5.1 5.1 4.4 3.8 4.6 7.3 9.3 10.5 0.0 5.0 3.3 2.7 1.6 6.8 6.5 2.5 5.5 6.3 4.0 5.9 2.6 5.4 6.4 6.8 0.8 4.7 1.4 2.4 4.2 3.9 6.7 10.2 10.2 13.0 8.0 5.7 6.8 9.1 9.8 7.5 8.9 7.4 0.5 1.7 2.4 6.4 7.2 2.5 4.0 3.4 0.0 11.8 1.9 3.3 1.4 1.0 2.5 1.1 0.0 1.4 1.1 2.2 1.6 1.1 1.8 1.4 6.4 1.2 3.1 0.6 0.8 2.3 1.6 0.0 1.0 2.0 3.6 0.4 0.0 1.4 2.1 10.6 0.0 2.5 5.0 3.4 1.4 1.7 1.8 1.7 1.1 ZNF528 KIAA1827 ENSG00000167555 "Zinc finger protein 528" Q3MIS6 19 52397849-52418412 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 24.5;U-266/84: 30.9" HPA065435 Approved "Nuclear speckles,Cytosol" No No "Nuclear speckles" Cytosol "HPA065435: " "unprognostic (1.90e-2)" "unprognostic (1.69e-1)" "unprognostic (1.59e-1)" "unprognostic (3.73e-1)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "unprognostic (9.60e-2)" "unprognostic (4.81e-3)" "unprognostic (1.26e-2)" "unprognostic (2.45e-1)" "unprognostic (1.42e-2)" "unprognostic (2.98e-3)" "unprognostic (3.26e-3)" "unprognostic (2.78e-2)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" 9.8 11.7 16.6 8.9 20.2 5.8 12.2 21.1 21.4 12.4 9.1 15.7 7.9 5.5 15.3 21.7 10.0 15.6 11.4 11.4 15.3 11.2 11.1 5.2 9.3 9.3 17.5 11.4 21.3 6.4 12.7 21.0 10.9 15.3 13.4 10.0 13.3 12.8 12.1 7.6 12.6 7.5 9.8 15.6 11.8 10.0 13.8 22.0 8.2 19.9 5.1 11.5 12.6 10.8 10.5 8.4 10.6 5.0 16.5 12.7 3.4 0.1 0.0 2.9 17.7 6.9 8.5 7.5 6.6 10.9 4.0 9.0 0.2 3.3 0.1 1.6 8.1 10.3 2.0 0.0 4.3 5.2 0.0 4.9 2.7 1.0 1.6 10.1 0.1 7.4 8.6 7.6 4.4 0.0 1.2 9.6 0.1 1.7 0.3 5.8 0.1 9.9 1.4 7.7 0.1 4.7 0.1 12.0 3.1 5.0 24.5 12.3 10.2 0.0 0.5 4.1 11.1 11.8 1.5 11.0 7.0 8.1 2.7 8.9 0.3 30.9 6.0 3.5 0.1 10.9 7.1 5.0 10.6 6.7 4.7 12.7 7.3 8.1 10.0 5.0 10.5 8.0 7.1 1.4 16.5 5.0 8.4 8.9 3.4 16.6 20.2 21.1 21.4 15.3 11.2 17.5 11.4 15.3 22.0 6.0 2.7 2.7 3.5 3.3 18.7 10.9 5.1 10.7 6.8 1.8 13.7 3.5 3.3 4.1 1.1 7.5 2.6 0.0 1.7 4.0 3.0 6.9 8.1 1.0 3.1 20.6 1.2 4.9 3.2 2.9 4.6 4.7 1.7 0.0 4.9 14.1 5.0 7.0 3.9 3.1 21.5 0.0 3.9 13.0 10.4 2.8 2.6 9.6 3.4 3.8 ZNF551 DKFZp686H1038 ENSG00000204519 "Zinc finger protein 551" Q7Z340 19 57681969-57717301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 21.4" "Low region specificity" "Detected in all" HPA038187 Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA038187: AB_2675884" "unprognostic (1.96e-1)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (6.24e-3)" "unprognostic (1.30e-1)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.68e-5)" "unprognostic (2.92e-1)" "unprognostic (5.89e-2)" "unprognostic (4.83e-3)" "prognostic favorable (1.32e-4)" "unprognostic (4.70e-2)" "unprognostic (2.73e-1)" "unprognostic (1.26e-2)" "unprognostic (1.54e-1)" 6.6 5.6 4.4 8.3 6.9 12.8 7.9 17.3 5.2 5.2 5.1 6.8 8.6 4.2 6.3 5.9 5.3 5.9 6.1 4.9 4.9 4.6 5.1 3.2 3.8 10.8 3.8 3.3 6.8 10.7 6.1 11.3 5.3 4.9 6.0 5.1 6.4 6.0 5.8 8.8 7.3 5.6 6.8 4.0 8.2 5.1 18.1 5.7 13.0 11.1 5.2 10.3 6.4 6.0 6.6 4.7 2.1 3.1 4.7 8.1 3.8 2.6 5.9 7.3 5.3 1.4 1.7 7.8 3.2 2.3 4.5 2.1 5.0 2.6 4.8 2.1 2.4 3.3 3.0 4.9 7.3 7.1 0.0 21.4 8.5 0.2 2.2 1.3 6.0 7.8 3.0 2.8 4.6 4.2 2.6 1.8 5.1 5.8 0.0 4.0 2.5 12.3 2.4 15.4 5.1 9.6 7.8 12.7 6.4 1.8 15.4 7.1 5.9 4.8 3.1 2.5 7.3 3.9 7.9 2.2 5.2 5.4 1.7 6.0 5.3 11.3 11.0 1.0 3.0 4.9 1.9 2.1 2.1 3.3 3.1 6.2 6.6 4.9 5.2 4.7 5.5 8.1 7.3 1.1 4.7 1.6 3.8 3.9 3.8 4.4 6.9 17.3 5.2 4.9 4.6 3.8 3.3 4.9 5.7 6.0 3.8 2.2 5.2 4.6 7.5 1.2 2.5 6.7 9.1 1.8 7.9 3.4 1.7 2.7 9.6 2.0 1.6 0.0 0.9 2.4 1.9 2.9 1.1 1.7 2.3 3.2 2.4 2.5 2.4 2.7 3.1 2.1 1.7 0.0 3.3 4.0 1.4 0.0 4.6 0.6 14.6 0.0 1.3 7.0 14.0 6.1 2.4 3.3 4.1 7.9 ZNF560 FLJ31986 ENSG00000198028 "Zinc finger protein 560" Q96MR9 19 9466507-9498607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 21.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 48.7" "Cancer enriched" "Detected in some" 7 "testis cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.8;SuSa: 8.8" "HPA045439, HPA074438" Enhanced "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA045439: AB_2732520, HPA074438: " "unprognostic (4.43e-3)" "unprognostic (8.91e-2)" "unprognostic (9.85e-3)" "unprognostic (2.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.29e-1)" "unprognostic (1.04e-1)" "unprognostic (1.39e-1)" "unprognostic (6.57e-3)" "unprognostic (6.33e-5)" "unprognostic (5.60e-2)" "unprognostic (2.32e-1)" "unprognostic (9.15e-3)" "unprognostic (1.65e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 21.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.8 2.4 0.0 1.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 1.0 17.9 0.0 0.0 1.3 0.0 4.4 2.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 11.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.0 8.3 0.0 0.0 0.0 0.0 0.0 ZNF821 ENSG00000102984 "Zinc finger protein 821" O75541 16 71859680-71895336 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;testis: 23.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 108.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.3;naive B-cell: 11.5" "Group enriched" "Detected in many" 8 "B-cells: 11.5;T-cells: 5.1" "Cell line enhanced" "Detected in many" "AF22: 14.0;SCLC-21H: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036372, HPA042742" Enhanced Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA036372: AB_10669790, HPA042742: AB_2678140" "unprognostic (3.16e-1)" "unprognostic (1.77e-1)" "unprognostic (6.50e-2)" "unprognostic (1.12e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.69e-2)" "unprognostic (2.28e-2)" "unprognostic (7.72e-2)" "unprognostic (5.25e-2)" "unprognostic (3.04e-2)" "prognostic favorable (4.27e-5)" "unprognostic (2.83e-2)" "prognostic favorable (6.32e-10)" "unprognostic (1.82e-2)" "unprognostic (1.79e-1)" "unprognostic (7.97e-2)" "unprognostic (1.02e-1)" 2.0 4.2 6.3 3.7 7.5 3.1 4.8 26.9 13.4 4.3 3.8 5.1 2.3 2.1 5.8 11.1 2.5 3.5 3.9 2.9 5.7 7.6 5.9 2.6 3.4 6.0 5.2 6.0 7.3 2.4 5.6 9.2 2.5 7.1 4.4 5.0 5.2 5.2 5.1 4.0 6.0 4.3 3.0 4.8 3.7 3.3 23.7 3.4 2.2 6.1 0.7 7.3 2.4 4.0 11.5 0.9 0.4 0.5 1.0 5.1 0.7 1.1 0.9 14.0 6.7 2.8 3.6 2.4 1.4 3.1 3.1 4.9 1.9 0.9 2.6 2.4 2.7 3.4 2.0 4.6 2.1 3.8 3.9 5.2 0.5 1.0 0.8 1.7 0.9 3.0 3.1 3.5 2.1 1.3 5.3 2.4 0.6 1.6 2.0 3.4 3.3 1.5 0.9 5.5 4.0 0.6 6.1 3.0 4.5 3.5 0.4 14.1 6.7 1.8 1.2 1.5 6.3 4.7 3.0 4.6 3.3 3.5 1.2 0.9 4.7 2.4 10.6 1.1 2.6 3.2 0.0 0.5 0.4 2.2 0.0 1.9 9.3 2.3 1.6 0.9 11.5 1.4 0.5 0.4 1.0 0.5 0.0 5.1 0.7 6.3 7.5 26.9 13.4 5.7 7.6 5.2 6.0 7.1 3.4 0.0 3.4 20.5 6.0 7.1 41.7 1.1 12.7 2.7 1.2 15.7 43.2 5.2 18.3 8.1 108.2 5.8 26.4 0.0 4.1 4.3 8.5 6.0 9.2 1.7 6.8 30.2 22.5 12.9 4.0 40.3 11.5 9.3 3.3 2.8 9.2 20.9 5.9 14.4 11.7 8.6 47.4 12.9 4.7 50.4 18.3 6.6 5.1 17.5 6.4 3.4 ZNF843 MGC46336 ENSG00000176723 "Zinc finger protein 843" Q8N446 16 31432593-31443160 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 4.3;Cardiomyocytes: 4.8;Glandular cells: 3.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 5.9;EFO-21: 4.7;HMC-1: 4.3" "HPA030911, HPA030912, HPA077945" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA030911: AB_2673656, HPA030912: AB_10670434, HPA077945: " "unprognostic (9.27e-2)" "unprognostic (1.32e-1)" "unprognostic (3.43e-3)" "unprognostic (9.24e-2)" "unprognostic (1.33e-1)" "unprognostic (6.25e-3)" "unprognostic (2.86e-1)" "unprognostic (8.30e-3)" "unprognostic (3.55e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-3)" "unprognostic (2.93e-3)" "unprognostic (5.96e-3)" "unprognostic (1.23e-2)" "unprognostic (7.66e-2)" "unprognostic (1.28e-5)" "unprognostic (1.17e-1)" 1.2 1.4 3.5 2.5 3.4 0.8 1.7 3.9 5.4 3.5 1.2 2.3 1.9 0.6 2.8 5.6 1.2 3.3 2.0 7.4 3.0 3.2 1.8 0.9 2.4 0.8 2.5 2.3 10.6 5.0 3.1 5.7 2.2 1.9 3.2 0.4 3.9 7.5 3.2 5.1 2.5 1.3 1.9 1.9 1.1 0.9 1.2 1.7 0.1 2.6 2.8 0.6 1.0 1.3 1.0 0.9 2.5 0.6 4.8 2.3 2.2 0.3 0.7 0.7 3.2 5.9 1.7 0.2 0.6 0.5 0.0 0.3 0.4 0.9 0.1 4.7 0.8 0.2 0.3 0.3 0.3 0.3 0.5 0.0 0.2 0.6 0.2 1.7 0.5 4.3 3.1 0.8 0.0 0.3 2.0 0.0 0.5 0.5 0.7 1.6 2.1 0.2 1.0 1.7 0.2 0.2 0.4 0.0 0.1 0.4 0.2 0.1 1.8 1.9 0.3 0.8 0.6 0.4 0.6 0.1 0.7 0.5 2.0 0.1 0.7 0.4 0.3 0.2 0.3 1.0 2.3 0.6 0.6 2.2 0.4 1.3 0.6 0.8 2.3 0.3 1.0 0.6 1.6 2.5 4.8 0.4 0.9 0.4 2.2 3.5 3.4 3.9 3.5 3.0 3.2 2.5 2.3 1.9 1.7 0.0 0.3 0.0 4.3 0.7 2.4 4.8 0.0 0.0 1.2 0.0 2.0 0.2 0.0 0.2 0.1 0.9 0.0 0.0 0.2 0.1 0.9 3.2 1.1 0.0 0.5 0.0 1.2 1.3 0.8 0.0 1.4 0.2 0.0 0.0 0.0 1.1 0.1 0.0 1.4 0.4 1.9 0.0 1.4 0.5 0.9 1.3 0.2 0.0 0.0 2.0 ZNHIT6 "BCD1, C1orf181, FLJ20729, NY-BR-75" ENSG00000117174 "Zinc finger HIT-type containing 6" Q9NWK9 1 85649423-85708433 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018132 Uncertain Approved "Nuclear speckles,Vesicles" No No "Nuclear speckles, Vesicles" "HPA018132: AB_1848789" "unprognostic (1.37e-1)" "unprognostic (4.01e-1)" "unprognostic (1.24e-1)" "unprognostic (2.27e-3)" "unprognostic (1.61e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (6.08e-6)" "unprognostic (1.11e-1)" "unprognostic (3.89e-2)" "unprognostic (8.48e-2)" "unprognostic (9.91e-3)" "unprognostic (2.92e-2)" "unprognostic (1.27e-3)" "unprognostic (5.91e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (7.37e-2)" 18.5 12.6 20.7 15.9 28.0 15.5 21.5 19.2 25.6 23.5 13.8 21.4 14.2 9.0 20.4 14.9 19.9 14.6 12.0 12.4 22.5 18.8 12.9 10.3 12.9 19.4 21.5 20.5 21.9 11.5 17.4 20.3 15.1 19.5 17.4 14.0 8.1 15.3 15.1 15.7 17.1 12.0 19.8 26.1 14.5 11.0 11.0 26.6 14.8 17.4 13.8 18.9 19.5 25.7 7.6 6.0 1.3 2.3 5.7 6.4 2.5 13.0 9.5 9.0 8.2 19.6 18.4 11.5 17.4 16.9 11.9 11.7 9.4 6.9 10.2 20.9 10.6 26.4 11.1 15.4 10.8 19.4 14.5 13.4 21.0 10.7 10.7 17.2 33.9 8.4 17.7 9.9 16.1 14.0 11.8 13.9 16.5 19.8 13.9 17.9 5.3 19.6 8.3 13.0 10.3 16.8 16.2 19.7 11.6 18.0 25.9 8.7 5.6 13.7 18.8 18.5 9.9 9.0 8.7 15.9 15.2 10.3 12.9 24.6 8.9 9.2 29.4 3.3 21.0 13.5 1.3 2.1 0.2 5.7 2.3 6.4 5.6 5.1 6.4 3.6 7.6 6.4 6.3 0.3 5.7 1.9 6.0 5.4 2.5 20.7 28.0 19.2 25.6 22.5 18.8 21.5 20.5 19.5 26.6 14.9 22.7 11.5 9.5 14.3 29.6 17.3 10.2 21.4 36.4 29.6 31.4 7.6 3.3 10.5 3.2 13.2 7.8 0.0 7.7 11.9 14.3 7.1 26.6 8.7 6.8 14.3 9.1 15.4 12.6 2.2 12.4 10.5 6.8 9.0 11.8 23.0 9.0 7.0 12.0 3.9 39.4 19.4 9.5 24.2 14.9 14.3 2.3 14.6 14.0 10.1